Cancer Type,Pathway,F-statistic,p-value,Higher in
Diffuse Glioma,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,11.812364667596567,0.0013386918708066418,Diffuse Glioma
Diffuse Glioma,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",10.908997037019219,0.001961284092138132,Diffuse Glioma
Diffuse Glioma,Respiratory Electron Transport R-HSA-611105,9.611586528278886,0.0034465661631155504,Diffuse Glioma
Diffuse Glioma,Mitochondrial Biogenesis R-HSA-1592230,7.662097192992248,0.008354195385787562,Diffuse Glioma
Diffuse Glioma,Translation R-HSA-72766,4.145696350541562,0.048079152200292435,Diffuse Glioma
Diffuse Glioma,tRNA Aminoacylation R-HSA-379724,8.697642829964668,0.005187895230388384,Diffuse Glioma
Diffuse Glioma,Mitochondrial tRNA Aminoacylation R-HSA-379726,8.424111476777302,0.0058753693167365745,Diffuse Glioma
Diffuse Glioma,Leishmania Infection R-HSA-9658195,9.206953720173804,0.004125419754902398,Other Types
Diffuse Glioma,Cristae Formation R-HSA-8949613,16.28936697577126,0.0002253336693238567,Diffuse Glioma
Diffuse Glioma,Golgi-to-ER Retrograde Transport R-HSA-8856688,15.955173475151557,0.0002559142831974698,Other Types
Diffuse Glioma,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,14.559067833013323,0.0004396556919910292,Other Types
Diffuse Glioma,VEGFA-VEGFR2 Pathway R-HSA-4420097,10.967679246181783,0.0019127365014318983,Other Types
Diffuse Glioma,Asparagine N-linked Glycosylation R-HSA-446203,8.079183448322645,0.0068833664063655845,Other Types
Diffuse Glioma,Cytoprotection By HMOX1 R-HSA-9707564,12.967757208484526,0.0008310708415153062,Diffuse Glioma
Diffuse Glioma,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,7.14392436522422,0.010663981179225533,Diffuse Glioma
Diffuse Glioma,TP53 Regulates Metabolic Genes R-HSA-5628897,19.081138673944167,8.034732879078375e-05,Diffuse Glioma
Diffuse Glioma,Signaling By MET R-HSA-6806834,7.853259852295592,0.0076423198789393855,Other Types
Diffuse Glioma,Signaling By VEGF R-HSA-194138,11.12855575191202,0.0017860502426379878,Other Types
Diffuse Glioma,Mitotic G2-G2/M Phases R-HSA-453274,4.523922290571667,0.0393412676108939,Other Types
Diffuse Glioma,FCGR3A-mediated Phagocytosis R-HSA-9664422,14.946789760674482,0.00037771073833392965,Other Types
Diffuse Glioma,Mitochondrial Protein Import R-HSA-1268020,5.199473859949898,0.027734214825069346,Diffuse Glioma
Diffuse Glioma,Metabolism Of Nucleotides R-HSA-15869,22.141909338416657,2.753248710027662e-05,Diffuse Glioma
Diffuse Glioma,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,10.590287509440744,0.0022487355308045166,Other Types
Diffuse Glioma,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,11.40832416592712,0.0015864101524795053,Other Types
Diffuse Glioma,RAC1 GTPase Cycle R-HSA-9013149,5.131893595312508,0.028708097510577776,Other Types
Diffuse Glioma,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,12.370002202760773,0.001061853055107062,Other Types
Diffuse Glioma,"Platelet Activation, Signaling And Aggregation R-HSA-76002",13.313974188868064,0.0007221883132500997,Other Types
Diffuse Glioma,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,13.708450394152633,0.000616212301608539,Other Types
Diffuse Glioma,Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,5.700892699277172,0.02153215892937927,Diffuse Glioma
Diffuse Glioma,RAC3 GTPase Cycle R-HSA-9013423,10.57691770452731,0.0022617285996212543,Other Types
Diffuse Glioma,EPH-Ephrin Signaling R-HSA-2682334,8.18840469174556,0.0065456178058604765,Other Types
Diffuse Glioma,Mitochondrial Translation R-HSA-5368287,16.079434562523197,0.00024406244673219916,Diffuse Glioma
Diffuse Glioma,Muscle Contraction R-HSA-397014,7.487060323198823,0.009068221629624984,Other Types
Diffuse Glioma,Transport To Golgi And Subsequent Modification R-HSA-948021,4.099145820608865,0.0492937666089919,Other Types
Diffuse Glioma,COPI-mediated Anterograde Transport R-HSA-6807878,8.28107419285905,0.00627287887456751,Other Types
Diffuse Glioma,Death Receptor Signaling R-HSA-73887,11.076447447517987,0.0018260834071589334,Other Types
Diffuse Glioma,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,15.577691267633197,0.0002957830563779119,Other Types
Diffuse Glioma,MET Promotes Cell Motility R-HSA-8875878,8.639112565547839,0.005327456975274285,Other Types
Diffuse Glioma,Transport Of Small Molecules R-HSA-382551,7.6275288542062,0.008490307689156868,Diffuse Glioma
Diffuse Glioma,Platelet Aggregation (Plug Formation) R-HSA-76009,14.431205198132334,0.0004623613076305454,Other Types
Diffuse Glioma,Integrin Signaling R-HSA-354192,14.431205198132334,0.0004623613076305454,Other Types
Diffuse Glioma,EPHB-mediated Forward Signaling R-HSA-3928662,30.828428131104005,1.7447968981742844e-06,Other Types
Diffuse Glioma,Protein Localization R-HSA-9609507,6.652300525774801,0.013494753828403577,Diffuse Glioma
Diffuse Glioma,Downstream Signal Transduction R-HSA-186763,11.520522984449249,0.0015131024058758593,Other Types
Diffuse Glioma,Mitochondrial Translation Termination R-HSA-5419276,32.58861961115967,1.0416183306875145e-06,Diffuse Glioma
Diffuse Glioma,GPCR Downstream Signaling R-HSA-388396,5.02743228832137,0.030287063029561287,Other Types
Diffuse Glioma,Signaling By GPCR R-HSA-372790,5.02743228832137,0.030287063029561287,Other Types
Diffuse Glioma,Hemostasis R-HSA-109582,4.643979889299261,0.036942614518169894,Other Types
Diffuse Glioma,Costimulation By CD28 Family R-HSA-388841,4.722310785070617,0.035463689181690634,Other Types
Diffuse Glioma,Signaling By PDGF R-HSA-186797,7.645945178241779,0.008417501834520683,Other Types
Diffuse Glioma,RHO GTPase Effectors R-HSA-195258,13.397680339615786,0.0006981933963250415,Other Types
Diffuse Glioma,Nucleotide Biosynthesis R-HSA-8956320,19.35152033119428,7.291922523499945e-05,Diffuse Glioma
Diffuse Glioma,P75 NTR Receptor-Mediated Signaling R-HSA-193704,5.210775502609107,0.027574867406050436,Other Types
Diffuse Glioma,Mitochondrial Translation Initiation R-HSA-5368286,21.464107393701997,3.472819965985789e-05,Diffuse Glioma
Diffuse Glioma,Metabolism Of Vitamins And Cofactors R-HSA-196854,31.72559152983266,1.339197946248466e-06,Diffuse Glioma
Diffuse Glioma,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,16.45381726343835,0.0002117216388333347,Diffuse Glioma
Diffuse Glioma,Mitochondrial Translation Elongation R-HSA-5389840,16.38140343679579,0.00021760568269679894,Diffuse Glioma
Diffuse Glioma,Cell-Cell Communication R-HSA-1500931,11.536513434608791,0.0015029497977603317,Other Types
Diffuse Glioma,RAC2 GTPase Cycle R-HSA-9013404,4.606170026148491,0.03768038241382363,Other Types
Diffuse Glioma,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,18.31355365071738,0.00010610442016633334,Other Types
Diffuse Glioma,CD28 Co-Stimulation R-HSA-389356,5.646000460583809,0.022131734316889386,Other Types
Diffuse Glioma,Signaling To ERKs R-HSA-187687,10.220604947047073,0.0026389834908187564,Other Types
Diffuse Glioma,RHOJ GTPase Cycle R-HSA-9013409,9.125201624412755,0.0042790601313121785,Other Types
Diffuse Glioma,"PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",6.636261097773769,0.013599700284232491,Other Types
Diffuse Glioma,Cell Junction Organization R-HSA-446728,21.90073016799391,2.989440942007709e-05,Other Types
Diffuse Glioma,XBP1(S) Activates Chaperone Genes R-HSA-381038,10.298861432456832,0.0025507633816611707,Other Types
Diffuse Glioma,IRE1alpha Activates Chaperones R-HSA-381070,10.298861432456832,0.0025507633816611707,Other Types
Diffuse Glioma,Smooth Muscle Contraction R-HSA-445355,12.955964954632126,0.0008350714665553795,Other Types
Diffuse Glioma,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,20.258724224645913,5.284449917483333e-05,Diffuse Glioma
Diffuse Glioma,Metabolism R-HSA-1430728,37.52179744836624,2.6206491315927003e-07,Diffuse Glioma
Diffuse Glioma,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,7.190403008708109,0.010431300845236188,Other Types
Diffuse Glioma,Heme Biosynthesis R-HSA-189451,12.336658007053794,0.0010765746493003022,Diffuse Glioma
Diffuse Glioma,Metabolism Of Porphyrins R-HSA-189445,12.336657164645104,0.0010765750239378187,Diffuse Glioma
Diffuse Glioma,rRNA Modification In Mitochondrion R-HSA-6793080,5.74380815369674,0.021075593864776834,Diffuse Glioma
Diffuse Glioma,FCERI Mediated MAPK Activation R-HSA-2871796,6.59595286925067,0.013867316273039443,Other Types
Diffuse Glioma,MET Activates RAP1 And RAC1 R-HSA-8875555,4.185301826090374,0.047071546726855436,Other Types
Diffuse Glioma,Drug ADME R-HSA-9748784,13.13747497182549,0.0007756799448441702,Diffuse Glioma
Diffuse Glioma,Prolonged ERK Activation Events R-HSA-169893,15.72580892822579,0.00027941073878222025,Other Types
Diffuse Glioma,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,15.669433459605468,0.0002855268177449423,Other Types
Diffuse Glioma,Netrin-1 Signaling R-HSA-373752,6.9181242534549785,0.011876061004525275,Other Types
Diffuse Glioma,RHOV GTPase Cycle R-HSA-9013424,8.388289520484951,0.005972338791935956,Other Types
Diffuse Glioma,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,18.66929110633688,9.322890798556393e-05,Diffuse Glioma
Diffuse Glioma,Citric Acid Cycle (TCA Cycle) R-HSA-71403,22.566835703846994,2.3835700038900333e-05,Diffuse Glioma
Diffuse Glioma,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,13.993692786226912,0.000549875449084508,Diffuse Glioma
Diffuse Glioma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,18.72843921014563,9.125264139262917e-05,Other Types
Diffuse Glioma,Ubiquinol Biosynthesis R-HSA-2142789,5.161042899001579,0.028283569260278144,Diffuse Glioma
Diffuse Glioma,DCC Mediated Attractive Signaling R-HSA-418885,15.474933336212933,0.0003077330807536734,Other Types
Diffuse Glioma,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,4.073701126268928,0.04997186922689486,Other Types
Diffuse Glioma,mTORC1-mediated Signaling R-HSA-166208,6.081336062045558,0.01782788168348441,Other Types
Diffuse Glioma,Signaling By RAF1 Mutants R-HSA-9656223,7.257867135705714,0.01010316132944171,Other Types
Diffuse Glioma,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,7.257867135705714,0.01010316132944171,Other Types
Diffuse Glioma,Semaphorin Interactions R-HSA-373755,5.3032835254009,0.02630716506251111,Other Types
Diffuse Glioma,G Alpha (I) Signaling Events R-HSA-418594,4.217776436748423,0.04626260278859212,Other Types
Diffuse Glioma,G Alpha (12/13) Signaling Events R-HSA-416482,4.337490731578232,0.04340930574321712,Other Types
Diffuse Glioma,PRC2 Methylates Histones And DNA R-HSA-212300,4.395718423148423,0.04209149960511971,Diffuse Glioma
Diffuse Glioma,Metabolism Of Cofactors R-HSA-8978934,7.604418592856315,0.008582621573085095,Diffuse Glioma
Diffuse Glioma,Unfolded Protein Response (UPR) R-HSA-381119,8.137818466804408,0.006699800337552378,Other Types
Diffuse Glioma,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,6.593548118498045,0.013883459290447436,Other Types
Diffuse Glioma,Frs2-mediated Activation R-HSA-170968,16.82592205272932,0.0001840177796648287,Other Types
Diffuse Glioma,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,22.059288651119715,2.831872408034866e-05,Other Types
Diffuse Glioma,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,4.632028122649537,0.03717411046619326,Other Types
Diffuse Glioma,Regulation Of Signaling By CBL R-HSA-912631,6.617431761814804,0.01372401773673071,Other Types
Diffuse Glioma,MET Receptor Recycling R-HSA-8875656,7.493779784796771,0.009039641639920886,Other Types
Diffuse Glioma,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,5.8231990669941744,0.020258223164165465,Other Types
Diffuse Glioma,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,5.580751310787469,0.02286794017935309,Other Types
Diffuse Glioma,Interleukin-12 Signaling R-HSA-9020591,4.893568423083604,0.03244949842427183,Other Types
Diffuse Glioma,Kinesins R-HSA-983189,18.620281968885187,9.490050009935234e-05,Other Types
Diffuse Glioma,GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,5.88437820706193,0.019651640807992105,Other Types
Diffuse Glioma,MET Activates PTK2 Signaling R-HSA-8874081,12.661426980724663,0.0009418830222002826,Other Types
Diffuse Glioma,Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,10.092182949215484,0.002790831638093555,Other Types
Diffuse Glioma,Protein Ubiquitination R-HSA-8852135,4.689162713499655,0.03608152995463228,Other Types
Diffuse Glioma,ERBB2 Regulates Cell Motility R-HSA-6785631,9.371443760502054,0.0038337478009186255,Other Types
Diffuse Glioma,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",7.610841502279965,0.008556858363856484,Other Types
Diffuse Glioma,Negative Regulation Of MAPK Pathway R-HSA-5675221,4.217672691062596,0.046265162740841685,Other Types
Diffuse Glioma,Cilium Assembly R-HSA-5617833,25.86753420888752,8.048245163784842e-06,Other Types
Diffuse Glioma,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,8.251243195857674,0.006359331353801586,Other Types
Diffuse Glioma,Platelet Degranulation R-HSA-114608,10.56439172280445,0.002273973736095539,Other Types
Diffuse Glioma,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,12.386057728250288,0.0010548404390270363,Other Types
Diffuse Glioma,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,7.4841845134412175,0.009080482799358925,Other Types
Diffuse Glioma,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,7.304254840649718,0.009883941367274359,Other Types
Diffuse Glioma,RAF Activation R-HSA-5673000,4.527120304023881,0.03927521816415505,Other Types
Diffuse Glioma,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,12.60281840261471,0.0009648068255619657,Diffuse Glioma
Diffuse Glioma,Apoptotic Factor-Mediated Response R-HSA-111471,4.1928808532860815,0.04688137698673634,Diffuse Glioma
Diffuse Glioma,Elastic Fibre Formation R-HSA-1566948,5.352203279736373,0.025662369376192064,Other Types
Diffuse Glioma,MAP2K And MAPK Activation R-HSA-5674135,9.006492472464263,0.004513062275136238,Other Types
Diffuse Glioma,VxPx Cargo-Targeting To Cilium R-HSA-5620916,9.850926743102603,0.0031016878249810155,Other Types
Diffuse Glioma,G Alpha (S) Signaling Events R-HSA-418555,9.9361048451599,0.0029879418228268423,Other Types
Diffuse Glioma,NCAM Signaling For Neurite Out-Growth R-HSA-375165,6.765780789548829,0.012776569484810325,Other Types
Diffuse Glioma,Signal Amplification R-HSA-392518,9.037604826203038,0.0044504477922490465,Other Types
Diffuse Glioma,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,10.667115021470783,0.002175588270110169,Other Types
Diffuse Glioma,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,7.466760763075276,0.009155149127818393,Other Types
Diffuse Glioma,G Alpha (Q) Signaling Events R-HSA-416476,5.127061791075843,0.028779131530189326,Other Types
Diffuse Glioma,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,7.459838282071416,0.009184995754123477,Other Types
Diffuse Glioma,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,4.908263558033767,0.03220412767875335,Other Types
Diffuse Glioma,GPER1 Signaling R-HSA-9634597,12.661215894154687,0.0009419645457970526,Other Types
Diffuse Glioma,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,6.759062855433694,0.012817925298497344,Other Types
Diffuse Glioma,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,12.832154123877672,0.0008783236436376918,Diffuse Glioma
Diffuse Glioma,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,18.03681670314742,0.00011740897179936685,Other Types
Diffuse Glioma,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,5.760066386765923,0.020905359851040126,Other Types
Diffuse Glioma,Depolymerisation Of Nuclear Lamina R-HSA-4419969,9.492649671971886,0.003632865543719708,Other Types
Diffuse Glioma,Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,5.46939015017033,0.024186142737563584,Other Types
Diffuse Glioma,MHC Class II Antigen Presentation R-HSA-2132295,6.76295617436036,0.012793940479092282,Other Types
Diffuse Glioma,RNA Polymerase III Chain Elongation R-HSA-73780,4.399939352326428,0.041997684164861285,Other Types
Diffuse Glioma,Transferrin Endocytosis And Recycling R-HSA-917977,4.222993067730818,0.04613408069665806,Diffuse Glioma
Diffuse Glioma,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,11.204621871985855,0.0017292690931667493,Other Types
Diffuse Glioma,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,10.541193338739935,0.002296837697887496,Other Types
Diffuse Glioma,Mitotic Prometaphase R-HSA-68877,6.560762442584294,0.014105568213198527,Other Types
Diffuse Glioma,Post NMDA Receptor Activation Events R-HSA-438064,7.579193515348146,0.008684606176488146,Other Types
Diffuse Glioma,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,4.888260271415601,0.03253862892767124,Other Types
Diffuse Glioma,Apoptotic Execution Phase R-HSA-75153,4.624952124821404,0.037311910468823144,Other Types
Diffuse Glioma,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,7.489603623082732,0.009057392850829026,Other Types
Diffuse Glioma,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,7.489603623082732,0.009057392850829026,Other Types
Diffuse Glioma,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,7.489603623082732,0.009057392850829026,Other Types
Diffuse Glioma,Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,6.551443356525298,0.014169393631275446,Other Types
Diffuse Glioma,Cell-cell Junction Organization R-HSA-421270,6.033374195631784,0.018254574235376193,Other Types
Diffuse Glioma,Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,4.088892425059268,0.04956579865056158,Other Types
Diffuse Glioma,Defective Pyroptosis R-HSA-9710421,10.552510596573725,0.0022856533375682094,Diffuse Glioma
Diffuse Glioma,SARS-CoV-1 Infection R-HSA-9678108,9.284586254522639,0.003984932899985131,Other Types
Diffuse Glioma,CD209 (DC-SIGN) Signaling R-HSA-5621575,6.024208160421899,0.018337362012846695,Other Types
Diffuse Glioma,RHO GTPases Activate Formins R-HSA-5663220,5.936301117056361,0.01915215410243959,Other Types
Diffuse Glioma,Regulation Of IFNG Signaling R-HSA-877312,5.9609421370277635,0.01891990603125908,Other Types
Diffuse Glioma,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,6.218154864848318,0.01666848175850322,Other Types
Diffuse Glioma,Spry Regulation Of FGF Signaling R-HSA-1295596,6.304483842196933,0.015978772226332805,Other Types
Diffuse Glioma,AURKA Activation By TPX2 R-HSA-8854518,16.795141374228223,0.0001861576648382806,Other Types
Diffuse Glioma,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,9.200169628668453,0.004137943817219188,Other Types
Diffuse Glioma,Centrosome Maturation R-HSA-380287,13.933818297054,0.000563147573085028,Other Types
Diffuse Glioma,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,10.373312297887903,0.0024697284586122077,Diffuse Glioma
Diffuse Glioma,RNA Polymerase III Transcription Termination R-HSA-73980,10.10430463336423,0.0027761109094095356,Other Types
Diffuse Glioma,Oncogenic MAPK Signaling R-HSA-6802957,4.2239337175988965,0.04611094752264904,Other Types
Diffuse Glioma,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,4.100871290725313,0.049248149430495644,Other Types
Diffuse Glioma,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,11.44539892025892,0.0015617797083458218,Other Types
Diffuse Glioma,Mitochondrial Calcium Ion Transport R-HSA-8949215,9.052512381855315,0.004420773389313483,Diffuse Glioma
Diffuse Glioma,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,8.856019981263389,0.004829378216858323,Other Types
Diffuse Glioma,RHO GTPases Activate PAKs R-HSA-5627123,12.453682687065413,0.0010258360501762254,Other Types
Diffuse Glioma,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,8.360097516194257,0.006049850760787128,Other Types
Diffuse Glioma,Glycolysis R-HSA-70171,5.264621945946011,0.026829137836897006,Other Types
Diffuse Glioma,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,5.656085438236975,0.02202024343308384,Other Types
Diffuse Glioma,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,5.314075149581089,0.026163433714688447,Other Types
Diffuse Glioma,Regulation Of TP53 Expression And Degradation R-HSA-6806003,13.192377361428576,0.0007586064614995987,Other Types
Diffuse Glioma,Integrin Cell Surface Interactions R-HSA-216083,5.018478665739345,0.03042671313240973,Other Types
Diffuse Glioma,NF-kB Is Activated And Signals Survival R-HSA-209560,4.076988400698532,0.049883690450980074,Other Types
Diffuse Glioma,Regulation Of TP53 Degradation R-HSA-6804757,15.048789919096038,0.0003629924183492571,Other Types
Diffuse Glioma,Chromatin Modifying Enzymes R-HSA-3247509,8.319881806245643,0.0061622784355687575,Diffuse Glioma
Diffuse Glioma,RNA Polymerase III Transcription Initiation R-HSA-76046,6.0908509739168,0.017744513230314958,Other Types
Diffuse Glioma,Oncogene Induced Senescence R-HSA-2559585,10.355469124131167,0.0024888979810584223,Other Types
Diffuse Glioma,Cellular Response To Chemical Stress R-HSA-9711123,8.966950233011369,0.00459399517414131,Diffuse Glioma
Diffuse Glioma,Signaling By FGFR1 R-HSA-5654736,6.854972077927687,0.012240832860457775,Other Types
Diffuse Glioma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,16.250079834952125,0.00022871997712540408,Other Types
Diffuse Glioma,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,7.34874463421673,0.00967845622636785,Diffuse Glioma
Diffuse Glioma,trans-Golgi Network Vesicle Budding R-HSA-199992,5.948286466704831,0.019038808409571756,Diffuse Glioma
Diffuse Glioma,MyD88-independent TLR4 Cascade R-HSA-166166,4.337150601755478,0.04341713470499339,Other Types
Diffuse Glioma,Transcriptional Regulation By E2F6 R-HSA-8953750,8.835333310839017,0.004874673215898687,Diffuse Glioma
Diffuse Glioma,Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,5.548040025752016,0.023246920897783,Other Types
Diffuse Glioma,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,17.292227742424398,0.00015458340069377048,Other Types
Diffuse Glioma,Transcriptional Regulation By TP53 R-HSA-3700989,15.392891351563366,0.0003176387469261815,Diffuse Glioma
Diffuse Glioma,Diseases Of Glycosylation R-HSA-3781865,11.983166138875838,0.0012465873511835139,Other Types
Diffuse Glioma,HATs Acetylate Histones R-HSA-3214847,6.088690476054385,0.017763406415118498,Diffuse Glioma
Diffuse Glioma,Signaling By FGFR3 R-HSA-5654741,4.538449603984411,0.039042201571903516,Other Types
Diffuse Glioma,Signaling By FGFR4 R-HSA-5654743,4.538449603984411,0.039042201571903516,Other Types
Diffuse Glioma,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,6.299995879625126,0.016013862804817758,Other Types
Diffuse Glioma,PKMTs Methylate Histone Lysines R-HSA-3214841,13.464331089526043,0.0006796893482267245,Diffuse Glioma
Diffuse Glioma,Processing Of SMDT1 R-HSA-8949664,7.274362793788751,0.010024616783258887,Diffuse Glioma
Diffuse Glioma,p75NTR Signals Via NF-kB R-HSA-193639,7.607154447077559,0.008571637571638825,Other Types
Diffuse Glioma,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,7.890261518621553,0.007512152933433775,Other Types
Diffuse Glioma,Interleukin-7 Signaling R-HSA-1266695,21.469062988692013,3.4668950933674185e-05,Diffuse Glioma
Diffuse Glioma,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,19.821864616146303,6.166690766514486e-05,Other Types
Diffuse Glioma,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,8.413889290594371,0.005902868702789732,Diffuse Glioma
Diffuse Glioma,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,5.981719417194096,0.018726427619804836,Other Types
Diffuse Glioma,PI-3K cascade:FGFR1 R-HSA-5654689,4.607790580185984,0.03764843434856208,Other Types
Diffuse Glioma,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,10.397345516597088,0.0024441554930695786,Other Types
Diffuse Glioma,MET Activates RAS Signaling R-HSA-8851805,5.922041511047471,0.01928795365582759,Other Types
Diffuse Glioma,Pyruvate Metabolism R-HSA-70268,4.461669421002198,0.04065141379193118,Diffuse Glioma
Diffuse Glioma,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,8.71116483745063,0.005156208655078113,Diffuse Glioma
Diffuse Glioma,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,8.157609924138184,0.006639022238717629,Diffuse Glioma
Diffuse Glioma,E2F Mediated Regulation Of DNA Replication R-HSA-113510,9.68283135347292,0.003339844793827742,Other Types
Diffuse Glioma,PTK6 Regulates Cell Cycle R-HSA-8849470,9.287365199304105,0.003979999108825997,Other Types
Diffuse Glioma,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,8.770284904588056,0.005020066259851662,Other Types
Diffuse Glioma,Extra-nuclear Estrogen Signaling R-HSA-9009391,11.72731254399268,0.0013872128073788494,Other Types
Diffuse Glioma,Regulation Of MECP2 Expression And Activity R-HSA-9022692,4.881809361317014,0.03264730555797569,Other Types
Diffuse Glioma,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,5.724412055353167,0.021280638593866977,Other Types
Diffuse Glioma,Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,8.18101119177548,0.006567914916027319,Other Types
Diffuse Glioma,RUNX2 Regulates Bone Development R-HSA-8941326,7.737581550650583,0.008064996771119342,Other Types
Diffuse Glioma,SLC-mediated Transmembrane Transport R-HSA-425407,16.53447442719889,0.0002053644382827129,Diffuse Glioma
Diffuse Glioma,Amino Acid Transport Across Plasma Membrane R-HSA-352230,6.552687289529868,0.014160856202021305,Diffuse Glioma
Diffuse Glioma,Signaling By NOTCH2 R-HSA-1980145,9.920448568136791,0.003008512731236655,Diffuse Glioma
Diffuse Glioma,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,9.091315729406242,0.004344513640331541,Other Types
Diffuse Glioma,Sulfur Amino Acid Metabolism R-HSA-1614635,4.676711202228148,0.036316627555311905,Diffuse Glioma
Diffuse Glioma,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,4.149946828690999,0.04796989201314629,Other Types
Diffuse Glioma,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,13.67565777815241,0.0006243626431840276,Diffuse Glioma
Diffuse Glioma,Attenuation Phase R-HSA-3371568,7.587383727943384,0.008651352312182534,Diffuse Glioma
Diffuse Glioma,Glycosaminoglycan Metabolism R-HSA-1630316,11.334685594697303,0.0016365576097162303,Other Types
Diffuse Glioma,Intrinsic Pathway For Apoptosis R-HSA-109606,17.651860178067217,0.00013528507623257366,Diffuse Glioma
Diffuse Glioma,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,4.995376643222093,0.030790270089226638,Other Types
Diffuse Glioma,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,4.995376081523835,0.030790278985714604,Other Types
Diffuse Glioma,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,5.690780595961293,0.02164128239563306,Diffuse Glioma
Diffuse Glioma,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,9.294910234175065,0.003966636173514479,Diffuse Glioma
Diffuse Glioma,PPARA Activates Gene Expression R-HSA-1989781,4.914762973811893,0.03209624694930623,Diffuse Glioma
Diffuse Glioma,Intra-Golgi Traffic R-HSA-6811438,11.524608229543663,0.0015105017391309405,Other Types
Diffuse Glioma,Metabolism Of Lipids R-HSA-556833,4.973777588106787,0.03113443691755459,Diffuse Glioma
Diffuse Glioma,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,6.722252925883051,0.013047086449148947,Diffuse Glioma
Diffuse Glioma,SUMOylation Of Intracellular Receptors R-HSA-4090294,9.13008986973151,0.00426970480210613,Diffuse Glioma
Diffuse Glioma,Generic Transcription Pathway R-HSA-212436,4.940334875018903,0.03167558101105197,Diffuse Glioma
Diffuse Glioma,Base Excision Repair R-HSA-73884,4.229778458031751,0.045967493409392456,Diffuse Glioma
Diffuse Glioma,Cyclin D Associated Events In G1 R-HSA-69231,4.764050514343321,0.03470201673570683,Other Types
Diffuse Glioma,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,5.437756402341471,0.02457538420207741,Other Types
Diffuse Glioma,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,4.269253699436917,0.045011299423432405,Diffuse Glioma
Diffuse Glioma,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",17.48209595497547,0.0001440580326917231,Diffuse Glioma
Diffuse Glioma,SARS-CoV Infections R-HSA-9679506,5.359286177808601,0.025570435854174404,Diffuse Glioma
Diffuse Glioma,Adherens Junctions Interactions R-HSA-418990,11.160324929868455,0.0017620993226773053,Other Types
Diffuse Glioma,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,5.0957467511532295,0.029244143053597953,Diffuse Glioma
Diffuse Glioma,Potential Therapeutics For SARS R-HSA-9679191,15.740011514613055,0.00027789178582350197,Diffuse Glioma
Diffuse Glioma,Transcription Of HIV Genome R-HSA-167172,6.141213619797142,0.01731016143763599,Diffuse Glioma
Diffuse Glioma,MASTL Facilitates Mitotic Progression R-HSA-2465910,4.823785268411633,0.03364272148367768,Other Types
Diffuse Glioma,Iron Uptake And Transport R-HSA-917937,11.020879081944466,0.001869822437839573,Diffuse Glioma
Diffuse Glioma,Basigin Interactions R-HSA-210991,16.002484741102013,0.00025133190449115324,Diffuse Glioma
Diffuse Glioma,SUMOylation Of Transcription Cofactors R-HSA-3899300,6.168295333334814,0.017081329036481165,Diffuse Glioma
Diffuse Glioma,Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,5.947833793735843,0.019043076213582266,Other Types
Diffuse Glioma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,13.733390170390333,0.0006100888684474912,Diffuse Glioma
Diffuse Glioma,Late SARS-CoV-2 Infection Events R-HSA-9772573,6.578811196027628,0.013982828527322314,Other Types
Diffuse Glioma,Epigenetic Regulation Of Gene Expression R-HSA-212165,11.539953398060437,0.0015007751326405383,Diffuse Glioma
Diffuse Glioma,Estrogen-dependent Gene Expression R-HSA-9018519,5.746990376885965,0.02104215683662345,Diffuse Glioma
Diffuse Glioma,Beta-catenin Phosphorylation Cascade R-HSA-196299,4.319360681539023,0.04382877393716005,Other Types
Diffuse Glioma,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,4.319360954694473,0.04382876758399549,Other Types
Diffuse Glioma,CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,4.319360681539023,0.04382877393716005,Other Types
Diffuse Glioma,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,6.440074012244532,0.014956566948702553,Other Types
Diffuse Glioma,Regulated Proteolysis Of p75NTR R-HSA-193692,6.439785053443737,0.014958669298747668,Other Types
Diffuse Glioma,HIV Elongation Arrest And Recovery R-HSA-167287,6.66259297529572,0.013427867074627429,Diffuse Glioma
Diffuse Glioma,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,8.810746781629826,0.004929094902768897,Diffuse Glioma
Diffuse Glioma,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,4.095429233548025,0.04939218146741742,Diffuse Glioma
Diffuse Glioma,RHO GTPases Activate IQGAPs R-HSA-5626467,4.289956671489076,0.04451853272749753,Other Types
Diffuse Glioma,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,6.469434810924021,0.014744591770789926,Diffuse Glioma
Diffuse Glioma,Regulation Of NF-kappa B Signaling R-HSA-9758274,6.424693429655209,0.015068911594973465,Other Types
Diffuse Glioma,Aggrephagy R-HSA-9646399,9.150503187049248,0.004230870945736448,Other Types
Diffuse Glioma,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,5.682884404297755,0.021726907388045526,Diffuse Glioma
Diffuse Glioma,Interleukin-37 Signaling R-HSA-9008059,7.166788172876272,0.010548835599775264,Diffuse Glioma
Diffuse Glioma,FOXO-mediated Transcription R-HSA-9614085,7.229303153983548,0.010240727991972363,Diffuse Glioma
Diffuse Glioma,"WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",5.381642518021584,0.025282584414089718,Diffuse Glioma
Diffuse Glioma,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,5.381642425121586,0.02528258560293649,Diffuse Glioma
Diffuse Glioma,Retrograde Neurotrophin Signaling R-HSA-177504,4.306096099841516,0.04413847719226412,Diffuse Glioma
Diffuse Glioma,HDACs Deacetylate Histones R-HSA-3214815,6.648877449028321,0.013517078105691659,Diffuse Glioma
Diffuse Glioma,E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,4.51002871239881,0.039629624201300465,Other Types
Diffuse Glioma,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",5.5382296668691176,0.023361896234197703,Diffuse Glioma
Diffuse Glioma,Nef Mediated CD4 Down-regulation R-HSA-167590,4.8711009667665035,0.032828577478722955,Diffuse Glioma
Diffuse Glioma,Nef Mediated CD8 Down-regulation R-HSA-182218,4.8711009667665035,0.032828577478722955,Diffuse Glioma
Diffuse Glioma,Regulation Of Beta-Cell Development R-HSA-186712,13.081893081416059,0.0007933782907679361,Diffuse Glioma
Diffuse Glioma,RND3 GTPase Cycle R-HSA-9696264,7.938243718314992,0.007346864406263044,Diffuse Glioma
Diffuse Glioma,Regulation Of Gene Expression In Beta Cells R-HSA-210745,16.605710231156078,0.000199916853082027,Diffuse Glioma
Diffuse Glioma,Activation Of HOX Genes During Differentiation R-HSA-5619507,8.50997321264566,0.005649694361724091,Diffuse Glioma
Diffuse Glioma,Chromosome Maintenance R-HSA-73886,5.029520576121196,0.030254591885786223,Diffuse Glioma
Diffuse Glioma,LDL Clearance R-HSA-8964038,5.211754111283287,0.027561116183848596,Diffuse Glioma
Diffuse Glioma,VLDLR Internalisation And Degradation R-HSA-8866427,4.461168032863257,0.040662157012419674,Diffuse Glioma
Diffuse Glioma,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,4.911466921744343,0.032150907477591965,Diffuse Glioma
Diffuse Glioma,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,4.256296520108429,0.04532273572541873,Diffuse Glioma
Diffuse Glioma,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,6.021134323038122,0.018365215243862552,Diffuse Glioma
Diffuse Glioma,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,7.399152065561508,0.009451136038205209,Diffuse Glioma
Diffuse Glioma,SARS-CoV-2 Modulates Autophagy R-HSA-9754560,4.638571169564313,0.03704718207312465,Diffuse Glioma
Diffuse Glioma,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,4.3581574145425135,0.04293649034247204,Diffuse Glioma
Diffuse Glioma,Signaling By NOTCH3 R-HSA-9012852,8.84067608336998,0.00486293175921279,Diffuse Glioma
Cervical Squamous Cell Carcinoma,Adaptive Immune System R-HSA-1280218,10.942013890101014,0.010732192154150118,Other Types
Cervical Squamous Cell Carcinoma,CLEC7A (Dectin-1) Signaling R-HSA-5607764,7.822695616531136,0.023308678671,Other Types
Cervical Squamous Cell Carcinoma,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,10.500516084756292,0.011869626621446059,Other Types
Cervical Squamous Cell Carcinoma,FCERI Mediated NF-kB Activation R-HSA-2871837,13.0964175315983,0.006793446296186151,Other Types
Cervical Squamous Cell Carcinoma,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,6.875004424706124,0.030554320318137117,Other Types
Cervical Squamous Cell Carcinoma,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,10.27315124990572,0.012514650046984878,Other Types
Cervical Squamous Cell Carcinoma,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,7.6606804103970925,0.024379596209151366,Other Types
Cervical Squamous Cell Carcinoma,Switching Of Origins To A Post-Replicative State R-HSA-69052,6.2831885648052594,0.03656244916149548,Other Types
Cervical Squamous Cell Carcinoma,Activation Of NF-kappaB In B Cells R-HSA-1169091,7.967225656994075,0.022403052985619325,Other Types
Cervical Squamous Cell Carcinoma,Downstream TCR Signaling R-HSA-202424,12.118396594228356,0.008305609927416188,Other Types
Cervical Squamous Cell Carcinoma,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,8.28941505547927,0.02053881109024219,Other Types
Cervical Squamous Cell Carcinoma,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,12.040265566196432,0.008443876731762012,Other Types
Cervical Squamous Cell Carcinoma,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,6.190852073313252,0.03763102774014198,Other Types
Cervical Squamous Cell Carcinoma,RAF/MAP Kinase Cascade R-HSA-5673001,6.414890756560345,0.03510406039859448,Other Types
Cervical Squamous Cell Carcinoma,Signaling By Hedgehog R-HSA-5358351,8.211994180749992,0.02096832841407729,Other Types
Cervical Squamous Cell Carcinoma,ABC-family Proteins Mediated Transport R-HSA-382556,8.591000348399602,0.01896790514255654,Other Types
Cervical Squamous Cell Carcinoma,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,6.424670692330495,0.034998733259588626,Other Types
Cervical Squamous Cell Carcinoma,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,6.424670692330495,0.034998733259588626,Other Types
Cervical Squamous Cell Carcinoma,Antigen processing-Cross Presentation R-HSA-1236975,8.111589302419752,0.021542395779003982,Other Types
Cervical Squamous Cell Carcinoma,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,11.648832875799222,0.00918183607049249,Other Types
Cervical Squamous Cell Carcinoma,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,6.336286741758057,0.03596538758831625,Other Types
Cervical Squamous Cell Carcinoma,PCP/CE Pathway R-HSA-4086400,5.346233827467169,0.049519314325961676,Other Types
Cervical Squamous Cell Carcinoma,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,6.701549046414141,0.03217632401054025,Other Types
Cervical Squamous Cell Carcinoma,Hh Mutants Are Degraded By ERAD R-HSA-5362768,8.00697779456909,0.022161793619111192,Other Types
Cervical Squamous Cell Carcinoma,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,8.00697779456909,0.022161793619111192,Other Types
Cervical Squamous Cell Carcinoma,Hedgehog Ligand Biogenesis R-HSA-5358346,8.00697779456909,0.022161793619111192,Other Types
Cervical Squamous Cell Carcinoma,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,11.614348381710311,0.009250667143858476,Other Types
Cervical Squamous Cell Carcinoma,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,13.243376287666523,0.006597120426658529,Other Types
Cervical Squamous Cell Carcinoma,ABC Transporter Disorders R-HSA-5619084,8.043531053408962,0.021942838063646705,Other Types
Cervical Squamous Cell Carcinoma,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,8.043531053408962,0.021942838063646705,Other Types
Cervical Squamous Cell Carcinoma,Vpu Mediated Degradation Of CD4 R-HSA-180534,11.328975874379811,0.00984591473465774,Other Types
Cervical Squamous Cell Carcinoma,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,13.429114531989672,0.006359065038528067,Other Types
Cervical Squamous Cell Carcinoma,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,6.942883996848154,0.02994784308734595,Other Types
Cervical Squamous Cell Carcinoma,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,11.28070603856546,0.009951311552298742,Other Types
Cervical Squamous Cell Carcinoma,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,14.02780724036466,0.005661628937398461,Other Types
Cervical Squamous Cell Carcinoma,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,11.428057478911889,0.009633931168944907,Other Types
Cervical Squamous Cell Carcinoma,ER-Phagosome Pathway R-HSA-1236974,8.449734872276952,0.01968412148634853,Other Types
Cervical Squamous Cell Carcinoma,Transcriptional Regulation By RUNX3 R-HSA-8878159,8.083583582249927,0.02170604936423693,Other Types
Cervical Squamous Cell Carcinoma,UCH Proteinases R-HSA-5689603,29.709578136640992,0.0006082370631245278,Other Types
Cervical Squamous Cell Carcinoma,Cellular Response To Hypoxia R-HSA-1234174,24.96363169513527,0.0010576226224513542,Other Types
Cervical Squamous Cell Carcinoma,Transcriptional Regulation By RUNX2 R-HSA-8878166,6.589487054359454,0.033282543221229824,Other Types
Cervical Squamous Cell Carcinoma,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,8.297253469608847,0.02049594667198161,Other Types
Cervical Squamous Cell Carcinoma,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,6.31358102708228,0.03621917503749253,Other Types
Cervical Squamous Cell Carcinoma,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,7.790481411584609,0.02351680446082099,Other Types
Cervical Squamous Cell Carcinoma,Intracellular Signaling By Second Messengers R-HSA-9006925,13.384187036782716,0.00641564511245583,Other Types
Cervical Squamous Cell Carcinoma,PIP3 Activates AKT Signaling R-HSA-1257604,13.357504266562724,0.006449547693519142,Other Types
Cervical Squamous Cell Carcinoma,PTEN Regulation R-HSA-6807070,13.219681130060904,0.006628289053843248,Other Types
Cervical Squamous Cell Carcinoma,KEAP1-NFE2L2 Pathway R-HSA-9755511,11.358837318665193,0.009781414669242683,Other Types
Cervical Squamous Cell Carcinoma,Neutrophil Degranulation R-HSA-6798695,5.864884895479207,0.04173582110893746,Other Types
Cervical Squamous Cell Carcinoma,Influenza Infection R-HSA-168255,7.430782103555669,0.026008367705394816,Other Types
Cervical Squamous Cell Carcinoma,Late Endosomal Microautophagy R-HSA-9615710,6.947902708564724,0.029903610856530188,Other Types
Cervical Squamous Cell Carcinoma,Viral Messenger RNA Synthesis R-HSA-168325,7.024059929229614,0.029242446032254055,Other Types
Cervical Squamous Cell Carcinoma,Neddylation R-HSA-8951664,5.782860593070596,0.04285733876152771,Other Types
Cervical Squamous Cell Carcinoma,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,6.626869464807509,0.03290823728258317,Other Types
Cervical Squamous Cell Carcinoma,Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,5.549696906809847,0.04626200271158616,Other Types
Cervical Squamous Cell Carcinoma,Diseases Of Mitotic Cell Cycle R-HSA-9675126,5.807799199905009,0.04251233878770623,Other Types
Cervical Squamous Cell Carcinoma,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,5.807799199905009,0.04251233878770623,Other Types
Cervical Squamous Cell Carcinoma,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,6.839818866894801,0.030874815864984174,Other Types
Cervical Squamous Cell Carcinoma,PRC2 Methylates Histones And DNA R-HSA-212300,42.76652862783405,0.00018042928094219466,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Transcriptional Regulation By Small RNAs R-HSA-5578749,5.384616881610077,0.04888296001008247,Other Types
Cervical Squamous Cell Carcinoma,Influenza Viral RNA Transcription And Replication R-HSA-168273,5.969295378888944,0.04036165174526484,Other Types
Cervical Squamous Cell Carcinoma,Transport Of SLBP Independent Mature mRNA R-HSA-159227,6.261940112443569,0.036804900882880805,Other Types
Cervical Squamous Cell Carcinoma,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,6.261940112443569,0.036804900882880805,Other Types
Cervical Squamous Cell Carcinoma,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,6.634654218938195,0.0328309620782966,Other Types
Cervical Squamous Cell Carcinoma,Signaling By ERBB2 R-HSA-1227986,16.324520058126843,0.003733870266677518,Other Types
Cervical Squamous Cell Carcinoma,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,10.315609242243841,0.012390909756599164,Other Types
Cervical Squamous Cell Carcinoma,Interleukin-12 Signaling R-HSA-9020591,68.22561856196907,3.466677160222898e-05,Other Types
Cervical Squamous Cell Carcinoma,Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,5.649936622807095,0.044757574042532285,Other Types
Cervical Squamous Cell Carcinoma,RAF-independent MAPK1/3 Activation R-HSA-112409,5.369477686101058,0.04913270031905556,Other Types
Cervical Squamous Cell Carcinoma,Protein Ubiquitination R-HSA-8852135,13.102865923751871,0.006784679075500707,Other Types
Cervical Squamous Cell Carcinoma,PI3K/AKT Signaling In Cancer R-HSA-2219528,5.927293906477203,0.04090741935118974,Other Types
Cervical Squamous Cell Carcinoma,FGFR2 Mutant Receptor Activation R-HSA-1839126,12.10209129896776,0.0083342288064487,Other Types
Cervical Squamous Cell Carcinoma,FGFR2 Alternative Splicing R-HSA-6803529,11.273812233806158,0.009966479663681643,Other Types
Cervical Squamous Cell Carcinoma,Signaling By FGFR2 IIIa TM R-HSA-8851708,12.410369784346305,0.007813427069705524,Other Types
Cervical Squamous Cell Carcinoma,NS1 Mediated Effects On Host Pathways R-HSA-168276,7.31396882919002,0.026888749669623433,Other Types
Cervical Squamous Cell Carcinoma,rRNA Processing R-HSA-72312,7.444887915285366,0.025904539675716553,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Interleukin-12 Family Signaling R-HSA-447115,140.334307932165,2.3650612111098267e-06,Other Types
Cervical Squamous Cell Carcinoma,Biological Oxidations R-HSA-211859,11.848304053584672,0.008796074492685976,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,MAPK3 (ERK1) Activation R-HSA-110056,5.423010099956333,0.04825683553407067,Other Types
Cervical Squamous Cell Carcinoma,Gene Silencing By RNA R-HSA-211000,6.243984438027001,0.03701137462951843,Other Types
Cervical Squamous Cell Carcinoma,Tight Junction Interactions R-HSA-420029,6.096503839925881,0.03876420648897135,Other Types
Cervical Squamous Cell Carcinoma,Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,5.719415012383165,0.04375124914111698,Other Types
Cervical Squamous Cell Carcinoma,Interleukin-6 Signaling R-HSA-1059683,10.596446640930125,0.011610047757380101,Other Types
Cervical Squamous Cell Carcinoma,SUMOylation Of RNA Binding Proteins R-HSA-4570464,7.295801221980841,0.027029042244892026,Other Types
Cervical Squamous Cell Carcinoma,APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,10.703836423953165,0.011327875278835055,Other Types
Cervical Squamous Cell Carcinoma,Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,10.347848085426692,0.012297979413632698,Other Types
Cervical Squamous Cell Carcinoma,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,5.3642453465291675,0.04921939278056701,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,DNA Double Strand Break Response R-HSA-5693606,6.213522293061931,0.0373650381982218,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,6.196229733183148,0.03756771464443318,Other Types
Cervical Squamous Cell Carcinoma,Defective Pyroptosis R-HSA-9710421,10.20214030962423,0.012725102201483585,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,PI3K Cascade R-HSA-109704,6.105819909623608,0.038650402433964844,Other Types
Cervical Squamous Cell Carcinoma,SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,6.6841858928701985,0.032344638671994504,Other Types
Cervical Squamous Cell Carcinoma,Phase I - Functionalization Of Compounds R-HSA-211945,9.110872647114988,0.016599300226133748,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,5.845852815591876,0.041992687376289466,Other Types
Cervical Squamous Cell Carcinoma,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,9.87492549661921,0.013754493127282373,Other Types
Cervical Squamous Cell Carcinoma,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,6.6130034380078655,0.03304645034227689,Other Types
Cervical Squamous Cell Carcinoma,Interleukin-20 Family Signaling R-HSA-8854691,9.658408972138924,0.014493696934551843,Other Types
Cervical Squamous Cell Carcinoma,Interleukin-6 Family Signaling R-HSA-6783589,22.780919212388586,0.0014033181181585506,Other Types
Cervical Squamous Cell Carcinoma,SUMOylation Of DNA Replication Proteins R-HSA-4615885,6.196981538766889,0.037558874155159766,Other Types
Cervical Squamous Cell Carcinoma,Growth Hormone Receptor Signaling R-HSA-982772,7.321775365437474,0.02682874967819578,Other Types
Cervical Squamous Cell Carcinoma,"Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",13.330202644325487,0.006484469692960896,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Nuclear Import Of Rev Protein R-HSA-180746,5.920698384017514,0.040993972419748545,Other Types
Cervical Squamous Cell Carcinoma,Cellular Response To Chemical Stress R-HSA-9711123,6.203947387048318,0.03747708822232698,Other Types
Cervical Squamous Cell Carcinoma,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,11.23013387666566,0.010063261663328623,Other Types
Cervical Squamous Cell Carcinoma,MAPK1 (ERK2) Activation R-HSA-112411,10.03131667000114,0.013249914011961707,Other Types
Cervical Squamous Cell Carcinoma,SUMOylation Of SUMOylation Proteins R-HSA-4085377,7.0621342257414845,0.028918841360524118,Other Types
Cervical Squamous Cell Carcinoma,Synthesis Of diphthamide-EEF2 R-HSA-5358493,8.462672116926836,0.01961712545492229,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,PI3K Events In ERBB2 Signaling R-HSA-1963642,15.80327924886717,0.00408829625945952,Other Types
Cervical Squamous Cell Carcinoma,Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,15.222971686129283,0.004534010958566112,Other Types
Cervical Squamous Cell Carcinoma,FGFR1 Mutant Receptor Activation R-HSA-1839124,23.491728368776517,0.001276994606569014,Other Types
Cervical Squamous Cell Carcinoma,Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,5.843493608555037,0.04202466835730183,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Phase II - Conjugation Of Compounds R-HSA-156580,7.948760392358225,0.022516248820077692,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,NGF-stimulated Transcription R-HSA-9031628,9.255468457636956,0.016007713508655194,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Homology Directed Repair R-HSA-5693538,6.120595050743681,0.03847078020060733,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Cellular Responses To Stress R-HSA-2262752,6.657636669812166,0.03260416570832956,Other Types
Cervical Squamous Cell Carcinoma,Cellular Responses To Stimuli R-HSA-8953897,6.657636669812166,0.03260416570832956,Other Types
Cervical Squamous Cell Carcinoma,Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,7.753908782358501,0.023755943959836455,Other Types
Cervical Squamous Cell Carcinoma,Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,6.332540567759105,0.03600710363056045,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,6.751097014711146,0.031702083797399576,Other Types
Cervical Squamous Cell Carcinoma,Downregulation Of ERBB2 Signaling R-HSA-8863795,10.87274230741983,0.010901290945456887,Other Types
Cervical Squamous Cell Carcinoma,IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,304.8867715794214,1.1807552790247953e-07,Other Types
Cervical Squamous Cell Carcinoma,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,5.912787126626153,0.041098099386485294,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Nephrin Family Interactions R-HSA-373753,16.263043912639617,0.003773612241861209,Other Types
Cervical Squamous Cell Carcinoma,Meiotic Recombination R-HSA-912446,13.917717152218076,0.005782387921154821,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Interleukin-2 Family Signaling R-HSA-451927,10.808360723116975,0.011061467922623074,Other Types
Cervical Squamous Cell Carcinoma,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,6.837581666801525,0.030895337629166287,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Regulation Of TP53 Activity R-HSA-5633007,11.685192286159616,0.009109958338660955,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Oxidative Stress Induced Senescence R-HSA-2559580,7.027539313330042,0.029212683945567572,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,12.158312202607714,0.00823606981471944,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,G2/M DNA Damage Checkpoint R-HSA-69473,7.874681374949777,0.022977699203849074,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Meiosis R-HSA-1500620,5.547165675493348,0.046300819911898286,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Reproduction R-HSA-1474165,5.547166002052544,0.046300814901337396,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Heme Signaling R-HSA-9707616,6.319073623860584,0.036157574963522024,Other Types
Cervical Squamous Cell Carcinoma,AKT Phosphorylates Targets In Cytosol R-HSA-198323,15.510542907230178,0.004305908142787927,Other Types
Cervical Squamous Cell Carcinoma,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,7.402152479041103,0.026220724204844677,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,12.135676955510238,0.008275414258031128,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Fatty Acid Metabolism R-HSA-8978868,8.863312624006058,0.017677629220088205,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Fatty acyl-CoA Biosynthesis R-HSA-75105,5.431844051497083,0.04811421937550886,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Cleavage Of Damaged Pyrimidine R-HSA-110329,13.24006474495286,0.006601465354563174,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Packaging Of Telomere Ends R-HSA-171306,13.24006474495286,0.006601465354563174,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Cleavage Of Damaged Purine R-HSA-110331,13.24006474495286,0.006601465354563174,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,"Base-Excision Repair, AP Site Formation R-HSA-73929",13.24006474495286,0.006601465354563174,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,10.93395880421081,0.010751685101912533,Other Types
Cervical Squamous Cell Carcinoma,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,6.117209410629076,0.03851184577488462,Other Types
Cervical Squamous Cell Carcinoma,Removal Of Flap Intermediate From C-strand R-HSA-174437,5.346116394703524,0.04952127741510494,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,8.647289559230883,0.018691695040438307,Other Types
Cervical Squamous Cell Carcinoma,Regulation Of Beta-Cell Development R-HSA-186712,12.34642921213967,0.007918010540981702,Other Types
Cervical Squamous Cell Carcinoma,Regulation Of BACH1 Activity R-HSA-9708530,5.365028465312379,0.049206405200087996,Other Types
Cervical Squamous Cell Carcinoma,Regulation Of Gene Expression In Beta Cells R-HSA-210745,8.460702856004964,0.01962730476182703,Other Types
Cervical Squamous Cell Carcinoma,Condensation Of Prometaphase Chromosomes R-HSA-2514853,95.69683082842238,1.000042624264284e-05,Other Types
Cervical Squamous Cell Carcinoma,Formation Of Incision Complex In GG-NER R-HSA-5696395,6.967536000590493,0.0297313666370458,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Processive Synthesis On C-strand Of Telomere R-HSA-174414,5.440625634466415,0.04797298094143939,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,Synthesis Of PC R-HSA-1483191,13.125761303961188,0.006753665098678379,Other Types
Cervical Squamous Cell Carcinoma,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,6.456683871188848,0.03465675346445373,Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,7.884112626580455,0.02291829077591424,Cervical Squamous Cell Carcinoma
Melanoma,Adaptive Immune System R-HSA-1280218,5.340091646190775,0.039414467537210354,Other Types
Melanoma,Cristae Formation R-HSA-8949613,11.42050976798173,0.005473979613325006,Melanoma
Melanoma,Golgi-to-ER Retrograde Transport R-HSA-8856688,9.18220467423584,0.010462401617798819,Other Types
Melanoma,Cytoprotection By HMOX1 R-HSA-9707564,5.118175887782424,0.043028955100850044,Melanoma
Melanoma,TP53 Regulates Metabolic Genes R-HSA-5628897,14.357009842067537,0.0025806459473483837,Melanoma
Melanoma,Signaling By MET R-HSA-6806834,9.66444020971273,0.009041507874837618,Other Types
Melanoma,Signaling By VEGF R-HSA-194138,6.18649056929381,0.02857499680669688,Other Types
Melanoma,Metabolism Of Nucleotides R-HSA-15869,13.85870747844015,0.002912324649858004,Melanoma
Melanoma,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,9.962284031433807,0.00827739205981658,Other Types
Melanoma,Developmental Biology R-HSA-1266738,4.77340469638689,0.04946560648656504,Melanoma
Melanoma,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,5.578055322184391,0.035934110852904794,Other Types
Melanoma,mRNA Splicing - Major Pathway R-HSA-72163,6.858063607011247,0.022434918773462615,Melanoma
Melanoma,RAC3 GTPase Cycle R-HSA-9013423,5.343275742747369,0.039365308343786085,Other Types
Melanoma,Signaling By WNT R-HSA-195721,5.534333138217756,0.036545158469147035,Melanoma
Melanoma,TCF Dependent Signaling In Response To WNT R-HSA-201681,5.57920526778023,0.035918204831986766,Melanoma
Melanoma,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,15.63412488203064,0.0019139237552133828,Melanoma
Melanoma,mRNA Splicing R-HSA-72172,6.712956576818439,0.023617080177266644,Melanoma
Melanoma,KEAP1-NFE2L2 Pathway R-HSA-9755511,4.951693859638138,0.04600298398114876,Melanoma
Melanoma,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,5.594068467433826,0.03571337148813683,Other Types
Melanoma,Platelet Aggregation (Plug Formation) R-HSA-76009,5.948712630641771,0.031214941267347748,Other Types
Melanoma,Integrin Signaling R-HSA-354192,5.948712630641771,0.031214941267347748,Other Types
Melanoma,EPHB-mediated Forward Signaling R-HSA-3928662,12.975514391790284,0.0036315246345474616,Other Types
Melanoma,Mitochondrial Translation Termination R-HSA-5419276,9.470341996240329,0.009584245017591912,Melanoma
Melanoma,mRNA Splicing - Minor Pathway R-HSA-72165,13.128213521995773,0.003493443682033761,Melanoma
Melanoma,Nucleotide Biosynthesis R-HSA-8956320,61.11704935891536,4.756609765284516e-06,Melanoma
Melanoma,Metabolism Of Vitamins And Cofactors R-HSA-196854,20.026999486552395,0.0007588065382760048,Melanoma
Melanoma,Cell-Cell Communication R-HSA-1500931,10.639776488157777,0.006805043141454269,Other Types
Melanoma,RHOJ GTPase Cycle R-HSA-9013409,6.0931946205078065,0.02957788550053271,Other Types
Melanoma,Cell Junction Organization R-HSA-446728,13.194666718508087,0.0034352812880482026,Other Types
Melanoma,Deubiquitination R-HSA-5688426,5.235671089862033,0.04106805007581459,Melanoma
Melanoma,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,8.57343542415413,0.01264989061263877,Other Types
Melanoma,Nuclear Envelope Breakdown R-HSA-2980766,6.769995767955739,0.02314378278714233,Other Types
Melanoma,Metabolism R-HSA-1430728,4.816975547301845,0.04859132416384473,Melanoma
Melanoma,Heme Biosynthesis R-HSA-189451,7.754084440862256,0.01650852773355373,Melanoma
Melanoma,Metabolism Of Porphyrins R-HSA-189445,7.754084079389296,0.01650852972006691,Melanoma
Melanoma,RHOV GTPase Cycle R-HSA-9013424,7.954442262528151,0.015449557601070866,Other Types
Melanoma,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,61.174486675812986,4.733945976878095e-06,Melanoma
Melanoma,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,11.952126740177984,0.004741713154162627,Melanoma
Melanoma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,9.116479986248244,0.010675787928589317,Other Types
Melanoma,Unfolded Protein Response (UPR) R-HSA-381119,4.837456380666684,0.04818677396201603,Other Types
Melanoma,Frs2-mediated Activation R-HSA-170968,7.229744032401836,0.019712876738991726,Other Types
Melanoma,Regulation Of Signaling By CBL R-HSA-912631,4.8476564775347715,0.047986803355976056,Other Types
Melanoma,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,8.346424759227123,0.013600911533804994,Other Types
Melanoma,ERBB2 Regulates Cell Motility R-HSA-6785631,12.654876342092637,0.003942862505756047,Other Types
Melanoma,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",8.136843283573958,0.014554662751346288,Other Types
Melanoma,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,11.148316790644849,0.00589999505798359,Melanoma
Melanoma,FGFR2 Mutant Receptor Activation R-HSA-1839126,6.35352252656202,0.026878602651669206,Melanoma
Melanoma,Late Phase Of HIV Life Cycle R-HSA-162599,29.686765058678816,0.00014800803398806568,Melanoma
Melanoma,Cilium Assembly R-HSA-5617833,8.935907867242724,0.011288978529855623,Other Types
Melanoma,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,5.522350952832598,0.03671477747987206,Other Types
Melanoma,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,4.903749617721919,0.04690473241475315,Other Types
Melanoma,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,5.893111940742112,0.03187352195276377,Other Types
Melanoma,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,5.893111940742112,0.03187352195276377,Other Types
Melanoma,Signaling By FGFR2 IIIa TM R-HSA-8851708,5.671822685152488,0.034664258675068144,Melanoma
Melanoma,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,11.307177161215407,0.005646815106380642,Other Types
Melanoma,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,7.139509962700623,0.020335966978908597,Other Types
Melanoma,HIV Life Cycle R-HSA-162587,14.883203399208968,0.002277394204250681,Melanoma
Melanoma,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,4.82317783894292,0.04846838384318006,Melanoma
Melanoma,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,10.064735771930653,0.008032303721413229,Other Types
Melanoma,RHOH GTPase Cycle R-HSA-9013407,4.924837099462571,0.04650552637847871,Melanoma
Melanoma,Post NMDA Receptor Activation Events R-HSA-438064,8.310759809318597,0.013757880185713547,Other Types
Melanoma,SARS-CoV-1 Infection R-HSA-9678108,5.140831800191178,0.04264227125671544,Other Types
Melanoma,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,13.729979838579963,0.0030059711466560424,Other Types
Melanoma,Rab Regulation Of Trafficking R-HSA-9007101,9.586049797358088,0.00925623011506717,Melanoma
Melanoma,AURKA Activation By TPX2 R-HSA-8854518,5.4473452570254635,0.03779817103650903,Other Types
Melanoma,Centrosome Maturation R-HSA-380287,5.162267334364558,0.042280239651686376,Other Types
Melanoma,RNA Polymerase III Transcription Termination R-HSA-73980,4.923983019094843,0.046521615575973695,Other Types
Melanoma,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,17.28378224904987,0.0013289937494796837,Melanoma
Melanoma,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,9.162040565632873,0.01052732892032579,Other Types
Melanoma,mRNA Capping R-HSA-72086,178.5052667472088,1.4488421625115993e-08,Melanoma
Melanoma,Glycolysis R-HSA-70171,20.6992694595806,0.0006665877311222059,Other Types
Melanoma,Signaling By FGFR1 R-HSA-5654736,8.016335290082907,0.015138797941338777,Other Types
Melanoma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,6.392380978408407,0.026501283524386618,Other Types
Melanoma,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,13.44345251497851,0.0032273873464375006,Melanoma
Melanoma,Transcriptional Regulation By E2F6 R-HSA-8953750,7.428619991885103,0.018417625811233223,Melanoma
Melanoma,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,6.124509095810195,0.029236669666834282,Melanoma
Melanoma,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,87.05842289121819,7.531852159392377e-07,Melanoma
Melanoma,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,4.979105698648507,0.045496752742637564,Other Types
Melanoma,Transcriptional Regulation By TP53 R-HSA-3700989,12.308460935631272,0.004315064158867013,Melanoma
Melanoma,Diseases Of Glycosylation R-HSA-3781865,5.671771208225361,0.034664940979817045,Other Types
Melanoma,HIV Transcription Initiation R-HSA-167161,20.271286003087532,0.0007236679229258861,Melanoma
Melanoma,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,5.782271050403089,0.03323647784889681,Melanoma
Melanoma,Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,6.229186948673089,0.028129546377004492,Melanoma
Melanoma,Interleukin-7 Signaling R-HSA-1266695,6.918925372758366,0.021960060539994258,Melanoma
Melanoma,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,5.755701340445848,0.03357344196857501,Other Types
Melanoma,Transcriptional Regulation By MECP2 R-HSA-8986944,4.88919966394763,0.04718257385922471,Melanoma
Melanoma,PI3K Events In ERBB2 Signaling R-HSA-1963642,7.526557642703082,0.017816904189941456,Other Types
Melanoma,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,6.31599857263468,0.02724903658515058,Other Types
Melanoma,PI-3K cascade:FGFR1 R-HSA-5654689,10.760340476393713,0.006576518212693407,Other Types
Melanoma,Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,25.07717865626981,0.0003053439216732112,Melanoma
Melanoma,Unwinding Of DNA R-HSA-176974,6.551865840631541,0.025017103751728047,Melanoma
Melanoma,tRNA Processing In Nucleus R-HSA-6784531,14.3330386021861,0.002595551587680406,Other Types
Melanoma,PTK6 Regulates Cell Cycle R-HSA-8849470,36.27991054485575,5.9988047574410356e-05,Other Types
Melanoma,Extra-nuclear Estrogen Signaling R-HSA-9009391,10.206061485885584,0.007708088924242365,Other Types
Melanoma,Detoxification Of Reactive Oxygen Species R-HSA-3299685,10.174871572964298,0.007778297221600102,Other Types
Melanoma,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,6.745487104486457,0.023345758101083258,Other Types
Melanoma,SLC-mediated Transmembrane Transport R-HSA-425407,5.814053119968716,0.03283868809165814,Melanoma
Melanoma,Signaling By NOTCH2 R-HSA-1980145,8.728813896771527,0.01204407366177758,Melanoma
Melanoma,RNA Polymerase II Pre-transcription Events R-HSA-674695,14.735290520848872,0.002358206033814368,Melanoma
Melanoma,RND2 GTPase Cycle R-HSA-9696270,4.84410908647161,0.04805623603072471,Melanoma
Melanoma,G1/S-Specific Transcription R-HSA-69205,15.545800365237959,0.001952948391487754,Melanoma
Melanoma,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,42.218714699527816,2.9468854066609674e-05,Melanoma
Melanoma,Signaling By Hippo R-HSA-2028269,6.1097570244079895,0.029396827839798436,Melanoma
Melanoma,Formation Of Early Elongation Complex R-HSA-113418,12.202274242353502,0.004437308557575178,Melanoma
Melanoma,NoRC Negatively Regulates rRNA Expression R-HSA-427413,7.986770533126947,0.015286309661450689,Melanoma
Melanoma,Formation Of RNA Pol II Elongation Complex R-HSA-112382,27.904272349720905,0.00019382108357316434,Melanoma
Melanoma,Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,7.617914464044033,0.017277338178070045,Melanoma
Melanoma,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,8.617084078723902,0.012476146375889844,Melanoma
Melanoma,Glycosaminoglycan Metabolism R-HSA-1630316,5.287554733725355,0.04023627553997309,Other Types
Melanoma,Intrinsic Pathway For Apoptosis R-HSA-109606,38.42104613002868,4.597119515078522e-05,Melanoma
Melanoma,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,10.540622743327559,0.007000005320947089,Melanoma
Melanoma,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,13.090863700484032,0.0035266404937830936,Melanoma
Melanoma,Dual Incision In TC-NER R-HSA-6782135,39.696863830178124,3.9444808220225714e-05,Melanoma
Melanoma,PPARA Activates Gene Expression R-HSA-1989781,12.405229374319042,0.004207091854777807,Melanoma
Melanoma,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,18.434293531957028,0.0010437751896865389,Melanoma
Melanoma,SUMOylation Of Intracellular Receptors R-HSA-4090294,10.7615274517767,0.0065743136016931,Melanoma
Melanoma,Circadian Clock R-HSA-400253,5.462704843158434,0.03757323974629584,Melanoma
Melanoma,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,7.605977974204791,0.01734672795491683,Other Types
Melanoma,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,5.0706703849811,0.04385348095723509,Other Types
Melanoma,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",8.129097496924603,0.014591398662377882,Melanoma
Melanoma,DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,9.039348448943844,0.01093278403120859,Melanoma
Melanoma,p75NTR Recruits Signaling Complexes R-HSA-209543,6.129510956946654,0.029182601947542686,Other Types
Melanoma,Adherens Junctions Interactions R-HSA-418990,7.756345719851579,0.016496106162283683,Other Types
Melanoma,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,7.648642181597446,0.017100215049735544,Melanoma
Melanoma,Metabolism Of Carbohydrates R-HSA-71387,8.692654662554064,0.01218194552298106,Other Types
Melanoma,tRNA Processing R-HSA-72306,10.211806728679509,0.007695237866780661,Other Types
Melanoma,Nucleotide Excision Repair R-HSA-5696398,4.918533356706355,0.04662443382047987,Melanoma
Melanoma,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,12.159946412257595,0.004487167303264711,Melanoma
Melanoma,Potential Therapeutics For SARS R-HSA-9679191,9.704559968274152,0.008933885290326404,Melanoma
Melanoma,MicroRNA (miRNA) Biogenesis R-HSA-203927,8.78669952137064,0.011827172467772637,Melanoma
Melanoma,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,8.812972229495534,0.011730248569254757,Other Types
Melanoma,Transcription Of HIV Genome R-HSA-167172,33.44814376320774,8.695607779733022e-05,Melanoma
Melanoma,Iron Uptake And Transport R-HSA-917937,7.045846176830631,0.021007572143773058,Melanoma
Melanoma,Basigin Interactions R-HSA-210991,6.407125051173119,0.026359766233134532,Melanoma
Melanoma,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",7.370761146323165,0.018783775724283292,Other Types
Melanoma,DNA Strand Elongation R-HSA-69190,6.2808365568323685,0.02760167186691061,Melanoma
Melanoma,SUMOylation Of Transcription Cofactors R-HSA-3899300,6.711307251705977,0.023630935783491864,Melanoma
Melanoma,Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,23.611033760681977,0.00039213603543804433,Other Types
Melanoma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,7.038894101666756,0.02105846061939184,Melanoma
Melanoma,Late SARS-CoV-2 Infection Events R-HSA-9772573,5.9958330910117725,0.030669459457427772,Other Types
Melanoma,Epigenetic Regulation Of Gene Expression R-HSA-212165,6.547413310130266,0.025057178281713017,Melanoma
Melanoma,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,11.119602948993577,0.005947168133835868,Melanoma
Melanoma,Meiosis R-HSA-1500620,5.361818549112046,0.03908047780369399,Other Types
Melanoma,Reproduction R-HSA-1474165,5.3618188599267835,0.03908047305004196,Other Types
Melanoma,HIV Elongation Arrest And Recovery R-HSA-167287,10.44330292181818,0.007197778896076991,Melanoma
Melanoma,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,10.519595682271026,0.007042189781478363,Melanoma
Melanoma,AKT Phosphorylates Targets In Cytosol R-HSA-198323,6.993416939106312,0.021394975491006996,Melanoma
Melanoma,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,27.98898589496352,0.00019129921269812143,Melanoma
Melanoma,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,28.4519972737456,0.0001781743439925764,Melanoma
Melanoma,STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,4.84031407682096,0.04813064881496396,Melanoma
Melanoma,Aggrephagy R-HSA-9646399,9.02421042315131,0.010984074875186503,Other Types
Melanoma,RORA Activates Gene Expression R-HSA-1368082,5.872927151192681,0.03211669253584298,Melanoma
Melanoma,Pre-NOTCH Expression And Processing R-HSA-1912422,5.540520444749183,0.03645793760315375,Melanoma
Melanoma,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,14.685001849756311,0.002386443175666616,Melanoma
Melanoma,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,6.884911488631925,0.02222395972288452,Melanoma
Melanoma,Interleukin-37 Signaling R-HSA-9008059,7.307992031031278,0.01919078533529551,Melanoma
Melanoma,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,5.427510761718265,0.03809101830297981,Melanoma
Melanoma,FOXO-mediated Transcription R-HSA-9614085,5.366921982850036,0.03900251809059075,Melanoma
Melanoma,HDACs Deacetylate Histones R-HSA-3214815,18.389601716107112,0.0010534233335280617,Melanoma
Melanoma,G0 And Early G1 R-HSA-1538133,6.432691539041374,0.02611649460567315,Melanoma
Melanoma,E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,4.753827950650677,0.04986457142322723,Other Types
Melanoma,Pre-NOTCH Transcription And Translation R-HSA-1912408,6.1449097035842035,0.029016893972377385,Melanoma
Melanoma,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",8.8424404089301,0.011622648340255257,Melanoma
Melanoma,Regulation Of Beta-Cell Development R-HSA-186712,20.04696837084752,0.0007558603991418134,Melanoma
Melanoma,RND3 GTPase Cycle R-HSA-9696264,10.71943736048487,0.00665302269877224,Melanoma
Melanoma,Regulation Of Gene Expression In Beta Cells R-HSA-210745,44.64889780140507,2.2538323046761613e-05,Melanoma
Melanoma,Dual Incision In GG-NER R-HSA-5696400,6.59202639814197,0.02465905969066069,Melanoma
Melanoma,TBC/RABGAPs R-HSA-8854214,6.162481523024829,0.028829166462810692,Melanoma
Melanoma,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,9.110425466730945,0.01069570171618698,Other Types
Melanoma,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,8.123108049120454,0.01461987987861002,Melanoma
Melanoma,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,6.22937401931001,0.0281276129156105,Melanoma
Melanoma,Signaling By NOTCH3 R-HSA-9012852,9.383635818416147,0.00983903762555056,Melanoma
Mature B-Cell Neoplasms,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,6.989079283382319,0.011655707799398382,Other Types
Mature B-Cell Neoplasms,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",6.223299409605583,0.016837750314001244,Other Types
Mature B-Cell Neoplasms,Respiratory Electron Transport R-HSA-611105,5.54215931657019,0.023561934570629432,Other Types
Mature B-Cell Neoplasms,Mitochondrial Biogenesis R-HSA-1592230,6.8436589971422,0.012489520391233563,Other Types
Mature B-Cell Neoplasms,tRNA Aminoacylation R-HSA-379724,4.748393930714762,0.03527456773452694,Other Types
Mature B-Cell Neoplasms,Mitochondrial tRNA Aminoacylation R-HSA-379726,4.711006167929048,0.03596406043075724,Other Types
Mature B-Cell Neoplasms,Leishmania Infection R-HSA-9658195,4.887874323316655,0.03282652348309247,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Cristae Formation R-HSA-8949613,11.530298792859105,0.0015582392645869005,Other Types
Mature B-Cell Neoplasms,Golgi-to-ER Retrograde Transport R-HSA-8856688,12.27034602711143,0.0011481091538844113,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,10.531639802713233,0.002374373934845892,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,VEGFA-VEGFR2 Pathway R-HSA-4420097,6.5245821360829686,0.014551836618081281,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Asparagine N-linked Glycosylation R-HSA-446203,8.237016719794108,0.0065284872977304335,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Cytoprotection By HMOX1 R-HSA-9707564,12.621466753222485,0.000995099223141791,Other Types
Mature B-Cell Neoplasms,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,6.984371112808473,0.011681748350039373,Other Types
Mature B-Cell Neoplasms,TP53 Regulates Metabolic Genes R-HSA-5628897,12.468733386589278,0.0010588219910751956,Other Types
Mature B-Cell Neoplasms,Signaling By MET R-HSA-6806834,7.504673671493864,0.009147773517416568,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Signaling By VEGF R-HSA-194138,6.325102309854192,0.01602489326346574,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Mitotic G2-G2/M Phases R-HSA-453274,4.384207747971435,0.042656884169292066,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,FCGR3A-mediated Phagocytosis R-HSA-9664422,8.163090384712728,0.006752291110225055,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Metabolism Of Nucleotides R-HSA-15869,22.446360256799338,2.7200410306218384e-05,Other Types
Mature B-Cell Neoplasms,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,14.13160173821702,0.0005449965070481449,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,7.155479478561655,0.010774149988405056,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,8.510755994601594,0.005766210296835261,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,"Platelet Activation, Signaling And Aggregation R-HSA-76002",6.482410982181775,0.0148506652431592,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,7.672521122580179,0.008461361199274462,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,RAC3 GTPase Cycle R-HSA-9013423,5.731247886927679,0.021444354803481964,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,EPH-Ephrin Signaling R-HSA-2682334,5.2521889185139745,0.02726104523003273,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Mitochondrial Translation R-HSA-5368287,8.619983447538445,0.0054890439910814095,Other Types
Mature B-Cell Neoplasms,Muscle Contraction R-HSA-397014,4.436321535660464,0.04150408073421718,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Death Receptor Signaling R-HSA-73887,6.1616443238895435,0.01735152598818827,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,9.586580520153596,0.0035733704490903237,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,MET Promotes Cell Motility R-HSA-8875878,6.749985963716443,0.013060337168373758,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Transport Of Small Molecules R-HSA-382551,4.275907938127427,0.045166286662617725,Other Types
Mature B-Cell Neoplasms,Platelet Aggregation (Plug Formation) R-HSA-76009,12.980826091134228,0.0008606393925651043,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Integrin Signaling R-HSA-354192,12.980826091134228,0.0008606393925651043,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,EPHB-mediated Forward Signaling R-HSA-3928662,21.79162072060298,3.3868863587780634e-05,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Protein Localization R-HSA-9609507,4.813227027828654,0.0341128159018498,Other Types
Mature B-Cell Neoplasms,Downstream Signal Transduction R-HSA-186763,6.16557963881667,0.017318233808473953,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Mitochondrial Translation Termination R-HSA-5419276,22.31997917709861,2.837072331971603e-05,Other Types
Mature B-Cell Neoplasms,Signaling By PDGF R-HSA-186797,5.846671063301067,0.020253394087222706,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,RHO GTPase Effectors R-HSA-195258,8.608516576766267,0.0055174630045994565,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Nucleotide Biosynthesis R-HSA-8956320,14.558773596494852,0.0004613467895507907,Other Types
Mature B-Cell Neoplasms,Mitochondrial Translation Initiation R-HSA-5368286,13.379592284726348,0.0007336252457410281,Other Types
Mature B-Cell Neoplasms,Metabolism Of Vitamins And Cofactors R-HSA-196854,25.013203140236715,1.1790355170904677e-05,Other Types
Mature B-Cell Neoplasms,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,9.442121575264503,0.0038072976671841775,Other Types
Mature B-Cell Neoplasms,Mitochondrial Translation Elongation R-HSA-5389840,8.138280867498807,0.006829221715431898,Other Types
Mature B-Cell Neoplasms,Cell-Cell Communication R-HSA-1500931,5.402844641355998,0.02526641055211652,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,14.32196374858475,0.0005058955661119245,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Signaling To ERKs R-HSA-187687,6.307345733765823,0.01616357794179369,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,RHOJ GTPase Cycle R-HSA-9013409,5.98920259886353,0.018880220083216936,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,"PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",5.719975450820525,0.021564654116953144,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Cell Junction Organization R-HSA-446728,15.111275350895255,0.00037275510942600125,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,XBP1(S) Activates Chaperone Genes R-HSA-381038,6.395595103276958,0.015486810326071404,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,IRE1alpha Activates Chaperones R-HSA-381070,6.395595103276958,0.015486810326071404,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Smooth Muscle Contraction R-HSA-445355,9.313923387113121,0.004028546422179434,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,13.903239225805985,0.0005961581557520445,Other Types
Mature B-Cell Neoplasms,Metabolism R-HSA-1430728,25.80978529889409,9.162689718760374e-06,Other Types
Mature B-Cell Neoplasms,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,4.103311170274783,0.04950651662092792,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Heme Biosynthesis R-HSA-189451,11.261418097152795,0.0017435314032668396,Other Types
Mature B-Cell Neoplasms,Metabolism Of Porphyrins R-HSA-189445,11.261417512857623,0.0017435318303908778,Other Types
Mature B-Cell Neoplasms,Drug ADME R-HSA-9748784,9.535299582803649,0.003654612710139325,Other Types
Mature B-Cell Neoplasms,Prolonged ERK Activation Events R-HSA-169893,10.910473040159449,0.0020212274838047987,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,7.605810782281245,0.008727343146625028,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,RHOV GTPase Cycle R-HSA-9013424,4.838493553583699,0.03367139691856436,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,24.375423384371544,1.4462877095255769e-05,Other Types
Mature B-Cell Neoplasms,Citric Acid Cycle (TCA Cycle) R-HSA-71403,13.12196314754587,0.0008132127232652304,Other Types
Mature B-Cell Neoplasms,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,12.375086155580174,0.0011000170011936916,Other Types
Mature B-Cell Neoplasms,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,10.712974460632012,0.002197804088464951,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Ubiquinol Biosynthesis R-HSA-2142789,5.238284975657929,0.027453548728680822,Other Types
Mature B-Cell Neoplasms,DCC Mediated Attractive Signaling R-HSA-418885,6.95999204394077,0.011817588014717842,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,mTORC1-mediated Signaling R-HSA-166208,7.939195900217989,0.007481489696180157,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Signaling By RAF1 Mutants R-HSA-9656223,4.133662160147733,0.04871124807449638,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,4.133662160147733,0.04871124807449638,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Metabolism Of Cofactors R-HSA-8978934,5.420226116992312,0.025046651294741654,Other Types
Mature B-Cell Neoplasms,Unfolded Protein Response (UPR) R-HSA-381119,4.612383631403465,0.037854317024915145,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,5.130106453184263,0.029002621920118918,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Frs2-mediated Activation R-HSA-170968,10.973142846860025,0.00196839141334595,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,14.64946992951699,0.000445399644396067,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Regulation Of Signaling By CBL R-HSA-912631,4.5727971659520374,0.0386433014928877,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,MET Receptor Recycling R-HSA-8875656,6.794437368576137,0.012786050890668286,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,5.912170496505407,0.01960944363902286,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Kinesins R-HSA-983189,11.329047654265139,0.0016948286584289995,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,MET Activates PTK2 Signaling R-HSA-8874081,7.33551634440757,0.009900125400239684,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,5.643617143938709,0.022398983069414367,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,ERBB2 Regulates Cell Motility R-HSA-6785631,10.72371682904028,0.002187790763228389,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Cilium Assembly R-HSA-5617833,18.579980595519604,0.0001032107957264245,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,7.76857993475416,0.008093468654354792,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Platelet Degranulation R-HSA-114608,6.152270435800375,0.01743110544175681,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,12.368871546247178,0.0011028101305406933,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,4.249876323268323,0.04579328115630554,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,4.566983196906754,0.03876068141596985,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,8.25185824543594,0.006484517314216519,Other Types
Mature B-Cell Neoplasms,Elastic Fibre Formation R-HSA-1566948,4.111807023760795,0.049282477205979495,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,MAP2K And MAPK Activation R-HSA-5674135,5.644576627007238,0.0223882855953937,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,VxPx Cargo-Targeting To Cilium R-HSA-5620916,8.671771891721297,0.005362622137280626,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,10.705277835478018,0.002205008255688353,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,7.637608627426602,0.008599463924378537,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,5.713692790553101,0.02163201857187926,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,GPER1 Signaling R-HSA-9634597,5.728772413202352,0.021470710826957735,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,15.751839347482951,0.00029202617048695645,Other Types
Mature B-Cell Neoplasms,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,14.762059721989182,0.0004264088543064896,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Depolymerisation Of Nuclear Lamina R-HSA-4419969,4.9944778473234335,0.03108013235074304,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,MHC Class II Antigen Presentation R-HSA-2132295,4.979310646796667,0.03132232131411563,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,RNA Polymerase III Chain Elongation R-HSA-73780,4.546590078883575,0.03917549085752489,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,4.284255053617375,0.04496723570617259,Other Types
Mature B-Cell Neoplasms,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,7.283271838338903,0.01014566282989942,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,6.3621347145993505,0.0157397568249835,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Post NMDA Receptor Activation Events R-HSA-438064,7.861474856720254,0.007753903782195942,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Defective Pyroptosis R-HSA-9710421,5.476050239492246,0.024354721832613512,Other Types
Mature B-Cell Neoplasms,SARS-CoV-1 Infection R-HSA-9678108,5.424103811273408,0.024997907133574047,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Regulation Of IFNG Signaling R-HSA-877312,4.929150118416307,0.03213799926624004,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,6.501353266018674,0.014715631093684822,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,AURKA Activation By TPX2 R-HSA-8854518,10.946182606250396,0.001990939496316528,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,6.289005800338936,0.016308174669344602,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Centrosome Maturation R-HSA-380287,9.317891118589804,0.004021497519165077,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,6.662089957361013,0.013621455714622359,Other Types
Mature B-Cell Neoplasms,RNA Polymerase III Transcription Termination R-HSA-73980,11.211431830311026,0.0017804806963082815,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,6.7213540989811555,0.01324034672499828,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Mitochondrial Calcium Ion Transport R-HSA-8949215,5.948192826175765,0.019264730007572287,Other Types
Mature B-Cell Neoplasms,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,9.857752468330052,0.0031745133204366316,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,RHO GTPases Activate PAKs R-HSA-5627123,9.183626855972141,0.004267482940943618,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Glycolysis R-HSA-70171,6.266578706383827,0.016486888881996856,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,4.798970916388866,0.034364653512068286,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Regulation Of TP53 Expression And Degradation R-HSA-6806003,8.722773567641793,0.005241147637835987,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Integrin Cell Surface Interactions R-HSA-216083,4.780799782544971,0.03468858889398459,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Regulation Of TP53 Degradation R-HSA-6804757,10.026931189894947,0.002949850325293457,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Chromatin Modifying Enzymes R-HSA-3247509,4.60075171460501,0.03808430954860855,Other Types
Mature B-Cell Neoplasms,RNA Polymerase III Transcription Initiation R-HSA-76046,4.208946424115734,0.04679849669073384,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Oncogene Induced Senescence R-HSA-2559585,5.006320364869681,0.03089244590983271,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Cellular Response To Chemical Stress R-HSA-9711123,4.892229270824025,0.032753127049231244,Other Types
Mature B-Cell Neoplasms,Regulation Of IFNA/IFNB Signaling R-HSA-912694,9.598088700857435,0.003555403574122093,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,5.498230754615357,0.024085562015171594,Other Types
Mature B-Cell Neoplasms,Transcriptional Regulation By E2F6 R-HSA-8953750,6.181517670579814,0.017184101698346114,Other Types
Mature B-Cell Neoplasms,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,12.253919911909339,0.0011558509632932934,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Transcriptional Regulation By TP53 R-HSA-3700989,16.20297394252883,0.00024638780395375983,Other Types
Mature B-Cell Neoplasms,Diseases Of Glycosylation R-HSA-3781865,11.871561728953173,0.0013525939449349639,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,HATs Acetylate Histones R-HSA-3214847,5.269390583187284,0.027024905546920733,Other Types
Mature B-Cell Neoplasms,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,4.384510101186408,0.04265009567640912,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,PKMTs Methylate Histone Lysines R-HSA-3214841,7.162973012313709,0.01073616928716078,Other Types
Mature B-Cell Neoplasms,Protein Folding R-HSA-391251,4.3923300090593616,0.04247493154054471,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Processing Of SMDT1 R-HSA-8949664,5.271503627932399,0.026996051432225394,Other Types
Mature B-Cell Neoplasms,p75NTR Signals Via NF-kB R-HSA-193639,5.071989440889235,0.02987377380455111,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,4.838557975665741,0.03367027940734144,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Interleukin-7 Signaling R-HSA-1266695,16.63711800301497,0.00020952874976455085,Other Types
Mature B-Cell Neoplasms,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,14.273909487047717,0.0005154778794917908,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,5.905411647446326,0.019674859709859514,Other Types
Mature B-Cell Neoplasms,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,5.822157203818326,0.02050023248522468,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Mitophagy R-HSA-5205647,7.348179438974505,0.009841574031230003,Other Types
Mature B-Cell Neoplasms,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,10.648151125690637,0.002259269000661655,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Pyruvate Metabolism R-HSA-70268,4.491153918249438,0.04032779976400967,Other Types
Mature B-Cell Neoplasms,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,6.693069362167317,0.013420789818818932,Other Types
Mature B-Cell Neoplasms,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,7.863364263111226,0.007747157215698737,Other Types
Mature B-Cell Neoplasms,E2F Mediated Regulation Of DNA Replication R-HSA-113510,5.462117615682409,0.024525455976568678,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,PTK6 Regulates Cell Cycle R-HSA-8849470,14.831651182395442,0.0004150999146553947,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Extra-nuclear Estrogen Signaling R-HSA-9009391,6.243460840423841,0.01667331434756854,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,SLC-mediated Transmembrane Transport R-HSA-425407,11.920872842803492,0.0013253422714800474,Other Types
Mature B-Cell Neoplasms,Amino Acid Transport Across Plasma Membrane R-HSA-352230,6.386093814936059,0.015558188918646635,Other Types
Mature B-Cell Neoplasms,Signaling By NOTCH2 R-HSA-1980145,6.626759670621529,0.013854241275356996,Other Types
Mature B-Cell Neoplasms,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,6.314141201804632,0.016110351277828172,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,4.125254519859245,0.048930133912449256,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,13.834269066906499,0.0006125896480734518,Other Types
Mature B-Cell Neoplasms,Glycosaminoglycan Metabolism R-HSA-1630316,12.10784355079032,0.0012271788474842438,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Intrinsic Pathway For Apoptosis R-HSA-109606,19.237989146267886,8.169501935676468e-05,Other Types
Mature B-Cell Neoplasms,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,4.714149358378628,0.035905533156222316,Other Types
Mature B-Cell Neoplasms,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,4.453052848436404,0.04114122825885928,Other Types
Mature B-Cell Neoplasms,Intra-Golgi Traffic R-HSA-6811438,6.954220313868177,0.011849995142002873,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,8.945418367228166,0.0047441552634270474,Other Types
Mature B-Cell Neoplasms,SUMOylation Of Intracellular Receptors R-HSA-4090294,9.982280115710513,0.0030074553974328362,Other Types
Mature B-Cell Neoplasms,Nephrin Family Interactions R-HSA-373753,4.818445174372852,0.03402113885652904,Other Types
Mature B-Cell Neoplasms,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,5.478139503301458,0.024329230450997826,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",11.875057640377642,0.0013506425316689764,Other Types
Mature B-Cell Neoplasms,Adherens Junctions Interactions R-HSA-418990,4.4102118744391765,0.042077331891845426,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Potential Therapeutics For SARS R-HSA-9679191,11.682691374438672,0.0014625890590107518,Other Types
Mature B-Cell Neoplasms,Transcription Of HIV Genome R-HSA-167172,6.167047698881987,0.017305831849175418,Other Types
Mature B-Cell Neoplasms,Iron Uptake And Transport R-HSA-917937,7.681750734795984,0.008425249175690172,Other Types
Mature B-Cell Neoplasms,Basigin Interactions R-HSA-210991,11.912188842049769,0.0013300989622275373,Other Types
Mature B-Cell Neoplasms,SUMOylation Of Transcription Cofactors R-HSA-3899300,7.534695790673272,0.009020755916599016,Other Types
Mature B-Cell Neoplasms,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,14.829096625501464,0.0004155093927057598,Other Types
Mature B-Cell Neoplasms,Late SARS-CoV-2 Infection Events R-HSA-9772573,5.398173547634872,0.025325823673616833,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Epigenetic Regulation Of Gene Expression R-HSA-212165,13.5385359415483,0.0006886670044815285,Other Types
Mature B-Cell Neoplasms,Inositol Phosphate Metabolism R-HSA-1483249,6.544194449987939,0.014415067825494838,Other Types
Mature B-Cell Neoplasms,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,5.362503183107317,0.02578454357326761,Other Types
Mature B-Cell Neoplasms,SHC1 Events In ERBB2 Signaling R-HSA-1250196,4.526128227466917,0.039596574336786546,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,6.304145104474806,0.016188712890794876,Other Types
Mature B-Cell Neoplasms,Aggrephagy R-HSA-9646399,8.563587421745487,0.0056303329441981815,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,7.644073242827725,0.008573711385239453,Other Types
Mature B-Cell Neoplasms,Interleukin-37 Signaling R-HSA-9008059,4.986272936904676,0.031210894284191913,Other Types
Mature B-Cell Neoplasms,"WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",4.941425444751802,0.03193627448419595,Other Types
Mature B-Cell Neoplasms,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,4.941425375528909,0.03193627561787257,Other Types
Mature B-Cell Neoplasms,Retrograde Neurotrophin Signaling R-HSA-177504,4.182551368271618,0.047459567909345995,Other Types
Mature B-Cell Neoplasms,HDACs Deacetylate Histones R-HSA-3214815,4.641157134000718,0.0372918746658789,Other Types
Mature B-Cell Neoplasms,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",5.353667058259263,0.025899560494525273,Other Types
Mature B-Cell Neoplasms,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",4.281666893412184,0.04502885172043198,Other Types
Mature B-Cell Neoplasms,Nef Mediated CD4 Down-regulation R-HSA-167590,4.872234397222181,0.033091590411911315,Other Types
Mature B-Cell Neoplasms,Nef Mediated CD8 Down-regulation R-HSA-182218,4.872234397222181,0.033091590411911315,Other Types
Mature B-Cell Neoplasms,Regulation Of Beta-Cell Development R-HSA-186712,9.303968932426919,0.004046288978354915,Other Types
Mature B-Cell Neoplasms,RND3 GTPase Cycle R-HSA-9696264,4.638567924330822,0.03734211148609263,Other Types
Mature B-Cell Neoplasms,Regulation Of Gene Expression In Beta Cells R-HSA-210745,9.718240079907224,0.003373450799492413,Other Types
Mature B-Cell Neoplasms,Activation Of HOX Genes During Differentiation R-HSA-5619507,6.20469640876511,0.016991023988128396,Other Types
Mature B-Cell Neoplasms,LDL Clearance R-HSA-8964038,4.533967538398865,0.03943466835246313,Other Types
Mature B-Cell Neoplasms,VLDLR Internalisation And Degradation R-HSA-8866427,4.520284182892995,0.0397177441782434,Other Types
Mature B-Cell Neoplasms,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,5.968256470585964,0.019075568424838863,Other Types
Mature B-Cell Neoplasms,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,4.782888998326742,0.03465117603326652,Other Types
Mature B-Cell Neoplasms,DNA Repair R-HSA-73894,4.15677996875542,0.04811491819394992,Other Types
Mature B-Cell Neoplasms,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,4.562872802125521,0.038843902184217814,Mature B-Cell Neoplasms
Mature B-Cell Neoplasms,Signaling By NOTCH3 R-HSA-9012852,7.612506016823529,0.008700249454771504,Other Types
Acute Myeloid Leukemia,Cristae Formation R-HSA-8949613,9.738172744975936,0.0036687206418518866,Other Types
Acute Myeloid Leukemia,Golgi-to-ER Retrograde Transport R-HSA-8856688,8.028488234311357,0.007690222655512377,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,7.382003854705603,0.010286435921916266,Acute Myeloid Leukemia
Acute Myeloid Leukemia,VEGFA-VEGFR2 Pathway R-HSA-4420097,4.978897205470845,0.032358673108677474,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Asparagine N-linked Glycosylation R-HSA-446203,4.8421610479337405,0.03466465781649968,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Cytoprotection By HMOX1 R-HSA-9707564,5.183586736762947,0.029214458205493926,Other Types
Acute Myeloid Leukemia,TP53 Regulates Metabolic Genes R-HSA-5628897,12.038158892598508,0.001435876258245004,Other Types
Acute Myeloid Leukemia,Signaling By MET R-HSA-6806834,5.006800198847268,0.031909056200607314,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Signaling By VEGF R-HSA-194138,4.8863058729602775,0.033901075421257865,Acute Myeloid Leukemia
Acute Myeloid Leukemia,FCGR3A-mediated Phagocytosis R-HSA-9664422,6.078482620464091,0.018888721514022554,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Metabolism Of Nucleotides R-HSA-15869,15.708671859979033,0.00035957759315959,Other Types
Acute Myeloid Leukemia,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,9.485716178659416,0.004082279855433045,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,5.145588177534735,0.029771924764267283,Acute Myeloid Leukemia
Acute Myeloid Leukemia,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,5.830044686828451,0.02128413008594896,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,6.0749502756838645,0.01892065266640149,Acute Myeloid Leukemia
Acute Myeloid Leukemia,RAC3 GTPase Cycle R-HSA-9013423,4.342748516194016,0.044753243815073125,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Mitochondrial Translation R-HSA-5368287,6.592576479871269,0.014809459451358324,Other Types
Acute Myeloid Leukemia,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,7.943648837351604,0.007986514949848329,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Platelet Aggregation (Plug Formation) R-HSA-76009,6.342477820280363,0.016659978340821648,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Integrin Signaling R-HSA-354192,6.342477820280363,0.016659978340821648,Acute Myeloid Leukemia
Acute Myeloid Leukemia,EPHB-mediated Forward Signaling R-HSA-3928662,11.37630637654627,0.001869313768048184,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Protein Localization R-HSA-9609507,4.650711571372245,0.03820170560985574,Other Types
Acute Myeloid Leukemia,Mitochondrial Translation Termination R-HSA-5419276,17.4602194980242,0.0001935476356689443,Other Types
Acute Myeloid Leukemia,RHO GTPase Effectors R-HSA-195258,4.358394634162151,0.0443920618382158,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Nucleotide Biosynthesis R-HSA-8956320,15.722528156731839,0.00035778509599603166,Other Types
Acute Myeloid Leukemia,Mitochondrial Translation Initiation R-HSA-5368286,9.081127743472047,0.004852822023230101,Other Types
Acute Myeloid Leukemia,Metabolism Of Vitamins And Cofactors R-HSA-196854,12.083493476748263,0.001410405538612991,Other Types
Acute Myeloid Leukemia,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,6.771873253080305,0.013620166098797409,Other Types
Acute Myeloid Leukemia,Mitochondrial Translation Elongation R-HSA-5389840,6.761516840908473,0.013685973305651808,Other Types
Acute Myeloid Leukemia,Cell-Cell Communication R-HSA-1500931,5.523677338399075,0.024703172404604238,Acute Myeloid Leukemia
Acute Myeloid Leukemia,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,8.608768359663781,0.0059549113948189104,Acute Myeloid Leukemia
Acute Myeloid Leukemia,RHOJ GTPase Cycle R-HSA-9013409,6.138629982012172,0.018353890398857986,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Cell Junction Organization R-HSA-446728,17.524970825341466,0.00018925328946239065,Acute Myeloid Leukemia
Acute Myeloid Leukemia,XBP1(S) Activates Chaperone Genes R-HSA-381038,5.223674474199576,0.028638679066265573,Acute Myeloid Leukemia
Acute Myeloid Leukemia,IRE1alpha Activates Chaperones R-HSA-381070,5.223674474199576,0.028638679066265573,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Smooth Muscle Contraction R-HSA-445355,4.683579797725707,0.03756729765869544,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,6.585026562383117,0.014861943644352338,Other Types
Acute Myeloid Leukemia,Metabolism R-HSA-1430728,11.731955557504271,0.0016213081670283047,Other Types
Acute Myeloid Leukemia,Heme Biosynthesis R-HSA-189451,8.797482582331194,0.00548537173409992,Other Types
Acute Myeloid Leukemia,Metabolism Of Porphyrins R-HSA-189445,8.797481936205623,0.005485373271960986,Other Types
Acute Myeloid Leukemia,Drug ADME R-HSA-9748784,8.25380802332951,0.006959221432139903,Other Types
Acute Myeloid Leukemia,Prolonged ERK Activation Events R-HSA-169893,6.685257210634024,0.0141812635592176,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,4.527649137617065,0.040683726268379544,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,19.42526987492883,9.931922864663537e-05,Other Types
Acute Myeloid Leukemia,Citric Acid Cycle (TCA Cycle) R-HSA-71403,7.490597403370734,0.009791428203531507,Other Types
Acute Myeloid Leukemia,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,6.454240584912522,0.015803808098744824,Other Types
Acute Myeloid Leukemia,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,7.168294216762691,0.011341228195090435,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Ubiquinol Biosynthesis R-HSA-2142789,5.582598824411591,0.02400178869208139,Other Types
Acute Myeloid Leukemia,DCC Mediated Attractive Signaling R-HSA-418885,5.904779222321771,0.020530582184661823,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Metabolism Of Cofactors R-HSA-8978934,6.772910204028978,0.013613595920985109,Other Types
Acute Myeloid Leukemia,Unfolded Protein Response (UPR) R-HSA-381119,4.678919708960413,0.03765653630005263,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Frs2-mediated Activation R-HSA-170968,10.250505936030924,0.002961021561746123,Acute Myeloid Leukemia
Acute Myeloid Leukemia,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,9.124390959338678,0.004763429863600375,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Kinesins R-HSA-983189,7.543511780921089,0.009559583735757634,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,4.699951621894694,0.03725562104690492,Acute Myeloid Leukemia
Acute Myeloid Leukemia,ERBB2 Regulates Cell Motility R-HSA-6785631,8.404412785324398,0.0065124847411101704,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Late Phase Of HIV Life Cycle R-HSA-162599,5.951799447549994,0.020071365288613443,Other Types
Acute Myeloid Leukemia,Cilium Assembly R-HSA-5617833,12.432923530007232,0.0012295406415288456,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,8.425269842708095,0.006453087280966315,Acute Myeloid Leukemia
Acute Myeloid Leukemia,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,7.3122541862786585,0.010618567925543023,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,5.098701375942661,0.030475870954794395,Acute Myeloid Leukemia
Acute Myeloid Leukemia,MAP2K And MAPK Activation R-HSA-5674135,6.153282802189475,0.018226101184845214,Acute Myeloid Leukemia
Acute Myeloid Leukemia,VxPx Cargo-Targeting To Cilium R-HSA-5620916,5.527396390263838,0.024658248013671707,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,11.735601047664982,0.0016189559015664006,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,7.984983424646596,0.00784065279161864,Acute Myeloid Leukemia
Acute Myeloid Leukemia,GPER1 Signaling R-HSA-9634597,5.8705708524224525,0.020871843757855776,Acute Myeloid Leukemia
Acute Myeloid Leukemia,HIV Life Cycle R-HSA-162587,5.7939826825755185,0.021658451226568717,Other Types
Acute Myeloid Leukemia,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,6.932160057696595,0.012644104512995054,Other Types
Acute Myeloid Leukemia,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,9.290410250685317,0.0044364404677958765,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Post NMDA Receptor Activation Events R-HSA-438064,11.70206306304194,0.0016407346154602744,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Cell-cell Junction Organization R-HSA-421270,7.037424979615181,0.012044367060886144,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Defective Pyroptosis R-HSA-9710421,4.505143658293327,0.04115654524428978,Other Types
Acute Myeloid Leukemia,Regulation Of IFNG Signaling R-HSA-877312,4.55255680243423,0.040167396534645884,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,11.492913875975798,0.0017838084313925066,Acute Myeloid Leukemia
Acute Myeloid Leukemia,AURKA Activation By TPX2 R-HSA-8854518,6.352493196444035,0.016581241704492707,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Centrosome Maturation R-HSA-380287,4.699089609113627,0.03727196049638259,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,5.939388986940881,0.02019147657700724,Other Types
Acute Myeloid Leukemia,RNA Polymerase III Transcription Termination R-HSA-73980,6.953629474013992,0.012519215022776597,Acute Myeloid Leukemia
Acute Myeloid Leukemia,mRNA Capping R-HSA-72086,4.609972604671874,0.03900442270419223,Other Types
Acute Myeloid Leukemia,Glycolysis R-HSA-70171,4.9286417800562745,0.03318606737312563,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Regulation Of IFNA/IFNB Signaling R-HSA-912694,6.153447504296198,0.018224670292540886,Acute Myeloid Leukemia
Acute Myeloid Leukemia,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,5.738382349097473,0.022249679431642817,Other Types
Acute Myeloid Leukemia,Transcriptional Regulation By E2F6 R-HSA-8953750,6.0736242152316136,0.0189326549057404,Other Types
Acute Myeloid Leukemia,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,4.457910199974716,0.042168670394705475,Other Types
Acute Myeloid Leukemia,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,4.448287341233377,0.042378213448781114,Other Types
Acute Myeloid Leukemia,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,6.786976345495108,0.013524809742902103,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Transcriptional Regulation By TP53 R-HSA-3700989,8.917864708760092,0.005206720585877077,Other Types
Acute Myeloid Leukemia,Diseases Of Glycosylation R-HSA-3781865,7.807120773514877,0.008489423861167859,Acute Myeloid Leukemia
Acute Myeloid Leukemia,PKMTs Methylate Histone Lysines R-HSA-3214841,5.720556532976441,0.02244292912309313,Other Types
Acute Myeloid Leukemia,HIV Transcription Initiation R-HSA-167161,10.23436353859586,0.002980936677254693,Other Types
Acute Myeloid Leukemia,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,4.8722817328613255,0.03414163671678235,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Interleukin-7 Signaling R-HSA-1266695,15.528954173932874,0.00038371248710736175,Other Types
Acute Myeloid Leukemia,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,8.439062587843734,0.00641412771367895,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,7.6274356509254515,0.009203914711242298,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,6.789286114713672,0.013510290295268797,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Unwinding Of DNA R-HSA-176974,5.871804174378444,0.020859433630468993,Other Types
Acute Myeloid Leukemia,tRNA Processing In Nucleus R-HSA-6784531,4.609086125737349,0.039022094654348256,Acute Myeloid Leukemia
Acute Myeloid Leukemia,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,4.518724439986758,0.04087050670256411,Other Types
Acute Myeloid Leukemia,E2F Mediated Regulation Of DNA Replication R-HSA-113510,5.591324016749562,0.02389978335519625,Acute Myeloid Leukemia
Acute Myeloid Leukemia,PTK6 Regulates Cell Cycle R-HSA-8849470,12.211682507382003,0.0013409587045426438,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Extra-nuclear Estrogen Signaling R-HSA-9009391,9.76987396005857,0.0036200495252021185,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Detoxification Of Reactive Oxygen Species R-HSA-3299685,4.596647672823096,0.03927098559212953,Acute Myeloid Leukemia
Acute Myeloid Leukemia,SLC-mediated Transmembrane Transport R-HSA-425407,6.958270636916748,0.01249239251748966,Other Types
Acute Myeloid Leukemia,Amino Acid Transport Across Plasma Membrane R-HSA-352230,4.387668924888377,0.04372488348224523,Other Types
Acute Myeloid Leukemia,RNA Polymerase II Pre-transcription Events R-HSA-674695,8.18930333996151,0.00716053902968105,Other Types
Acute Myeloid Leukemia,RND2 GTPase Cycle R-HSA-9696270,4.395218125974115,0.043554631093538396,Other Types
Acute Myeloid Leukemia,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,6.48697531886132,0.015562153684597903,Other Types
Acute Myeloid Leukemia,NoRC Negatively Regulates rRNA Expression R-HSA-427413,5.540484438266923,0.024500856964933374,Other Types
Acute Myeloid Leukemia,Formation Of RNA Pol II Elongation Complex R-HSA-112382,5.611360579957004,0.023667320115761815,Other Types
Acute Myeloid Leukemia,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,9.577079181730877,0.003927120478692854,Other Types
Acute Myeloid Leukemia,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,6.00739870936889,0.01954270679137109,Other Types
Acute Myeloid Leukemia,Glycosaminoglycan Metabolism R-HSA-1630316,9.382607089202972,0.004265315690094741,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Intrinsic Pathway For Apoptosis R-HSA-109606,13.096625525928212,0.0009506494248922059,Other Types
Acute Myeloid Leukemia,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,4.763785285749601,0.03606723032295701,Other Types
Acute Myeloid Leukemia,Dual Incision In TC-NER R-HSA-6782135,6.228258323637391,0.017587155295139982,Other Types
Acute Myeloid Leukemia,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,9.437689723750623,0.004166464997953013,Other Types
Acute Myeloid Leukemia,SUMOylation Of Intracellular Receptors R-HSA-4090294,4.954171674057244,0.03276289016837102,Other Types
Acute Myeloid Leukemia,Telomere Extension By Telomerase R-HSA-171319,4.997310468324228,0.03206119754909836,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,5.541423922590773,0.024489601318209753,Acute Myeloid Leukemia
Acute Myeloid Leukemia,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",17.41231867715003,0.0001967910681097701,Other Types
Acute Myeloid Leukemia,Adherens Junctions Interactions R-HSA-418990,10.329372354797147,0.0028657488158505507,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Nucleotide Excision Repair R-HSA-5696398,4.3355718973391815,0.04491999548305383,Other Types
Acute Myeloid Leukemia,Potential Therapeutics For SARS R-HSA-9679191,9.916842849782016,0.003403269152123508,Other Types
Acute Myeloid Leukemia,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,4.254595408396071,0.04684979462909157,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Transcription Of HIV Genome R-HSA-167172,13.933177548788032,0.0006916049041397828,Other Types
Acute Myeloid Leukemia,Iron Uptake And Transport R-HSA-917937,5.821038638413869,0.021376948725398623,Other Types
Acute Myeloid Leukemia,Basigin Interactions R-HSA-210991,7.610417825274708,0.009274866998630808,Other Types
Acute Myeloid Leukemia,DNA Strand Elongation R-HSA-69190,6.13961596698278,0.01834526106081824,Other Types
Acute Myeloid Leukemia,SUMOylation Of Transcription Cofactors R-HSA-3899300,6.1474467991110116,0.018276881724700402,Other Types
Acute Myeloid Leukemia,Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,5.15005360773754,0.029705814777630905,Acute Myeloid Leukemia
Acute Myeloid Leukemia,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,11.844989242384711,0.0015500410668216123,Other Types
Acute Myeloid Leukemia,Late SARS-CoV-2 Infection Events R-HSA-9772573,6.8746947427327125,0.012985056398783357,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Epigenetic Regulation Of Gene Expression R-HSA-212165,12.25332487162802,0.0013191915286386302,Other Types
Acute Myeloid Leukemia,HIV Elongation Arrest And Recovery R-HSA-167287,4.2332451773874915,0.047373730560713555,Other Types
Acute Myeloid Leukemia,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,4.204621760774144,0.04808633582015041,Other Types
Acute Myeloid Leukemia,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,5.794504607715309,0.021652982910394993,Other Types
Acute Myeloid Leukemia,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,6.758822725208159,0.013703148670966971,Other Types
Acute Myeloid Leukemia,RHO GTPases Activate IQGAPs R-HSA-5626467,5.133815334730317,0.029946992041420234,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,7.386526810059976,0.010265288856432764,Other Types
Acute Myeloid Leukemia,Aggrephagy R-HSA-9646399,4.399002337522483,0.043469563216213404,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,4.210658367824387,0.047935069113559096,Other Types
Acute Myeloid Leukemia,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,7.353845574116795,0.010419150967072181,Other Types
Acute Myeloid Leukemia,Interleukin-37 Signaling R-HSA-9008059,4.22078741567896,0.04768243317341935,Other Types
Acute Myeloid Leukemia,FOXO-mediated Transcription R-HSA-9614085,6.276773121193125,0.01718667665933945,Other Types
Acute Myeloid Leukemia,HDACs Deacetylate Histones R-HSA-3214815,11.972548515410251,0.0014736118817183469,Other Types
Acute Myeloid Leukemia,E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,4.68864819852944,0.03747050363509269,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Pre-NOTCH Transcription And Translation R-HSA-1912408,4.259306735441137,0.04673504241265603,Other Types
Acute Myeloid Leukemia,Regulation Of Beta-Cell Development R-HSA-186712,9.22628919760369,0.004559786385964104,Other Types
Acute Myeloid Leukemia,RND3 GTPase Cycle R-HSA-9696264,8.015484975286899,0.007734857095011303,Other Types
Acute Myeloid Leukemia,Regulation Of Gene Expression In Beta Cells R-HSA-210745,10.277490735738985,0.002928047252399785,Other Types
Acute Myeloid Leukemia,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,7.073437765580221,0.01184629938696812,Other Types
Acute Myeloid Leukemia,Dual Incision In GG-NER R-HSA-5696400,4.963629104251145,0.03260762925295711,Other Types
Acute Myeloid Leukemia,RND1 GTPase Cycle R-HSA-9696273,4.445087391889102,0.042448148016659706,Other Types
Acute Myeloid Leukemia,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,4.498096402905357,0.041305842416213864,Other Types
Acute Myeloid Leukemia,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,8.664209029786901,0.005812647020766432,Acute Myeloid Leukemia
Acute Myeloid Leukemia,Lagging Strand Synthesis R-HSA-69186,5.0032236443843185,0.031966303279572554,Other Types
Acute Myeloid Leukemia,Signaling By NOTCH3 R-HSA-9012852,6.539815716826216,0.015180474453920099,Other Types
Mature T and NK Neoplasms,Cristae Formation R-HSA-8949613,9.901703336846547,0.003713956059455413,Other Types
Mature T and NK Neoplasms,Golgi-to-ER Retrograde Transport R-HSA-8856688,8.356471120114385,0.007080371793622337,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,8.721234977573928,0.006061535018097334,Mature T and NK Neoplasms
Mature T and NK Neoplasms,VEGFA-VEGFR2 Pathway R-HSA-4420097,4.850514574467509,0.035462839967862196,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Asparagine N-linked Glycosylation R-HSA-446203,4.491969550817944,0.04244147328300826,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Cytoprotection By HMOX1 R-HSA-9707564,5.192264188443211,0.029973884575416693,Other Types
Mature T and NK Neoplasms,TP53 Regulates Metabolic Genes R-HSA-5628897,19.121964251017996,0.00013584570046280378,Other Types
Mature T and NK Neoplasms,Signaling By MET R-HSA-6806834,5.808295930493215,0.022289700826283326,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Signaling By VEGF R-HSA-194138,4.75739153849031,0.03714450188943447,Mature T and NK Neoplasms
Mature T and NK Neoplasms,FCGR3A-mediated Phagocytosis R-HSA-9664422,7.3393413318678995,0.01103918672808668,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Metabolism Of Nucleotides R-HSA-15869,13.82066703164864,0.0008244511519338037,Other Types
Mature T and NK Neoplasms,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,9.829118538810588,0.0038254463837123385,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,6.086301550854245,0.019553515247659626,Mature T and NK Neoplasms
Mature T and NK Neoplasms,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,6.572104909015707,0.015611791050195709,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,7.374195698382495,0.01086941470871223,Mature T and NK Neoplasms
Mature T and NK Neoplasms,RAC3 GTPase Cycle R-HSA-9013423,4.794600262627233,0.03646222776526881,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Mitochondrial Translation R-HSA-5368287,6.384480666373096,0.017020659677299963,Other Types
Mature T and NK Neoplasms,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,9.297087419131401,0.004761707134853456,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Platelet Aggregation (Plug Formation) R-HSA-76009,7.072092903128241,0.012440804954183088,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Integrin Signaling R-HSA-354192,7.072092903128241,0.012440804954183088,Mature T and NK Neoplasms
Mature T and NK Neoplasms,EPHB-mediated Forward Signaling R-HSA-3928662,11.27916050065796,0.0021453564612891733,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Protein Localization R-HSA-9609507,4.864452463177453,0.03521845466464454,Other Types
Mature T and NK Neoplasms,Mitochondrial Translation Termination R-HSA-5419276,18.527640166855683,0.00016443532307552008,Other Types
Mature T and NK Neoplasms,RHO GTPase Effectors R-HSA-195258,4.389382401576293,0.044708706782503244,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Nucleotide Biosynthesis R-HSA-8956320,18.151819327473056,0.00018579379424414996,Other Types
Mature T and NK Neoplasms,Mitochondrial Translation Initiation R-HSA-5368286,7.734774671735819,0.009270236117704835,Other Types
Mature T and NK Neoplasms,Metabolism Of Vitamins And Cofactors R-HSA-196854,10.44179508930336,0.0029866050683778284,Other Types
Mature T and NK Neoplasms,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,6.494560561232257,0.016178029842330844,Other Types
Mature T and NK Neoplasms,Mitochondrial Translation Elongation R-HSA-5389840,5.717469535775047,0.02327236168143188,Other Types
Mature T and NK Neoplasms,Cell-Cell Communication R-HSA-1500931,5.286999038925621,0.02862306949928427,Mature T and NK Neoplasms
Mature T and NK Neoplasms,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,9.002441592847541,0.005384449878488982,Mature T and NK Neoplasms
Mature T and NK Neoplasms,RHOJ GTPase Cycle R-HSA-9013409,5.498497971322327,0.025842366976651984,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Cell Junction Organization R-HSA-446728,15.429345060662808,0.0004651937862968122,Mature T and NK Neoplasms
Mature T and NK Neoplasms,XBP1(S) Activates Chaperone Genes R-HSA-381038,4.889916046991539,0.03477676425374276,Mature T and NK Neoplasms
Mature T and NK Neoplasms,IRE1alpha Activates Chaperones R-HSA-381070,4.889916046991539,0.03477676425374276,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,6.22871814197274,0.018295874076266778,Other Types
Mature T and NK Neoplasms,Metabolism R-HSA-1430728,10.101900698276719,0.0034242172889609418,Other Types
Mature T and NK Neoplasms,Heme Biosynthesis R-HSA-189451,10.491195449518482,0.0029281896262121094,Other Types
Mature T and NK Neoplasms,Metabolism Of Porphyrins R-HSA-189445,10.491194850872967,0.0029281903266007298,Other Types
Mature T and NK Neoplasms,Drug ADME R-HSA-9748784,9.18196672412809,0.004995232165348847,Other Types
Mature T and NK Neoplasms,Prolonged ERK Activation Events R-HSA-169893,6.84579170970334,0.01377948630253057,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,21.37605729654865,6.732615393408622e-05,Other Types
Mature T and NK Neoplasms,Citric Acid Cycle (TCA Cycle) R-HSA-71403,7.296996120063214,0.011249330922655811,Other Types
Mature T and NK Neoplasms,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,7.273657157173255,0.011367008131708427,Other Types
Mature T and NK Neoplasms,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,8.188975948054143,0.007609039695122723,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Ubiquinol Biosynthesis R-HSA-2142789,5.198925637052616,0.02987664265067618,Other Types
Mature T and NK Neoplasms,DCC Mediated Attractive Signaling R-HSA-418885,5.4952189044229245,0.025883144456816946,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Metabolism Of Cofactors R-HSA-8978934,6.2745685055716,0.017909997727152533,Other Types
Mature T and NK Neoplasms,Unfolded Protein Response (UPR) R-HSA-381119,4.485996737538739,0.042569922125591665,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Frs2-mediated Activation R-HSA-170968,8.835200272995172,0.005776641940532513,Mature T and NK Neoplasms
Mature T and NK Neoplasms,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,7.84586114112716,0.008830481216349901,Mature T and NK Neoplasms
Mature T and NK Neoplasms,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,4.55226818333091,0.041168497247806496,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Kinesins R-HSA-983189,11.408144662712296,0.0020402690533796756,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,5.098635342548637,0.03137814889758489,Mature T and NK Neoplasms
Mature T and NK Neoplasms,ERBB2 Regulates Cell Motility R-HSA-6785631,9.112052432791359,0.005143071044313798,Mature T and NK Neoplasms
Mature T and NK Neoplasms,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,4.515339797651281,0.04194299497154696,Other Types
Mature T and NK Neoplasms,Late Phase Of HIV Life Cycle R-HSA-162599,7.500002291517175,0.010279810111336867,Other Types
Mature T and NK Neoplasms,Cilium Assembly R-HSA-5617833,12.252228785888125,0.0014755595944234326,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,8.343879105691874,0.0071187005921828925,Mature T and NK Neoplasms
Mature T and NK Neoplasms,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,7.2483855559702,0.01149593968544081,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,4.91582361162427,0.03433363658477884,Mature T and NK Neoplasms
Mature T and NK Neoplasms,MAP2K And MAPK Activation R-HSA-5674135,6.278052389584891,0.017881042671717813,Mature T and NK Neoplasms
Mature T and NK Neoplasms,VxPx Cargo-Targeting To Cilium R-HSA-5620916,4.899009750723186,0.03462050929396164,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,11.667105919454503,0.001845630980933276,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,9.262514067538163,0.00483057619155516,Mature T and NK Neoplasms
Mature T and NK Neoplasms,GPER1 Signaling R-HSA-9634597,5.322386795003066,0.028135767381371874,Mature T and NK Neoplasms
Mature T and NK Neoplasms,HIV Life Cycle R-HSA-162587,7.228166103114429,0.01160024022223795,Other Types
Mature T and NK Neoplasms,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,7.5649035466933565,0.009989295975714492,Other Types
Mature T and NK Neoplasms,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,9.118138351154446,0.0051300159918761115,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Depolymerisation Of Nuclear Lamina R-HSA-4419969,4.25895416415465,0.04778765485219296,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Post NMDA Receptor Activation Events R-HSA-438064,11.311113007115662,0.0021187920218369936,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Cell-cell Junction Organization R-HSA-421270,5.83670097653235,0.021991780481616954,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,11.140690953091116,0.002264689730244484,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Rab Regulation Of Trafficking R-HSA-9007101,5.263315604032405,0.02895437784822612,Other Types
Mature T and NK Neoplasms,AURKA Activation By TPX2 R-HSA-8854518,6.033296989889123,0.02004545124534475,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Centrosome Maturation R-HSA-380287,4.601255046646484,0.04016543068962721,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,6.326482707346825,0.01748377913761446,Other Types
Mature T and NK Neoplasms,RNA Polymerase III Transcription Termination R-HSA-73980,5.687726126033425,0.02360439607127475,Mature T and NK Neoplasms
Mature T and NK Neoplasms,mRNA Capping R-HSA-72086,5.406300474810238,0.027016281831749266,Other Types
Mature T and NK Neoplasms,Glycolysis R-HSA-70171,6.554104566459053,0.01574127956106329,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Regulation Of IFNA/IFNB Signaling R-HSA-912694,5.67778723627251,0.023716501015099565,Mature T and NK Neoplasms
Mature T and NK Neoplasms,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,6.8750974775589135,0.013597615350416627,Other Types
Mature T and NK Neoplasms,Transcriptional Regulation By E2F6 R-HSA-8953750,5.797021655123398,0.022409171147540832,Other Types
Mature T and NK Neoplasms,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,5.020634315835788,0.0326034223654064,Other Types
Mature T and NK Neoplasms,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,5.117550411186912,0.031088721604740608,Other Types
Mature T and NK Neoplasms,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,6.5455010096228,0.015803583751996555,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Transcriptional Regulation By TP53 R-HSA-3700989,9.315450000365056,0.0047255611444773134,Other Types
Mature T and NK Neoplasms,Diseases Of Glycosylation R-HSA-3781865,6.905556690878107,0.01341135070549102,Mature T and NK Neoplasms
Mature T and NK Neoplasms,PKMTs Methylate Histone Lysines R-HSA-3214841,6.235316472558156,0.01823978774328671,Other Types
Mature T and NK Neoplasms,Protein Folding R-HSA-391251,4.336756701199884,0.045923677051112416,Mature T and NK Neoplasms
Mature T and NK Neoplasms,HIV Transcription Initiation R-HSA-167161,12.474872660243463,0.001356438823927707,Other Types
Mature T and NK Neoplasms,Chaperonin-mediated Protein Folding R-HSA-390466,4.248409532742001,0.04804668968950592,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,6.021524814941401,0.020156535057843733,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Interleukin-7 Signaling R-HSA-1266695,13.404808473722877,0.0009597057762217207,Other Types
Mature T and NK Neoplasms,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,8.298631394110153,0.007258294400474417,Mature T and NK Neoplasms
Mature T and NK Neoplasms,PI3K Events In ERBB2 Signaling R-HSA-1963642,4.921612471990438,0.034235476514812964,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,7.396054862720668,0.010764388945681993,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,6.5907753225863805,0.015478707653277204,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Unwinding Of DNA R-HSA-176974,6.530052489552347,0.015916132652624378,Other Types
Mature T and NK Neoplasms,tRNA Processing In Nucleus R-HSA-6784531,6.208555856307417,0.018468425169368134,Mature T and NK Neoplasms
Mature T and NK Neoplasms,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,4.473496399554615,0.04284014622939723,Other Types
Mature T and NK Neoplasms,E2F Mediated Regulation Of DNA Replication R-HSA-113510,4.58468951019851,0.04050156996171271,Mature T and NK Neoplasms
Mature T and NK Neoplasms,PTK6 Regulates Cell Cycle R-HSA-8849470,12.352364093943496,0.001420648979746281,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Extra-nuclear Estrogen Signaling R-HSA-9009391,9.33453216209739,0.0046883123656640754,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Detoxification Of Reactive Oxygen Species R-HSA-3299685,5.136153577988719,0.0308069310121912,Mature T and NK Neoplasms
Mature T and NK Neoplasms,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,4.191488580727766,0.04947223531398789,Mature T and NK Neoplasms
Mature T and NK Neoplasms,SLC-mediated Transmembrane Transport R-HSA-425407,7.12870982230975,0.012128468642972576,Other Types
Mature T and NK Neoplasms,Amino Acid Transport Across Plasma Membrane R-HSA-352230,5.151863752433731,0.0305711506937663,Other Types
Mature T and NK Neoplasms,Signaling By NOTCH2 R-HSA-1980145,4.17103963864146,0.04999580566963876,Other Types
Mature T and NK Neoplasms,RNA Polymerase II Pre-transcription Events R-HSA-674695,10.766795969486562,0.0026240892091159464,Other Types
Mature T and NK Neoplasms,RND2 GTPase Cycle R-HSA-9696270,4.403204479454558,0.044395542808841046,Other Types
Mature T and NK Neoplasms,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,7.520918687821621,0.010185194132242184,Other Types
Mature T and NK Neoplasms,Formation Of Early Elongation Complex R-HSA-113418,4.988395799741255,0.0331251552900168,Other Types
Mature T and NK Neoplasms,NoRC Negatively Regulates rRNA Expression R-HSA-427413,6.740537831037901,0.01445484719216906,Other Types
Mature T and NK Neoplasms,Formation Of RNA Pol II Elongation Complex R-HSA-112382,8.82657057189198,0.00579769993200312,Other Types
Mature T and NK Neoplasms,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,7.965968144599202,0.008380319834185617,Other Types
Mature T and NK Neoplasms,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,7.245998711326301,0.011508198839319361,Other Types
Mature T and NK Neoplasms,Glycosaminoglycan Metabolism R-HSA-1630316,8.145521404225626,0.007753074750931054,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Intrinsic Pathway For Apoptosis R-HSA-109606,12.41389732448277,0.0013879987949110078,Other Types
Mature T and NK Neoplasms,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,4.897741328499274,0.034642257733113635,Other Types
Mature T and NK Neoplasms,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,5.816136274827275,0.022207030032805213,Other Types
Mature T and NK Neoplasms,Dual Incision In TC-NER R-HSA-6782135,7.155715738856888,0.011982497667006405,Other Types
Mature T and NK Neoplasms,PPARA Activates Gene Expression R-HSA-1989781,4.760919849877989,0.03707920384168146,Other Types
Mature T and NK Neoplasms,Intra-Golgi Traffic R-HSA-6811438,4.396782536989969,0.04454073963797643,Mature T and NK Neoplasms
Mature T and NK Neoplasms,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,10.967005858058114,0.002424570649189408,Other Types
Mature T and NK Neoplasms,SUMOylation Of Intracellular Receptors R-HSA-4090294,7.350392312934671,0.010985048839648579,Other Types
Mature T and NK Neoplasms,Telomere Extension By Telomerase R-HSA-171319,4.577891249772296,0.04064041703286196,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,5.412819688347849,0.026931379953215942,Mature T and NK Neoplasms
Mature T and NK Neoplasms,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",21.520890476486304,6.443141197996976e-05,Other Types
Mature T and NK Neoplasms,DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,4.31464304948238,0.04644511882499247,Other Types
Mature T and NK Neoplasms,Adherens Junctions Interactions R-HSA-418990,9.838934493079714,0.0038101602364488184,Mature T and NK Neoplasms
Mature T and NK Neoplasms,tRNA Processing R-HSA-72306,6.029357086255348,0.020082554013496966,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Nucleotide Excision Repair R-HSA-5696398,4.765103009788735,0.0370019508581762,Other Types
Mature T and NK Neoplasms,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,5.555333721097976,0.025146657752363046,Other Types
Mature T and NK Neoplasms,Potential Therapeutics For SARS R-HSA-9679191,13.40693340020218,0.0009589569757503794,Other Types
Mature T and NK Neoplasms,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,5.700179117206166,0.023464752259049045,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Transcription Of HIV Genome R-HSA-167172,17.5885906854511,0.0002235542366410349,Other Types
Mature T and NK Neoplasms,Iron Uptake And Transport R-HSA-917937,8.673178246428495,0.006186190338591015,Other Types
Mature T and NK Neoplasms,Basigin Interactions R-HSA-210991,10.382196795519762,0.003058755861755018,Other Types
Mature T and NK Neoplasms,DNA Strand Elongation R-HSA-69190,7.259690306369951,0.011438069382117382,Other Types
Mature T and NK Neoplasms,SUMOylation Of Transcription Cofactors R-HSA-3899300,9.46808534206779,0.004436321084138314,Other Types
Mature T and NK Neoplasms,Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,6.8197981366367095,0.01394301863960912,Mature T and NK Neoplasms
Mature T and NK Neoplasms,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,14.106842149240816,0.0007433415978629902,Other Types
Mature T and NK Neoplasms,Late SARS-CoV-2 Infection Events R-HSA-9772573,6.733132040214923,0.014503705440780825,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Epigenetic Regulation Of Gene Expression R-HSA-212165,12.428664549441267,0.0013802837422356039,Other Types
Mature T and NK Neoplasms,Inositol Phosphate Metabolism R-HSA-1483249,5.604593233630541,0.024560285200905113,Other Types
Mature T and NK Neoplasms,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,4.32012978398036,0.046315130433952106,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,5.580943123735304,0.024839916975074226,Other Types
Mature T and NK Neoplasms,HIV Elongation Arrest And Recovery R-HSA-167287,6.527323716688833,0.01593610353994021,Other Types
Mature T and NK Neoplasms,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,6.309917414721602,0.017618566126564983,Other Types
Mature T and NK Neoplasms,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,8.783232640940174,0.0059047144089936525,Other Types
Mature T and NK Neoplasms,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,8.610994644327809,0.00635162052928353,Other Types
Mature T and NK Neoplasms,RHO GTPases Activate IQGAPs R-HSA-5626467,4.746567922874127,0.0373456073312636,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,8.631302375758128,0.0062970747373812305,Other Types
Mature T and NK Neoplasms,Aggrephagy R-HSA-9646399,4.81806456371927,0.03603909948939817,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Pre-NOTCH Expression And Processing R-HSA-1912422,4.250614305088666,0.047992399378957704,Other Types
Mature T and NK Neoplasms,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,9.241886451971427,0.0048721775164688955,Other Types
Mature T and NK Neoplasms,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,4.750282861350766,0.037276447574691375,Other Types
Mature T and NK Neoplasms,Interleukin-37 Signaling R-HSA-9008059,4.362533379467923,0.0453240509828326,Other Types
Mature T and NK Neoplasms,FOXO-mediated Transcription R-HSA-9614085,5.758118796888563,0.022826828405850635,Other Types
Mature T and NK Neoplasms,HDACs Deacetylate Histones R-HSA-3214815,18.255133430268597,0.00017964111847729235,Other Types
Mature T and NK Neoplasms,E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,4.206525888763817,0.049091116733542134,Mature T and NK Neoplasms
Mature T and NK Neoplasms,Pre-NOTCH Transcription And Translation R-HSA-1912408,4.815151851999126,0.03609132802157302,Other Types
Mature T and NK Neoplasms,Regulation Of Beta-Cell Development R-HSA-186712,10.10079609178841,0.0034257474067202125,Other Types
Mature T and NK Neoplasms,RND3 GTPase Cycle R-HSA-9696264,10.03604734695008,0.0035167392828385304,Other Types
Mature T and NK Neoplasms,Regulation Of Gene Expression In Beta Cells R-HSA-210745,10.936598271476319,0.002453790748368405,Other Types
Mature T and NK Neoplasms,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,7.002902871771453,0.012834429932453895,Other Types
Mature T and NK Neoplasms,Dual Incision In GG-NER R-HSA-5696400,5.189839525157899,0.030009365506219216,Other Types
Mature T and NK Neoplasms,TBC/RABGAPs R-HSA-8854214,5.018032527935533,0.03264519077158531,Other Types
Mature T and NK Neoplasms,RND1 GTPase Cycle R-HSA-9696273,4.232462872128456,0.048441399807748045,Other Types
Mature T and NK Neoplasms,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,8.9126370556252,0.00559133958997448,Mature T and NK Neoplasms
Mature T and NK Neoplasms,RNA Polymerase I Promoter Clearance R-HSA-73854,4.440360811428244,0.04356569768125193,Other Types
Mature T and NK Neoplasms,RNA Polymerase I Transcription R-HSA-73864,4.440360811428244,0.04356569768125193,Other Types
Mature T and NK Neoplasms,Lagging Strand Synthesis R-HSA-69186,5.7014315411076435,0.023450758154552918,Other Types
Mature T and NK Neoplasms,Signaling By NOTCH3 R-HSA-9012852,7.810506347166152,0.008967934233706329,Other Types
Neuroblastoma,Translation R-HSA-72766,5.5404102568649005,0.028919841123340614,Other Types
Neuroblastoma,tRNA Aminoacylation R-HSA-379724,13.032021721468324,0.0017473192141523011,Other Types
Neuroblastoma,Mitochondrial tRNA Aminoacylation R-HSA-379726,5.92293974829298,0.024446417950436148,Other Types
Neuroblastoma,Cytoprotection By HMOX1 R-HSA-9707564,8.005731106570902,0.010359180669593994,Other Types
Neuroblastoma,"Platelet Activation, Signaling And Aggregation R-HSA-76002",6.1708666210783525,0.02196493317822527,Neuroblastoma
Neuroblastoma,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,5.22270649168222,0.03334526634074001,Neuroblastoma
Neuroblastoma,Death Receptor Signaling R-HSA-73887,4.473156658190881,0.0471800593251456,Neuroblastoma
Neuroblastoma,Platelet Aggregation (Plug Formation) R-HSA-76009,4.750881893359403,0.041407361123986616,Neuroblastoma
Neuroblastoma,Integrin Signaling R-HSA-354192,4.750881893359403,0.041407361123986616,Neuroblastoma
Neuroblastoma,EPHB-mediated Forward Signaling R-HSA-3928662,11.100502948612949,0.0033249131555135977,Neuroblastoma
Neuroblastoma,Mitochondrial Translation Termination R-HSA-5419276,4.760601409341238,0.04122040604726704,Other Types
Neuroblastoma,Mitochondrial Translation Initiation R-HSA-5368286,5.270651361118933,0.03263082577869107,Other Types
Neuroblastoma,Metabolism Of Vitamins And Cofactors R-HSA-196854,9.736394549223556,0.005390505209247363,Other Types
Neuroblastoma,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,5.470977920234434,0.029827221059539916,Neuroblastoma
Neuroblastoma,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,5.937597586016701,0.024291229751918553,Other Types
Neuroblastoma,Metabolism R-HSA-1430728,15.487761002984238,0.000818113934025892,Other Types
Neuroblastoma,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,5.218024778577271,0.03341597352998362,Neuroblastoma
Neuroblastoma,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,4.356571719224325,0.049872804979197445,Neuroblastoma
Neuroblastoma,Citric Acid Cycle (TCA Cycle) R-HSA-71403,5.536857368354441,0.028965508227400728,Other Types
Neuroblastoma,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,4.404002356010098,0.04875668064464737,Other Types
Neuroblastoma,mTORC1-mediated Signaling R-HSA-166208,5.5577788898326315,0.028697759910802544,Neuroblastoma
Neuroblastoma,Signaling By ERBB2 R-HSA-1227986,5.762118690914614,0.0262244960933112,Neuroblastoma
Neuroblastoma,Interleukin-12 Signaling R-HSA-9020591,5.228690961934545,0.03325513026067959,Neuroblastoma
Neuroblastoma,MET Activates PTK2 Signaling R-HSA-8874081,5.033913812495814,0.03633599084683573,Neuroblastoma
Neuroblastoma,Protein Ubiquitination R-HSA-8852135,4.6292586470453845,0.04383021659150894,Neuroblastoma
Neuroblastoma,Cilium Assembly R-HSA-5617833,4.422026746141238,0.0483400332414724,Neuroblastoma
Neuroblastoma,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,4.357074497296078,0.04986082176786043,Neuroblastoma
Neuroblastoma,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,7.1915691502439945,0.014340032996842101,Other Types
Neuroblastoma,TNF Signaling R-HSA-75893,6.611652342515428,0.01822128902266618,Neuroblastoma
Neuroblastoma,Signal Amplification R-HSA-392518,5.933849896143599,0.024330802167987314,Neuroblastoma
Neuroblastoma,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,7.553819794756376,0.012389293213595042,Other Types
Neuroblastoma,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,5.195097964394829,0.03376469348344085,Neuroblastoma
Neuroblastoma,RNA Polymerase III Chain Elongation R-HSA-73780,4.558106500893323,0.04532228505674072,Neuroblastoma
Neuroblastoma,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,5.695009218503547,0.02700922351830703,Other Types
Neuroblastoma,Sema4D In Semaphorin Signaling R-HSA-400685,4.6989430527001685,0.042422895482978694,Neuroblastoma
Neuroblastoma,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,4.875184281465135,0.03908719736189935,Neuroblastoma
Neuroblastoma,Mitochondrial Calcium Ion Transport R-HSA-8949215,4.511065426992573,0.046340509630829196,Other Types
Neuroblastoma,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,5.655447016940896,0.027484225048247057,Neuroblastoma
Neuroblastoma,RHO GTPases Activate PAKs R-HSA-5627123,5.599819597502062,0.028168138343624888,Neuroblastoma
Neuroblastoma,Integrin Cell Surface Interactions R-HSA-216083,4.904203229363422,0.038567035049091744,Neuroblastoma
Neuroblastoma,NF-kB Is Activated And Signals Survival R-HSA-209560,6.51426846200491,0.01898227295197816,Neuroblastoma
Neuroblastoma,Regulation Of TP53 Degradation R-HSA-6804757,5.1700664124538696,0.034150139826148423,Neuroblastoma
Neuroblastoma,DNA Replication Initiation R-HSA-68952,4.417461283326712,0.048445181806374873,Neuroblastoma
Neuroblastoma,Regulation Of TP53 Activity Thru Association With Co-factors R-HSA-6804759,5.550017206285736,0.028796764591432416,Neuroblastoma
Neuroblastoma,Regulated Necrosis R-HSA-5218859,6.394263707599827,0.019969539135842825,Neuroblastoma
Neuroblastoma,Transcriptional Regulation By TP53 R-HSA-3700989,4.679106477153158,0.04281820294314201,Other Types
Neuroblastoma,Diseases Of Glycosylation R-HSA-3781865,4.922130438945875,0.03824961926873998,Neuroblastoma
Neuroblastoma,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,5.547923687561302,0.028823534600550905,Neuroblastoma
Neuroblastoma,Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,7.147685632903397,0.014598843056239624,Neuroblastoma
Neuroblastoma,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,8.206667951810848,0.00957812695146687,Other Types
Neuroblastoma,Mitophagy R-HSA-5205647,4.395720414063037,0.048949497248643045,Other Types
Neuroblastoma,Glycerophospholipid Biosynthesis R-HSA-1483206,7.491424719116949,0.01270300946631959,Other Types
Neuroblastoma,RHO GTPases Activate ROCKs R-HSA-5627117,5.2630377695747015,0.032743112302165964,Neuroblastoma
Neuroblastoma,Detoxification Of Reactive Oxygen Species R-HSA-3299685,6.972442213349264,0.015685804024739226,Other Types
Neuroblastoma,Regulation Of Necroptotic Cell Death R-HSA-5675482,4.399745024283741,0.04885568950771819,Neuroblastoma
Neuroblastoma,Downregulation Of ERBB2 Signaling R-HSA-8863795,5.499990585522763,0.029444213147728073,Neuroblastoma
Neuroblastoma,TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,6.77357573153134,0.017030540899669374,Neuroblastoma
Neuroblastoma,Meiotic Recombination R-HSA-912446,4.573467103777359,0.04499533732720067,Other Types
Neuroblastoma,Viral mRNA Translation R-HSA-192823,6.426044824431873,0.019702580920069337,Other Types
Neuroblastoma,SARS-CoV-2 Modulates Autophagy R-HSA-9754560,5.112111377612829,0.03506183069281632,Other Types
Osteosarcoma,tRNA Aminoacylation R-HSA-379724,4.840071015934101,0.03689253305582271,Osteosarcoma
Osteosarcoma,Membrane Trafficking R-HSA-199991,4.326858641477519,0.04751271542025151,Other Types
Osteosarcoma,Mitochondrial tRNA Aminoacylation R-HSA-379726,4.352273504864956,0.04691276172744443,Osteosarcoma
Osteosarcoma,G1/S DNA Damage Checkpoints R-HSA-69615,6.422616190018838,0.017630668351801066,Other Types
Osteosarcoma,p53-Dependent G1 DNA Damage Response R-HSA-69563,7.42686626066789,0.011341081797905132,Other Types
Osteosarcoma,Golgi-to-ER Retrograde Transport R-HSA-8856688,4.734522416353308,0.03883938693621768,Other Types
Osteosarcoma,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,4.823570880829575,0.03718957667016571,Other Types
Osteosarcoma,Asparagine N-linked Glycosylation R-HSA-446203,7.676589276383522,0.01019178824993275,Other Types
Osteosarcoma,Cytoprotection By HMOX1 R-HSA-9707564,8.078728023762315,0.008599929881991788,Osteosarcoma
Osteosarcoma,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,4.580857251784134,0.041881864846020626,Osteosarcoma
Osteosarcoma,TP53 Regulates Metabolic Genes R-HSA-5628897,5.576873494737916,0.025971746974812256,Osteosarcoma
Osteosarcoma,Mitotic G2-G2/M Phases R-HSA-453274,6.391992105368075,0.017874969882079,Other Types
Osteosarcoma,Metabolism Of Nucleotides R-HSA-15869,6.973920779964861,0.013805600429772483,Osteosarcoma
Osteosarcoma,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,5.73768283937863,0.024098360801355675,Other Types
Osteosarcoma,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,7.375740456400138,0.011593468736667884,Other Types
Osteosarcoma,G1/S Transition R-HSA-69206,6.998912932924691,0.013655275764753746,Other Types
Osteosarcoma,"Platelet Activation, Signaling And Aggregation R-HSA-76002",8.656671782211118,0.00676855821978145,Other Types
Osteosarcoma,Mitotic G1 Phase And G1/S Transition R-HSA-453279,6.300459255073534,0.018627661371400293,Other Types
Osteosarcoma,Cyclin E Associated Events During G1/S Transition R-HSA-69202,7.165809273267894,0.012696301016142218,Other Types
Osteosarcoma,Mitochondrial Translation R-HSA-5368287,5.168383048161507,0.03149821266396956,Osteosarcoma
Osteosarcoma,Muscle Contraction R-HSA-397014,5.723647974317205,0.024255763876590935,Other Types
Osteosarcoma,Death Receptor Signaling R-HSA-73887,4.746125100979706,0.03861987063433182,Other Types
Osteosarcoma,MET Promotes Cell Motility R-HSA-8875878,4.659934684512724,0.040284217546784885,Other Types
Osteosarcoma,Platelet Aggregation (Plug Formation) R-HSA-76009,8.335099878366089,0.0077281886270300915,Other Types
Osteosarcoma,Integrin Signaling R-HSA-354192,8.335099878366089,0.0077281886270300915,Other Types
Osteosarcoma,EPHB-mediated Forward Signaling R-HSA-3928662,7.873439608379469,0.00937560784352332,Other Types
Osteosarcoma,Downstream Signal Transduction R-HSA-186763,5.939536739576974,0.02195502784412334,Other Types
Osteosarcoma,Mitochondrial Translation Termination R-HSA-5419276,8.955097371667353,0.005993452795850503,Osteosarcoma
Osteosarcoma,Signaling By PDGF R-HSA-186797,5.01575120367911,0.033888430165578846,Other Types
Osteosarcoma,RHO GTPase Effectors R-HSA-195258,6.86154300905859,0.014504361409731402,Other Types
Osteosarcoma,Nucleotide Biosynthesis R-HSA-8956320,4.779955240274931,0.03798767860916268,Osteosarcoma
Osteosarcoma,Mitochondrial Translation Initiation R-HSA-5368286,9.151270540635311,0.005536953216016149,Osteosarcoma
Osteosarcoma,Metabolism Of Vitamins And Cofactors R-HSA-196854,10.505201779555852,0.0032525632391540637,Osteosarcoma
Osteosarcoma,Mitochondrial Translation Elongation R-HSA-5389840,4.905622886961194,0.03573825799304756,Osteosarcoma
Osteosarcoma,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,5.334037838822221,0.02911369156980655,Other Types
Osteosarcoma,Signaling To ERKs R-HSA-187687,4.634387421967532,0.04079280014943262,Other Types
Osteosarcoma,Smooth Muscle Contraction R-HSA-445355,4.296911549851678,0.048230720409707335,Other Types
Osteosarcoma,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,5.773475988960849,0.02370202167059935,Osteosarcoma
Osteosarcoma,Metabolism R-HSA-1430728,12.203998393690712,0.001724787693261674,Osteosarcoma
Osteosarcoma,rRNA Modification In Mitochondrion R-HSA-6793080,4.68639115070135,0.03976498077456488,Osteosarcoma
Osteosarcoma,Prolonged ERK Activation Events R-HSA-169893,5.675908271843008,0.02479973917585395,Other Types
Osteosarcoma,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,6.169303747097159,0.019767730838671376,Other Types
Osteosarcoma,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,10.437806218422073,0.003337901369350127,Osteosarcoma
Osteosarcoma,Citric Acid Cycle (TCA Cycle) R-HSA-71403,8.219623438607842,0.008108270717734229,Osteosarcoma
Osteosarcoma,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,7.048280458331182,0.013363587408845095,Osteosarcoma
Osteosarcoma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,12.022877659457139,0.0018424820183257236,Other Types
Osteosarcoma,Semaphorin Interactions R-HSA-373755,4.879219943274333,0.0361982693772088,Other Types
Osteosarcoma,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,9.692528719324947,0.004462650339269805,Other Types
Osteosarcoma,MET Receptor Recycling R-HSA-8875656,4.648565478734952,0.040509671079219704,Other Types
Osteosarcoma,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,4.3072477449467845,0.04798153668655543,Other Types
Osteosarcoma,Signaling By ERBB2 R-HSA-1227986,5.274130204862087,0.029952106164354366,Other Types
Osteosarcoma,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,4.900070861904484,0.03583444650420459,Other Types
Osteosarcoma,Kinesins R-HSA-983189,4.5299301465817265,0.04294819347861162,Other Types
Osteosarcoma,MET Activates PTK2 Signaling R-HSA-8874081,7.048539219933054,0.013362076643636912,Other Types
Osteosarcoma,Protein Ubiquitination R-HSA-8852135,5.873241556415636,0.022634811390227876,Other Types
Osteosarcoma,Cilium Assembly R-HSA-5617833,8.128248220142176,0.008423509779911284,Other Types
Osteosarcoma,Platelet Degranulation R-HSA-114608,5.3131057440940115,0.029403643959772754,Other Types
Osteosarcoma,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,5.6598332780598115,0.024985931998132704,Other Types
Osteosarcoma,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,6.6350878018019595,0.01603351225783213,Osteosarcoma
Osteosarcoma,Apoptotic Factor-Mediated Response R-HSA-111471,5.880191556239788,0.022562467857267527,Osteosarcoma
Osteosarcoma,Elastic Fibre Formation R-HSA-1566948,4.3866035644193495,0.04611578001170827,Other Types
Osteosarcoma,VxPx Cargo-Targeting To Cilium R-HSA-5620916,4.636447676748982,0.04075152101754622,Other Types
Osteosarcoma,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,4.75594675724654,0.038435131075435953,Other Types
Osteosarcoma,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,6.167449857781132,0.019784387205105638,Osteosarcoma
Osteosarcoma,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,6.932957436937639,0.014055933725636509,Other Types
Osteosarcoma,Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,9.543891197182987,0.004733023876871215,Other Types
Osteosarcoma,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,5.489614794751847,0.027055320896166885,Osteosarcoma
Osteosarcoma,Transferrin Endocytosis And Recycling R-HSA-917977,5.4403580105078895,0.027689027483527216,Osteosarcoma
Osteosarcoma,SARS-CoV-1 Infection R-HSA-9678108,5.349923964085088,0.02889575172561979,Other Types
Osteosarcoma,CD209 (DC-SIGN) Signaling R-HSA-5621575,5.1314432811156445,0.032059015233717264,Other Types
Osteosarcoma,RHO GTPases Activate Formins R-HSA-5663220,5.80045752029132,0.023408014709327574,Other Types
Osteosarcoma,Centrosome Maturation R-HSA-380287,4.429720905480675,0.04513619296648888,Other Types
Osteosarcoma,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,5.075993605200384,0.03292176017402427,Other Types
Osteosarcoma,Mitochondrial Calcium Ion Transport R-HSA-8949215,4.781183259902055,0.037964948257539606,Osteosarcoma
Osteosarcoma,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,7.639183764983566,0.010355503892162414,Other Types
Osteosarcoma,RHO GTPases Activate PAKs R-HSA-5627123,7.190478543509467,0.012560930158845312,Other Types
Osteosarcoma,Signaling By TGFB Family Members R-HSA-9006936,4.87235359410007,0.03631897729225619,Other Types
Osteosarcoma,Regulation Of TP53 Expression And Degradation R-HSA-6806003,5.109781685798334,0.03239302388162433,Other Types
Osteosarcoma,Integrin Cell Surface Interactions R-HSA-216083,6.998101001183343,0.013660131100700707,Other Types
Osteosarcoma,NF-kB Is Activated And Signals Survival R-HSA-209560,4.360700890192222,0.046715698756766434,Other Types
Osteosarcoma,Regulation Of TP53 Degradation R-HSA-6804757,6.172031346806507,0.01974325266567207,Other Types
Osteosarcoma,DNA Replication Initiation R-HSA-68952,6.392136852873886,0.01787380644093896,Other Types
Osteosarcoma,Extracellular Matrix Organization R-HSA-1474244,4.449799951414897,0.04468797977965916,Other Types
Osteosarcoma,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,5.120234087094087,0.03223137411937197,Osteosarcoma
Osteosarcoma,Signaling By TGF-beta Receptor Complex R-HSA-170834,6.948492864125995,0.01396041254651279,Other Types
Osteosarcoma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,5.617245340783485,0.025486734655051226,Other Types
Osteosarcoma,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,5.284798947948232,0.02980085676997534,Other Types
Osteosarcoma,Transcriptional Regulation By TP53 R-HSA-3700989,11.143137112677135,0.0025526905658624843,Osteosarcoma
Osteosarcoma,HATs Acetylate Histones R-HSA-3214847,4.656235622219041,0.040357416613959515,Osteosarcoma
Osteosarcoma,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,5.645009518753179,0.025159002863603428,Other Types
Osteosarcoma,Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,4.427343563343328,0.0451895932603802,Other Types
Osteosarcoma,Clathrin-mediated Endocytosis R-HSA-8856828,4.297711929518047,0.04821137322785306,Osteosarcoma
Osteosarcoma,Interleukin-7 Signaling R-HSA-1266695,7.687862152530484,0.010143006589652975,Osteosarcoma
Osteosarcoma,Transmission Across Chemical Synapses R-HSA-112315,6.06055610880541,0.02077145616045369,Osteosarcoma
Osteosarcoma,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,5.714506312217185,0.024358899970348662,Other Types
Osteosarcoma,Neuronal System R-HSA-112316,7.516383672127561,0.010913544783418279,Osteosarcoma
Osteosarcoma,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,5.998878650487065,0.021365619429335455,Other Types
Osteosarcoma,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,4.357093586314926,0.04679993693880022,Osteosarcoma
Osteosarcoma,PTK6 Regulates Cell Cycle R-HSA-8849470,9.625820808590642,0.004581853155552771,Other Types
Osteosarcoma,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,7.6462898629703675,0.01032418188783404,Other Types
Osteosarcoma,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,5.507452800806179,0.026829803319162807,Other Types
Osteosarcoma,Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,6.608215691765527,0.01622642776627961,Other Types
Osteosarcoma,RUNX2 Regulates Bone Development R-HSA-8941326,6.307503001892168,0.01856851674864235,Other Types
Osteosarcoma,SLC-mediated Transmembrane Transport R-HSA-425407,4.892577021066061,0.03596473413076065,Osteosarcoma
Osteosarcoma,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,6.800506999299931,0.014900088696897063,Other Types
Osteosarcoma,Sulfur Amino Acid Metabolism R-HSA-1614635,5.5414209924104325,0.026406091103179475,Osteosarcoma
Osteosarcoma,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,4.985027407306753,0.03439355338927271,Osteosarcoma
Osteosarcoma,Attenuation Phase R-HSA-3371568,5.236056859110813,0.03049884948492803,Osteosarcoma
Osteosarcoma,Glycosaminoglycan Metabolism R-HSA-1630316,6.1639547840660756,0.019815830966240913,Other Types
Osteosarcoma,Intrinsic Pathway For Apoptosis R-HSA-109606,8.423726454256082,0.007449682297901381,Osteosarcoma
Osteosarcoma,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,5.067490049505625,0.03305633449384662,Other Types
Osteosarcoma,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,5.067489953379706,0.0330563360185529,Other Types
Osteosarcoma,Downregulation Of ERBB2 Signaling R-HSA-8863795,4.302647252013304,0.04809226615683982,Other Types
Osteosarcoma,Intra-Golgi Traffic R-HSA-6811438,4.268517771706371,0.048922733590796526,Other Types
Osteosarcoma,SUMOylation Of Intracellular Receptors R-HSA-4090294,5.399882820984099,0.028222071265971756,Osteosarcoma
Osteosarcoma,Cyclin D Associated Events In G1 R-HSA-69231,6.867039315623591,0.014469296640612712,Other Types
Osteosarcoma,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,6.6566897471462685,0.01588025917255336,Osteosarcoma
Osteosarcoma,Recycling Pathway Of L1 R-HSA-437239,6.562494754411775,0.0165605517926372,Osteosarcoma
Osteosarcoma,Potential Therapeutics For SARS R-HSA-9679191,4.343910818044879,0.047109232734527134,Osteosarcoma
Osteosarcoma,Iron Uptake And Transport R-HSA-917937,9.06548168039067,0.005731744158587552,Osteosarcoma
Osteosarcoma,SUMOylation Of Transcription Cofactors R-HSA-3899300,4.555056231220902,0.042418351424335525,Osteosarcoma
Osteosarcoma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,11.23598632123359,0.0024652745894002096,Osteosarcoma
Osteosarcoma,SHC-mediated cascade:FGFR4 R-HSA-5654719,5.124395297697755,0.03216726917343569,Other Types
Osteosarcoma,SHC-mediated cascade:FGFR2 R-HSA-5654699,5.124395297697755,0.03216726917343569,Other Types
Osteosarcoma,SHC-mediated cascade:FGFR3 R-HSA-5654704,5.124395297697755,0.03216726917343569,Other Types
Osteosarcoma,Epigenetic Regulation Of Gene Expression R-HSA-212165,4.67377049701995,0.040011737377648376,Osteosarcoma
Osteosarcoma,Inositol Phosphate Metabolism R-HSA-1483249,10.85765770134321,0.002843245763902917,Osteosarcoma
Osteosarcoma,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,4.450858095859917,0.04466449792339109,Osteosarcoma
Osteosarcoma,SHC1 Events In ERBB2 Signaling R-HSA-1250196,4.698094370839874,0.039537677904145065,Other Types
Osteosarcoma,Aggrephagy R-HSA-9646399,4.743874009568118,0.0386623516436194,Other Types
Osteosarcoma,Metal Ion SLC Transporters R-HSA-425410,4.882247183332669,0.036145193517712296,Other Types
Osteosarcoma,"WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",7.305027747584238,0.011952748341288727,Osteosarcoma
Osteosarcoma,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,7.305027573900966,0.011952749238593888,Osteosarcoma
Osteosarcoma,Retrograde Neurotrophin Signaling R-HSA-177504,5.197249568616466,0.031067552613599864,Osteosarcoma
Osteosarcoma,TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,8.130332876835983,0.008416170294629858,Other Types
Osteosarcoma,Plasma Lipoprotein Clearance R-HSA-8964043,7.3383842507288835,0.0117817715667337,Osteosarcoma
Osteosarcoma,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",10.501194798180666,0.0032575700892857264,Osteosarcoma
Osteosarcoma,Nef Mediated CD4 Down-regulation R-HSA-167590,7.405533479957573,0.01144565341764246,Osteosarcoma
Osteosarcoma,Nef Mediated CD8 Down-regulation R-HSA-182218,7.405533479957573,0.01144565341764246,Osteosarcoma
Osteosarcoma,Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,4.960873570679565,0.03479654224106387,Other Types
Osteosarcoma,Signaling By FLT3 Fusion Proteins R-HSA-9703465,6.610120348563294,0.01621267048759538,Other Types
Osteosarcoma,Regulation Of Gene Expression In Beta Cells R-HSA-210745,4.644584779895662,0.04058894165789354,Osteosarcoma
Osteosarcoma,STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,5.226733877853488,0.03063441154796557,Other Types
Osteosarcoma,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",5.6866220621892385,0.02467649607042658,Osteosarcoma
Osteosarcoma,Metalloprotease DUBs R-HSA-5689901,5.204657725561429,0.030958086889681827,Other Types
Osteosarcoma,LDL Clearance R-HSA-8964038,7.397777688194999,0.011483933198143689,Osteosarcoma
Osteosarcoma,VLDLR Internalisation And Degradation R-HSA-8866427,7.49611196510715,0.01100879320754365,Osteosarcoma
Osteosarcoma,Metabolism Of Steroids R-HSA-8957322,6.534180563931093,0.016771258752204612,Osteosarcoma
Osteosarcoma,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,7.235208915665231,0.012319494295372038,Osteosarcoma
Osteosarcoma,Cholesterol Biosynthesis R-HSA-191273,4.869808356485211,0.0363638354342088,Osteosarcoma
Lung Neuroendocrine Tumor,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",5.917975110004706,0.031576997084113066,Other Types
Lung Neuroendocrine Tumor,Cristae Formation R-HSA-8949613,8.299041385747719,0.013809921409253266,Other Types
Lung Neuroendocrine Tumor,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,7.387740523773171,0.018675438684161504,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Asparagine N-linked Glycosylation R-HSA-446203,5.181999051996087,0.04195023120557894,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Cytoprotection By HMOX1 R-HSA-9707564,7.438484404875504,0.018356046491582362,Other Types
Lung Neuroendocrine Tumor,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,4.863844215531068,0.04767148627599799,Other Types
Lung Neuroendocrine Tumor,TP53 Regulates Metabolic Genes R-HSA-5628897,13.837360435216388,0.0029276149620262324,Other Types
Lung Neuroendocrine Tumor,Signaling By MET R-HSA-6806834,4.987651488947101,0.04534029941179326,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,FCGR3A-mediated Phagocytosis R-HSA-9664422,12.432540134932996,0.004177194907777044,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Mitochondrial Protein Import R-HSA-1268020,7.941800670547519,0.015513953432091705,Other Types
Lung Neuroendocrine Tumor,Metabolism Of Nucleotides R-HSA-15869,4.820042456040527,0.04853048592744353,Other Types
Lung Neuroendocrine Tumor,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,6.1094480066749135,0.02940019388316006,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,"Platelet Activation, Signaling And Aggregation R-HSA-76002",4.9504753156649715,0.046025643886862734,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,12.37846653240254,0.004236632893878984,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,RAC3 GTPase Cycle R-HSA-9013423,7.138634070515834,0.02034212859768248,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,EPH-Ephrin Signaling R-HSA-2682334,11.333282694753645,0.005606441848261618,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Mitochondrial Translation R-HSA-5368287,9.882799100917646,0.008473614695522545,Other Types
Lung Neuroendocrine Tumor,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,6.837165497327788,0.022600771709830967,Other Types
Lung Neuroendocrine Tumor,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,32.96782045274527,9.282671675626604e-05,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Transport Of Small Molecules R-HSA-382551,5.329391076624667,0.03958021184261539,Other Types
Lung Neuroendocrine Tumor,Platelet Aggregation (Plug Formation) R-HSA-76009,5.981764136715789,0.030831129482489807,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Integrin Signaling R-HSA-354192,5.981764136715789,0.030831129482489807,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,EPHB-mediated Forward Signaling R-HSA-3928662,11.463413284260064,0.005410177262410986,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Protein Localization R-HSA-9609507,18.090155657120476,0.0011208291494343601,Other Types
Lung Neuroendocrine Tumor,Mitochondrial Translation Termination R-HSA-5419276,25.547445015526964,0.00028241613764876946,Other Types
Lung Neuroendocrine Tumor,Nucleotide Biosynthesis R-HSA-8956320,7.09325889907421,0.02066437439013144,Other Types
Lung Neuroendocrine Tumor,Mitochondrial Translation Initiation R-HSA-5368286,11.117753541832325,0.005950221628788395,Other Types
Lung Neuroendocrine Tumor,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,5.163247561719148,0.04226377241264571,Other Types
Lung Neuroendocrine Tumor,Mitochondrial Translation Elongation R-HSA-5389840,7.752228374737364,0.01651873166815462,Other Types
Lung Neuroendocrine Tumor,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,7.980863195104576,0.015315987176382486,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,RHOJ GTPase Cycle R-HSA-9013409,5.55921964456543,0.03619584572596378,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Cell Junction Organization R-HSA-446728,8.348927200405775,0.013589977370168064,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,XBP1(S) Activates Chaperone Genes R-HSA-381038,7.361481502939365,0.01884329884380941,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,IRE1alpha Activates Chaperones R-HSA-381070,7.361481502939365,0.01884329884380941,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Metabolism R-HSA-1430728,12.195436383101208,0.0044453187898869945,Other Types
Lung Neuroendocrine Tumor,Heme Biosynthesis R-HSA-189451,12.759636507516365,0.00383781577880196,Other Types
Lung Neuroendocrine Tumor,Metabolism Of Porphyrins R-HSA-189445,12.759636069799162,0.0038378162108057144,Other Types
Lung Neuroendocrine Tumor,FCERI Mediated MAPK Activation R-HSA-2871796,10.475932916134589,0.007130744608177825,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Drug ADME R-HSA-9748784,6.09046886262241,0.029607810048423992,Other Types
Lung Neuroendocrine Tumor,Prolonged ERK Activation Events R-HSA-169893,5.94259968439505,0.03128654997973442,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,5.2474831758388785,0.04087689026483415,Other Types
Lung Neuroendocrine Tumor,Citric Acid Cycle (TCA Cycle) R-HSA-71403,8.949113933020282,0.011242750213053347,Other Types
Lung Neuroendocrine Tumor,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,16.09448462652091,0.0017247186693309224,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Ubiquinol Biosynthesis R-HSA-2142789,5.030480289033198,0.04456584761836725,Other Types
Lung Neuroendocrine Tumor,Metabolism Of Cofactors R-HSA-8978934,6.5723837990964755,0.024833414268199697,Other Types
Lung Neuroendocrine Tumor,Unfolded Protein Response (UPR) R-HSA-381119,8.572863253734758,0.012652187030398636,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Frs2-mediated Activation R-HSA-170968,11.844095355487736,0.00488071559315696,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,4.791098354824843,0.04910831115700456,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Erythropoietin Activates RAS R-HSA-9027284,5.14048784290256,0.042648110638237396,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,11.532277246798492,0.005309585504095608,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Kinesins R-HSA-983189,9.615622463165057,0.009174528560440251,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,FGFR2 Mutant Receptor Activation R-HSA-1839126,6.109043544529783,0.029404600268500784,Other Types
Lung Neuroendocrine Tumor,FGFR2 Alternative Splicing R-HSA-6803529,6.650323315333653,0.02415008552092474,Other Types
Lung Neuroendocrine Tumor,Late Phase Of HIV Life Cycle R-HSA-162599,21.907951556783324,0.0005317254699360865,Other Types
Lung Neuroendocrine Tumor,Cilium Assembly R-HSA-5617833,14.93413139890943,0.002250323921320139,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,10.38745268620457,0.0073142441219407935,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,4.825756778697468,0.04841737462112631,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Signaling By FGFR2 IIIa TM R-HSA-8851708,5.988507197185222,0.03075351695486414,Other Types
Lung Neuroendocrine Tumor,VxPx Cargo-Targeting To Cilium R-HSA-5620916,18.30080864049995,0.0010729034967031242,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,NCAM Signaling For Neurite Out-Growth R-HSA-375165,5.468024260926026,0.03749571316138489,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,13.159214472841077,0.0034661679013108146,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,6.0994375748880305,0.029509483121868314,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,4.984698969860082,0.04539428009030859,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,HIV Life Cycle R-HSA-162587,11.719626906485962,0.005046841478394891,Other Types
Lung Neuroendocrine Tumor,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,5.893751119992789,0.03186585750857569,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Depolymerisation Of Nuclear Lamina R-HSA-4419969,12.90067809244499,0.0037015292825618635,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,6.167802004520188,0.02877261053598112,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Post NMDA Receptor Activation Events R-HSA-438064,18.31448324083587,0.00106987616483032,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,7.244841658294979,0.019610844735097933,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Spry Regulation Of FGF Signaling R-HSA-1295596,4.981298355040578,0.04545654873674882,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,AURKA Activation By TPX2 R-HSA-8854518,18.802900324094313,0.0009680226050694405,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Centrosome Maturation R-HSA-380287,5.969626950650492,0.030971416690950177,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,5.182528961341341,0.04194141117597699,Other Types
Lung Neuroendocrine Tumor,RNA Polymerase III Transcription Termination R-HSA-73980,5.742233790770339,0.03374579545611808,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,mRNA Capping R-HSA-72086,32.66277591681554,9.67954729607199e-05,Other Types
Lung Neuroendocrine Tumor,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,5.231804859378682,0.04113085098306527,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,6.6018257920829075,0.02457262024943672,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Oncogene Induced Senescence R-HSA-2559585,5.7495529921380335,0.03365199612217269,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Regulation Of IFNA/IFNB Signaling R-HSA-912694,9.145234266889213,0.01058180726286353,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,24.437826725833776,0.0003400989063910483,Other Types
Lung Neuroendocrine Tumor,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,11.973841724101725,0.004714336800880062,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Transcriptional Regulation By TP53 R-HSA-3700989,11.690054076152949,0.005087282487097147,Other Types
Lung Neuroendocrine Tumor,Diseases Of Glycosylation R-HSA-3781865,6.476122778249848,0.02570931921963378,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,PKMTs Methylate Histone Lysines R-HSA-3214841,7.460507714808059,0.01821944128855141,Other Types
Lung Neuroendocrine Tumor,HIV Transcription Initiation R-HSA-167161,15.937668073102031,0.001786598974287148,Other Types
Lung Neuroendocrine Tumor,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,9.875068819120656,0.008492988778814891,Other Types
Lung Neuroendocrine Tumor,Interleukin-7 Signaling R-HSA-1266695,5.0824566814721095,0.043647161221866175,Other Types
Lung Neuroendocrine Tumor,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,12.370833062707957,0.004245103351831144,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,9.312685812396653,0.010053479978962191,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,4.856759980162232,0.0478091715739936,Other Types
Lung Neuroendocrine Tumor,Unwinding Of DNA R-HSA-176974,5.863028206291442,0.032236754582220264,Other Types
Lung Neuroendocrine Tumor,Interferon Gamma Signaling R-HSA-877300,7.530028855994483,0.01779604170895858,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,6.304916164150326,0.027359599689459956,Other Types
Lung Neuroendocrine Tumor,Extra-nuclear Estrogen Signaling R-HSA-9009391,14.042542657627365,0.002784451519832135,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,SLC-mediated Transmembrane Transport R-HSA-425407,6.692903988002258,0.02378619341441029,Other Types
Lung Neuroendocrine Tumor,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,13.07188076069707,0.0035436544308957863,Other Types
Lung Neuroendocrine Tumor,Signaling By Hippo R-HSA-2028269,5.624137475113763,0.03530322862045535,Other Types
Lung Neuroendocrine Tumor,Formation Of Early Elongation Complex R-HSA-113418,9.368759530034472,0.009883550391617084,Other Types
Lung Neuroendocrine Tumor,NoRC Negatively Regulates rRNA Expression R-HSA-427413,6.175053771565174,0.028695737661269736,Other Types
Lung Neuroendocrine Tumor,Formation Of RNA Pol II Elongation Complex R-HSA-112382,5.47142443708108,0.037446258166705285,Other Types
Lung Neuroendocrine Tumor,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,6.191588316619667,0.028521373441504082,Other Types
Lung Neuroendocrine Tumor,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,6.833439860637033,0.02263049182611562,Other Types
Lung Neuroendocrine Tumor,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,6.424582810781053,0.02619336132903115,Other Types
Lung Neuroendocrine Tumor,Intrinsic Pathway For Apoptosis R-HSA-109606,11.072194496502625,0.006026027567071095,Other Types
Lung Neuroendocrine Tumor,Dual Incision In TC-NER R-HSA-6782135,13.110212302611346,0.003509397337283224,Other Types
Lung Neuroendocrine Tumor,Gene Expression (Transcription) R-HSA-74160,6.5961289693951475,0.024622827486870495,Other Types
Lung Neuroendocrine Tumor,Intra-Golgi Traffic R-HSA-6811438,10.442019085377046,0.007200431495012258,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,5.175829219365347,0.042053087968605504,Other Types
Lung Neuroendocrine Tumor,SUMOylation Of Intracellular Receptors R-HSA-4090294,5.505979242425002,0.03694805601688539,Other Types
Lung Neuroendocrine Tumor,Nephrin Family Interactions R-HSA-373753,5.963196401067366,0.031046051882821703,Other Types
Lung Neuroendocrine Tumor,Generic Transcription Pathway R-HSA-212436,5.322705308689192,0.03968419256837753,Other Types
Lung Neuroendocrine Tumor,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,8.656173559033881,0.012322934977208912,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",12.1592758085141,0.004487962495766091,Other Types
Lung Neuroendocrine Tumor,Adherens Junctions Interactions R-HSA-418990,10.2956072485409,0.007510626400522738,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,6.274993327056464,0.02766079710465319,Other Types
Lung Neuroendocrine Tumor,Nucleotide Excision Repair R-HSA-5696398,6.07324279233128,0.02979776062556892,Other Types
Lung Neuroendocrine Tumor,Transcription Of HIV Genome R-HSA-167172,9.193514727988672,0.010426190451301456,Other Types
Lung Neuroendocrine Tumor,Basigin Interactions R-HSA-210991,12.14759368628408,0.00450184156724987,Other Types
Lung Neuroendocrine Tumor,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",5.40090767562621,0.038488067293279825,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,DNA Strand Elongation R-HSA-69190,10.657476046420893,0.006770916386895703,Other Types
Lung Neuroendocrine Tumor,SUMOylation Of Transcription Cofactors R-HSA-3899300,5.428698266258461,0.03807340925313761,Other Types
Lung Neuroendocrine Tumor,Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,8.247662154840693,0.014040856287745764,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,6.044816289866534,0.03011439812102323,Other Types
Lung Neuroendocrine Tumor,Epigenetic Regulation Of Gene Expression R-HSA-212165,8.058495016199963,0.0149313424760221,Other Types
Lung Neuroendocrine Tumor,HIV Elongation Arrest And Recovery R-HSA-167287,10.79194286169423,0.006518117217133686,Other Types
Lung Neuroendocrine Tumor,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,6.588433987035859,0.02469083834836064,Other Types
Lung Neuroendocrine Tumor,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,12.477514244263686,0.004128503542981638,Other Types
Lung Neuroendocrine Tumor,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,6.12951818950364,0.02918252385322575,Other Types
Lung Neuroendocrine Tumor,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,6.7042751914409715,0.023690118842222514,Other Types
Lung Neuroendocrine Tumor,Aggrephagy R-HSA-9646399,5.838593522796786,0.032535413395378486,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,7.299476176745566,0.01924680469244753,Other Types
Lung Neuroendocrine Tumor,SHC-related Events Triggered By IGF1R R-HSA-2428933,13.081828359045181,0.0035347266683768645,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,9.760750961518083,0.008785675558421326,Other Types
Lung Neuroendocrine Tumor,FOXO-mediated Transcription R-HSA-9614085,6.412898138293379,0.02630459938378199,Other Types
Lung Neuroendocrine Tumor,Termination Of Translesion DNA Synthesis R-HSA-5656169,7.329236825265824,0.019051871159488216,Other Types
Lung Neuroendocrine Tumor,Translesion Synthesis By POLH R-HSA-110320,11.4446289855096,0.00543800353110173,Other Types
Lung Neuroendocrine Tumor,Pre-NOTCH Transcription And Translation R-HSA-1912408,4.82576704609971,0.048417171669481444,Other Types
Lung Neuroendocrine Tumor,Regulation Of Beta-Cell Development R-HSA-186712,6.607262280600932,0.024524820654305845,Other Types
Lung Neuroendocrine Tumor,RND3 GTPase Cycle R-HSA-9696264,5.694021603462744,0.034371508166725476,Other Types
Lung Neuroendocrine Tumor,Regulation Of Gene Expression In Beta Cells R-HSA-210745,10.13644532580593,0.007865831468325772,Other Types
Lung Neuroendocrine Tumor,Activation Of HOX Genes During Differentiation R-HSA-5619507,11.537148242486543,0.005302553853348586,Other Types
Lung Neuroendocrine Tumor,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,10.584056695787277,0.006913805255812435,Other Types
Lung Neuroendocrine Tumor,Dual Incision In GG-NER R-HSA-5696400,5.5745166437314175,0.03598311052470776,Other Types
Lung Neuroendocrine Tumor,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,5.032656608319967,0.04452691922287367,Other Types
Lung Neuroendocrine Tumor,Translesion Synthesis By REV1 R-HSA-110312,5.927748648580434,0.03146133544111891,Other Types
Lung Neuroendocrine Tumor,Translesion Synthesis By POLK R-HSA-5655862,5.927748648580434,0.03146133544111891,Other Types
Lung Neuroendocrine Tumor,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,18.656251188125797,0.0009973635391998057,Lung Neuroendocrine Tumor
Lung Neuroendocrine Tumor,Lagging Strand Synthesis R-HSA-69186,6.595237791938958,0.024630692620668485,Other Types
Lung Neuroendocrine Tumor,Translesion Synthesis By POLI R-HSA-5656121,5.927748648580434,0.03146133544111891,Other Types
Head and Neck Squamous Cell Carcinoma,Leishmania Infection R-HSA-9658195,4.450645329496134,0.04395574881242008,Other Types
Head and Neck Squamous Cell Carcinoma,Cristae Formation R-HSA-8949613,4.980798592814775,0.033811960280773753,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Golgi-to-ER Retrograde Transport R-HSA-8856688,11.795078222675421,0.0018688898957627638,Other Types
Head and Neck Squamous Cell Carcinoma,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,11.627589873695188,0.0019908835283321746,Other Types
Head and Neck Squamous Cell Carcinoma,VEGFA-VEGFR2 Pathway R-HSA-4420097,5.038638335421253,0.032872545011428646,Other Types
Head and Neck Squamous Cell Carcinoma,TP53 Regulates Metabolic Genes R-HSA-5628897,15.778256380654085,0.0004527211962727884,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Signaling By VEGF R-HSA-194138,5.1113452437389775,0.031732381552330796,Other Types
Head and Neck Squamous Cell Carcinoma,FCGR3A-mediated Phagocytosis R-HSA-9664422,6.83348709065132,0.014238901200146798,Other Types
Head and Neck Squamous Cell Carcinoma,Metabolism Of Nucleotides R-HSA-15869,14.86154222192096,0.0006189337153838507,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,9.57560806427213,0.004441017181482012,Other Types
Head and Neck Squamous Cell Carcinoma,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,5.59290372466118,0.025197791526155602,Other Types
Head and Neck Squamous Cell Carcinoma,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,8.355151269768331,0.007350998386483762,Other Types
Head and Neck Squamous Cell Carcinoma,ER To Golgi Anterograde Transport R-HSA-199977,4.463664719067704,0.04366940617439061,Other Types
Head and Neck Squamous Cell Carcinoma,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,7.002456653142311,0.013204789430753474,Other Types
Head and Neck Squamous Cell Carcinoma,mRNA Splicing - Major Pathway R-HSA-72163,5.51292729163465,0.026171597253765944,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Signaling By WNT R-HSA-195721,6.9745168704399845,0.013369964689312506,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,TCF Dependent Signaling In Response To WNT R-HSA-201681,4.712752014796301,0.038571824611329755,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Transport To Golgi And Subsequent Modification R-HSA-948021,4.86157268548617,0.035843617908785985,Other Types
Head and Neck Squamous Cell Carcinoma,mRNA Splicing R-HSA-72172,5.581936807356144,0.025328933846889803,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,COPI-mediated Anterograde Transport R-HSA-6807878,6.326762163606135,0.01790956457088228,Other Types
Head and Neck Squamous Cell Carcinoma,KEAP1-NFE2L2 Pathway R-HSA-9755511,4.7502923028222535,0.0378625400078257,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,4.99616409414103,0.033559533761571995,Other Types
Head and Neck Squamous Cell Carcinoma,Transport Of Small Molecules R-HSA-382551,6.443485470418359,0.016980401960457712,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Platelet Aggregation (Plug Formation) R-HSA-76009,7.879057807322823,0.009002713026622101,Other Types
Head and Neck Squamous Cell Carcinoma,Integrin Signaling R-HSA-354192,7.879057807322823,0.009002713026622101,Other Types
Head and Neck Squamous Cell Carcinoma,EPHB-mediated Forward Signaling R-HSA-3928662,4.324019334051341,0.046852494211952964,Other Types
Head and Neck Squamous Cell Carcinoma,Downstream Signal Transduction R-HSA-186763,5.412063532782569,0.02745932719746779,Other Types
Head and Neck Squamous Cell Carcinoma,Mitochondrial Translation Termination R-HSA-5419276,9.397639584980402,0.004773313105313931,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Signaling By PDGF R-HSA-186797,4.6120293724459005,0.04054885992277923,Other Types
Head and Neck Squamous Cell Carcinoma,RHO GTPase Effectors R-HSA-195258,5.035004441204679,0.032930707649156565,Other Types
Head and Neck Squamous Cell Carcinoma,Nucleotide Biosynthesis R-HSA-8956320,30.113059200164535,7.328562277395214e-06,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Mitochondrial Translation Initiation R-HSA-5368286,5.135902735078456,0.03135721440504364,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Metabolism Of Vitamins And Cofactors R-HSA-196854,6.714197955449305,0.015022172242349993,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,5.1156743417436354,0.03166588684594627,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Mitochondrial Translation Elongation R-HSA-5389840,4.399551195061905,0.045099870242243476,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,7.173477204820976,0.01224106343087153,Other Types
Head and Neck Squamous Cell Carcinoma,Signaling To ERKs R-HSA-187687,5.2896181583343145,0.02911735431018276,Other Types
Head and Neck Squamous Cell Carcinoma,"PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",6.364923905134474,0.017599794196738135,Other Types
Head and Neck Squamous Cell Carcinoma,Cell Junction Organization R-HSA-446728,7.4438292607056695,0.01087052789217727,Other Types
Head and Neck Squamous Cell Carcinoma,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,6.448607010111245,0.016940860048519125,Other Types
Head and Neck Squamous Cell Carcinoma,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,5.206007408627993,0.03031291789145043,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Heme Biosynthesis R-HSA-189451,5.40302874510119,0.027578039748408584,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Metabolism Of Porphyrins R-HSA-189445,5.403028603824577,0.027578041609130893,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,FCERI Mediated MAPK Activation R-HSA-2871796,5.647938173827394,0.024550878803389454,Other Types
Head and Neck Squamous Cell Carcinoma,Drug ADME R-HSA-9748784,8.445207068433609,0.007077330098821784,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Prolonged ERK Activation Events R-HSA-169893,5.8228650992622395,0.022613040243800057,Other Types
Head and Neck Squamous Cell Carcinoma,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,35.42088641463959,2.085047673127717e-06,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Citric Acid Cycle (TCA Cycle) R-HSA-71403,6.097588284604354,0.019900301182540683,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,7.338996183889766,0.011381020226402838,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,23.031149466749365,4.803720677115946e-05,Other Types
Head and Neck Squamous Cell Carcinoma,Frs2-mediated Activation R-HSA-170968,6.175531705963186,0.019197251120064606,Other Types
Head and Neck Squamous Cell Carcinoma,Ion Channel Transport R-HSA-983712,6.183254177302392,0.019129091774201818,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,9.733974146691772,0.004166344405460065,Other Types
Head and Neck Squamous Cell Carcinoma,Erythropoietin Activates RAS R-HSA-9027284,4.488059721507829,0.043138447171300554,Other Types
Head and Neck Squamous Cell Carcinoma,Regulation Of Signaling By CBL R-HSA-912631,4.524794463192661,0.04235241539340877,Other Types
Head and Neck Squamous Cell Carcinoma,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,13.740519655165302,0.0009168871526167672,Other Types
Head and Neck Squamous Cell Carcinoma,Kinesins R-HSA-983189,19.96381135056285,0.00011851751365420399,Other Types
Head and Neck Squamous Cell Carcinoma,Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,5.2806819032302075,0.029242616367354823,Other Types
Head and Neck Squamous Cell Carcinoma,ERBB2 Regulates Cell Motility R-HSA-6785631,6.389808579956101,0.017400962156200822,Other Types
Head and Neck Squamous Cell Carcinoma,Late Phase Of HIV Life Cycle R-HSA-162599,9.670434543938239,0.004274271691638632,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Cilium Assembly R-HSA-5617833,11.810486709587016,0.0018580793282775606,Other Types
Head and Neck Squamous Cell Carcinoma,Elastic Fibre Formation R-HSA-1566948,5.1113937368761215,0.03173163584609577,Other Types
Head and Neck Squamous Cell Carcinoma,MAP2K And MAPK Activation R-HSA-5674135,4.889942531440486,0.035348205611962426,Other Types
Head and Neck Squamous Cell Carcinoma,rRNA Processing R-HSA-72312,4.60752091766412,0.040639949676182244,Other Types
Head and Neck Squamous Cell Carcinoma,Lysosome Vesicle Biogenesis R-HSA-432720,8.070969459551794,0.008292802538788622,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,8.607833468237454,0.00661075954906533,Other Types
Head and Neck Squamous Cell Carcinoma,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,7.525504267527214,0.010490104853833978,Other Types
Head and Neck Squamous Cell Carcinoma,HIV Life Cycle R-HSA-162587,8.033520272661764,0.008426399335065744,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,6.853417963625274,0.014112439749446943,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,4.437042759841778,0.04425715282007955,Other Types
Head and Neck Squamous Cell Carcinoma,RHOH GTPase Cycle R-HSA-9013407,7.124765374886225,0.0125074939040015,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Suppression Of Phagosomal Maturation R-HSA-9637687,5.650884141141297,0.024516769111523964,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Transferrin Endocytosis And Recycling R-HSA-917977,6.847034506557174,0.014152808672774225,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,5.527118430486493,0.025995821005685968,Other Types
Head and Neck Squamous Cell Carcinoma,Post NMDA Receptor Activation Events R-HSA-438064,9.048413430236055,0.005506468396732232,Other Types
Head and Neck Squamous Cell Carcinoma,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,5.000438021784671,0.03348969237318277,Other Types
Head and Neck Squamous Cell Carcinoma,Gap Junction Trafficking And Regulation R-HSA-157858,9.961614582618694,0.003803260377806312,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,MTOR Signaling R-HSA-165159,5.80341630891157,0.022819946667457666,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Non-integrin membrane-ECM Interactions R-HSA-3000171,5.034751909802133,0.03293475379313755,Other Types
Head and Neck Squamous Cell Carcinoma,Syndecan Interactions R-HSA-3000170,5.034751909802133,0.03293475379313755,Other Types
Head and Neck Squamous Cell Carcinoma,Defective Pyroptosis R-HSA-9710421,6.219573870747184,0.018812069840364414,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,9.092299005219795,0.005407964401377585,Other Types
Head and Neck Squamous Cell Carcinoma,Rab Regulation Of Trafficking R-HSA-9007101,5.490205215628658,0.026455773824547436,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,AURKA Activation By TPX2 R-HSA-8854518,9.0632408008241,0.005472971371727614,Other Types
Head and Neck Squamous Cell Carcinoma,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,4.298135019583507,0.0474704779012783,Other Types
Head and Neck Squamous Cell Carcinoma,Centrosome Maturation R-HSA-380287,8.28490518716862,0.007572453298364972,Other Types
Head and Neck Squamous Cell Carcinoma,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,11.15295356762283,0.0023858171876558172,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,6.0993389014477986,0.019884203963451193,Other Types
Head and Neck Squamous Cell Carcinoma,mRNA Capping R-HSA-72086,6.761450604305418,0.014706407361914236,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Glycolysis R-HSA-70171,6.114513738831794,0.01974526593081969,Other Types
Head and Neck Squamous Cell Carcinoma,Regulation Of TP53 Expression And Degradation R-HSA-6806003,4.352956489032047,0.04617222472584191,Other Types
Head and Neck Squamous Cell Carcinoma,Regulation Of TP53 Degradation R-HSA-6804757,4.551603804973416,0.041788819696624825,Other Types
Head and Neck Squamous Cell Carcinoma,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,7.525601872236635,0.010489659008750547,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,7.5586837004945195,0.010339728714943756,Other Types
Head and Neck Squamous Cell Carcinoma,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,14.349330391700473,0.0007395731559065011,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,trans-Golgi Network Vesicle Budding R-HSA-199992,9.536284960103451,0.004512220486046578,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Autophagy R-HSA-9612973,4.6705093598623515,0.039387644867576205,Other Types
Head and Neck Squamous Cell Carcinoma,Transcriptional Regulation By E2F6 R-HSA-8953750,4.500227061683781,0.042876312784989955,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,4.206286521551364,0.04973789930969136,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,5.409520810456835,0.02749268020892341,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,9.881788607423752,0.003926521430176543,Other Types
Head and Neck Squamous Cell Carcinoma,Transcriptional Regulation By TP53 R-HSA-3700989,6.365217151472897,0.017597436674875844,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,RHOC GTPase Cycle R-HSA-9013106,7.36159832708778,0.0112687861658863,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,PKMTs Methylate Histone Lysines R-HSA-3214841,5.612447919372338,0.024965931532583037,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,HIV Transcription Initiation R-HSA-167161,12.850022119440604,0.001263930707143333,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Clathrin-mediated Endocytosis R-HSA-8856828,6.80157831486308,0.014443949037657515,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Golgi Associated Vesicle Biogenesis R-HSA-432722,9.060258999182762,0.005479689860682581,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,6.1393716515431995,0.01951996729422961,Other Types
Head and Neck Squamous Cell Carcinoma,Interleukin-7 Signaling R-HSA-1266695,11.726208143844445,0.0019180463750563376,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,RHOB GTPase Cycle R-HSA-9013026,7.643963199638457,0.009963893237527801,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,12.10431328199,0.0016643420454328268,Other Types
Head and Neck Squamous Cell Carcinoma,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,7.080129341260946,0.012757196613495152,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,4.420434478224323,0.04462828219976651,Other Types
Head and Neck Squamous Cell Carcinoma,APC Truncation Mutants Have Impaired AXIN Binding R-HSA-5467337,4.818293590576152,0.03661427576933195,Other Types
Head and Neck Squamous Cell Carcinoma,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,11.884151711318632,0.0018073211258177004,Other Types
Head and Neck Squamous Cell Carcinoma,MET Activates RAS Signaling R-HSA-8851805,5.350535860374052,0.028279066435450334,Other Types
Head and Neck Squamous Cell Carcinoma,Unwinding Of DNA R-HSA-176974,7.285529875537007,0.011651398305567762,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,tRNA Processing In Nucleus R-HSA-6784531,12.348464724145652,0.0015199272407519732,Other Types
Head and Neck Squamous Cell Carcinoma,Glycerophospholipid Biosynthesis R-HSA-1483206,4.844413316205667,0.03614699747020714,Other Types
Head and Neck Squamous Cell Carcinoma,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,6.313141975569834,0.01802156639597213,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,4.732971731399471,0.03818797942000932,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,E2F Mediated Regulation Of DNA Replication R-HSA-113510,8.926838356746519,0.005789663820934864,Other Types
Head and Neck Squamous Cell Carcinoma,PTK6 Regulates Cell Cycle R-HSA-8849470,27.99432685420696,1.2523331576370883e-05,Other Types
Head and Neck Squamous Cell Carcinoma,Extra-nuclear Estrogen Signaling R-HSA-9009391,5.898132344314849,0.021831520975335094,Other Types
Head and Neck Squamous Cell Carcinoma,Detoxification Of Reactive Oxygen Species R-HSA-3299685,5.386764846970153,0.027793168139970872,Other Types
Head and Neck Squamous Cell Carcinoma,SLC-mediated Transmembrane Transport R-HSA-425407,6.788079790679269,0.014531661105496196,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Amino Acid Transport Across Plasma Membrane R-HSA-352230,5.097310290260397,0.03194902139964817,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,RNA Polymerase II Pre-transcription Events R-HSA-674695,13.244157354111467,0.0010954375805981708,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,RND2 GTPase Cycle R-HSA-9696270,4.198547327133195,0.04993441105194159,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,G1/S-Specific Transcription R-HSA-69205,5.137347957135341,0.03133528886304576,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,6.992651743016493,0.013262499164485212,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Signaling By Hippo R-HSA-2028269,7.348362510277434,0.011334363200929908,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Formation Of Early Elongation Complex R-HSA-113418,5.169795833520065,0.030847453635787583,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,NoRC Negatively Regulates rRNA Expression R-HSA-427413,6.379546820639777,0.017482655313758474,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Formation Of RNA Pol II Elongation Complex R-HSA-112382,12.43985059143798,0.0014694027308541963,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,6.829287272231671,0.014265706747777825,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,6.154069547709879,0.019388081281352176,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,11.783848695228702,0.0018768113036926075,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Glycosaminoglycan Metabolism R-HSA-1630316,13.296485772393131,0.0010749551828860319,Other Types
Head and Neck Squamous Cell Carcinoma,Intrinsic Pathway For Apoptosis R-HSA-109606,18.632476719781405,0.00017889950334238277,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,7.924040065932559,0.008830574789419138,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,4.826373250760353,0.03646902029186794,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Impaired BRCA2 Binding To PALB2 R-HSA-9709603,8.557754036249964,0.006750771579959706,Other Types
Head and Neck Squamous Cell Carcinoma,Dual Incision In TC-NER R-HSA-6782135,6.692386601732695,0.01517042088066586,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,5.275064142863702,0.02932166657394843,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,PPARA Activates Gene Expression R-HSA-1989781,6.332071123500936,0.017866114617438537,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,5.062905592272034,0.03248703413088622,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,18.915194182684953,0.000163745299601309,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,SUMOylation Of Intracellular Receptors R-HSA-4090294,6.38018706593965,0.017477546094660287,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Nephrin Family Interactions R-HSA-373753,7.732824079394889,0.009588046670481439,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,4.593542455807482,0.04092382222459728,Other Types
Head and Neck Squamous Cell Carcinoma,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,5.376327985637986,0.027932194816200837,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",10.996009928745595,0.0025344238260708064,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,5.32395270667632,0.02864155643378536,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Recycling Pathway Of L1 R-HSA-437239,11.187270429449889,0.0023545950467717043,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,8.08308992398195,0.008250058797065621,Other Types
Head and Neck Squamous Cell Carcinoma,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,8.08308992398195,0.008250058797065621,Other Types
Head and Neck Squamous Cell Carcinoma,Adherens Junctions Interactions R-HSA-418990,6.839078742777263,0.01420329761239661,Other Types
Head and Neck Squamous Cell Carcinoma,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,6.185292029812573,0.019111149764531953,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Metabolism Of Carbohydrates R-HSA-71387,4.68332726437768,0.03913808943797753,Other Types
Head and Neck Squamous Cell Carcinoma,tRNA Processing R-HSA-72306,14.230933573050955,0.0007709218485330527,Other Types
Head and Neck Squamous Cell Carcinoma,Nucleotide Excision Repair R-HSA-5696398,6.982332059801038,0.013323536442829485,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Translation Initiation Complex Formation R-HSA-72649,4.6292762178457725,0.040202489206639096,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,4.363328718671718,0.04593107607482436,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,7.15575750428531,0.012337257997568622,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Potential Therapeutics For SARS R-HSA-9679191,9.392537811982608,0.00478322791244485,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,MicroRNA (miRNA) Biogenesis R-HSA-203927,5.962800928609423,0.021183718050766197,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,9.596089509347541,0.0044044140412638185,Other Types
Head and Neck Squamous Cell Carcinoma,SHC-mediated cascade:FGFR1 R-HSA-5654688,4.465241700914423,0.0436348639784151,Other Types
Head and Neck Squamous Cell Carcinoma,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,4.808166886231328,0.03679723943383177,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Transcription Of HIV Genome R-HSA-167172,15.732987191758655,0.00045968624137083554,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Iron Uptake And Transport R-HSA-917937,21.300516986288002,7.936231913049977e-05,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Basigin Interactions R-HSA-210991,8.103792178915418,0.008177603958872365,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,DNA Strand Elongation R-HSA-69190,6.804127605139563,0.014427449065321776,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,SUMOylation Of Transcription Cofactors R-HSA-3899300,19.153054929091006,0.00015206337743691204,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,6.7571380904712335,0.014734922523191894,Other Types
Head and Neck Squamous Cell Carcinoma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,26.62965370549031,1.7889050828653773e-05,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Late SARS-CoV-2 Infection Events R-HSA-9772573,11.327935871518937,0.002231153764044936,Other Types
Head and Neck Squamous Cell Carcinoma,Epigenetic Regulation Of Gene Expression R-HSA-212165,9.589327977128786,0.004416461539990862,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Beta-catenin Phosphorylation Cascade R-HSA-196299,4.419039488222885,0.044659612174514085,Other Types
Head and Neck Squamous Cell Carcinoma,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,4.419039756833414,0.04465960613945273,Other Types
Head and Neck Squamous Cell Carcinoma,CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,4.419039488222885,0.044659612174514085,Other Types
Head and Neck Squamous Cell Carcinoma,Inositol Phosphate Metabolism R-HSA-1483249,10.02109437488351,0.0037141423440312667,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,8.28266908532649,0.00757962081975537,Other Types
Head and Neck Squamous Cell Carcinoma,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,6.930815428209198,0.013632863894854012,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,HIV Elongation Arrest And Recovery R-HSA-167287,11.127356447645171,0.0024093972830734572,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,10.692521250712124,0.002850974401742537,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,11.058640288263032,0.002473953761504,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,8.895269525959012,0.005865758475171806,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Telomere Maintenance R-HSA-157579,5.465124255037846,0.026773406274730613,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,8.246636198314528,0.007696142251599662,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,4.300507966734446,0.047413447219113045,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Aggrephagy R-HSA-9646399,8.89755198681423,0.005860220501177097,Other Types
Head and Neck Squamous Cell Carcinoma,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,5.324070701724491,0.028639936159798974,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,4.445740387287877,0.04406416758746948,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,17.324270322841855,0.0002715829592048133,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,11.184549754223887,0.002357054177870875,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,5.555931943706128,0.025642914134019035,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Interleukin-37 Signaling R-HSA-9008059,4.512870253139783,0.04260580303915601,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,5.035781756388221,0.032918256692160856,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,"WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",8.633345808986839,0.006540647631688245,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,8.633345907047374,0.006540647363759755,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Termination Of Translesion DNA Synthesis R-HSA-5656169,4.378636036568516,0.045577750114752756,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Retrograde Neurotrophin Signaling R-HSA-177504,6.932810720206579,0.013620738345515061,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,HDACs Deacetylate Histones R-HSA-3214815,13.408690024505216,0.001032415021360903,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,5.272346014397042,0.02935999932183275,Other Types
Head and Neck Squamous Cell Carcinoma,Plasma Lipoprotein Clearance R-HSA-8964043,6.301195055740104,0.01812044070518934,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",7.941501078901347,0.008764722967709476,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Pre-NOTCH Transcription And Translation R-HSA-1912408,7.2325800078327935,0.011926085010479228,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Nef Mediated CD4 Down-regulation R-HSA-167590,5.517003323983071,0.026120976476516664,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Nef Mediated CD8 Down-regulation R-HSA-182218,5.517003323983071,0.026120976476516664,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Regulation Of Beta-Cell Development R-HSA-186712,18.13097858352175,0.0002096203654858017,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,4.975193114426134,0.03390457042483832,Other Types
Head and Neck Squamous Cell Carcinoma,RND3 GTPase Cycle R-HSA-9696264,8.833618489311498,0.006017513454775487,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Regulation Of Gene Expression In Beta Cells R-HSA-210745,13.003129940428277,0.0011953704711510148,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Activation Of HOX Genes During Differentiation R-HSA-5619507,6.193251482698588,0.019041248401062104,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Chromosome Maintenance R-HSA-73886,7.93143866476232,0.008802606473320611,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,4.3842718685061755,0.04544842680120963,Other Types
Head and Neck Squamous Cell Carcinoma,LDL Clearance R-HSA-8964038,7.5395175512254875,0.010426304939718968,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,VLDLR Internalisation And Degradation R-HSA-8866427,7.473219289080409,0.010731931284491751,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Dual Incision In GG-NER R-HSA-5696400,6.720090540503171,0.014982393550998922,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,7.20625941466871,0.012065250183680043,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,TBC/RABGAPs R-HSA-8854214,13.899533643602743,0.0008665364826895305,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,RND1 GTPase Cycle R-HSA-9696273,8.400722451465903,0.007211103095965596,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,8.347389705660898,0.007375117637726545,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,4.774620615971427,0.03741061521157175,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,8.081788741798007,0.008254636010841004,Other Types
Head and Neck Squamous Cell Carcinoma,RNA Polymerase I Promoter Clearance R-HSA-73854,4.211458391714292,0.049607058097706186,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,RNA Polymerase I Transcription R-HSA-73864,4.211458391714292,0.049607058097706186,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Lagging Strand Synthesis R-HSA-69186,4.534565003735169,0.04214604222212741,Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma,Signaling By NOTCH3 R-HSA-9012852,11.52121064158874,0.0020728170032784723,Head and Neck Squamous Cell Carcinoma
Bladder Urothelial Carcinoma,M Phase R-HSA-68886,5.477218740321549,0.04739009582160747,Other Types
Bladder Urothelial Carcinoma,Cristae Formation R-HSA-8949613,55.8549864302378,7.103214487848679e-05,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Asparagine N-linked Glycosylation R-HSA-446203,6.042505188214494,0.03943230445321142,Other Types
Bladder Urothelial Carcinoma,Cytoprotection By HMOX1 R-HSA-9707564,6.984883559509587,0.029580219849221757,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,TP53 Regulates Metabolic Genes R-HSA-5628897,17.673447117495137,0.0029802665475269323,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Signaling By MET R-HSA-6806834,13.166144769311584,0.006699394437393094,Other Types
Bladder Urothelial Carcinoma,Signaling By VEGF R-HSA-194138,5.501126456117422,0.0470141449935857,Other Types
Bladder Urothelial Carcinoma,Metabolism Of Nucleotides R-HSA-15869,9.567598249479953,0.014818598846820304,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,21.595744096198864,0.001650844848295433,Other Types
Bladder Urothelial Carcinoma,TCF Dependent Signaling In Response To WNT R-HSA-201681,5.3243752813201475,0.04988643465446046,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,11.020602695890975,0.010544323292814179,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Transport Of Small Molecules R-HSA-382551,5.481705691935885,0.047319246782046624,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Platelet Aggregation (Plug Formation) R-HSA-76009,5.680521778674972,0.044310985629141555,Other Types
Bladder Urothelial Carcinoma,Integrin Signaling R-HSA-354192,5.680521778674972,0.044310985629141555,Other Types
Bladder Urothelial Carcinoma,EPHB-mediated Forward Signaling R-HSA-3928662,13.267797746651025,0.006565188730970792,Other Types
Bladder Urothelial Carcinoma,Mitochondrial Translation Termination R-HSA-5419276,15.789116943545089,0.004098502171096732,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,mRNA Splicing - Minor Pathway R-HSA-72165,6.572483958293544,0.03345457970129199,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Neutrophil Degranulation R-HSA-6798695,6.013194785365663,0.039801079629351595,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Nucleotide Biosynthesis R-HSA-8956320,55.178792491572494,7.416686346329612e-05,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Metabolism Of Vitamins And Cofactors R-HSA-196854,12.246921694830878,0.008084291626348102,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,5.614201065586767,0.04528665435993693,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Cell-Cell Communication R-HSA-1500931,5.8823251187789465,0.041502192053801984,Other Types
Bladder Urothelial Carcinoma,Cell Junction Organization R-HSA-446728,13.820592960748687,0.005891619558396136,Other Types
Bladder Urothelial Carcinoma,Heme Biosynthesis R-HSA-189451,5.712879475130327,0.04384467414932513,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Metabolism Of Porphyrins R-HSA-189445,5.712879242650433,0.04384467747712295,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,RHOV GTPase Cycle R-HSA-9013424,10.41518082725987,0.012106700689393741,Other Types
Bladder Urothelial Carcinoma,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,55.91210502984839,7.077500852698267e-05,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Citric Acid Cycle (TCA Cycle) R-HSA-71403,5.709315761296824,0.04389572418982208,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,6.196043857389982,0.037569900767264956,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Ubiquinol Biosynthesis R-HSA-2142789,10.724528342696027,0.011274501104074046,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,DCC Mediated Attractive Signaling R-HSA-418885,7.482366239676664,0.02563121047985014,Other Types
Bladder Urothelial Carcinoma,Metabolism Of Cofactors R-HSA-8978934,8.107239862601043,0.02156770960110945,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Frs2-mediated Activation R-HSA-170968,6.653346825349015,0.032646347766509556,Other Types
Bladder Urothelial Carcinoma,ERBB2 Regulates Cell Motility R-HSA-6785631,19.197930450055654,0.0023439337827080367,Other Types
Bladder Urothelial Carcinoma,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",6.312927893592059,0.03622650886273059,Other Types
Bladder Urothelial Carcinoma,PI3K/AKT Signaling In Cancer R-HSA-2219528,7.484318059587782,0.02561707603457864,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Late Phase Of HIV Life Cycle R-HSA-162599,16.139980459548617,0.0038547743988804986,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Cilium Assembly R-HSA-5617833,7.111341579330696,0.028507300420185375,Other Types
Bladder Urothelial Carcinoma,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,5.96296545266928,0.04044330772949971,Other Types
Bladder Urothelial Carcinoma,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,6.218148405423058,0.03731105373551948,Other Types
Bladder Urothelial Carcinoma,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,12.614255183097711,0.007491327176322019,Other Types
Bladder Urothelial Carcinoma,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,6.27290363926996,0.03667954939759619,Other Types
Bladder Urothelial Carcinoma,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,7.24123373551263,0.027456026436521706,Other Types
Bladder Urothelial Carcinoma,HIV Life Cycle R-HSA-162587,15.655605705997802,0.004196303640860266,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,5.673172794302453,0.04441777178461689,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,RHOH GTPase Cycle R-HSA-9013407,18.02826492005048,0.002814526039123432,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Post NMDA Receptor Activation Events R-HSA-438064,6.182861260480724,0.037725356984313264,Other Types
Bladder Urothelial Carcinoma,Establishment Of Sister Chromatid Cohesion R-HSA-2468052,7.6772536626195755,0.02426722982193891,Other Types
Bladder Urothelial Carcinoma,DNA Double Strand Break Response R-HSA-5693606,6.439558394295914,0.034839165669093126,Other Types
Bladder Urothelial Carcinoma,MTOR Signaling R-HSA-165159,22.097763394481678,0.0015398166332351664,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Cell-cell Junction Organization R-HSA-421270,6.669718621729509,0.03248573467315428,Other Types
Bladder Urothelial Carcinoma,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,14.109402501136456,0.005574163030632665,Other Types
Bladder Urothelial Carcinoma,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,10.086653085800055,0.01307697301971445,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,RHO GTPases Activate PAKs R-HSA-5627123,5.47076120053303,0.0474922980311518,Other Types
Bladder Urothelial Carcinoma,mRNA Capping R-HSA-72086,117.40843685682002,4.648415581020712e-06,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Glycolysis R-HSA-70171,12.834865500030855,0.007161361831048845,Other Types
Bladder Urothelial Carcinoma,TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,8.085260247736144,0.021696207544519012,Other Types
Bladder Urothelial Carcinoma,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,5.7997274921553625,0.04262361441936547,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,5.820440785752362,0.04233880515036867,Other Types
Bladder Urothelial Carcinoma,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,6.325785332264909,0.03608248288339576,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,8.997143079354561,0.017084075861871145,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,56.55698109685345,6.795110333063403e-05,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Transcriptional Regulation By TP53 R-HSA-3700989,6.0213366228257215,0.03969820312191511,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,RHOC GTPase Cycle R-HSA-9013106,7.435893537062924,0.0259706834891803,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,HIV Transcription Initiation R-HSA-167161,10.215947827795796,0.012683834592899701,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,5.431110776474028,0.048126036964513924,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Clathrin-mediated Endocytosis R-HSA-8856828,5.508784994345033,0.04689451833380425,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Interleukin-7 Signaling R-HSA-1266695,17.35494264368175,0.003139587474132892,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,RHOB GTPase Cycle R-HSA-9013026,5.9198244706554,0.04100545825789785,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,7.175519452482566,0.0279816307128072,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,PI-3K cascade:FGFR1 R-HSA-5654689,5.662358385659417,0.04457550982993472,Other Types
Bladder Urothelial Carcinoma,Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,15.007579588172696,0.00471485589646662,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Unwinding Of DNA R-HSA-176974,9.30014709654214,0.015830310608331608,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Cell Cycle R-HSA-1640170,5.634432543108644,0.04498614636985366,Other Types
Bladder Urothelial Carcinoma,tRNA Processing In Nucleus R-HSA-6784531,7.697852418373467,0.02412848152433878,Other Types
Bladder Urothelial Carcinoma,PTK6 Regulates Cell Cycle R-HSA-8849470,25.254286198015937,0.001020036245816344,Other Types
Bladder Urothelial Carcinoma,Detoxification Of Reactive Oxygen Species R-HSA-3299685,11.796643518675266,0.008893995669988178,Other Types
Bladder Urothelial Carcinoma,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,9.98282544551832,0.013403835215166285,Other Types
Bladder Urothelial Carcinoma,SLC-mediated Transmembrane Transport R-HSA-425407,5.840765893740634,0.04206168340248206,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,RNA Polymerase II Pre-transcription Events R-HSA-674695,19.767104262741388,0.0021506483827803784,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,RND2 GTPase Cycle R-HSA-9696270,5.9253431898789515,0.040932994386928705,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,G1/S-Specific Transcription R-HSA-69205,13.125781934653846,0.006753637232796678,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Meiotic Synapsis R-HSA-1221632,11.086152189548464,0.01039077908928325,Other Types
Bladder Urothelial Carcinoma,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,26.36842220517531,0.0008905699433413866,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Signaling By Hippo R-HSA-2028269,5.351689765499397,0.04942821836695961,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Formation Of Early Elongation Complex R-HSA-113418,6.116294389975036,0.03852295393066876,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,NoRC Negatively Regulates rRNA Expression R-HSA-427413,7.337760925697155,0.026706414501074135,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Formation Of RNA Pol II Elongation Complex R-HSA-112382,16.650474918711883,0.0035317013543993627,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,6.436284059220595,0.03487418092745907,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,7.880218748669761,0.022942795163544145,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Intrinsic Pathway For Apoptosis R-HSA-109606,20.58246916647135,0.0019072345720646893,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,17.378186493194484,0.0031276048436100295,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Dual Incision In TC-NER R-HSA-6782135,25.48246221652237,0.0009916948634075334,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,PPARA Activates Gene Expression R-HSA-1989781,16.787064990901666,0.0034510721464119606,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,9.984558134215836,0.013398296638766542,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,SUMOylation Of Intracellular Receptors R-HSA-4090294,10.50294568249462,0.011862962754169655,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,6.266098283074339,0.036757294495701864,Other Types
Bladder Urothelial Carcinoma,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",5.369427797188099,0.0491335259875361,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Adherens Junctions Interactions R-HSA-418990,6.404189832231908,0.035219767678887993,Other Types
Bladder Urothelial Carcinoma,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,19.322701636580938,0.0022997580266055843,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Potential Therapeutics For SARS R-HSA-9679191,8.71923447654995,0.018346006899491382,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Transcription Of HIV Genome R-HSA-167172,113.80926559504368,5.226816040486833e-06,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Iron Uptake And Transport R-HSA-917937,6.025060031505705,0.03965126849756717,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,DNA Strand Elongation R-HSA-69190,5.958161645518623,0.04050541704269609,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,14.375857334984943,0.005300096385235373,Other Types
Bladder Urothelial Carcinoma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,5.7669928963153545,0.04307870825948028,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Late SARS-CoV-2 Infection Events R-HSA-9772573,5.348308165584909,0.04948465458358431,Other Types
Bladder Urothelial Carcinoma,Epigenetic Regulation Of Gene Expression R-HSA-212165,9.581261099037182,0.014769133888057184,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,23.94583774045611,0.001203697463274144,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,G2/M DNA Damage Checkpoint R-HSA-69473,14.253987677291281,0.005423298456503436,Other Types
Bladder Urothelial Carcinoma,Meiosis R-HSA-1500620,14.039088024076534,0.0056494344317990835,Other Types
Bladder Urothelial Carcinoma,Reproduction R-HSA-1474165,14.039087789927313,0.005649434684571689,Other Types
Bladder Urothelial Carcinoma,HIV Elongation Arrest And Recovery R-HSA-167287,15.897257839190171,0.004021372823366592,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,16.65180465996874,0.0035309050911794208,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,AKT Phosphorylates Targets In Cytosol R-HSA-198323,17.19064997303791,0.003225945007779103,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,16.99390955000018,0.003333313722596073,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,17.39661450313172,0.003118145578822567,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,11.507537606371235,0.009468017836483605,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,FOXO-mediated Transcription R-HSA-9614085,6.685047802977172,0.03233625720685487,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,HDACs Deacetylate Histones R-HSA-3214815,122.86139328513252,3.916319245098095e-06,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",7.913326928979732,0.022735494334921915,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Regulation Of Beta-Cell Development R-HSA-186712,18.722894573301286,0.0025221694636349537,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,RND3 GTPase Cycle R-HSA-9696264,8.545230635435368,0.019196301695017428,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Regulation Of BACH1 Activity R-HSA-9708530,5.481352009202179,0.04732482653366173,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Signaling By FLT3 Fusion Proteins R-HSA-9703465,5.439109289712697,0.04799733124503991,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Regulation Of Gene Expression In Beta Cells R-HSA-210745,283.5858509347644,1.5666604411617696e-07,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Dual Incision In GG-NER R-HSA-5696400,7.522734865740157,0.025340869802893733,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,RND1 GTPase Cycle R-HSA-9696273,6.070731222925173,0.03908126831481667,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,18.602301606601475,0.002570094776008759,Other Types
Bladder Urothelial Carcinoma,RNA Polymerase I Promoter Clearance R-HSA-73854,6.526458621852434,0.03392595451436737,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,5.620955264020654,0.04518604740591147,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,RNA Polymerase I Transcription R-HSA-73864,6.526458621852434,0.03392595451436737,Bladder Urothelial Carcinoma
Bladder Urothelial Carcinoma,Signaling By NOTCH3 R-HSA-9012852,6.168256538682465,0.03789853910741999,Bladder Urothelial Carcinoma
Myeloproliferative Neoplasms,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,4.194825108420567,0.04750296479608017,Other Types
Myeloproliferative Neoplasms,Cristae Formation R-HSA-8949613,9.393848927826452,0.003993533000580799,Other Types
Myeloproliferative Neoplasms,Golgi-to-ER Retrograde Transport R-HSA-8856688,7.074907605438676,0.011383044880284939,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,6.247064973122965,0.016877384906345626,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,VEGFA-VEGFR2 Pathway R-HSA-4420097,4.996336332256572,0.03135582226500539,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Cytoprotection By HMOX1 R-HSA-9707564,6.082824101633711,0.018275296372315966,Other Types
Myeloproliferative Neoplasms,TP53 Regulates Metabolic Genes R-HSA-5628897,10.444509219854586,0.0025428608681992435,Other Types
Myeloproliferative Neoplasms,Signaling By MET R-HSA-6806834,5.177270401080435,0.028610361264332536,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Signaling By VEGF R-HSA-194138,4.868225423231681,0.033472765433410774,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,FCGR3A-mediated Phagocytosis R-HSA-9664422,6.2263764171735785,0.017046943811352043,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Metabolism Of Nucleotides R-HSA-15869,12.527564125012526,0.0010775643051409215,Other Types
Myeloproliferative Neoplasms,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,8.806672176259672,0.0051700135890376505,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,4.696155343903349,0.036565068812840246,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,4.944553752819938,0.032193397197653954,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,6.319337659235817,0.016299176976453812,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,RAC3 GTPase Cycle R-HSA-9013423,4.400635814625649,0.04263010923569848,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Mitochondrial Translation R-HSA-5368287,6.417617880502375,0.015546897678484077,Other Types
Myeloproliferative Neoplasms,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,8.134030923323298,0.0069886284896886084,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Platelet Aggregation (Plug Formation) R-HSA-76009,6.277595577387827,0.016630475665956438,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Integrin Signaling R-HSA-354192,6.277595577387827,0.016630475665956438,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,EPHB-mediated Forward Signaling R-HSA-3928662,13.067798638267636,0.0008686853743010243,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Protein Localization R-HSA-9609507,4.763267096458881,0.03532339117071084,Other Types
Myeloproliferative Neoplasms,Mitochondrial Translation Termination R-HSA-5419276,16.438810423184027,0.00024015911996275397,Other Types
Myeloproliferative Neoplasms,Nucleotide Biosynthesis R-HSA-8956320,11.599407157133511,0.0015708796566810007,Other Types
Myeloproliferative Neoplasms,Mitochondrial Translation Initiation R-HSA-5368286,8.61271601210647,0.005635881280931125,Other Types
Myeloproliferative Neoplasms,Metabolism Of Vitamins And Cofactors R-HSA-196854,11.847250294850765,0.00141925008330487,Other Types
Myeloproliferative Neoplasms,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,7.784545379444649,0.008193965276514436,Other Types
Myeloproliferative Neoplasms,Mitochondrial Translation Elongation R-HSA-5389840,6.812653256140576,0.012879432958313104,Other Types
Myeloproliferative Neoplasms,Cell-Cell Communication R-HSA-1500931,5.194930622568735,0.02835672985203727,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,8.177172615778995,0.006853534881078812,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,RHOJ GTPase Cycle R-HSA-9013409,6.709734412886394,0.013523287666857823,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Cell Junction Organization R-HSA-446728,13.241579729944341,0.0008109913332920207,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,XBP1(S) Activates Chaperone Genes R-HSA-381038,5.734129233617425,0.02167559205569851,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,IRE1alpha Activates Chaperones R-HSA-381070,5.734129233617425,0.02167559205569851,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Smooth Muscle Contraction R-HSA-445355,4.272001342444785,0.04560749679162568,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,7.034332936563859,0.011601792143316659,Other Types
Myeloproliferative Neoplasms,Metabolism R-HSA-1430728,13.131151526154754,0.0008471642085296002,Other Types
Myeloproliferative Neoplasms,Heme Biosynthesis R-HSA-189451,8.008929953012645,0.007396723776929762,Other Types
Myeloproliferative Neoplasms,Metabolism Of Porphyrins R-HSA-189445,8.008929351213016,0.007396725800305204,Other Types
Myeloproliferative Neoplasms,Drug ADME R-HSA-9748784,7.002914233796883,0.011774277549115258,Other Types
Myeloproliferative Neoplasms,Prolonged ERK Activation Events R-HSA-169893,6.394961614510058,0.015716938635975775,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,4.332433767572047,0.044181230665564244,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,RHOV GTPase Cycle R-HSA-9013424,4.5988584471983085,0.03845069938374314,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,12.382116462270549,0.001142478479390222,Other Types
Myeloproliferative Neoplasms,Citric Acid Cycle (TCA Cycle) R-HSA-71403,8.698311119228935,0.0054249893686957665,Other Types
Myeloproliferative Neoplasms,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,4.575927745972112,0.03891041628675263,Other Types
Myeloproliferative Neoplasms,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,5.50728824941485,0.024251575641537897,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Ubiquinol Biosynthesis R-HSA-2142789,5.309600355822903,0.026768132768077258,Other Types
Myeloproliferative Neoplasms,DCC Mediated Attractive Signaling R-HSA-418885,6.996836094405874,0.011807962699874356,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Metabolism Of Cofactors R-HSA-8978934,6.286036077801102,0.016562904161815863,Other Types
Myeloproliferative Neoplasms,Unfolded Protein Response (UPR) R-HSA-381119,5.183768756114475,0.02851674808126082,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Frs2-mediated Activation R-HSA-170968,9.389837550684302,0.0040005238712517745,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,7.2035943980832275,0.010718058857134663,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Kinesins R-HSA-983189,8.83254254213122,0.005111051520753106,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,4.747445467791842,0.0356119133676084,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,ERBB2 Regulates Cell Motility R-HSA-6785631,7.002997499067099,0.011773816808760416,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Late Phase Of HIV Life Cycle R-HSA-162599,5.280655461228382,0.02715979435079767,Other Types
Myeloproliferative Neoplasms,Cilium Assembly R-HSA-5617833,12.424821243399853,0.001122999494629693,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,7.72797127001322,0.008409171622030096,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,7.66028153907583,0.008674644767379261,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,4.316423258822805,0.044554265433956894,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,MAP2K And MAPK Activation R-HSA-5674135,5.170570190439012,0.02870723213876647,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,VxPx Cargo-Targeting To Cilium R-HSA-5620916,6.00159784127368,0.019012385403213712,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,10.402914170530185,0.0025880712394533963,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,6.479581326411835,0.01509188488246643,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,GPER1 Signaling R-HSA-9634597,5.968106743545942,0.019325592018844245,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,HIV Life Cycle R-HSA-162587,5.091006715068048,0.029885214383740265,Other Types
Myeloproliferative Neoplasms,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,6.214955906061378,0.017141329933517198,Other Types
Myeloproliferative Neoplasms,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,8.547808406987736,0.0058016335803865214,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Depolymerisation Of Nuclear Lamina R-HSA-4419969,4.232678409157626,0.04656267807605853,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Post NMDA Receptor Activation Events R-HSA-438064,9.420726744113606,0.00394702598680306,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Cell-cell Junction Organization R-HSA-421270,5.325340837872206,0.026557721002093835,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Defective Pyroptosis R-HSA-9710421,5.077821318785151,0.030085460174067984,Other Types
Myeloproliferative Neoplasms,Regulation Of IFNG Signaling R-HSA-877312,4.941858659997062,0.032237652024126186,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,8.700746009428867,0.00541911486476965,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,AURKA Activation By TPX2 R-HSA-8854518,7.47583239087939,0.009444659826510894,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Centrosome Maturation R-HSA-380287,4.76827613614676,0.03523257916761375,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,5.551506167408823,0.023724537328904945,Other Types
Myeloproliferative Neoplasms,RNA Polymerase III Transcription Termination R-HSA-73980,6.814092963878475,0.012870663400044146,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,mRNA Capping R-HSA-72086,4.51552758614841,0.04015036065867723,Other Types
Myeloproliferative Neoplasms,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,4.384197189037192,0.04299843278201569,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Regulation Of TP53 Degradation R-HSA-6804757,4.176584593252376,0.04796350215028804,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Regulation Of IFNA/IFNB Signaling R-HSA-912694,6.2074731995649595,0.017203477106669175,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,4.269853519885932,0.045659109425576924,Other Types
Myeloproliferative Neoplasms,Transcriptional Regulation By E2F6 R-HSA-8953750,4.957091715688186,0.031988385528114935,Other Types
Myeloproliferative Neoplasms,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,4.251526906654252,0.04610212032439297,Other Types
Myeloproliferative Neoplasms,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,7.231412722340711,0.01057986261671582,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Transcriptional Regulation By TP53 R-HSA-3700989,8.72274893448577,0.005366336735849438,Other Types
Myeloproliferative Neoplasms,Diseases Of Glycosylation R-HSA-3781865,7.097365343728339,0.011263877288765501,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,PKMTs Methylate Histone Lysines R-HSA-3214841,6.63537543223727,0.014009978893686431,Other Types
Myeloproliferative Neoplasms,HIV Transcription Initiation R-HSA-167161,8.231987150890859,0.006685903056905152,Other Types
Myeloproliferative Neoplasms,Interleukin-7 Signaling R-HSA-1266695,11.02628299560291,0.0019914070174315295,Other Types
Myeloproliferative Neoplasms,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,8.941841948314222,0.004869748419905928,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,6.30127993698712,0.016441616191290146,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,5.713546218964571,0.021896644179573377,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Unwinding Of DNA R-HSA-176974,5.754958391409506,0.021454351978206034,Other Types
Myeloproliferative Neoplasms,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,4.22290442060462,0.046803491591536406,Other Types
Myeloproliferative Neoplasms,E2F Mediated Regulation Of DNA Replication R-HSA-113510,4.827543174632391,0.0341772143120572,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,PTK6 Regulates Cell Cycle R-HSA-8849470,7.193231368290674,0.010770034529353628,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Extra-nuclear Estrogen Signaling R-HSA-9009391,9.203625434362982,0.004339847806694009,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Detoxification Of Reactive Oxygen Species R-HSA-3299685,4.11118539971272,0.049655528949281866,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,SLC-mediated Transmembrane Transport R-HSA-425407,5.7760863022733595,0.02123243180563293,Other Types
Myeloproliferative Neoplasms,RNA Polymerase II Pre-transcription Events R-HSA-674695,5.840251916036851,0.02057353950466097,Other Types
Myeloproliferative Neoplasms,RND2 GTPase Cycle R-HSA-9696270,4.133097739836396,0.049081398860668694,Other Types
Myeloproliferative Neoplasms,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,6.065606043686048,0.0184289258579656,Other Types
Myeloproliferative Neoplasms,NoRC Negatively Regulates rRNA Expression R-HSA-427413,4.4131497579665595,0.042352040932424236,Other Types
Myeloproliferative Neoplasms,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,8.702787803892253,0.005414193992821028,Other Types
Myeloproliferative Neoplasms,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,4.8564922406457285,0.033674297049557385,Other Types
Myeloproliferative Neoplasms,Glycosaminoglycan Metabolism R-HSA-1630316,7.442344075450964,0.009592157465002492,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Intrinsic Pathway For Apoptosis R-HSA-109606,13.445701961994068,0.0007483680948890814,Other Types
Myeloproliferative Neoplasms,Dual Incision In TC-NER R-HSA-6782135,5.868521054787955,0.02029029900090733,Other Types
Myeloproliferative Neoplasms,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,7.1161141881417045,0.011165415819154582,Other Types
Myeloproliferative Neoplasms,SUMOylation Of Intracellular Receptors R-HSA-4090294,4.777208373402223,0.03507127271444949,Other Types
Myeloproliferative Neoplasms,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,5.368803011015866,0.025986002360430145,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",14.77620360380284,0.00044732323887367807,Other Types
Myeloproliferative Neoplasms,Adherens Junctions Interactions R-HSA-418990,12.017562041431058,0.0013241109107113484,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Nucleotide Excision Repair R-HSA-5696398,4.238568480498009,0.04641821504683022,Other Types
Myeloproliferative Neoplasms,Potential Therapeutics For SARS R-HSA-9679191,7.572471755666559,0.009032480035962742,Other Types
Myeloproliferative Neoplasms,Transcription Of HIV Genome R-HSA-167172,10.347220085342277,0.0026499495264889266,Other Types
Myeloproliferative Neoplasms,Basigin Interactions R-HSA-210991,7.163816004679152,0.01091904594132936,Other Types
Myeloproliferative Neoplasms,DNA Strand Elongation R-HSA-69190,5.98802097858805,0.019138689656924758,Other Types
Myeloproliferative Neoplasms,SUMOylation Of Transcription Cofactors R-HSA-3899300,4.451107985441092,0.04152067249363167,Other Types
Myeloproliferative Neoplasms,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,8.826191416967195,0.0051254598223442575,Other Types
Myeloproliferative Neoplasms,Late SARS-CoV-2 Infection Events R-HSA-9772573,5.744959398983518,0.021560251401626554,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Epigenetic Regulation Of Gene Expression R-HSA-212165,9.362310249753401,0.004048850643963451,Other Types
Myeloproliferative Neoplasms,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,4.367901647195741,0.04336699744524815,Other Types
Myeloproliferative Neoplasms,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,5.122788395965499,0.02940848081739192,Other Types
Myeloproliferative Neoplasms,RHO GTPases Activate IQGAPs R-HSA-5626467,6.2407971146894745,0.016928562090335768,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,6.04992504584635,0.01857005412540612,Other Types
Myeloproliferative Neoplasms,Aggrephagy R-HSA-9646399,4.733139060778144,0.03587501989826364,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,4.284089446898036,0.04531820956416945,Other Types
Myeloproliferative Neoplasms,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,5.6361377124196705,0.02275007385184799,Other Types
Myeloproliferative Neoplasms,FOXO-mediated Transcription R-HSA-9614085,5.787242262950418,0.0211162560875135,Other Types
Myeloproliferative Neoplasms,HDACs Deacetylate Histones R-HSA-3214815,7.243753938558212,0.010519167043230365,Other Types
Myeloproliferative Neoplasms,E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,4.1711263554079565,0.0481022648785468,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Pre-NOTCH Transcription And Translation R-HSA-1912408,4.307123758114262,0.044772524151847064,Other Types
Myeloproliferative Neoplasms,Regulation Of Beta-Cell Development R-HSA-186712,7.644057557495398,0.008739598184243897,Other Types
Myeloproliferative Neoplasms,RND3 GTPase Cycle R-HSA-9696264,6.762491010121919,0.013189028114524918,Other Types
Myeloproliferative Neoplasms,Regulation Of Gene Expression In Beta Cells R-HSA-210745,9.031339699566793,0.004681214059092392,Other Types
Myeloproliferative Neoplasms,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,6.166586041283754,0.017547382784873777,Other Types
Myeloproliferative Neoplasms,Dual Incision In GG-NER R-HSA-5696400,4.820134581858093,0.03430723242807717,Other Types
Myeloproliferative Neoplasms,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,8.424553721332572,0.006130888649522326,Myeloproliferative Neoplasms
Myeloproliferative Neoplasms,Lagging Strand Synthesis R-HSA-69186,4.556822710280658,0.03929802871608095,Other Types
Myeloproliferative Neoplasms,Signaling By NOTCH3 R-HSA-9012852,4.94297139070533,0.03221937237993841,Other Types
Renal Cell Carcinoma,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,34.12109708257638,4.3768446329547207e-07,Renal Cell Carcinoma
Renal Cell Carcinoma,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",31.969998209652164,8.423157386155552e-07,Renal Cell Carcinoma
Renal Cell Carcinoma,Respiratory Electron Transport R-HSA-611105,28.040603835299404,2.9280100939639894e-06,Renal Cell Carcinoma
Renal Cell Carcinoma,Complex I Biogenesis R-HSA-6799198,13.453651818950453,0.0006118423295854976,Renal Cell Carcinoma
Renal Cell Carcinoma,Adaptive Immune System R-HSA-1280218,18.45936187913863,8.421329584750717e-05,Other Types
Renal Cell Carcinoma,Mitochondrial Biogenesis R-HSA-1592230,32.933691473522885,6.267715868375608e-07,Renal Cell Carcinoma
Renal Cell Carcinoma,Nervous System Development R-HSA-9675108,15.508784131419345,0.0002649935641187745,Other Types
Renal Cell Carcinoma,Translation R-HSA-72766,14.077136560520744,0.0004729704929514885,Renal Cell Carcinoma
Renal Cell Carcinoma,Cytokine Signaling In Immune System R-HSA-1280215,13.018706865083498,0.0007336295656600703,Other Types
Renal Cell Carcinoma,Signaling By Interleukins R-HSA-449147,22.795808970225302,1.7298571895782016e-05,Other Types
Renal Cell Carcinoma,Innate Immune System R-HSA-168249,6.389956958470291,0.014822376569906188,Other Types
Renal Cell Carcinoma,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,5.772147777836829,0.020198224384990665,Other Types
Renal Cell Carcinoma,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,20.59196344241464,3.8125017540684425e-05,Other Types
Renal Cell Carcinoma,Axon Guidance R-HSA-422475,12.479073801431083,0.0009210487805314775,Other Types
Renal Cell Carcinoma,M Phase R-HSA-68886,15.353024073990722,0.0002820162253890663,Other Types
Renal Cell Carcinoma,Mitotic Metaphase And Anaphase R-HSA-2555396,17.00964624752518,0.00014678371950618892,Other Types
Renal Cell Carcinoma,tRNA Aminoacylation R-HSA-379724,31.28899985726897,1.0403591440162887e-06,Renal Cell Carcinoma
Renal Cell Carcinoma,C-type Lectin Receptors (CLRs) R-HSA-5621481,17.355781552033353,0.00012838084990921152,Other Types
Renal Cell Carcinoma,Vesicle-mediated Transport R-HSA-5653656,8.581686459014607,0.005182677835575778,Other Types
Renal Cell Carcinoma,Mitotic Anaphase R-HSA-68882,16.73368090271828,0.00016342646130442792,Other Types
Renal Cell Carcinoma,CLEC7A (Dectin-1) Signaling R-HSA-5607764,20.6991566631682,3.666338225687429e-05,Other Types
Renal Cell Carcinoma,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,21.86764439986052,2.4047735113231736e-05,Other Types
Renal Cell Carcinoma,FCERI Mediated NF-kB Activation R-HSA-2871837,28.519713543883242,2.5061526470140664e-06,Other Types
Renal Cell Carcinoma,Signaling By B Cell Receptor (BCR) R-HSA-983705,18.227035766053984,9.196804162196686e-05,Other Types
Renal Cell Carcinoma,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,20.301907617757806,4.239361534059462e-05,Other Types
Renal Cell Carcinoma,Membrane Trafficking R-HSA-199991,6.70092216524173,0.012715024218008356,Other Types
Renal Cell Carcinoma,MAPK Family Signaling Cascades R-HSA-5683057,15.483668979684582,0.00026766386099445874,Other Types
Renal Cell Carcinoma,TCR Signaling R-HSA-202403,20.26973171372665,4.28969977567887e-05,Other Types
Renal Cell Carcinoma,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,21.2552966294046,2.9965811763040754e-05,Other Types
Renal Cell Carcinoma,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,20.4584548375633,4.003108867807284e-05,Other Types
Renal Cell Carcinoma,Switching Of Origins To A Post-Replicative State R-HSA-69052,24.45324251054764,9.719348237649125e-06,Other Types
Renal Cell Carcinoma,DNA Replication Pre-Initiation R-HSA-69002,23.421633803406593,1.3890536614726195e-05,Other Types
Renal Cell Carcinoma,Activation Of NF-kappaB In B Cells R-HSA-1169091,20.55557933118233,3.863487078627042e-05,Other Types
Renal Cell Carcinoma,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,21.668815642697556,2.5822402379363154e-05,Other Types
Renal Cell Carcinoma,MAPK6/MAPK4 Signaling R-HSA-5687128,21.931405600540884,2.3505996324719676e-05,Other Types
Renal Cell Carcinoma,MAPK1/MAPK3 Signaling R-HSA-5684996,18.16648231708436,9.410950968503653e-05,Other Types
Renal Cell Carcinoma,Interleukin-1 Signaling R-HSA-9020702,15.621594964277934,0.00025333888744773913,Other Types
Renal Cell Carcinoma,Mitochondrial tRNA Aminoacylation R-HSA-379726,26.56053564850574,4.766955858460935e-06,Renal Cell Carcinoma
Renal Cell Carcinoma,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,18.663210387265693,7.797231420981156e-05,Other Types
Renal Cell Carcinoma,Downstream TCR Signaling R-HSA-202424,23.227817130753458,1.4863851172299369e-05,Other Types
Renal Cell Carcinoma,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,16.57556888911449,0.0001738411201381081,Other Types
Renal Cell Carcinoma,Assembly Of Pre-Replicative Complex R-HSA-68867,19.87086647776632,4.9682629749190644e-05,Other Types
Renal Cell Carcinoma,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,24.875537016141944,8.411104261486236e-06,Other Types
Renal Cell Carcinoma,Signaling By ROBO Receptors R-HSA-376176,13.69289902274315,0.0005540782185210298,Other Types
Renal Cell Carcinoma,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,20.605722820180052,3.793404316576136e-05,Other Types
Renal Cell Carcinoma,RAF/MAP Kinase Cascade R-HSA-5673001,19.317937391480697,6.099929621526884e-05,Other Types
Renal Cell Carcinoma,Separation Of Sister Chromatids R-HSA-2467813,17.85642270976677,0.00010592212602111167,Other Types
Renal Cell Carcinoma,Signaling By Hedgehog R-HSA-5358351,29.845545567990452,1.6382706674447192e-06,Other Types
Renal Cell Carcinoma,ABC-family Proteins Mediated Transport R-HSA-382556,20.359762154330042,4.150396801852842e-05,Other Types
Renal Cell Carcinoma,Disorders Of Transmembrane Transporters R-HSA-5619115,10.467055811166285,0.002203123960541614,Other Types
Renal Cell Carcinoma,Synthesis Of DNA R-HSA-69239,17.25102471230916,0.00013368092068661032,Other Types
Renal Cell Carcinoma,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,19.484481824403662,5.7331583447580055e-05,Other Types
Renal Cell Carcinoma,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,19.484481824403662,5.7331583447580055e-05,Other Types
Renal Cell Carcinoma,Antigen processing-Cross Presentation R-HSA-1236975,20.716399031462416,3.643379649068967e-05,Other Types
Renal Cell Carcinoma,Interleukin-1 Family Signaling R-HSA-446652,13.884037133363051,0.00051204954453663,Other Types
Renal Cell Carcinoma,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,24.75216296432204,8.773121292070043e-06,Other Types
Renal Cell Carcinoma,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,19.548930920917762,5.5974806582195704e-05,Other Types
Renal Cell Carcinoma,S Phase R-HSA-69242,15.673235660803822,0.0002481841179835144,Other Types
Renal Cell Carcinoma,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,19.491998989407048,5.71715768281e-05,Other Types
Renal Cell Carcinoma,Organelle Biogenesis And Maintenance R-HSA-1852241,5.438707424669408,0.023937668661338153,Renal Cell Carcinoma
Renal Cell Carcinoma,G1/S DNA Damage Checkpoints R-HSA-69615,24.482862436968404,9.621002953790463e-06,Other Types
Renal Cell Carcinoma,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,17.561819720044454,0.00011858792648124458,Other Types
Renal Cell Carcinoma,PCP/CE Pathway R-HSA-4086400,16.686920388174947,0.00016643672069450183,Other Types
Renal Cell Carcinoma,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,24.43642023425498,9.77566907156227e-06,Other Types
Renal Cell Carcinoma,Hh Mutants Are Degraded By ERAD R-HSA-5362768,23.475282810492782,1.3633055595094883e-05,Other Types
Renal Cell Carcinoma,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,23.475282810492782,1.3633055595094883e-05,Other Types
Renal Cell Carcinoma,Hedgehog Ligand Biogenesis R-HSA-5358346,23.475282810492782,1.3633055595094883e-05,Other Types
Renal Cell Carcinoma,HIV Infection R-HSA-162906,6.773083322218583,0.012273177767950253,Other Types
Renal Cell Carcinoma,Leishmania Infection R-HSA-9658195,7.363013278852733,0.009218575488561394,Other Types
Renal Cell Carcinoma,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,24.359544622378912,1.003741879482146e-05,Other Types
Renal Cell Carcinoma,Regulation Of Apoptosis R-HSA-169911,24.359544622378912,1.003741879482146e-05,Other Types
Renal Cell Carcinoma,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,28.86598993948722,2.241085147935021e-06,Other Types
Renal Cell Carcinoma,Hedgehog Off State R-HSA-5610787,27.44339401106348,3.5599127184715595e-06,Other Types
Renal Cell Carcinoma,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,24.28351782213697,1.0303483595978625e-05,Other Types
Renal Cell Carcinoma,Orc1 Removal From Chromatin R-HSA-68949,20.888884494808064,3.421811281355973e-05,Other Types
Renal Cell Carcinoma,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,21.783812473690542,2.477992388937394e-05,Other Types
Renal Cell Carcinoma,p53-Dependent G1 DNA Damage Response R-HSA-69563,26.079004588786884,5.598751580527083e-06,Other Types
Renal Cell Carcinoma,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,23.503574140629215,1.3499287352091856e-05,Other Types
Renal Cell Carcinoma,Cristae Formation R-HSA-8949613,33.4472808348615,5.362419519738593e-07,Renal Cell Carcinoma
Renal Cell Carcinoma,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,22.19385388919132,2.1406880696911074e-05,Other Types
Renal Cell Carcinoma,ABC Transporter Disorders R-HSA-5619084,22.036594716959964,2.26399614043151e-05,Other Types
Renal Cell Carcinoma,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,22.036594716959964,2.26399614043151e-05,Other Types
Renal Cell Carcinoma,Host Interactions Of HIV Factors R-HSA-162909,14.400727653601585,0.0004143351937175714,Other Types
Renal Cell Carcinoma,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,18.113618884597265,9.602166104605797e-05,Other Types
Renal Cell Carcinoma,DNA Replication R-HSA-69306,15.700358701761342,0.00024552080787118455,Other Types
Renal Cell Carcinoma,Vpu Mediated Degradation Of CD4 R-HSA-180534,26.04485622566432,5.6632203992164985e-06,Other Types
Renal Cell Carcinoma,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,24.305792742710437,1.0224775589540892e-05,Other Types
Renal Cell Carcinoma,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,18.442004520555773,8.476830527640172e-05,Other Types
Renal Cell Carcinoma,Beta-catenin Independent WNT Signaling R-HSA-3858494,10.216827434652197,0.0024624370801051188,Other Types
Renal Cell Carcinoma,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,13.630051204922978,0.0005686755447534362,Other Types
Renal Cell Carcinoma,Degradation Of GLI1 By Proteasome R-HSA-5610780,24.71058943459114,8.898744905682712e-06,Other Types
Renal Cell Carcinoma,RHO GTPase Cycle R-HSA-9012999,8.948730043810134,0.004373588004030576,Other Types
Renal Cell Carcinoma,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,26.916097925728064,4.236215183163724e-06,Other Types
Renal Cell Carcinoma,Asymmetric Localization Of PCP Proteins R-HSA-4608870,23.190730573012587,1.5058074845801486e-05,Other Types
Renal Cell Carcinoma,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,17.499174322370223,0.00012147992358157192,Other Types
Renal Cell Carcinoma,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,29.575627925569286,1.7852381097623696e-06,Other Types
Renal Cell Carcinoma,ER-Phagosome Pathway R-HSA-1236974,19.329855027886524,6.072886590774386e-05,Other Types
Renal Cell Carcinoma,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,24.679794694708278,8.993008034479422e-06,Other Types
Renal Cell Carcinoma,Degradation Of GLI2 By Proteasome R-HSA-5610783,24.679794694708278,8.993008034479422e-06,Other Types
Renal Cell Carcinoma,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,24.699248990972997,8.933337586680167e-06,Other Types
Renal Cell Carcinoma,Metabolism Of Polyamines R-HSA-351202,16.962921901202275,0.0001494717098061419,Other Types
Renal Cell Carcinoma,Transcriptional Regulation By RUNX3 R-HSA-8878159,26.187751425740956,5.398504188624694e-06,Other Types
Renal Cell Carcinoma,Hedgehog On State R-HSA-5632684,26.439920126849966,4.962393827358399e-06,Other Types
Renal Cell Carcinoma,Stabilization Of P53 R-HSA-69541,18.32497403462264,8.861167728959944e-05,Other Types
Renal Cell Carcinoma,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,21.316477163183844,2.931141836346962e-05,Other Types
Renal Cell Carcinoma,Degradation Of DVL R-HSA-4641258,21.861346127010393,2.4101950874337976e-05,Other Types
Renal Cell Carcinoma,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,21.058114078486263,3.2180780944839246e-05,Other Types
Renal Cell Carcinoma,Golgi-to-ER Retrograde Transport R-HSA-8856688,19.986292280873236,4.761070607244824e-05,Other Types
Renal Cell Carcinoma,UCH Proteinases R-HSA-5689603,23.880262438946076,1.184323822769924e-05,Other Types
Renal Cell Carcinoma,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,19.23954566965004,6.280980059319997e-05,Other Types
Renal Cell Carcinoma,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,22.225229655648338,2.1169371567109644e-05,Other Types
Renal Cell Carcinoma,Degradation Of AXIN R-HSA-4641257,22.222116096553044,2.1192817152170724e-05,Other Types
Renal Cell Carcinoma,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,20.61651313105639,3.778497773258208e-05,Other Types
Renal Cell Carcinoma,VEGFA-VEGFR2 Pathway R-HSA-4420097,9.4957313655945,0.003406149290719044,Other Types
Renal Cell Carcinoma,Asparagine N-linked Glycosylation R-HSA-446203,19.469256781849566,5.765709210525119e-05,Other Types
Renal Cell Carcinoma,Regulation Of RAS By GAPs R-HSA-5658442,18.202177073381275,9.28409339618501e-05,Other Types
Renal Cell Carcinoma,Cellular Response To Hypoxia R-HSA-1234174,17.81508251118077,0.00010761053011154056,Other Types
Renal Cell Carcinoma,Cytoprotection By HMOX1 R-HSA-9707564,27.60537005186876,3.3755926045300107e-06,Renal Cell Carcinoma
Renal Cell Carcinoma,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,34.87306706057304,3.496493387201525e-07,Renal Cell Carcinoma
Renal Cell Carcinoma,Transcriptional Regulation By RUNX2 R-HSA-8878166,19.32580837223052,6.082055019931409e-05,Other Types
Renal Cell Carcinoma,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,18.861926231005114,7.235276820503584e-05,Other Types
Renal Cell Carcinoma,TP53 Regulates Metabolic Genes R-HSA-5628897,22.645943638912428,1.8237619847373344e-05,Renal Cell Carcinoma
Renal Cell Carcinoma,Signaling By MET R-HSA-6806834,14.177265459508455,0.00045395002144078123,Other Types
Renal Cell Carcinoma,Signaling By VEGF R-HSA-194138,10.714139733746977,0.001975136674899063,Other Types
Renal Cell Carcinoma,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,27.551770707726995,3.4354573393408104e-06,Other Types
Renal Cell Carcinoma,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,21.57519556480074,2.670489869488387e-05,Other Types
Renal Cell Carcinoma,Mitotic G2-G2/M Phases R-HSA-453274,23.28177030984294,1.4585955625815076e-05,Other Types
Renal Cell Carcinoma,FCGR3A-mediated Phagocytosis R-HSA-9664422,14.858832228848787,0.0003440292309721413,Other Types
Renal Cell Carcinoma,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,13.715871246402752,0.0005488411166372187,Other Types
Renal Cell Carcinoma,G2/M Transition R-HSA-69275,19.774535530913823,5.148390342679068e-05,Other Types
Renal Cell Carcinoma,Regulation Of PTEN Stability And Activity R-HSA-8948751,12.658157481797451,0.0008538248690831385,Other Types
Renal Cell Carcinoma,Mitochondrial Protein Import R-HSA-1268020,26.827653956819482,4.362190935759458e-06,Renal Cell Carcinoma
Renal Cell Carcinoma,Signaling By NOTCH4 R-HSA-9013694,15.878912786255635,0.00022871851015305805,Other Types
Renal Cell Carcinoma,Intracellular Signaling By Second Messengers R-HSA-9006925,14.975795417284704,0.0003281642478364142,Other Types
Renal Cell Carcinoma,Metabolism Of Nucleotides R-HSA-15869,27.901629447060827,3.063776452064136e-06,Renal Cell Carcinoma
Renal Cell Carcinoma,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,10.774923036766719,0.0019229497251764779,Other Types
Renal Cell Carcinoma,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,11.025964270040664,0.0017223026819250537,Other Types
Renal Cell Carcinoma,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,16.60279827567318,0.0001719991977788625,Other Types
Renal Cell Carcinoma,RAC1 GTPase Cycle R-HSA-9013149,17.23414347584915,0.0001345562052720674,Other Types
Renal Cell Carcinoma,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,23.139732203416234,1.5329493957623836e-05,Other Types
Renal Cell Carcinoma,ER To Golgi Anterograde Transport R-HSA-199977,12.589202559405319,0.0008790778366559348,Other Types
Renal Cell Carcinoma,G1/S Transition R-HSA-69206,18.66364381804925,7.795957226983085e-05,Other Types
Renal Cell Carcinoma,"Platelet Activation, Signaling And Aggregation R-HSA-76002",17.014981552543063,0.00014648002043443062,Other Types
Renal Cell Carcinoma,Signaling By Rho GTPases R-HSA-194315,11.706971874496295,0.001281262510662871,Other Types
Renal Cell Carcinoma,Programmed Cell Death R-HSA-5357801,21.656197715149062,2.5939544962838138e-05,Other Types
Renal Cell Carcinoma,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,13.846162660573214,0.0005201038605445149,Other Types
Renal Cell Carcinoma,PIP3 Activates AKT Signaling R-HSA-1257604,19.306485372766556,6.126034728907759e-05,Other Types
Renal Cell Carcinoma,Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,20.588356110003865,3.81752518551738e-05,Renal Cell Carcinoma
Renal Cell Carcinoma,Signaling By NOTCH R-HSA-157118,7.62840603844303,0.008118211536979685,Other Types
Renal Cell Carcinoma,mRNA Splicing - Major Pathway R-HSA-72163,10.507326696997342,0.0021641532649608742,Other Types
Renal Cell Carcinoma,Mitotic G1 Phase And G1/S Transition R-HSA-453279,16.49599598562094,0.00017934307915018166,Other Types
Renal Cell Carcinoma,PTEN Regulation R-HSA-6807070,12.842682932149382,0.0007899217974034092,Other Types
Renal Cell Carcinoma,RAC3 GTPase Cycle R-HSA-9013423,22.94858836420727,1.6393111945654427e-05,Other Types
Renal Cell Carcinoma,Signaling By WNT R-HSA-195721,6.100221441575912,0.017123405536550885,Other Types
Renal Cell Carcinoma,Cyclin E Associated Events During G1/S Transition R-HSA-69202,13.585710860575253,0.0005792165198276898,Other Types
Renal Cell Carcinoma,TCF Dependent Signaling In Response To WNT R-HSA-201681,10.379562319847963,0.002290361358778528,Other Types
Renal Cell Carcinoma,"Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",11.923357899957573,0.001167402080059583,Other Types
Renal Cell Carcinoma,EPH-Ephrin Signaling R-HSA-2682334,5.064909794059659,0.029033276654786253,Other Types
Renal Cell Carcinoma,Mitochondrial Translation R-HSA-5368287,37.19764153019926,1.7699196054177724e-07,Renal Cell Carcinoma
Renal Cell Carcinoma,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,12.771116998158153,0.0008140884660182928,Other Types
Renal Cell Carcinoma,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,7.083417986521167,0.010550987962775961,Other Types
Renal Cell Carcinoma,Muscle Contraction R-HSA-397014,12.682471522952094,0.0008451030671832405,Other Types
Renal Cell Carcinoma,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,5.01743312832036,0.029759827381425862,Other Types
Renal Cell Carcinoma,Transport To Golgi And Subsequent Modification R-HSA-948021,12.033005597924701,0.0011138133762635615,Other Types
Renal Cell Carcinoma,mRNA Splicing R-HSA-72172,9.949296740029654,0.002775568535751983,Other Types
Renal Cell Carcinoma,Cell Cycle Checkpoints R-HSA-69620,17.963475203496834,0.00010167745606855541,Other Types
Renal Cell Carcinoma,COPI-mediated Anterograde Transport R-HSA-6807878,18.997762869632066,6.875634974612806e-05,Other Types
Renal Cell Carcinoma,Death Receptor Signaling R-HSA-73887,7.478086295414216,0.008723188040017258,Other Types
Renal Cell Carcinoma,KEAP1-NFE2L2 Pathway R-HSA-9755511,5.1293237236834495,0.02807792404330008,Other Types
Renal Cell Carcinoma,Apoptosis R-HSA-109581,15.617213159077679,0.0002537814089483979,Other Types
Renal Cell Carcinoma,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,13.223433476032168,0.0006734119856030449,Other Types
Renal Cell Carcinoma,MET Promotes Cell Motility R-HSA-8875878,14.255877988531083,0.0004395793982501576,Other Types
Renal Cell Carcinoma,Platelet Aggregation (Plug Formation) R-HSA-76009,13.195781402691878,0.0006812330176738127,Other Types
Renal Cell Carcinoma,Integrin Signaling R-HSA-354192,13.195781402691878,0.0006812330176738127,Other Types
Renal Cell Carcinoma,EPHB-mediated Forward Signaling R-HSA-3928662,18.44637953088157,8.46280527117881e-05,Other Types
Renal Cell Carcinoma,Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,12.848430314613541,0.0007880139436764898,Other Types
Renal Cell Carcinoma,Protein Localization R-HSA-9609507,32.261190730892054,7.70042430087528e-07,Renal Cell Carcinoma
Renal Cell Carcinoma,Downstream Signal Transduction R-HSA-186763,15.650779969537425,0.00025041201360724065,Other Types
Renal Cell Carcinoma,Mitochondrial Translation Termination R-HSA-5419276,37.98259126096215,1.4126251348822256e-07,Renal Cell Carcinoma
Renal Cell Carcinoma,mRNA Splicing - Minor Pathway R-HSA-72165,8.393825726819347,0.005656681340493707,Other Types
Renal Cell Carcinoma,GPCR Downstream Signaling R-HSA-388396,15.381477109123951,0.000278823198096817,Other Types
Renal Cell Carcinoma,Signaling By GPCR R-HSA-372790,15.381477109123951,0.000278823198096817,Other Types
Renal Cell Carcinoma,Hemostasis R-HSA-109582,6.489743908658812,0.014108236068003722,Other Types
Renal Cell Carcinoma,Neutrophil Degranulation R-HSA-6798695,9.012789091283484,0.004246630220235491,Other Types
Renal Cell Carcinoma,Costimulation By CD28 Family R-HSA-388841,9.559182580534921,0.003309525108326213,Other Types
Renal Cell Carcinoma,Signaling By PDGF R-HSA-186797,10.129868551774733,0.002559921018698784,Other Types
Renal Cell Carcinoma,Budding And Maturation Of HIV Virion R-HSA-162588,15.302502481408268,0.00028778054548963584,Other Types
Renal Cell Carcinoma,RHO GTPase Effectors R-HSA-195258,17.887845855813232,0.0001046573007664943,Other Types
Renal Cell Carcinoma,Nucleotide Biosynthesis R-HSA-8956320,10.585048193426521,0.002090978583467047,Renal Cell Carcinoma
Renal Cell Carcinoma,P75 NTR Receptor-Mediated Signaling R-HSA-193704,5.559652370512561,0.0225019174695202,Other Types
Renal Cell Carcinoma,RHOU GTPase Cycle R-HSA-9013420,26.118879664820838,5.524439718236632e-06,Other Types
Renal Cell Carcinoma,Mitochondrial Translation Initiation R-HSA-5368286,38.424709907222024,1.2453267119417052e-07,Renal Cell Carcinoma
Renal Cell Carcinoma,Metabolism Of Vitamins And Cofactors R-HSA-196854,43.66886374189127,2.933980357371876e-08,Renal Cell Carcinoma
Renal Cell Carcinoma,CDC42 GTPase Cycle R-HSA-9013148,18.054538040920697,9.820688036950387e-05,Other Types
Renal Cell Carcinoma,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,17.224712952980965,0.00013504778244262432,Renal Cell Carcinoma
Renal Cell Carcinoma,G2/M Checkpoints R-HSA-69481,7.356606618078276,0.009247019429150922,Other Types
Renal Cell Carcinoma,Mitochondrial Translation Elongation R-HSA-5389840,30.971381840660026,1.1487993427229177e-06,Renal Cell Carcinoma
Renal Cell Carcinoma,Cell-Cell Communication R-HSA-1500931,18.955668862843677,6.985040484580046e-05,Other Types
Renal Cell Carcinoma,RAC2 GTPase Cycle R-HSA-9013404,25.28611604502995,7.314623315725066e-06,Other Types
Renal Cell Carcinoma,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,10.177008428127353,0.00250658107129971,Other Types
Renal Cell Carcinoma,Infectious Disease R-HSA-5663205,5.413892848070122,0.024244229928726872,Other Types
Renal Cell Carcinoma,Sphingolipid De Novo Biosynthesis R-HSA-1660661,9.101517888154373,0.004077170988350383,Other Types
Renal Cell Carcinoma,CD28 Co-Stimulation R-HSA-389356,11.601834942929129,0.001340742478080164,Other Types
Renal Cell Carcinoma,rRNA Processing In Mitochondrion R-HSA-8868766,7.121013229796696,0.010360503394237903,Renal Cell Carcinoma
Renal Cell Carcinoma,Signaling To ERKs R-HSA-187687,10.745356863857374,0.001948150807802867,Other Types
Renal Cell Carcinoma,RHOJ GTPase Cycle R-HSA-9013409,10.021327661403722,0.0026873361810250654,Other Types
Renal Cell Carcinoma,Influenza Infection R-HSA-168255,10.421504855338407,0.0022480963630184744,Other Types
Renal Cell Carcinoma,"PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",4.465391070316293,0.03981342476410444,Other Types
Renal Cell Carcinoma,Cell Junction Organization R-HSA-446728,17.791734764632466,0.00010857650995236671,Other Types
Renal Cell Carcinoma,HCMV Late Events R-HSA-9610379,8.58721660410993,0.005169377586486993,Other Types
Renal Cell Carcinoma,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,5.396358320131884,0.024463394104263556,Renal Cell Carcinoma
Renal Cell Carcinoma,XBP1(S) Activates Chaperone Genes R-HSA-381038,19.675249611315852,5.341201822896895e-05,Other Types
Renal Cell Carcinoma,IRE1alpha Activates Chaperones R-HSA-381070,19.675249611315852,5.341201822896895e-05,Other Types
Renal Cell Carcinoma,Smooth Muscle Contraction R-HSA-445355,21.575382944003092,2.6703101257941158e-05,Other Types
Renal Cell Carcinoma,Late Endosomal Microautophagy R-HSA-9615710,14.625269958569183,0.0003781626731782382,Other Types
Renal Cell Carcinoma,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,20.99294845903699,3.294986900159556e-05,Renal Cell Carcinoma
Renal Cell Carcinoma,Nuclear Envelope (NE) Reassembly R-HSA-2995410,14.111377537732658,0.00046637377977410755,Other Types
Renal Cell Carcinoma,Viral Messenger RNA Synthesis R-HSA-168325,6.074860134300283,0.01734224749907226,Other Types
Renal Cell Carcinoma,Mitotic Prophase R-HSA-68875,7.122836328649493,0.010351359673101947,Other Types
Renal Cell Carcinoma,Nuclear Envelope Breakdown R-HSA-2980766,11.085375826618707,0.0016781210261692474,Other Types
Renal Cell Carcinoma,"Cell Cycle, Mitotic R-HSA-69278",12.487790002343903,0.0009176515369394959,Other Types
Renal Cell Carcinoma,Metabolism R-HSA-1430728,75.5316541298225,2.030637255604313e-11,Renal Cell Carcinoma
Renal Cell Carcinoma,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,4.090359342737513,0.048719538613504386,Other Types
Renal Cell Carcinoma,Signaling By FGFR2 R-HSA-5654738,7.443718702160533,0.00886811129569751,Other Types
Renal Cell Carcinoma,Signaling By FGFR R-HSA-190236,6.93090842390907,0.011362758062284437,Other Types
Renal Cell Carcinoma,Heme Biosynthesis R-HSA-189451,26.86941676276506,4.302225513784918e-06,Renal Cell Carcinoma
Renal Cell Carcinoma,Metabolism Of Porphyrins R-HSA-189445,26.86941663565762,4.302225694977938e-06,Renal Cell Carcinoma
Renal Cell Carcinoma,Neddylation R-HSA-8951664,17.129585889575512,0.00014011277537077563,Other Types
Renal Cell Carcinoma,rRNA Modification In Mitochondrion R-HSA-6793080,12.649527066743598,0.0008569434036771442,Renal Cell Carcinoma
Renal Cell Carcinoma,RHOG GTPase Cycle R-HSA-9013408,9.81466481463664,0.0029487691603407216,Other Types
Renal Cell Carcinoma,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,6.37558241038667,0.014928386594832291,Other Types
Renal Cell Carcinoma,FCERI Mediated MAPK Activation R-HSA-2871796,8.558428850181928,0.005239010730089475,Other Types
Renal Cell Carcinoma,MET Activates RAP1 And RAC1 R-HSA-8875555,8.621607324037889,0.005087472137504413,Other Types
Renal Cell Carcinoma,Drug ADME R-HSA-9748784,21.931429997990577,2.3505791492860794e-05,Renal Cell Carcinoma
Renal Cell Carcinoma,Prolonged ERK Activation Events R-HSA-169893,18.38829648257783,8.65100052779028e-05,Other Types
Renal Cell Carcinoma,Immune System R-HSA-168256,7.567173369986246,0.00835909516100221,Other Types
Renal Cell Carcinoma,Signaling By FGFR In Disease R-HSA-1226099,11.223359046528838,0.0015800452355332786,Other Types
Renal Cell Carcinoma,APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,15.988835871701605,0.0002189772291934419,Other Types
Renal Cell Carcinoma,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,23.910225275750843,1.1720964244663219e-05,Other Types
Renal Cell Carcinoma,Netrin-1 Signaling R-HSA-373752,15.748047466448002,0.00024091039638221223,Other Types
Renal Cell Carcinoma,RHOV GTPase Cycle R-HSA-9013424,17.868719925927262,0.00010542525214215012,Other Types
Renal Cell Carcinoma,Phosphorylation Of APC/C R-HSA-176412,21.877552818678172,2.396270082453859e-05,Other Types
Renal Cell Carcinoma,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,15.823440454373705,0.00023380567894416328,Renal Cell Carcinoma
Renal Cell Carcinoma,Citric Acid Cycle (TCA Cycle) R-HSA-71403,24.911127701735634,8.309595098389532e-06,Renal Cell Carcinoma
Renal Cell Carcinoma,Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,21.41958891767936,2.824209720275961e-05,Other Types
Renal Cell Carcinoma,Diseases Of Mitotic Cell Cycle R-HSA-9675126,17.598646625535533,0.00011692153046518545,Other Types
Renal Cell Carcinoma,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,17.598646625535533,0.00011692153046518545,Other Types
Renal Cell Carcinoma,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,15.954865241383741,0.00022194042218093418,Renal Cell Carcinoma
Renal Cell Carcinoma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,11.00292779911808,0.0017397615528720756,Other Types
Renal Cell Carcinoma,Ubiquinol Biosynthesis R-HSA-2142789,9.025029146966354,0.004222817856609318,Renal Cell Carcinoma
Renal Cell Carcinoma,DCC Mediated Attractive Signaling R-HSA-418885,14.374129310355,0.00041885422616537687,Other Types
Renal Cell Carcinoma,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,25.71265758907708,6.332351820192136e-06,Other Types
Renal Cell Carcinoma,mTORC1-mediated Signaling R-HSA-166208,16.19780664504675,0.00020163721299173724,Other Types
Renal Cell Carcinoma,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,18.536229763906515,8.180070666612106e-05,Other Types
Renal Cell Carcinoma,Signaling By RAF1 Mutants R-HSA-9656223,8.919538117644587,0.004432766965357822,Other Types
Renal Cell Carcinoma,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,8.919538117644587,0.004432766965357822,Other Types
Renal Cell Carcinoma,Semaphorin Interactions R-HSA-373755,11.375657131438825,0.0014787558527009912,Other Types
Renal Cell Carcinoma,G Alpha (I) Signaling Events R-HSA-418594,13.025549175355028,0.000731528302205577,Other Types
Renal Cell Carcinoma,G Alpha (12/13) Signaling Events R-HSA-416482,6.3026108327356996,0.015479160732445676,Other Types
Renal Cell Carcinoma,PRC2 Methylates Histones And DNA R-HSA-212300,13.489221312050445,0.0006028693539131917,Renal Cell Carcinoma
Renal Cell Carcinoma,Metabolism Of Cofactors R-HSA-8978934,10.379033482994064,0.002290899571629174,Renal Cell Carcinoma
Renal Cell Carcinoma,Unfolded Protein Response (UPR) R-HSA-381119,13.56563037862229,0.0005840574558256928,Other Types
Renal Cell Carcinoma,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,16.758583229471736,0.00016184665291056358,Other Types
Renal Cell Carcinoma,Frs2-mediated Activation R-HSA-170968,18.18605577621675,9.341164835860865e-05,Other Types
Renal Cell Carcinoma,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,25.95086247864379,5.844705043338423e-06,Other Types
Renal Cell Carcinoma,Erythropoietin Activates RAS R-HSA-9027284,9.177003660811643,0.003938624497696781,Other Types
Renal Cell Carcinoma,Signaling By FGFR2 In Disease R-HSA-5655253,5.430349006396274,0.024040461697624634,Other Types
Renal Cell Carcinoma,Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,17.018305563929147,0.00014629114180858245,Other Types
Renal Cell Carcinoma,Influenza Viral RNA Transcription And Replication R-HSA-168273,7.711551871336521,0.007802841747658339,Other Types
Renal Cell Carcinoma,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,9.607429956683053,0.0032379901827124208,Other Types
Renal Cell Carcinoma,NRAGE Signals Death Thru JNK R-HSA-193648,7.100523555860839,0.010463861395211929,Other Types
Renal Cell Carcinoma,Transport Of Mature Transcript To Cytoplasm R-HSA-72202,7.696574357990702,0.007858677333259382,Other Types
Renal Cell Carcinoma,Transport Of SLBP Independent Mature mRNA R-HSA-159227,6.727417969240051,0.01255085272570782,Other Types
Renal Cell Carcinoma,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,6.727417969240051,0.01255085272570782,Other Types
Renal Cell Carcinoma,Regulation Of Signaling By CBL R-HSA-912631,14.540466269624925,0.00039141883334676755,Other Types
Renal Cell Carcinoma,MET Receptor Recycling R-HSA-8875656,6.369654218087007,0.014972341370147286,Other Types
Renal Cell Carcinoma,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,15.278903423943635,0.0002905152686157149,Other Types
Renal Cell Carcinoma,Assembly Of HIV Virion R-HSA-175474,4.117534021466738,0.04800619767155399,Other Types
Renal Cell Carcinoma,Signaling By ERBB2 R-HSA-1227986,12.661297657195824,0.0008526931485426075,Other Types
Renal Cell Carcinoma,"Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",6.115397217393244,0.016993866922741956,Other Types
Renal Cell Carcinoma,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,21.117672926551702,3.149426588407475e-05,Other Types
Renal Cell Carcinoma,Interferon Signaling R-HSA-913531,6.705713175072706,0.012685169975900386,Other Types
Renal Cell Carcinoma,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,4.871278714822851,0.03212230635368653,Other Types
Renal Cell Carcinoma,Interleukin-12 Signaling R-HSA-9020591,20.829103995493575,3.496963991344284e-05,Other Types
Renal Cell Carcinoma,Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,8.418358978718977,0.00559225965177935,Other Types
Renal Cell Carcinoma,RAF-independent MAPK1/3 Activation R-HSA-112409,13.139392492165724,0.0006974786934835522,Other Types
Renal Cell Carcinoma,Kinesins R-HSA-983189,24.09973990440552,1.0977506076611141e-05,Other Types
Renal Cell Carcinoma,GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,8.951792518108173,0.004367428183336636,Other Types
Renal Cell Carcinoma,MET Activates PTK2 Signaling R-HSA-8874081,8.883544834879759,0.004506900472398451,Other Types
Renal Cell Carcinoma,Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,16.863370582490326,0.00015537201287653158,Other Types
Renal Cell Carcinoma,Protein Ubiquitination R-HSA-8852135,18.973144633017483,6.939400283680145e-05,Other Types
Renal Cell Carcinoma,COPII-mediated Vesicle Transport R-HSA-204005,9.848436587966113,0.0029042786046279117,Other Types
Renal Cell Carcinoma,ERBB2 Regulates Cell Motility R-HSA-6785631,6.392131071442376,0.014806412866672537,Other Types
Renal Cell Carcinoma,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",21.221897902330515,3.0329472326226935e-05,Other Types
Renal Cell Carcinoma,Negative Regulation Of MAPK Pathway R-HSA-5675221,4.278458326657877,0.04400840614656109,Other Types
Renal Cell Carcinoma,PI3K/AKT Signaling In Cancer R-HSA-2219528,8.541129975937626,0.005281330465815492,Other Types
Renal Cell Carcinoma,"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",12.030280958094753,0.0011151132152961585,Other Types
Renal Cell Carcinoma,Cilium Assembly R-HSA-5617833,22.926410304269854,1.6521419265175488e-05,Other Types
Renal Cell Carcinoma,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,8.77956767904225,0.004728507350462155,Other Types
Renal Cell Carcinoma,Platelet Degranulation R-HSA-114608,4.540781909862104,0.03824619978122254,Other Types
Renal Cell Carcinoma,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,15.355824336130556,0.0002817002848817812,Other Types
Renal Cell Carcinoma,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,7.017338015278277,0.010894876124919111,Other Types
Renal Cell Carcinoma,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,7.017338015278277,0.010894876124919111,Other Types
Renal Cell Carcinoma,RHOQ GTPase Cycle R-HSA-9013406,5.36565006802459,0.02485236091874239,Other Types
Renal Cell Carcinoma,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,7.36836694359242,0.009194877820764781,Other Types
Renal Cell Carcinoma,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,6.488752908182265,0.014115145148198057,Other Types
Renal Cell Carcinoma,RAF Activation R-HSA-5673000,7.26474104765912,0.00966528872849834,Other Types
Renal Cell Carcinoma,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,30.758625357077264,1.2279826017036608e-06,Renal Cell Carcinoma
Renal Cell Carcinoma,NS1 Mediated Effects On Host Pathways R-HSA-168276,9.012299136402937,0.004247586347407612,Other Types
Renal Cell Carcinoma,Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,6.125349324403924,0.01690948565671524,Other Types
Renal Cell Carcinoma,Apoptotic Factor-Mediated Response R-HSA-111471,14.507721072999473,0.0003966669556335591,Renal Cell Carcinoma
Renal Cell Carcinoma,MAP2K And MAPK Activation R-HSA-5674135,8.280649870451617,0.005964199334748991,Other Types
Renal Cell Carcinoma,rRNA Processing R-HSA-72312,4.737141138815974,0.0344694171326712,Renal Cell Carcinoma
Renal Cell Carcinoma,VxPx Cargo-Targeting To Cilium R-HSA-5620916,13.313691390562184,0.0006485326864538582,Other Types
Renal Cell Carcinoma,Signaling By EGFR R-HSA-177929,14.782015717195605,0.00035488428011854064,Other Types
Renal Cell Carcinoma,Signaling By Erythropoietin R-HSA-9006335,12.856669031913054,0.0007852875177524556,Other Types
Renal Cell Carcinoma,RHOA GTPase Cycle R-HSA-8980692,8.100785109932286,0.006489871634253685,Other Types
Renal Cell Carcinoma,Interferon Alpha/Beta Signaling R-HSA-909733,19.542663617246046,5.6105259444061564e-05,Other Types
Renal Cell Carcinoma,Disorders Of Developmental Biology R-HSA-9675151,11.047712225396374,0.0017059894173827115,Other Types
Renal Cell Carcinoma,Interleukin-12 Family Signaling R-HSA-447115,20.399746871452884,4.090052966411079e-05,Other Types
Renal Cell Carcinoma,IkBA Variant Leads To EDA-ID R-HSA-5603029,7.6088779108688485,0.00819422367926722,Other Types
Renal Cell Carcinoma,G Alpha (S) Signaling Events R-HSA-418555,10.93505779692786,0.0017922895497340843,Other Types
Renal Cell Carcinoma,NCAM Signaling For Neurite Out-Growth R-HSA-375165,7.657120267779254,0.008007798144293464,Other Types
Renal Cell Carcinoma,Signal Amplification R-HSA-392518,8.763178627459492,0.004764474794853388,Other Types
Renal Cell Carcinoma,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,7.062637509308483,0.010657871124443054,Other Types
Renal Cell Carcinoma,Interleukin-17 Signaling R-HSA-448424,10.862084205892215,0.0018506333349997087,Other Types
Renal Cell Carcinoma,MAP Kinase Activation R-HSA-450294,10.862084205892215,0.0018506333349997087,Other Types
Renal Cell Carcinoma,Signaling By NTRK1 (TRKA) R-HSA-187037,6.108467655636316,0.017052886458535352,Other Types
Renal Cell Carcinoma,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,9.921609701577777,0.002810290678699353,Other Types
Renal Cell Carcinoma,Biological Oxidations R-HSA-211859,25.273410168029866,7.346214632919826e-06,Renal Cell Carcinoma
Renal Cell Carcinoma,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,5.410512040055252,0.024286321994327748,Other Types
Renal Cell Carcinoma,G Alpha (Q) Signaling Events R-HSA-416476,13.089388475406093,0.0007122249982021071,Other Types
Renal Cell Carcinoma,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,15.045492364490698,0.00031907667070594744,Other Types
Renal Cell Carcinoma,MAPK3 (ERK1) Activation R-HSA-110056,13.255544859180882,0.0006644477648937605,Other Types
Renal Cell Carcinoma,GPER1 Signaling R-HSA-9634597,9.281612498556497,0.0037547853623181434,Other Types
Renal Cell Carcinoma,Negative Regulation Of PI3K/AKT Network R-HSA-199418,8.027464744390029,0.006718035385448265,Other Types
Renal Cell Carcinoma,Tight Junction Interactions R-HSA-420029,6.231289335747882,0.016038481828618837,Other Types
Renal Cell Carcinoma,Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,8.32413919785219,0.005843989416263751,Other Types
Renal Cell Carcinoma,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,22.794265526870742,1.730798125795701e-05,Other Types
Renal Cell Carcinoma,HCMV Infection R-HSA-9609646,6.933882488253069,0.011346307976817533,Other Types
Renal Cell Carcinoma,Mitotic Spindle Checkpoint R-HSA-69618,15.093987044490193,0.000312909410216822,Other Types
Renal Cell Carcinoma,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,16.367936208671754,0.0001885835694951672,Renal Cell Carcinoma
Renal Cell Carcinoma,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,7.138978309772879,0.010270772960955965,Other Types
Renal Cell Carcinoma,Interleukin-6 Signaling R-HSA-1059683,14.695623238215395,0.000367522568749258,Other Types
Renal Cell Carcinoma,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,12.413023947249519,0.0009472256175002466,Other Types
Renal Cell Carcinoma,Depolymerisation Of Nuclear Lamina R-HSA-4419969,17.151492116240206,0.00013892903242336966,Other Types
Renal Cell Carcinoma,Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,33.30280943915695,5.602376499086175e-07,Other Types
Renal Cell Carcinoma,SUMOylation Of RNA Binding Proteins R-HSA-4570464,9.74299140140515,0.0030455883780729693,Other Types
Renal Cell Carcinoma,ISG15 Antiviral Mechanism R-HSA-1169408,8.208936411155957,0.006168174255411226,Other Types
Renal Cell Carcinoma,EGFR Downregulation R-HSA-182971,8.559031088567897,0.005237543896074584,Other Types
Renal Cell Carcinoma,APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,14.18306251211676,0.00045287366854867,Other Types
Renal Cell Carcinoma,Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,17.341221565841412,0.00012910414614021698,Other Types
Renal Cell Carcinoma,TRAF6 Mediated NF-kB Activation R-HSA-933542,8.469836732269256,0.005459593604402152,Other Types
Renal Cell Carcinoma,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,6.812324490803189,0.012039788799719264,Renal Cell Carcinoma
Renal Cell Carcinoma,MHC Class II Antigen Presentation R-HSA-2132295,9.814740354662321,0.002948668846951792,Other Types
Renal Cell Carcinoma,RNA Polymerase III Chain Elongation R-HSA-73780,4.986027340650531,0.030251196826424735,Other Types
Renal Cell Carcinoma,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,21.64671436175132,2.602795209924555e-05,Renal Cell Carcinoma
Renal Cell Carcinoma,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,23.3942341307593,1.4023991920852923e-05,Other Types
Renal Cell Carcinoma,Signaling By ERBB4 R-HSA-1236394,5.049114972220394,0.029272845022998206,Other Types
Renal Cell Carcinoma,Insulin Processing R-HSA-264876,6.61412776356818,0.013269024306912349,Other Types
Renal Cell Carcinoma,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,18.44136904355031,8.478869738812799e-05,Other Types
Renal Cell Carcinoma,Mitotic Prometaphase R-HSA-68877,13.434602978706701,0.0006167052011537316,Other Types
Renal Cell Carcinoma,CTLA4 Inhibitory Signaling R-HSA-389513,12.088352600545312,0.0010877507762080347,Other Types
Renal Cell Carcinoma,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,8.012457441964205,0.006765774846235153,Other Types
Renal Cell Carcinoma,Post NMDA Receptor Activation Events R-HSA-438064,13.416042525227692,0.0006214824030851154,Other Types
Renal Cell Carcinoma,Establishment Of Sister Chromatid Cohesion R-HSA-2468052,6.485416371069488,0.014138433423892217,Other Types
Renal Cell Carcinoma,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,6.466601398457146,0.014270526777178397,Other Types
Renal Cell Carcinoma,Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,7.888115852646758,0.0071754139800916765,Other Types
Renal Cell Carcinoma,Vpr-mediated Nuclear Import Of PICs R-HSA-180910,7.888115852646758,0.0071754139800916765,Other Types
Renal Cell Carcinoma,Apoptotic Execution Phase R-HSA-75153,7.397299034558053,0.009067925835975084,Other Types
Renal Cell Carcinoma,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,13.720859265101035,0.0005477108460545906,Other Types
Renal Cell Carcinoma,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,13.720859265101035,0.0005477108460545906,Other Types
Renal Cell Carcinoma,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,13.720859265101035,0.0005477108460545906,Other Types
Renal Cell Carcinoma,DNA Double Strand Break Response R-HSA-5693606,5.628919571171899,0.021721478454099552,Renal Cell Carcinoma
Renal Cell Carcinoma,RHO GTPases Activate CIT R-HSA-5625900,8.794474609740206,0.004696041681257075,Other Types
Renal Cell Carcinoma,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,6.1189095049035656,0.016964035916036888,Other Types
Renal Cell Carcinoma,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,6.45833336177554,0.014328989361863468,Other Types
Renal Cell Carcinoma,Nuclear Signaling By ERBB4 R-HSA-1251985,5.873241095882947,0.01919216339072636,Other Types
Renal Cell Carcinoma,Cell-cell Junction Organization R-HSA-421270,5.218839818907466,0.026806055822303262,Other Types
Renal Cell Carcinoma,Non-integrin membrane-ECM Interactions R-HSA-3000171,4.35073582660623,0.04233204893784055,Other Types
Renal Cell Carcinoma,Syndecan Interactions R-HSA-3000170,4.35073582660623,0.04233204893784055,Other Types
Renal Cell Carcinoma,GPVI-mediated Activation Cascade R-HSA-114604,9.19675622148962,0.0039031972137827517,Other Types
Renal Cell Carcinoma,Defective Pyroptosis R-HSA-9710421,9.181917803279646,0.003929779117385927,Renal Cell Carcinoma
Renal Cell Carcinoma,SARS-CoV-1 Infection R-HSA-9678108,19.86065378244651,4.9870433423635905e-05,Other Types
Renal Cell Carcinoma,PI3K Cascade R-HSA-109704,19.53112158428955,5.63463372385918e-05,Other Types
Renal Cell Carcinoma,Early SARS-CoV-2 Infection Events R-HSA-9772572,9.116905698403777,0.00404851634503799,Other Types
Renal Cell Carcinoma,CD209 (DC-SIGN) Signaling R-HSA-5621575,10.34523518869653,0.002325574851688505,Other Types
Renal Cell Carcinoma,RHO GTPases Activate Formins R-HSA-5663220,17.879997208382278,0.00010497173216868718,Other Types
Renal Cell Carcinoma,Regulation Of IFNG Signaling R-HSA-877312,19.36070740739581,6.003458250510417e-05,Other Types
Renal Cell Carcinoma,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,8.52288036653272,0.005326368103664646,Other Types
Renal Cell Carcinoma,Loss Of MECP2 Binding Ability To NCoR/SMRT Complex R-HSA-9022537,11.816202321415172,0.0012223952535419405,Other Types
Renal Cell Carcinoma,Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,4.829800198459143,0.03282909052728655,Other Types
Renal Cell Carcinoma,Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,4.829800198459143,0.03282909052728655,Other Types
Renal Cell Carcinoma,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,8.69660380518333,0.004913579629973101,Other Types
Renal Cell Carcinoma,Spry Regulation Of FGF Signaling R-HSA-1295596,11.81178301329375,0.0012247209132692075,Other Types
Renal Cell Carcinoma,IRS-mediated Signaling R-HSA-112399,11.393737398021143,0.0014671926648804447,Other Types
Renal Cell Carcinoma,AURKA Activation By TPX2 R-HSA-8854518,21.352779065424897,2.8930203956540905e-05,Other Types
Renal Cell Carcinoma,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,19.30690418397106,6.125077985567454e-05,Other Types
Renal Cell Carcinoma,Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,11.851292732936264,0.0012040928269754492,Other Types
Renal Cell Carcinoma,SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,6.310150427846321,0.015421261769013534,Other Types
Renal Cell Carcinoma,Toll-like Receptor Cascades R-HSA-168898,4.804197821276309,0.0332737203733298,Other Types
Renal Cell Carcinoma,Centrosome Maturation R-HSA-380287,25.473748476077187,6.864262810150392e-06,Other Types
Renal Cell Carcinoma,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,6.821785075694372,0.011984231125413617,Renal Cell Carcinoma
Renal Cell Carcinoma,Phase I - Functionalization Of Compounds R-HSA-211945,12.478298249328477,0.0009213517003207208,Renal Cell Carcinoma
Renal Cell Carcinoma,Oncogenic MAPK Signaling R-HSA-6802957,10.092591536174393,0.0026029471151721053,Other Types
Renal Cell Carcinoma,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,5.686335584186925,0.021096560981799795,Other Types
Renal Cell Carcinoma,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,5.575814033486956,0.022317170690682217,Other Types
Renal Cell Carcinoma,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,4.346805488277198,0.0424213993263213,Other Types
Renal Cell Carcinoma,Mitochondrial Calcium Ion Transport R-HSA-8949215,12.991755610875213,0.0007419680631865659,Renal Cell Carcinoma
Renal Cell Carcinoma,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,17.516729962983923,0.00012066210875415881,Other Types
Renal Cell Carcinoma,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,7.859525100015405,0.007273270636706311,Other Types
Renal Cell Carcinoma,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,7.248358391956602,0.0097419678207172,Other Types
Renal Cell Carcinoma,RHO GTPases Activate PAKs R-HSA-5627123,22.913903579937653,1.6594236875229898e-05,Other Types
Renal Cell Carcinoma,Interleukin-20 Family Signaling R-HSA-8854691,17.80519476551647,0.00010801851942532826,Other Types
Renal Cell Carcinoma,Interleukin-6 Family Signaling R-HSA-6783589,8.513824749036457,0.005348866762614578,Other Types
Renal Cell Carcinoma,RMTs Methylate Histone Arginines R-HSA-3214858,18.34122324734219,8.80673228352624e-05,Renal Cell Carcinoma
Renal Cell Carcinoma,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,9.239129738121527,0.0038283278408548526,Other Types
Renal Cell Carcinoma,Glycolysis R-HSA-70171,5.2872343024977555,0.02587609325940746,Other Types
Renal Cell Carcinoma,Growth Hormone Receptor Signaling R-HSA-982772,9.758163653684838,0.0030248170460395727,Other Types
Renal Cell Carcinoma,"Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",17.518239081370027,0.00012059207711706554,Renal Cell Carcinoma
Renal Cell Carcinoma,Opioid Signaling R-HSA-111885,8.269834945652198,0.005994497519895039,Other Types
Renal Cell Carcinoma,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,5.184489424680865,0.027286627779163224,Other Types
Renal Cell Carcinoma,Regulation Of TP53 Expression And Degradation R-HSA-6806003,9.262616201040297,0.0037874840983269597,Other Types
Renal Cell Carcinoma,Integrin Cell Surface Interactions R-HSA-216083,6.943178706031104,0.011295052047559439,Other Types
Renal Cell Carcinoma,Mismatch Repair (MMR) Directed By MSH2:MSH3 (MutSbeta) R-HSA-5358606,7.9435828663230295,0.006989524933952307,Other Types
Renal Cell Carcinoma,Mismatch Repair R-HSA-5358508,7.9435828663230295,0.006989524933952307,Other Types
Renal Cell Carcinoma,Mismatch Repair (MMR) Directed By MSH2:MSH6 (MutSalpha) R-HSA-5358565,7.9435828663230295,0.006989524933952307,Other Types
Renal Cell Carcinoma,NF-kB Is Activated And Signals Survival R-HSA-209560,6.9133033122487,0.01146065608885336,Other Types
Renal Cell Carcinoma,Regulation Of TP53 Degradation R-HSA-6804757,10.718256771516941,0.001971555266027474,Other Types
Renal Cell Carcinoma,Nuclear Import Of Rev Protein R-HSA-180746,8.491588827600609,0.0054045392615765155,Other Types
Renal Cell Carcinoma,Chromatin Modifying Enzymes R-HSA-3247509,11.955463729164656,0.0011514359555562293,Renal Cell Carcinoma
Renal Cell Carcinoma,DNA Replication Initiation R-HSA-68952,32.53387175379341,7.082187664906857e-07,Other Types
Renal Cell Carcinoma,BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,10.804122815979015,0.0018983974300845266,Other Types
Renal Cell Carcinoma,Signaling To RAS R-HSA-167044,5.206183451625856,0.02698205394941439,Other Types
Renal Cell Carcinoma,Extracellular Matrix Organization R-HSA-1474244,4.8753912746988455,0.032053129860320904,Other Types
Renal Cell Carcinoma,Oncogene Induced Senescence R-HSA-2559585,16.115700932069707,0.00020827217322614137,Other Types
Renal Cell Carcinoma,Uptake And Function Of Anthrax Toxins R-HSA-5210891,4.811599391811224,0.0331445144355439,Other Types
Renal Cell Carcinoma,Signaling By SCF-KIT R-HSA-1433557,10.005966508906715,0.002705901316666764,Other Types
Renal Cell Carcinoma,Signaling By TGF-beta Receptor Complex R-HSA-170834,6.612984280406017,0.013276492399596263,Other Types
Renal Cell Carcinoma,Signaling By FGFR1 R-HSA-5654736,13.644625814287112,0.0005652548331249954,Other Types
Renal Cell Carcinoma,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,14.049469497087465,0.0004783721374055968,Other Types
Renal Cell Carcinoma,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,5.344940662904157,0.02511842584585303,Other Types
Renal Cell Carcinoma,Post-translational Protein Phosphorylation R-HSA-8957275,5.344940662904157,0.02511842584585303,Other Types
Renal Cell Carcinoma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,25.28957850352083,7.306039030807521e-06,Other Types
Renal Cell Carcinoma,Regulation Of TP53 Activity Thru Association With Co-factors R-HSA-6804759,14.909393020063396,0.0003370747182550564,Other Types
Renal Cell Carcinoma,GAB1 Signalosome R-HSA-180292,11.769929268781832,0.001246978349567251,Other Types
Renal Cell Carcinoma,MyD88-independent TLR4 Cascade R-HSA-166166,13.382378346582254,0.0006302464126445226,Other Types
Renal Cell Carcinoma,Autophagy R-HSA-9612973,4.316400529280497,0.04311957715273212,Other Types
Renal Cell Carcinoma,Insulin Receptor Signaling Cascade R-HSA-74751,7.163204219055414,0.010151076910980317,Other Types
Renal Cell Carcinoma,Transcriptional Regulation By E2F6 R-HSA-8953750,5.023221568626054,0.02967020521707507,Renal Cell Carcinoma
Renal Cell Carcinoma,Regulated Necrosis R-HSA-5218859,7.380644525866033,0.009140775722680452,Other Types
Renal Cell Carcinoma,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,20.347415709557612,4.169217166735397e-05,Other Types
Renal Cell Carcinoma,IRS-related Events Triggered By IGF1R R-HSA-2428928,6.952217591731514,0.011245451028564522,Other Types
Renal Cell Carcinoma,Transcriptional Regulation By TP53 R-HSA-3700989,21.813316162196546,2.45196178388197e-05,Renal Cell Carcinoma
Renal Cell Carcinoma,TFAP2 (AP-2) Family Regulates Transcription Of Growth Factors And Their Receptors R-HSA-8866910,8.11431219367409,0.006448681126632204,Other Types
Renal Cell Carcinoma,MAPK1 (ERK2) Activation R-HSA-112411,12.060208529525346,0.0011009226556451188,Other Types
Renal Cell Carcinoma,SUMOylation Of SUMOylation Proteins R-HSA-4085377,6.725631711943346,0.0125618493505677,Other Types
Renal Cell Carcinoma,HATs Acetylate Histones R-HSA-3214847,12.393668607046788,0.0009550436400126005,Renal Cell Carcinoma
Renal Cell Carcinoma,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,17.758842009320805,0.00010995281962867375,Other Types
Renal Cell Carcinoma,Signaling By FGFR3 R-HSA-5654741,9.795148541528011,0.0029748067112618467,Other Types
Renal Cell Carcinoma,Signaling By FGFR4 R-HSA-5654743,9.795148541528011,0.0029748067112618467,Other Types
Renal Cell Carcinoma,Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,20.673452948399675,3.700844343067704e-05,Other Types
Renal Cell Carcinoma,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,6.622157636091814,0.013216707070556857,Other Types
Renal Cell Carcinoma,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,6.622157636091814,0.013216707070556857,Other Types
Renal Cell Carcinoma,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,6.622157636091814,0.013216707070556857,Other Types
Renal Cell Carcinoma,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,6.622157636091814,0.013216707070556857,Other Types
Renal Cell Carcinoma,Transcriptional Regulation By VENTX R-HSA-8853884,20.582623341891864,3.8255226529508326e-05,Other Types
Renal Cell Carcinoma,SARS-CoV-2 Infection R-HSA-9694516,7.968361843755165,0.006908136938509601,Other Types
Renal Cell Carcinoma,PKMTs Methylate Histone Lysines R-HSA-3214841,17.650891795403606,0.0001145993791322402,Renal Cell Carcinoma
Renal Cell Carcinoma,FRS-mediated FGFR1 Signaling R-HSA-5654693,7.583866493484906,0.008292683435357483,Other Types
Renal Cell Carcinoma,Synthesis Of diphthamide-EEF2 R-HSA-5358493,9.717476404720067,0.003080859073030354,Renal Cell Carcinoma
Renal Cell Carcinoma,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,8.827819957907595,0.004624268783766649,Other Types
Renal Cell Carcinoma,Signaling By Leptin R-HSA-2586552,9.535342079136896,0.0033454861836888575,Other Types
Renal Cell Carcinoma,Activation Of Pre-Replicative Complex R-HSA-68962,14.394421401823918,0.0004154019777682231,Other Types
Renal Cell Carcinoma,Phosphorylation Of Emi1 R-HSA-176417,17.15114183882835,0.00013894787774762442,Other Types
Renal Cell Carcinoma,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,7.979011207052691,0.006873467454407029,Renal Cell Carcinoma
Renal Cell Carcinoma,Signaling By FGFR1 In Disease R-HSA-5655302,14.670582616781143,0.00037127324861620394,Other Types
Renal Cell Carcinoma,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,5.569682836314855,0.022387065215218365,Other Types
Renal Cell Carcinoma,Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658,16.393502555524453,0.00018669972452047432,Other Types
Renal Cell Carcinoma,DAG And IP3 Signaling R-HSA-1489509,15.905577209618702,0.00022631458551307235,Other Types
Renal Cell Carcinoma,SARS-CoV-2-host Interactions R-HSA-9705683,4.759305395398661,0.03406914313088369,Other Types
Renal Cell Carcinoma,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,22.056053893980323,2.248343959070826e-05,Other Types
Renal Cell Carcinoma,Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,7.092147798437569,0.010506427060851323,Other Types
Renal Cell Carcinoma,Glucose Metabolism R-HSA-70326,6.00930032949396,0.017921931955374348,Other Types
Renal Cell Carcinoma,PI3K Events In ERBB2 Signaling R-HSA-1963642,6.235967009617887,0.016001145117818454,Other Types
Renal Cell Carcinoma,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,8.17938912455417,0.0062543516826199606,Renal Cell Carcinoma
Renal Cell Carcinoma,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,11.138320332656845,0.0016397528238917803,Other Types
Renal Cell Carcinoma,APC Truncation Mutants Have Impaired AXIN Binding R-HSA-5467337,6.851688147548739,0.01181041085771747,Other Types
Renal Cell Carcinoma,Mitophagy R-HSA-5205647,15.4293986497761,0.0002735307016635844,Renal Cell Carcinoma
Renal Cell Carcinoma,PI-3K cascade:FGFR1 R-HSA-5654689,18.474955997448365,8.371790753103246e-05,Other Types
Renal Cell Carcinoma,Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,4.194448761308603,0.04604816847693022,Other Types
Renal Cell Carcinoma,Signaling By KIT In Disease R-HSA-9669938,6.113586514829243,0.017009267702719176,Other Types
Renal Cell Carcinoma,Cell Cycle R-HSA-1640170,9.4788435646932,0.003432364443897509,Other Types
Renal Cell Carcinoma,Interferon Gamma Signaling R-HSA-877300,8.776871322547294,0.004734405005547706,Other Types
Renal Cell Carcinoma,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,4.883803455872322,0.031912130791794564,Other Types
Renal Cell Carcinoma,Glycerophospholipid Biosynthesis R-HSA-1483206,12.73476125552844,0.0008266612861513728,Renal Cell Carcinoma
Renal Cell Carcinoma,IGF1R Signaling Cascade R-HSA-2428924,7.0793137958921575,0.010572006984941954,Other Types
Renal Cell Carcinoma,Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,7.0793137958921575,0.010572006984941954,Other Types
Renal Cell Carcinoma,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,15.049982022744741,0.00031850039077529736,Renal Cell Carcinoma
Renal Cell Carcinoma,FRS-mediated FGFR4 Signaling R-HSA-5654712,5.102045886471393,0.028478295387202084,Other Types
Renal Cell Carcinoma,FRS-mediated FGFR3 Signaling R-HSA-5654706,5.102045886471393,0.028478295387202084,Other Types
Renal Cell Carcinoma,FRS-mediated FGFR2 Signaling R-HSA-5654700,5.102045886471393,0.028478295387202084,Other Types
Renal Cell Carcinoma,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,17.001375068533804,0.00014725583920189225,Renal Cell Carcinoma
Renal Cell Carcinoma,Folding Of Actin By CCT/TriC R-HSA-390450,9.863691938121509,0.0028844138921473358,Other Types
Renal Cell Carcinoma,E2F Mediated Regulation Of DNA Replication R-HSA-113510,31.577990748379943,9.509623339556237e-07,Other Types
Renal Cell Carcinoma,Regulation Of Insulin Secretion R-HSA-422356,4.8251844366254275,0.032908774584004576,Other Types
Renal Cell Carcinoma,DNA Double-Strand Break Repair R-HSA-5693532,5.152162123002914,0.027747373568858428,Renal Cell Carcinoma
Renal Cell Carcinoma,FGFR1 Mutant Receptor Activation R-HSA-1839124,21.008222312792167,3.276789926683967e-05,Other Types
Renal Cell Carcinoma,Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,5.586069441189411,0.022200783548197305,Renal Cell Carcinoma
Renal Cell Carcinoma,Cellular Senescence R-HSA-2559583,13.56154807623548,0.0005850467835572277,Other Types
Renal Cell Carcinoma,Activated NTRK2 Signals Thru FRS2 And FRS3 R-HSA-9028731,5.013919463234457,0.02981437160838871,Other Types
Renal Cell Carcinoma,Phase II - Conjugation Of Compounds R-HSA-156580,18.719186457273963,7.634461990110876e-05,Renal Cell Carcinoma
Renal Cell Carcinoma,SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,4.41847384877307,0.04082382125377405,Other Types
Renal Cell Carcinoma,HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,12.638429083897968,0.0008609711585017319,Renal Cell Carcinoma
Renal Cell Carcinoma,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,5.104248903012673,0.028445733399981188,Other Types
Renal Cell Carcinoma,PTK6 Regulates Cell Cycle R-HSA-8849470,9.81970128644316,0.0029420888456215253,Other Types
Renal Cell Carcinoma,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,17.781561629254618,0.00010900024224122675,Other Types
Renal Cell Carcinoma,Extra-nuclear Estrogen Signaling R-HSA-9009391,9.675664524328662,0.0031395920227395694,Other Types
Renal Cell Carcinoma,Regulation Of MECP2 Expression And Activity R-HSA-9022692,7.939849033282589,0.007001876717710665,Other Types
Renal Cell Carcinoma,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,14.141353177509455,0.0004606779854423061,Other Types
Renal Cell Carcinoma,Post-translational Protein Modification R-HSA-597592,5.634884786266014,0.021655638586835856,Other Types
Renal Cell Carcinoma,Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,14.686446294875703,0.0003688924959907304,Other Types
Renal Cell Carcinoma,PLC Beta Mediated Events R-HSA-112043,11.926180070196345,0.0011659893446897684,Other Types
Renal Cell Carcinoma,RUNX2 Regulates Bone Development R-HSA-8941326,18.90917468429675,7.108000858078797e-05,Other Types
Renal Cell Carcinoma,Signaling By NTRK2 (TRKB) R-HSA-9006115,8.72360823019716,0.004852513006557683,Other Types
Renal Cell Carcinoma,Detoxification Of Reactive Oxygen Species R-HSA-3299685,4.715945930643006,0.03485695080417614,Renal Cell Carcinoma
Renal Cell Carcinoma,Peptide Hormone Metabolism R-HSA-2980736,5.057422900803657,0.029146569862128175,Other Types
Renal Cell Carcinoma,PI-3K cascade:FGFR4 R-HSA-5654720,11.308821089927847,0.0015223392826317081,Other Types
Renal Cell Carcinoma,PI-3K cascade:FGFR2 R-HSA-5654695,11.308821089927847,0.0015223392826317081,Other Types
Renal Cell Carcinoma,PI-3K cascade:FGFR3 R-HSA-5654710,11.308821089927847,0.0015223392826317081,Other Types
Renal Cell Carcinoma,NGF-stimulated Transcription R-HSA-9031628,4.188564593570354,0.046194845759995794,Renal Cell Carcinoma
Renal Cell Carcinoma,G-protein Mediated Events R-HSA-112040,9.007899604273636,0.004256182049083133,Other Types
Renal Cell Carcinoma,SLC-mediated Transmembrane Transport R-HSA-425407,19.855538671285455,4.996477518784044e-05,Renal Cell Carcinoma
Renal Cell Carcinoma,TP53 Regulates Transcription Of Additional Cell Death Genes With Uncertain Roles In P53-Dependent Apoptosis R-HSA-6803205,6.761995126749493,0.012339994562796407,Other Types
Renal Cell Carcinoma,Amino Acid Transport Across Plasma Membrane R-HSA-352230,7.758329078150001,0.007631149640039946,Renal Cell Carcinoma
Renal Cell Carcinoma,Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,5.715897728488239,0.020782344930828103,Other Types
Renal Cell Carcinoma,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,9.471429535887495,0.0034439404854853797,Other Types
Renal Cell Carcinoma,Sulfur Amino Acid Metabolism R-HSA-1614635,4.578524199385033,0.03748684569910244,Renal Cell Carcinoma
Renal Cell Carcinoma,Homology Directed Repair R-HSA-5693538,10.878779102276487,0.0018371114210661464,Renal Cell Carcinoma
Renal Cell Carcinoma,Cellular Responses To Stress R-HSA-2262752,6.004695348340276,0.01796342085776127,Other Types
Renal Cell Carcinoma,Cellular Responses To Stimuli R-HSA-8953897,6.004695348340276,0.01796342085776127,Other Types
Renal Cell Carcinoma,Signal Transduction R-HSA-162582,8.753522734855162,0.0047858008728028515,Other Types
Renal Cell Carcinoma,Cap-dependent Translation Initiation R-HSA-72737,4.962316516222077,0.030627966590219345,Other Types
Renal Cell Carcinoma,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,14.202986346670729,0.000449194714635628,Renal Cell Carcinoma
Renal Cell Carcinoma,Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,16.640740704476517,0.0001694665900093794,Other Types
Renal Cell Carcinoma,Signaling By PDGFRA Extracellular Domain Mutants R-HSA-9673770,4.204506562458996,0.04579862636162648,Other Types
Renal Cell Carcinoma,Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,6.274588036680093,0.015696398721376365,Renal Cell Carcinoma
Renal Cell Carcinoma,Ovarian Tumor Domain Proteases R-HSA-5689896,5.157070990289232,0.027676873814212074,Other Types
Renal Cell Carcinoma,L1CAM Interactions R-HSA-373760,6.336169499940056,0.015223221319166093,Other Types
Renal Cell Carcinoma,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,4.555274680994556,0.037952659691795454,Other Types
Renal Cell Carcinoma,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,17.469036383371453,0.00012289742567595202,Other Types
Renal Cell Carcinoma,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,17.469035949658718,0.0001228974461991759,Other Types
Renal Cell Carcinoma,Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,7.534842798387886,0.008489328463238537,Renal Cell Carcinoma
Renal Cell Carcinoma,Selective Autophagy R-HSA-9663891,10.892098345925755,0.0018263981525305365,Renal Cell Carcinoma
Renal Cell Carcinoma,Downregulation Of ERBB2 Signaling R-HSA-8863795,9.633530624745049,0.0031999728719518832,Other Types
Renal Cell Carcinoma,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,4.743262876948872,0.03435835619631361,Renal Cell Carcinoma
Renal Cell Carcinoma,Disease R-HSA-1643685,6.6469929015196,0.013056283335382102,Other Types
Renal Cell Carcinoma,Impaired BRCA2 Binding To PALB2 R-HSA-9709603,9.206867146545616,0.0038851930246863913,Renal Cell Carcinoma
Renal Cell Carcinoma,RET Signaling R-HSA-8853659,13.044200849052753,0.0007258324096769214,Other Types
Renal Cell Carcinoma,IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,4.731408094293282,0.03457377843124546,Other Types
Renal Cell Carcinoma,Intra-Golgi Traffic R-HSA-6811438,6.823198269893951,0.01197595553338175,Other Types
Renal Cell Carcinoma,PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,12.057051523104416,0.001102410602045454,Renal Cell Carcinoma
Renal Cell Carcinoma,Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,12.057051634839949,0.0011024105493453863,Renal Cell Carcinoma
Renal Cell Carcinoma,SUMOylation Of Intracellular Receptors R-HSA-4090294,8.934341674707168,0.004402651657328929,Renal Cell Carcinoma
Renal Cell Carcinoma,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,10.400598950559962,0.0022690593858849632,Renal Cell Carcinoma
Renal Cell Carcinoma,Meiotic Recombination R-HSA-912446,38.4681213593293,1.2300532731581978e-07,Renal Cell Carcinoma
Renal Cell Carcinoma,Metabolism Of RNA R-HSA-8953854,5.4610831297514775,0.023664804699501617,Other Types
Renal Cell Carcinoma,Pyroptosis R-HSA-5620971,7.24591824500097,0.009753444111394022,Other Types
Renal Cell Carcinoma,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,10.256897007930595,0.0024188411008289378,Other Types
Renal Cell Carcinoma,Interleukin-2 Family Signaling R-HSA-451927,8.595500080018988,0.005149522914757093,Other Types
Renal Cell Carcinoma,Signaling By ALK R-HSA-201556,5.442356073822178,0.023892945116608836,Other Types
Renal Cell Carcinoma,Base Excision Repair R-HSA-73884,18.081195686298457,9.72145252995175e-05,Renal Cell Carcinoma
Renal Cell Carcinoma,Signaling By FGFR4 In Disease R-HSA-5655291,7.179849230694635,0.01006969633689562,Other Types
Renal Cell Carcinoma,Interleukin-15 Signaling R-HSA-8983432,6.432477070137765,0.014513470975250985,Other Types
Renal Cell Carcinoma,Cyclin D Associated Events In G1 R-HSA-69231,22.993031271765034,1.6139117753167564e-05,Other Types
Renal Cell Carcinoma,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,8.577543939744881,0.005192664479477092,Renal Cell Carcinoma
Renal Cell Carcinoma,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,5.193613434034629,0.027158082589393742,Other Types
Renal Cell Carcinoma,Resolution Of Abasic Sites (AP Sites) R-HSA-73933,8.923093092242524,0.004425515180093314,Renal Cell Carcinoma
Renal Cell Carcinoma,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",5.451307863220689,0.023783597649338885,Renal Cell Carcinoma
Renal Cell Carcinoma,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,4.638310520514298,0.03631719916204378,Other Types
Renal Cell Carcinoma,Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,5.164739442064244,0.0275671273083626,Renal Cell Carcinoma
Renal Cell Carcinoma,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,8.183691420414617,0.00624172476931264,Renal Cell Carcinoma
Renal Cell Carcinoma,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,8.183691420414617,0.00624172476931264,Renal Cell Carcinoma
Renal Cell Carcinoma,Adherens Junctions Interactions R-HSA-418990,5.915998427070536,0.018782913032846387,Other Types
Renal Cell Carcinoma,Signaling By FGFR3 In Disease R-HSA-5655332,8.609141162271959,0.005117002081712174,Other Types
Renal Cell Carcinoma,Diseases Of DNA Repair R-HSA-9675135,13.393839566379114,0.0006272481751033856,Renal Cell Carcinoma
Renal Cell Carcinoma,Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,13.393840346783405,0.0006272479714610141,Renal Cell Carcinoma
Renal Cell Carcinoma,Oxidative Stress Induced Senescence R-HSA-2559580,5.957353754949075,0.018395953391410626,Renal Cell Carcinoma
Renal Cell Carcinoma,Eukaryotic Translation Termination R-HSA-72764,7.399385900178183,0.009058841043674505,Renal Cell Carcinoma
Renal Cell Carcinoma,Potential Therapeutics For SARS R-HSA-9679191,7.7262009061640216,0.0077486374102334775,Renal Cell Carcinoma
Renal Cell Carcinoma,Methylation R-HSA-156581,6.141030302434084,0.016777437834212976,Renal Cell Carcinoma
Renal Cell Carcinoma,Signaling By ERBB2 KD Mutants R-HSA-9664565,5.911617223984608,0.018824414966411563,Other Types
Renal Cell Carcinoma,MASTL Facilitates Mitotic Progression R-HSA-2465910,17.08201580411419,0.00014271980261391955,Other Types
Renal Cell Carcinoma,Iron Uptake And Transport R-HSA-917937,5.330442647670021,0.02530651050152284,Renal Cell Carcinoma
Renal Cell Carcinoma,Basigin Interactions R-HSA-210991,7.342425751492007,0.009310310754665993,Renal Cell Carcinoma
Renal Cell Carcinoma,Interleukin Receptor SHC Signaling R-HSA-912526,7.62980595934,0.008112791224772055,Other Types
Renal Cell Carcinoma,Chk1/Chk2(Cds1) Mediated Inactivation Of Cyclin B:Cdk1 Complex R-HSA-75035,4.366382362389433,0.04197837043025424,Other Types
Renal Cell Carcinoma,Tie2 Signaling R-HSA-210993,4.715383834105064,0.034867292116915215,Other Types
Renal Cell Carcinoma,Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,7.072406711440578,0.010607481167289051,Other Types
Renal Cell Carcinoma,SUMOylation Of Transcription Cofactors R-HSA-3899300,4.9048074949925935,0.03156299035665817,Renal Cell Carcinoma
Renal Cell Carcinoma,Pre-NOTCH Processing In Golgi R-HSA-1912420,4.058216443683796,0.049578261957345625,Other Types
Renal Cell Carcinoma,Epigenetic Regulation Of Gene Expression R-HSA-212165,18.00474060639395,0.00010008912401072562,Renal Cell Carcinoma
Renal Cell Carcinoma,Activation Of BH3-only Proteins R-HSA-114452,8.215363345449953,0.006149596449305436,Other Types
Renal Cell Carcinoma,Downstream Signaling Of Activated FGFR3 R-HSA-5654708,4.565543615586264,0.037746148444103254,Other Types
Renal Cell Carcinoma,Downstream Signaling Of Activated FGFR2 R-HSA-5654696,4.565543505483081,0.03774615065177164,Other Types
Renal Cell Carcinoma,Downstream Signaling Of Activated FGFR4 R-HSA-5654716,4.565543505483081,0.03774615065177164,Other Types
Renal Cell Carcinoma,Beta-catenin Phosphorylation Cascade R-HSA-196299,5.437215465039472,0.02395598233629425,Other Types
Renal Cell Carcinoma,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,5.437215534927765,0.023955981478069217,Other Types
Renal Cell Carcinoma,CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,5.437215465039472,0.02395598233629425,Other Types
Renal Cell Carcinoma,Inositol Phosphate Metabolism R-HSA-1483249,6.620751240798692,0.01322585429715066,Renal Cell Carcinoma
Renal Cell Carcinoma,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,7.483154824754739,0.008702028326807094,Other Types
Renal Cell Carcinoma,G2/M DNA Damage Checkpoint R-HSA-69473,8.691776303188426,0.004924581638958523,Renal Cell Carcinoma
Renal Cell Carcinoma,Regulated Proteolysis Of p75NTR R-HSA-193692,5.111308059112634,0.02834166440739003,Other Types
Renal Cell Carcinoma,AKT Phosphorylates Targets In Cytosol R-HSA-198323,4.750701568875393,0.03422392344483624,Other Types
Renal Cell Carcinoma,Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,12.896743205461513,0.0007721663151102636,Renal Cell Carcinoma
Renal Cell Carcinoma,Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,7.318975089336538,0.009415985844572558,Renal Cell Carcinoma
Renal Cell Carcinoma,SHC1 Events In ERBB2 Signaling R-HSA-1250196,7.606927853816364,0.00820185551095808,Other Types
Renal Cell Carcinoma,Fatty Acid Metabolism R-HSA-8978868,20.758539620691394,3.587898624216357e-05,Renal Cell Carcinoma
Renal Cell Carcinoma,Resolution Of D-Loop Structures R-HSA-5693537,9.836972216185957,0.00291930178031073,Renal Cell Carcinoma
Renal Cell Carcinoma,Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,9.836972216185957,0.00291930178031073,Renal Cell Carcinoma
Renal Cell Carcinoma,Homologous DNA Pairing And Strand Exchange R-HSA-5693579,12.476147707477116,0.0009221922191417503,Renal Cell Carcinoma
Renal Cell Carcinoma,RHO GTPases Activate IQGAPs R-HSA-5626467,12.403541716555045,0.0009510472558712885,Other Types
Renal Cell Carcinoma,Ca2+ Pathway R-HSA-4086398,4.324155253249769,0.04294032949981542,Renal Cell Carcinoma
Renal Cell Carcinoma,Regulation Of NF-kappa B Signaling R-HSA-9758274,7.352082259388229,0.0092671625521276,Other Types
Renal Cell Carcinoma,Processive Synthesis On Lagging Strand R-HSA-69183,9.150081548995512,0.003987458287983193,Other Types
Renal Cell Carcinoma,Removal Of Flap Intermediate R-HSA-69166,9.150081548995512,0.003987458287983193,Other Types
Renal Cell Carcinoma,Fatty acyl-CoA Biosynthesis R-HSA-75105,18.796550144870327,7.415327232359765e-05,Renal Cell Carcinoma
Renal Cell Carcinoma,DAP12 Signaling R-HSA-2424491,4.450641967562025,0.04012810111722615,Other Types
Renal Cell Carcinoma,Signaling By ERBB2 ECD Mutants R-HSA-9665348,6.479958055570946,0.014176619595496324,Other Types
Renal Cell Carcinoma,Cleavage Of Damaged Pyrimidine R-HSA-110329,12.986802969579065,0.0007435111567129764,Renal Cell Carcinoma
Renal Cell Carcinoma,Packaging Of Telomere Ends R-HSA-171306,12.986802969579065,0.0007435111567129764,Renal Cell Carcinoma
Renal Cell Carcinoma,Cleavage Of Damaged Purine R-HSA-110331,12.986802969579065,0.0007435111567129764,Renal Cell Carcinoma
Renal Cell Carcinoma,"Base-Excision Repair, AP Site Formation R-HSA-73929",12.986802969579065,0.0007435111567129764,Renal Cell Carcinoma
Renal Cell Carcinoma,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,8.925126756287804,0.0044213723485262545,Other Types
Renal Cell Carcinoma,Constitutive Signaling By EGFRvIII R-HSA-5637810,5.601406285431198,0.02202794096307081,Other Types
Renal Cell Carcinoma,Impaired BRCA2 Binding To RAD51 R-HSA-9709570,10.46518738564467,0.0022049499006042174,Renal Cell Carcinoma
Renal Cell Carcinoma,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,8.911182631242816,0.00444986076819714,Renal Cell Carcinoma
Renal Cell Carcinoma,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,4.758895350086244,0.03407650252680405,Renal Cell Carcinoma
Renal Cell Carcinoma,Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,5.198070404072259,0.02709552685314096,Other Types
Renal Cell Carcinoma,Signaling By EGFR In Cancer R-HSA-1643713,5.198070404072259,0.02709552685314096,Other Types
Renal Cell Carcinoma,DAP12 Interactions R-HSA-2172127,5.707347635063176,0.020872705182739832,Other Types
Renal Cell Carcinoma,TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,4.224952124746531,0.04529588289053834,Other Types
Renal Cell Carcinoma,Signaling By CSF3 (G-CSF) R-HSA-9674555,5.195832138153063,0.02712692259641674,Other Types
Renal Cell Carcinoma,Signaling By ERBB2 In Cancer R-HSA-1227990,6.086231385873589,0.017243757939787805,Other Types
Renal Cell Carcinoma,Role Of LAT2/NTAL/LAB On Calcium Mobilization R-HSA-2730905,4.968470885486548,0.03052968854264982,Other Types
Renal Cell Carcinoma,TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,20.679047571965942,3.693305015997968e-05,Other Types
Renal Cell Carcinoma,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",5.067509166459278,0.02899405346361589,Renal Cell Carcinoma
Renal Cell Carcinoma,Nef Mediated CD4 Down-regulation R-HSA-167590,7.744733722252347,0.007680633628174888,Renal Cell Carcinoma
Renal Cell Carcinoma,Nef Mediated CD8 Down-regulation R-HSA-182218,7.744733722252347,0.007680633628174888,Renal Cell Carcinoma
Renal Cell Carcinoma,Constitutive Signaling By Overexpressed ERBB2 R-HSA-9634285,4.380065231410998,0.04167170971219943,Other Types
Renal Cell Carcinoma,Condensation Of Prometaphase Chromosomes R-HSA-2514853,5.49716009940878,0.02323186603312591,Other Types
Renal Cell Carcinoma,Activation Of HOX Genes During Differentiation R-HSA-5619507,7.437356154136057,0.008895220429673117,Renal Cell Carcinoma
Renal Cell Carcinoma,Signaling By NODAL R-HSA-1181150,8.582292405760214,0.0051812187430219205,Renal Cell Carcinoma
Renal Cell Carcinoma,HSF1 Activation R-HSA-3371511,4.300225276240017,0.043496086166933685,Other Types
Renal Cell Carcinoma,Chromosome Maintenance R-HSA-73886,7.641464370419854,0.008067800156392935,Renal Cell Carcinoma
Renal Cell Carcinoma,LDL Clearance R-HSA-8964038,4.447209579670102,0.040201718574317626,Renal Cell Carcinoma
Renal Cell Carcinoma,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,6.802777413649573,0.012096132367764792,Renal Cell Carcinoma
Renal Cell Carcinoma,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,6.560562744054502,0.013623712402176217,Renal Cell Carcinoma
Renal Cell Carcinoma,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,4.45838207988096,0.03996262842383267,Renal Cell Carcinoma
Renal Cell Carcinoma,Translesion Synthesis By REV1 R-HSA-110312,8.983536945516107,0.004304114912068836,Renal Cell Carcinoma
Renal Cell Carcinoma,Translesion Synthesis By POLK R-HSA-5655862,8.983536945516107,0.004304114912068836,Renal Cell Carcinoma
Renal Cell Carcinoma,DNA Repair R-HSA-73894,5.618793276958415,0.02183373729504539,Renal Cell Carcinoma
Renal Cell Carcinoma,HDR Thru Homologous Recombination (HRR) R-HSA-5685942,7.491688096271293,0.0086665272054835,Renal Cell Carcinoma
Renal Cell Carcinoma,Cholesterol Biosynthesis R-HSA-191273,5.157973176346809,0.02766393786446106,Renal Cell Carcinoma
Renal Cell Carcinoma,SARS-CoV-2 Modulates Autophagy R-HSA-9754560,12.012182404975144,0.0011237880078594524,Renal Cell Carcinoma
Renal Cell Carcinoma,RNA Polymerase I Promoter Clearance R-HSA-73854,7.013634075804142,0.010914501243377407,Renal Cell Carcinoma
Renal Cell Carcinoma,RNA Polymerase I Transcription R-HSA-73864,7.013634075804142,0.010914501243377407,Renal Cell Carcinoma
Renal Cell Carcinoma,Cytosolic tRNA Aminoacylation R-HSA-379716,7.050828134476168,0.01071912431317937,Other Types
Renal Cell Carcinoma,Amyloid Fiber Formation R-HSA-977225,17.03822534147043,0.00014516457760248516,Renal Cell Carcinoma
Renal Cell Carcinoma,Translesion Synthesis By POLI R-HSA-5656121,8.983536945516107,0.004304114912068836,Renal Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Golgi-to-ER Retrograde Transport R-HSA-8856688,6.333774578353281,0.03599335535204945,Other Types
Esophageal Squamous Cell Carcinoma,Signaling By VEGF R-HSA-194138,6.317538919990744,0.036174773435297465,Other Types
Esophageal Squamous Cell Carcinoma,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,8.05086374832585,0.0218992444306329,Other Types
Esophageal Squamous Cell Carcinoma,mRNA Splicing - Major Pathway R-HSA-72163,15.494159661191448,0.0043185112770697046,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,5.351468843509086,0.049431902871533734,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,mRNA Splicing R-HSA-72172,16.80376525503614,0.003441372966221738,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Transport Of Small Molecules R-HSA-382551,5.403729565475626,0.04856997961149649,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,mRNA Splicing - Minor Pathway R-HSA-72165,10.425048283141983,0.012078984617948658,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Neutrophil Degranulation R-HSA-6798695,6.740265225703462,0.031804997666047385,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Nucleotide Biosynthesis R-HSA-8956320,58.70024453028251,5.952337842007238e-05,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Metabolism Of Vitamins And Cofactors R-HSA-196854,6.097170769388394,0.03875604521377492,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Signaling To ERKs R-HSA-187687,7.29602905748048,0.027027277142408906,Other Types
Esophageal Squamous Cell Carcinoma,"PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",11.662014737228452,0.009155695193969478,Other Types
Esophageal Squamous Cell Carcinoma,Nuclear Envelope (NE) Reassembly R-HSA-2995410,5.805022853811174,0.04255057141695793,Other Types
Esophageal Squamous Cell Carcinoma,RHOV GTPase Cycle R-HSA-9013424,5.457006260369027,0.04771093327501588,Other Types
Esophageal Squamous Cell Carcinoma,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,58.53805294007589,6.011370731882165e-05,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Citric Acid Cycle (TCA Cycle) R-HSA-71403,5.973290112749654,0.04031022760088979,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,5.502558121158594,0.046991752795084975,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,DCC Mediated Attractive Signaling R-HSA-418885,5.774840461832785,0.04296904580346816,Other Types
Esophageal Squamous Cell Carcinoma,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,5.636367855812748,0.04495753350826799,Other Types
Esophageal Squamous Cell Carcinoma,ERBB2 Regulates Cell Motility R-HSA-6785631,5.57378161951403,0.04589472277221889,Other Types
Esophageal Squamous Cell Carcinoma,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",8.427019205221459,0.01980245563305989,Other Types
Esophageal Squamous Cell Carcinoma,FGFR2 Mutant Receptor Activation R-HSA-1839126,6.180757068576824,0.03775024631460645,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Signaling By FGFR2 IIIa TM R-HSA-8851708,5.531410174261394,0.04654337089874796,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,14.438053988311003,0.005238572924899992,Other Types
Esophageal Squamous Cell Carcinoma,Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,12.946990102487264,0.007000651130182663,Other Types
Esophageal Squamous Cell Carcinoma,RHOH GTPase Cycle R-HSA-9013407,116.15662983274515,4.8400571633916055e-06,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Suppression Of Phagosomal Maturation R-HSA-9637687,7.854685069491682,0.023104303049510732,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Transferrin Endocytosis And Recycling R-HSA-917977,6.093475768189503,0.03880128875518123,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Establishment Of Sister Chromatid Cohesion R-HSA-2468052,5.553951840557673,0.0461968454104792,Other Types
Esophageal Squamous Cell Carcinoma,DNA Double Strand Break Response R-HSA-5693606,14.576388975756014,0.00510491572058914,Other Types
Esophageal Squamous Cell Carcinoma,Gap Junction Trafficking And Regulation R-HSA-157858,5.689385006017839,0.0441826309220231,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,MTOR Signaling R-HSA-165159,8.483894547022722,0.01950784623253153,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,5.394241965615093,0.04872502361880529,Other Types
Esophageal Squamous Cell Carcinoma,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,7.928618826269564,0.022640545962028816,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,17.895538058779326,0.002875138506933429,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,mRNA Capping R-HSA-72086,10.170333803682153,0.012820809755970925,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,13.974281305133166,0.005719942670270395,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,6.159956886002396,0.0379974061960691,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,trans-Golgi Network Vesicle Budding R-HSA-199992,7.573219458698065,0.02498360012482173,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,8.922858429512111,0.017410377422363288,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,RHOC GTPase Cycle R-HSA-9013106,19.49722782324849,0.0022397012509422693,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Clathrin-mediated Endocytosis R-HSA-8856828,15.324958227756817,0.004451418597895066,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Golgi Associated Vesicle Biogenesis R-HSA-432722,7.132297571366522,0.028334289374578117,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Interleukin-7 Signaling R-HSA-1266695,8.090898380793174,0.02166315371205105,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,RHOB GTPase Cycle R-HSA-9013026,18.55666064108443,0.0025885304300297973,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,6.2416982978701565,0.03703776860851901,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,15.71087791043292,0.004155463711045684,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,tRNA Processing In Nucleus R-HSA-6784531,6.860118970030928,0.030689390862720566,Other Types
Esophageal Squamous Cell Carcinoma,PTK6 Regulates Cell Cycle R-HSA-8849470,23.069882149537293,0.0013501570705914,Other Types
Esophageal Squamous Cell Carcinoma,RNA Polymerase II Pre-transcription Events R-HSA-674695,6.731127012425632,0.03189215027065164,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Homology Directed Repair R-HSA-5693538,14.415152169384081,0.0052611221097701244,Other Types
Esophageal Squamous Cell Carcinoma,G1/S-Specific Transcription R-HSA-69205,11.526860012760267,0.009428226573919936,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,6.690833284077474,0.03228006872184653,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Signaling By Hippo R-HSA-2028269,6.547101843502327,0.03371349903338022,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,11.236555615175803,0.010048958586055326,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Intrinsic Pathway For Apoptosis R-HSA-109606,6.500260011128541,0.03419803679782426,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,8.621523749623407,0.018817493179144138,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Impaired BRCA2 Binding To PALB2 R-HSA-9709603,16.536878391680453,0.0036005632474328917,Other Types
Esophageal Squamous Cell Carcinoma,Dual Incision In TC-NER R-HSA-6782135,6.417656562334005,0.035074232703207135,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,5.593191279156665,0.045601434942874594,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,PPARA Activates Gene Expression R-HSA-1989781,8.364140656167596,0.02013472808798298,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,9.10892412816827,0.016607458766233284,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,13.874492129067887,0.005830684705720984,Other Types
Esophageal Squamous Cell Carcinoma,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,6.710591789068135,0.03208910533107906,Other Types
Esophageal Squamous Cell Carcinoma,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,15.054055252313724,0.004675079751052428,Other Types
Esophageal Squamous Cell Carcinoma,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,16.618203161060936,0.0035510952374053694,Other Types
Esophageal Squamous Cell Carcinoma,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,16.618203161060936,0.0035510952374053694,Other Types
Esophageal Squamous Cell Carcinoma,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,7.784312556612905,0.02355692706702324,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,MicroRNA (miRNA) Biogenesis R-HSA-203927,6.834422547872289,0.03092434557250928,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Transcription Of HIV Genome R-HSA-167172,14.57854246979447,0.00510286907654166,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Iron Uptake And Transport R-HSA-917937,17.358790644357004,0.003137599790030825,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,6.414699832751465,0.03510612059462476,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Inositol Phosphate Metabolism R-HSA-1483249,5.760786829089434,0.043165684663813306,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,SUMOylation Of Transcription Factors R-HSA-3232118,29.983662996798685,0.0005904287185707221,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,6.176379799948511,0.03780208949350895,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Meiosis R-HSA-1500620,14.096577166221577,0.00558779823745352,Other Types
Esophageal Squamous Cell Carcinoma,Reproduction R-HSA-1474165,14.096577279514953,0.005587798116821343,Other Types
Esophageal Squamous Cell Carcinoma,Telomere Maintenance R-HSA-157579,17.966577784886194,0.0028424955317261236,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Resolution Of D-Loop Structures R-HSA-5693537,7.348885542317629,0.02662169573021513,Other Types
Esophageal Squamous Cell Carcinoma,Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,7.348885542317629,0.02662169573021513,Other Types
Esophageal Squamous Cell Carcinoma,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,8.025518187800598,0.022050392708026497,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,11.226635734151468,0.010071063812831061,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,8.022570821398523,0.02206805474784281,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,5.5651641089126755,0.0460257072073115,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,HDACs Deacetylate Histones R-HSA-3214815,13.51509840411486,0.00625251560578769,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Viral mRNA Translation R-HSA-192823,10.363461616497414,0.01225328776778329,Other Types
Esophageal Squamous Cell Carcinoma,Regulation Of Beta-Cell Development R-HSA-186712,15.168831989690176,0.004578636469336608,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Regulation Of Gene Expression In Beta Cells R-HSA-210745,25.805655319476802,0.0009532168769779983,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Chromosome Maintenance R-HSA-73886,17.19674524873324,0.003222688342268481,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Metalloprotease DUBs R-HSA-5689901,14.3376438759869,0.00533834616967355,Other Types
Esophageal Squamous Cell Carcinoma,Dual Incision In GG-NER R-HSA-5696400,7.235843854711075,0.027498663456591972,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,TBC/RABGAPs R-HSA-8854214,11.691632350378374,0.009097301000423639,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,8.834904751358097,0.017806951282613673,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Signaling By NOTCH3 R-HSA-9012852,5.677859412275683,0.04434963396866125,Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma,Amyloid Fiber Formation R-HSA-977225,5.861127079526697,0.0417863797107198,Esophageal Squamous Cell Carcinoma
Esophagogastric Adenocarcinoma,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,5.255259955137601,0.030948561313472102,Other Types
Esophagogastric Adenocarcinoma,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",6.332500707317658,0.01894674223839221,Other Types
Esophagogastric Adenocarcinoma,Respiratory Electron Transport R-HSA-611105,4.455489652977048,0.04539612802684399,Other Types
Esophagogastric Adenocarcinoma,Mitochondrial Biogenesis R-HSA-1592230,4.7798444871990915,0.03878084314109621,Other Types
Esophagogastric Adenocarcinoma,Cristae Formation R-HSA-8949613,5.688384402252252,0.025325212935451452,Other Types
Esophagogastric Adenocarcinoma,Asparagine N-linked Glycosylation R-HSA-446203,6.507948293222563,0.0175341479185835,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Cytoprotection By HMOX1 R-HSA-9707564,10.12640521378527,0.0040096637187767865,Other Types
Esophagogastric Adenocarcinoma,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,6.291785839811981,0.019292277652828278,Other Types
Esophagogastric Adenocarcinoma,TP53 Regulates Metabolic Genes R-HSA-5628897,13.247834952190349,0.0013020994421561716,Other Types
Esophagogastric Adenocarcinoma,Signaling By MET R-HSA-6806834,6.767738710276616,0.015651688606731676,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Mitotic G2-G2/M Phases R-HSA-453274,5.535171684961011,0.027172737889848603,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Metabolism Of Nucleotides R-HSA-15869,10.437815871237756,0.003564722569705999,Other Types
Esophagogastric Adenocarcinoma,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,10.275925886383922,0.0037888791203565956,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,"Platelet Activation, Signaling And Aggregation R-HSA-76002",8.38638106363588,0.00793580592836885,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Mitochondrial Translation R-HSA-5368287,6.673359755754606,0.016308407980913132,Other Types
Esophagogastric Adenocarcinoma,Muscle Contraction R-HSA-397014,4.9579047478548155,0.035613516408921284,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,4.791935924073761,0.03855605178973915,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,MET Promotes Cell Motility R-HSA-8875878,5.0914376003099395,0.033427905662739114,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Transport Of Small Molecules R-HSA-382551,5.335458428109794,0.02981015730873067,Other Types
Esophagogastric Adenocarcinoma,Platelet Aggregation (Plug Formation) R-HSA-76009,10.419193693552877,0.0035897531874771803,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Integrin Signaling R-HSA-354192,10.419193693552877,0.0035897531874771803,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,EPHB-mediated Forward Signaling R-HSA-3928662,11.670674299414625,0.0022653083064260253,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Downstream Signal Transduction R-HSA-186763,8.501801695212315,0.007573653035329722,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Mitochondrial Translation Termination R-HSA-5419276,16.50163564129658,0.00045019505365019303,Other Types
Esophagogastric Adenocarcinoma,Signaling By PDGF R-HSA-186797,6.861835893793868,0.015025897505010525,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,RHO GTPase Effectors R-HSA-195258,6.278929372671782,0.019402832201931383,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Nucleotide Biosynthesis R-HSA-8956320,8.196221859401525,0.008574669623755051,Other Types
Esophagogastric Adenocarcinoma,Mitochondrial Translation Initiation R-HSA-5368286,10.38542947595567,0.0036356284166418618,Other Types
Esophagogastric Adenocarcinoma,Metabolism Of Vitamins And Cofactors R-HSA-196854,11.933636114479206,0.0020614709100233554,Other Types
Esophagogastric Adenocarcinoma,Mitochondrial Translation Elongation R-HSA-5389840,5.838929500952334,0.023644923151713734,Other Types
Esophagogastric Adenocarcinoma,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,6.312261748611465,0.01911764005134002,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Signaling To ERKs R-HSA-187687,5.4159194778384565,0.02871473625990173,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,"PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",4.720434578743212,0.039906886829476074,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Cell Junction Organization R-HSA-446728,7.516870338084426,0.011363549898038344,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Smooth Muscle Contraction R-HSA-445355,4.405884278194063,0.046515552223173266,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,9.33839455958056,0.005432130066106379,Other Types
Esophagogastric Adenocarcinoma,Metabolism R-HSA-1430728,12.306067169690191,0.001806253758466799,Other Types
Esophagogastric Adenocarcinoma,Heme Biosynthesis R-HSA-189451,4.6485415093592115,0.0413188593405894,Other Types
Esophagogastric Adenocarcinoma,Metabolism Of Porphyrins R-HSA-189445,4.648541359300123,0.04131886234563107,Other Types
Esophagogastric Adenocarcinoma,Drug ADME R-HSA-9748784,5.4874471798204105,0.027778494556509575,Other Types
Esophagogastric Adenocarcinoma,Prolonged ERK Activation Events R-HSA-169893,6.224909612500284,0.019875087127615428,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,10.143029050273372,0.003984434690518749,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,10.13167894322142,0.004001641204301994,Other Types
Esophagogastric Adenocarcinoma,Citric Acid Cycle (TCA Cycle) R-HSA-71403,7.029044690470593,0.013980923858983264,Other Types
Esophagogastric Adenocarcinoma,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,4.883188782475006,0.03690588342296877,Other Types
Esophagogastric Adenocarcinoma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,23.259789271305124,6.516319339905934e-05,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,mTORC1-mediated Signaling R-HSA-166208,5.786539956132256,0.02421518429880963,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Semaphorin Interactions R-HSA-373755,5.004139841715753,0.03483917671560573,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,6.8366716760065955,0.015190499236818249,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Frs2-mediated Activation R-HSA-170968,6.591580132681051,0.016902141440942983,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,14.743504359497734,0.0007892125599915067,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,MET Receptor Recycling R-HSA-8875656,7.7974822853707515,0.010105988325045055,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,9.97613293371764,0.0042458243852427175,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Kinesins R-HSA-983189,10.250961973654823,0.0038247968211873634,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,MET Activates PTK2 Signaling R-HSA-8874081,6.433983294107806,0.018114936398307302,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,5.305096188507538,0.03023555859184962,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,ERBB2 Regulates Cell Motility R-HSA-6785631,6.898631336365049,0.014788749551441981,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Calnexin/calreticulin Cycle R-HSA-901042,5.263168799310258,0.03083416878531752,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Cilium Assembly R-HSA-5617833,14.275476647205087,0.0009208653606794318,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,4.405899738764914,0.046515198526318066,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Platelet Degranulation R-HSA-114608,7.657892357039616,0.01071127150756979,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,6.788675095184588,0.015510000675743457,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,11.365434261877956,0.002529946124539201,Other Types
Esophagogastric Adenocarcinoma,Apoptotic Factor-Mediated Response R-HSA-111471,5.78073122405026,0.02427934774512949,Other Types
Esophagogastric Adenocarcinoma,VxPx Cargo-Targeting To Cilium R-HSA-5620916,9.277929683153753,0.005562215635640434,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Interferon Alpha/Beta Signaling R-HSA-909733,4.681848198139006,0.04065786914136727,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,6.954130048895424,0.014438838257806463,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,7.189589642968395,0.013052611085257938,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,4.4777259922834505,0.0449041916079869,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,5.231091771884089,0.031301071215461065,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,7.066102702956868,0.013760351740005975,Other Types
Esophagogastric Adenocarcinoma,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,11.512019873650695,0.002398870925591571,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,5.293754723230644,0.030396195253905828,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,MHC Class II Antigen Presentation R-HSA-2132295,5.6510769461011545,0.025761859102251077,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,8.831225746503609,0.006636105996148305,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,9.197387976114287,0.005740827903092568,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Post NMDA Receptor Activation Events R-HSA-438064,4.461416474962111,0.045264418593546504,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Defective Pyroptosis R-HSA-9710421,4.772763946628037,0.038913158729956036,Other Types
Esophagogastric Adenocarcinoma,SARS-CoV-1 Infection R-HSA-9678108,6.588199820425572,0.016927192255241585,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Regulation Of IFNG Signaling R-HSA-877312,6.280859320358408,0.019386191641991003,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,AURKA Activation By TPX2 R-HSA-8854518,11.855350502306083,0.0021199778645317555,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,5.62325092439491,0.026092986274542637,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Centrosome Maturation R-HSA-380287,10.294543320752373,0.0037623328923192105,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,RNA Polymerase III Transcription Termination R-HSA-73980,6.2620559846081605,0.019548995125774998,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Mitochondrial Calcium Ion Transport R-HSA-8949215,7.117750741376682,0.013459317328223676,Other Types
Esophagogastric Adenocarcinoma,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,4.356835786919982,0.04765304679942683,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,RHO GTPases Activate PAKs R-HSA-5627123,4.540385874347489,0.043549895642443257,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,7.0683671869149585,0.013746998397850584,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Signaling By TGFB Family Members R-HSA-9006936,9.85638633665255,0.004444922673474251,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,RNA Polymerase III Transcription Initiation R-HSA-76046,5.837482694532399,0.023660469910210775,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Oncogene Induced Senescence R-HSA-2559585,5.768719369462041,0.024412631155784643,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Cellular Response To Chemical Stress R-HSA-9711123,5.045752726267322,0.034158317708635144,Other Types
Esophagogastric Adenocarcinoma,Signaling By TGF-beta Receptor Complex R-HSA-170834,6.4263439578239785,0.0181761248258424,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,14.56289906603719,0.0008374135038843638,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,4.462618886122747,0.04523775035656853,Other Types
Esophagogastric Adenocarcinoma,Transcriptional Regulation By E2F6 R-HSA-8953750,5.462960318121583,0.02809512596985761,Other Types
Esophagogastric Adenocarcinoma,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,12.086019375526787,0.001952577191196314,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Transcriptional Regulation By TP53 R-HSA-3700989,24.5892740676316,4.615000041042617e-05,Other Types
Esophagogastric Adenocarcinoma,Diseases Of Glycosylation R-HSA-3781865,5.239273120781536,0.03118124143569172,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,5.763553965822977,0.02447019622564068,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,PKMTs Methylate Histone Lysines R-HSA-3214841,8.30303540481613,0.008209139121591033,Other Types
Esophagogastric Adenocarcinoma,mRNA 3-End Processing R-HSA-72187,4.441051788127903,0.04571878292294427,Other Types
Esophagogastric Adenocarcinoma,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,4.702057466745256,0.04026259093482954,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Interleukin-7 Signaling R-HSA-1266695,11.976924116060923,0.002029878134282618,Other Types
Esophagogastric Adenocarcinoma,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,11.96671361777174,0.0020372821136161665,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,PI-3K cascade:FGFR1 R-HSA-5654689,4.389326177125543,0.046896101288928245,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Neuronal System R-HSA-112316,4.387580965900255,0.04693641460857819,Other Types
Esophagogastric Adenocarcinoma,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,8.21703326646162,0.00850207020091372,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,MET Activates RAS Signaling R-HSA-8851805,5.244684742169652,0.031102260290680302,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,tRNA Processing In Nucleus R-HSA-6784531,5.6111781148452105,0.026238121879787753,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,E2F Mediated Regulation Of DNA Replication R-HSA-113510,7.5290009093307635,0.011305755863608168,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,PTK6 Regulates Cell Cycle R-HSA-8849470,12.079882724049568,0.001956839034130832,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,5.598928795163217,0.02638629784147758,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,6.371341082245041,0.018623491985841276,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,5.5392389462842315,0.027121796906847677,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,5.6559695328288715,0.02570412222380776,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,RUNX2 Regulates Bone Development R-HSA-8941326,4.796229271222495,0.03847658589551945,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,SLC-mediated Transmembrane Transport R-HSA-425407,6.418091413537282,0.01824248198747016,Other Types
Esophagogastric Adenocarcinoma,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,13.030380317829795,0.0014031062716175849,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,RND2 GTPase Cycle R-HSA-9696270,4.432460883629846,0.045911994812574894,Other Types
Esophagogastric Adenocarcinoma,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,9.262484415328679,0.005595989891936957,Other Types
Esophagogastric Adenocarcinoma,Attenuation Phase R-HSA-3371568,6.458290320147417,0.017921757160351794,Other Types
Esophagogastric Adenocarcinoma,Glycosaminoglycan Metabolism R-HSA-1630316,9.974018110400594,0.004249254736692821,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Intrinsic Pathway For Apoptosis R-HSA-109606,20.53376252870093,0.0001367297063585968,Other Types
Esophagogastric Adenocarcinoma,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,10.173738058576113,0.003938285052052077,Other Types
Esophagogastric Adenocarcinoma,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,4.957967461047447,0.03561245314428016,Other Types
Esophagogastric Adenocarcinoma,PPARA Activates Gene Expression R-HSA-1989781,8.53685022445164,0.00746730468377594,Other Types
Esophagogastric Adenocarcinoma,Gene Expression (Transcription) R-HSA-74160,5.170372748326922,0.03220663550744077,Other Types
Esophagogastric Adenocarcinoma,Intra-Golgi Traffic R-HSA-6811438,5.126441775602362,0.03288005834090871,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Metabolism Of Lipids R-HSA-556833,8.192002202604229,0.00858947258516928,Other Types
Esophagogastric Adenocarcinoma,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,5.503642711660556,0.027571259165724005,Other Types
Esophagogastric Adenocarcinoma,SUMOylation Of Intracellular Receptors R-HSA-4090294,6.952051936128267,0.014451774491757934,Other Types
Esophagogastric Adenocarcinoma,Nephrin Family Interactions R-HSA-373753,4.957542842554308,0.03561965299041309,Other Types
Esophagogastric Adenocarcinoma,Generic Transcription Pathway R-HSA-212436,6.227772416680049,0.019849742640808785,Other Types
Esophagogastric Adenocarcinoma,Cyclin D Associated Events In G1 R-HSA-69231,4.958582874120098,0.03560202106766949,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,6.291563415045577,0.019294184373027847,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,5.90829461966806,0.022912698503048765,Other Types
Esophagogastric Adenocarcinoma,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",5.956371823547214,0.022419968512132515,Other Types
Esophagogastric Adenocarcinoma,Recycling Pathway Of L1 R-HSA-437239,5.470799454058756,0.02799332548598335,Other Types
Esophagogastric Adenocarcinoma,Potential Therapeutics For SARS R-HSA-9679191,5.796436921400975,0.024106295571208566,Other Types
Esophagogastric Adenocarcinoma,Iron Uptake And Transport R-HSA-917937,5.028359138613341,0.034441081136140146,Other Types
Esophagogastric Adenocarcinoma,Basigin Interactions R-HSA-210991,6.685768552991988,0.016220349839500332,Other Types
Esophagogastric Adenocarcinoma,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",5.1196081458810605,0.03298621822416453,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,SUMOylation Of Transcription Cofactors R-HSA-3899300,4.851227515081728,0.037474681607833966,Other Types
Esophagogastric Adenocarcinoma,Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,5.672153424848698,0.025514160675364685,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,16.414310374039125,0.0004626243183781557,Other Types
Esophagogastric Adenocarcinoma,Late SARS-CoV-2 Infection Events R-HSA-9772573,7.793173349868354,0.010124099204244359,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Epigenetic Regulation Of Gene Expression R-HSA-212165,8.20662266961957,0.008538302174873709,Other Types
Esophagogastric Adenocarcinoma,Inositol Phosphate Metabolism R-HSA-1483249,5.446985265411057,0.028303859658660408,Other Types
Esophagogastric Adenocarcinoma,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,6.444655684045553,0.018029835626766386,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,4.321164326351945,0.04849999261557625,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,RHOBTB1 GTPase Cycle R-HSA-9013422,5.4300337632279785,0.028527242631065416,Other Types
Esophagogastric Adenocarcinoma,Processing Of Intronless Pre-mRNAs R-HSA-77595,4.9044797011997066,0.03653234464415435,Other Types
Esophagogastric Adenocarcinoma,HIV Elongation Arrest And Recovery R-HSA-167287,14.176004785136383,0.0009518229676484755,Other Types
Esophagogastric Adenocarcinoma,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,24.828078850561518,4.3423205059444333e-05,Other Types
Esophagogastric Adenocarcinoma,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,4.820821739481975,0.038024922561242694,Other Types
Esophagogastric Adenocarcinoma,SHC1 Events In ERBB2 Signaling R-HSA-1250196,5.483567522465827,0.02782839512361485,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,5.127113586995323,0.032869642421630485,Other Types
Esophagogastric Adenocarcinoma,STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,4.6712453578950175,0.04086699252123106,Other Types
Esophagogastric Adenocarcinoma,Aggrephagy R-HSA-9646399,9.293556095511892,0.005528272523543134,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,6.035501752805078,0.021634386799480747,Other Types
Esophagogastric Adenocarcinoma,"WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",7.9067156907669895,0.009658569550406598,Other Types
Esophagogastric Adenocarcinoma,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,7.9067156907669895,0.009658569550406598,Other Types
Esophagogastric Adenocarcinoma,Retrograde Neurotrophin Signaling R-HSA-177504,4.40679522820877,0.046494717267017274,Other Types
Esophagogastric Adenocarcinoma,TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,4.818381493859088,0.03806947344622495,Esophagogastric Adenocarcinoma
Esophagogastric Adenocarcinoma,Plasma Lipoprotein Clearance R-HSA-8964043,6.186170746677397,0.020221592422575103,Other Types
Esophagogastric Adenocarcinoma,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,4.628258167787259,0.041727297719876294,Other Types
Esophagogastric Adenocarcinoma,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",8.423348075348429,0.007817786171648375,Other Types
Esophagogastric Adenocarcinoma,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",6.582028799971138,0.016973030412328994,Other Types
Esophagogastric Adenocarcinoma,Nef Mediated CD4 Down-regulation R-HSA-167590,5.683852135949286,0.02537781683124136,Other Types
Esophagogastric Adenocarcinoma,Nef Mediated CD8 Down-regulation R-HSA-182218,5.683852135949286,0.02537781683124136,Other Types
Esophagogastric Adenocarcinoma,Regulation Of Beta-Cell Development R-HSA-186712,10.369748036387284,0.0036571524603544628,Other Types
Esophagogastric Adenocarcinoma,Regulation Of BACH1 Activity R-HSA-9708530,6.37225828748371,0.018615932680631164,Other Types
Esophagogastric Adenocarcinoma,Regulation Of Gene Expression In Beta Cells R-HSA-210745,13.99246068353728,0.001011964450744534,Other Types
Esophagogastric Adenocarcinoma,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",5.053342572400604,0.03403574525525489,Other Types
Esophagogastric Adenocarcinoma,Activation Of HOX Genes During Differentiation R-HSA-5619507,9.550408939113908,0.005001677870864136,Other Types
Esophagogastric Adenocarcinoma,LDL Clearance R-HSA-8964038,7.664475120747904,0.010681847681083224,Other Types
Esophagogastric Adenocarcinoma,VLDLR Internalisation And Degradation R-HSA-8866427,6.807636865473269,0.01538289819253117,Other Types
Esophagogastric Adenocarcinoma,Metabolism Of Steroids R-HSA-8957322,6.803940280897266,0.015407586160506834,Other Types
Esophagogastric Adenocarcinoma,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,6.763295798816539,0.0156819397974973,Other Types
Esophagogastric Adenocarcinoma,RND1 GTPase Cycle R-HSA-9696273,4.584384404781662,0.042626365289839256,Other Types
Esophagogastric Adenocarcinoma,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,4.827779059553925,0.03789822495804071,Other Types
Esophagogastric Adenocarcinoma,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,5.384700181087853,0.029134348565320958,Other Types
Esophagogastric Adenocarcinoma,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,4.765735053550687,0.03904500976494732,Other Types
Esophagogastric Adenocarcinoma,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,5.055506855586374,0.034000883220629385,Other Types
Esophagogastric Adenocarcinoma,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,5.513187587224696,0.027449930936849932,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,4.202234777614418,0.04731727582090705,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Mitochondrial Biogenesis R-HSA-1592230,4.242677759709199,0.04631772036232625,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Cristae Formation R-HSA-8949613,10.994145689671713,0.0020182827353286163,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Golgi-to-ER Retrograde Transport R-HSA-8856688,9.07507695732866,0.004591924316694567,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,7.650537700480734,0.008713592384335327,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,VEGFA-VEGFR2 Pathway R-HSA-4420097,5.16324532078752,0.0288135423253403,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Asparagine N-linked Glycosylation R-HSA-446203,4.173868304585622,0.04803250222056079,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Cytoprotection By HMOX1 R-HSA-9707564,6.228425740064526,0.017030066329977493,Other Types
B-Lymphoblastic Leukemia/Lymphoma,TP53 Regulates Metabolic Genes R-HSA-5628897,10.500546351657317,0.0024832767969427015,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Signaling By MET R-HSA-6806834,5.1156750623789335,0.029514459773139066,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Signaling By VEGF R-HSA-194138,4.983644989743587,0.03155888427022555,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,FCGR3A-mediated Phagocytosis R-HSA-9664422,6.103131853341992,0.018095873137200232,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Metabolism Of Nucleotides R-HSA-15869,16.258343316096706,0.0002566565506336226,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,9.290007066056042,0.0041787738562788996,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,5.335545293617626,0.026422271909775353,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,6.019505217046379,0.018847169425982132,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,6.2214560719111045,0.017087539675349272,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,RAC3 GTPase Cycle R-HSA-9013423,4.468471039829279,0.04114635818298089,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Mitochondrial Translation R-HSA-5368287,5.571519372223158,0.02349008842952163,Other Types
B-Lymphoblastic Leukemia/Lymphoma,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,8.08875430865371,0.007133475068798839,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Platelet Aggregation (Plug Formation) R-HSA-76009,6.402737574606884,0.015658353393863112,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Integrin Signaling R-HSA-354192,6.402737574606884,0.015658353393863112,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,EPHB-mediated Forward Signaling R-HSA-3928662,13.209731096884658,0.0008212528655454374,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Protein Localization R-HSA-9609507,4.191820379961104,0.047578492587869683,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Mitochondrial Translation Termination R-HSA-5419276,14.576492497246953,0.00048276749722968044,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Nucleotide Biosynthesis R-HSA-8956320,12.461277475632317,0.0011066493967080136,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Mitochondrial Translation Initiation R-HSA-5368286,7.472706650540806,0.009458323583584461,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Metabolism Of Vitamins And Cofactors R-HSA-196854,13.597197881498174,0.0007052131056934557,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,6.831074752882894,0.01276770673671814,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Mitochondrial Translation Elongation R-HSA-5389840,5.477724963092942,0.024611013839081847,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Cell-Cell Communication R-HSA-1500931,4.528367847848297,0.03988318979231631,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,9.050456504549063,0.004641961306333579,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,RHOJ GTPase Cycle R-HSA-9013409,6.522356991603752,0.01478614936124088,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Cell Junction Organization R-HSA-446728,13.511174734467247,0.0007293838257422737,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,XBP1(S) Activates Chaperone Genes R-HSA-381038,5.710161821914185,0.021933223970492813,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,IRE1alpha Activates Chaperones R-HSA-381070,5.710161821914185,0.021933223970492813,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Smooth Muscle Contraction R-HSA-445355,4.944184771012093,0.032199452159061046,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,7.59309767051268,0.00894702895457328,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Metabolism R-HSA-1430728,13.173258607933285,0.0008331734861962385,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Heme Biosynthesis R-HSA-189451,8.947007706284799,0.00485864893429485,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Metabolism Of Porphyrins R-HSA-189445,8.947007046125105,0.004858650351031473,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Drug ADME R-HSA-9748784,8.487948501861405,0.005959115765103058,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Prolonged ERK Activation Events R-HSA-169893,6.315834835099228,0.016326702920044435,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,RHOV GTPase Cycle R-HSA-9013424,4.569591760299802,0.03903849837647819,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,16.081206799510568,0.00027401931732936777,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Citric Acid Cycle (TCA Cycle) R-HSA-71403,7.0893320512136375,0.011306349811785516,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,6.428425643871633,0.015466481731730417,Other Types
B-Lymphoblastic Leukemia/Lymphoma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,4.912881359651315,0.03271768418456898,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Ubiquinol Biosynthesis R-HSA-2142789,5.772171012412241,0.02127336848961669,Other Types
B-Lymphoblastic Leukemia/Lymphoma,DCC Mediated Attractive Signaling R-HSA-418885,5.573237977880613,0.02347007278771075,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Metabolism Of Cofactors R-HSA-8978934,6.783783117955975,0.01305664956412485,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Unfolded Protein Response (UPR) R-HSA-381119,5.200190980899296,0.028281655057262014,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Frs2-mediated Activation R-HSA-170968,9.226975940480514,0.004295663977206908,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,7.569918611862366,0.009043118115857389,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Kinesins R-HSA-983189,8.799839386405674,0.0051857073367622885,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,4.315128151029844,0.04458459141417172,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,ERBB2 Regulates Cell Motility R-HSA-6785631,7.003140571896927,0.011773025174250239,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Late Phase Of HIV Life Cycle R-HSA-162599,5.076510157407766,0.03010545234489349,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Cilium Assembly R-HSA-5617833,12.124372139127656,0.0012679170792135245,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,7.451257745618252,0.009552658046634698,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,7.630391555836671,0.00879471485993911,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,4.59744974711137,0.03847876922180472,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,MAP2K And MAPK Activation R-HSA-5674135,5.043501431723319,0.030613551574641403,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,VxPx Cargo-Targeting To Cilium R-HSA-5620916,4.993236599014938,0.03140528649080626,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,10.21078232725353,0.002808285444292512,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,6.686614277204162,0.013672634975360521,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,GPER1 Signaling R-HSA-9634597,5.133844262390017,0.029244583966099517,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,HIV Life Cycle R-HSA-162587,4.9548102925050825,0.0320255836155812,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,8.056343244503626,0.007239133078350948,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,8.56289066314268,0.005762659603065365,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Post NMDA Receptor Activation Events R-HSA-438064,9.056594755575007,0.0046294321463412925,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Cell-cell Junction Organization R-HSA-421270,5.733951188015808,0.021677493799515484,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Defective Pyroptosis R-HSA-9710421,4.3024694591302355,0.044882200760112116,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Regulation Of IFNG Signaling R-HSA-877312,4.271115138381111,0.045628784694826466,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,8.710467786547772,0.005395727354541381,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,AURKA Activation By TPX2 R-HSA-8854518,6.74932617172129,0.013271598722827264,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Centrosome Maturation R-HSA-380287,4.8407798023339845,0.03394625209590377,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,5.612535435044167,0.02301740062439868,Other Types
B-Lymphoblastic Leukemia/Lymphoma,RNA Polymerase III Transcription Termination R-HSA-73980,6.792456638218462,0.013003134120220017,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Glycolysis R-HSA-70171,4.98730415898642,0.03150019090642527,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Regulation Of TP53 Degradation R-HSA-6804757,4.138210458345174,0.048948493237929845,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,5.38460059086502,0.025781515647598185,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,4.474593629811099,0.04101524966039592,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Transcriptional Regulation By E2F6 R-HSA-8953750,5.438425517296987,0.025097795722058735,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,7.1027863505060544,0.011235312887791607,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Transcriptional Regulation By TP53 R-HSA-3700989,8.801803787679056,0.0051811902426475666,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Diseases Of Glycosylation R-HSA-3781865,8.075879950482571,0.007175245861402154,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,PKMTs Methylate Histone Lysines R-HSA-3214841,5.850780038637452,0.02046755744928274,Other Types
B-Lymphoblastic Leukemia/Lymphoma,HIV Transcription Initiation R-HSA-167161,8.53372422740415,0.005838282696568122,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Interleukin-7 Signaling R-HSA-1266695,11.908526304772751,0.0013842103681916025,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,8.801802023358162,0.005181194297776905,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,4.151054991263013,0.048616342346834006,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,6.568957502675675,0.014460647201737358,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,5.780840244865604,0.021182840994655863,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Unwinding Of DNA R-HSA-176974,4.593929820071309,0.0385490054911131,Other Types
B-Lymphoblastic Leukemia/Lymphoma,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,4.352980792026154,0.04370751071790328,Other Types
B-Lymphoblastic Leukemia/Lymphoma,E2F Mediated Regulation Of DNA Replication R-HSA-113510,4.577876294608125,0.03887111881029301,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,PTK6 Regulates Cell Cycle R-HSA-8849470,9.510048833580273,0.0037965719178823837,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Extra-nuclear Estrogen Signaling R-HSA-9009391,8.071892650441292,0.00718823563262705,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Detoxification Of Reactive Oxygen Species R-HSA-3299685,4.165433401558575,0.048247465343473184,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,SLC-mediated Transmembrane Transport R-HSA-425407,6.519404243122056,0.014807038169164207,Other Types
B-Lymphoblastic Leukemia/Lymphoma,RNA Polymerase II Pre-transcription Events R-HSA-674695,6.66535773971457,0.013811510144444232,Other Types
B-Lymphoblastic Leukemia/Lymphoma,RND2 GTPase Cycle R-HSA-9696270,4.199816492408159,0.04737779103933135,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,5.707935237412086,0.02195732576018111,Other Types
B-Lymphoblastic Leukemia/Lymphoma,NoRC Negatively Regulates rRNA Expression R-HSA-427413,4.118899187982136,0.04945257939585236,Other Types
B-Lymphoblastic Leukemia/Lymphoma,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,8.718524401371257,0.005376427344396665,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,4.467561678328414,0.04116587028190461,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Glycosaminoglycan Metabolism R-HSA-1630316,7.337407495119126,0.010070560870450796,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Intrinsic Pathway For Apoptosis R-HSA-109606,13.252989197229956,0.0008073483768452906,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Dual Incision In TC-NER R-HSA-6782135,5.52560489632429,0.024031734114062127,Other Types
B-Lymphoblastic Leukemia/Lymphoma,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,7.524208408003273,0.009235866148002505,Other Types
B-Lymphoblastic Leukemia/Lymphoma,SUMOylation Of Intracellular Receptors R-HSA-4090294,5.604758392467919,0.023106229296928894,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Telomere Extension By Telomerase R-HSA-171319,4.492598917153544,0.040632330207109574,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,5.311641842137781,0.026740741247752737,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",14.895303637054983,0.00042750613219000045,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Adherens Junctions Interactions R-HSA-418990,9.404985852961747,0.00397419217055325,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Potential Therapeutics For SARS R-HSA-9679191,7.816130532334347,0.008076387582191034,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Transcription Of HIV Genome R-HSA-167172,11.553998144498252,0.0016004786229559618,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Basigin Interactions R-HSA-210991,7.5544241781003185,0.009107966753648057,Other Types
B-Lymphoblastic Leukemia/Lymphoma,DNA Strand Elongation R-HSA-69190,5.11969232740526,0.029454557065223114,Other Types
B-Lymphoblastic Leukemia/Lymphoma,SUMOylation Of Transcription Cofactors R-HSA-3899300,4.742833875610299,0.03569649351102568,Other Types
B-Lymphoblastic Leukemia/Lymphoma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,8.596518671108056,0.005676764771722398,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Late SARS-CoV-2 Infection Events R-HSA-9772573,4.69828882810164,0.0365248703317821,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Epigenetic Regulation Of Gene Expression R-HSA-212165,9.6127308926723,0.0036311293091732025,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,4.706442909186056,0.03637167772999365,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,5.3730581210257915,0.025930750867300848,Other Types
B-Lymphoblastic Leukemia/Lymphoma,RHO GTPases Activate IQGAPs R-HSA-5626467,5.238717677634034,0.027738347915216215,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,5.527851875603083,0.024004914293375878,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Aggrephagy R-HSA-9646399,4.153537042211996,0.04855244455960301,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,4.373453920284237,0.04324103112652738,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,5.645445431187418,0.022645577538793146,Other Types
B-Lymphoblastic Leukemia/Lymphoma,FOXO-mediated Transcription R-HSA-9614085,5.424646650083515,0.02527093093633955,Other Types
B-Lymphoblastic Leukemia/Lymphoma,HDACs Deacetylate Histones R-HSA-3214815,8.33653314138265,0.006378213244366402,Other Types
B-Lymphoblastic Leukemia/Lymphoma,E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,4.163810873653941,0.04828893663608599,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Regulation Of Beta-Cell Development R-HSA-186712,6.846773345648486,0.01267331687710235,Other Types
B-Lymphoblastic Leukemia/Lymphoma,RND3 GTPase Cycle R-HSA-9696264,6.499937277533198,0.01494555214638799,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Regulation Of Gene Expression In Beta Cells R-HSA-210745,7.159911667585283,0.010938990134354886,Other Types
B-Lymphoblastic Leukemia/Lymphoma,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,5.708712401696077,0.021948910047460895,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Dual Incision In GG-NER R-HSA-5696400,4.929652822249976,0.03243890964336828,Other Types
B-Lymphoblastic Leukemia/Lymphoma,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,7.933422830564017,0.007655316751752489,B-Lymphoblastic Leukemia/Lymphoma
B-Lymphoblastic Leukemia/Lymphoma,Lagging Strand Synthesis R-HSA-69186,4.436196737288964,0.04184510932398803,Other Types
B-Lymphoblastic Leukemia/Lymphoma,Signaling By NOTCH3 R-HSA-9012852,5.35434256380681,0.026174724198417612,Other Types
Ovarian Epithelial Tumor,Adaptive Immune System R-HSA-1280218,7.528116951996951,0.025302475449934657,Other Types
Ovarian Epithelial Tumor,Mitochondrial Biogenesis R-HSA-1592230,7.411670388566946,0.026149883784232858,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Nervous System Development R-HSA-9675108,5.552872599142851,0.0462133611396386,Other Types
Ovarian Epithelial Tumor,Translation R-HSA-72766,6.955195511726327,0.02983948340090657,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Cytokine Signaling In Immune System R-HSA-1280215,12.32042851676451,0.007961040831617491,Other Types
Ovarian Epithelial Tumor,Signaling By Interleukins R-HSA-449147,14.476816222078572,0.005200683125758497,Other Types
Ovarian Epithelial Tumor,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,13.975949983067038,0.005718113380213396,Other Types
Ovarian Epithelial Tumor,Axon Guidance R-HSA-422475,5.487304942443778,0.04723102380228978,Other Types
Ovarian Epithelial Tumor,M Phase R-HSA-68886,6.598769481689341,0.03318909749528688,Other Types
Ovarian Epithelial Tumor,Mitotic Metaphase And Anaphase R-HSA-2555396,8.481285586340986,0.019521238890133776,Other Types
Ovarian Epithelial Tumor,tRNA Aminoacylation R-HSA-379724,8.3635513672945,0.020137875249364823,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,C-type Lectin Receptors (CLRs) R-HSA-5621481,9.890738167850374,0.01370238808694061,Other Types
Ovarian Epithelial Tumor,Mitotic Anaphase R-HSA-68882,8.371280331172981,0.020096647157356505,Other Types
Ovarian Epithelial Tumor,CLEC7A (Dectin-1) Signaling R-HSA-5607764,7.857662905520145,0.023085393531492037,Other Types
Ovarian Epithelial Tumor,FCERI Mediated NF-kB Activation R-HSA-2871837,10.639676675240406,0.011495406934933424,Other Types
Ovarian Epithelial Tumor,Signaling By B Cell Receptor (BCR) R-HSA-983705,5.405377343126099,0.048543116201176184,Other Types
Ovarian Epithelial Tumor,TCR Signaling R-HSA-202403,12.289098149770739,0.008013282572954233,Other Types
Ovarian Epithelial Tumor,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,11.706573315884317,0.00906802095516405,Other Types
Ovarian Epithelial Tumor,Switching Of Origins To A Post-Replicative State R-HSA-69052,6.534805091163389,0.03383985054071015,Other Types
Ovarian Epithelial Tumor,DNA Replication Pre-Initiation R-HSA-69002,12.112355904106286,0.008316198062013667,Other Types
Ovarian Epithelial Tumor,Activation Of NF-kappaB In B Cells R-HSA-1169091,11.267398594793706,0.00998061739937299,Other Types
Ovarian Epithelial Tumor,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,6.038956406977369,0.03947672243681524,Other Types
Ovarian Epithelial Tumor,MAPK6/MAPK4 Signaling R-HSA-5687128,10.829205970015813,0.01100928424551071,Other Types
Ovarian Epithelial Tumor,Interleukin-1 Signaling R-HSA-9020702,5.890065088898569,0.04139904056257469,Other Types
Ovarian Epithelial Tumor,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,6.597125527310726,0.03320562283009388,Other Types
Ovarian Epithelial Tumor,Downstream TCR Signaling R-HSA-202424,10.279024903537179,0.012497439371624107,Other Types
Ovarian Epithelial Tumor,Assembly Of Pre-Replicative Complex R-HSA-68867,11.225574778206978,0.01007343163941038,Other Types
Ovarian Epithelial Tumor,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,6.9201179101562404,0.030149535124479973,Other Types
Ovarian Epithelial Tumor,Signaling By ROBO Receptors R-HSA-376176,5.38228532942232,0.04892131627113499,Other Types
Ovarian Epithelial Tumor,Separation Of Sister Chromatids R-HSA-2467813,6.7349396990273505,0.03185575130763173,Other Types
Ovarian Epithelial Tumor,Signaling By Hedgehog R-HSA-5358351,7.68429453130353,0.02421969102842228,Other Types
Ovarian Epithelial Tumor,Synthesis Of DNA R-HSA-69239,5.472762165401791,0.047460599134557094,Other Types
Ovarian Epithelial Tumor,Antigen processing-Cross Presentation R-HSA-1236975,9.446039497975132,0.015268011300507563,Other Types
Ovarian Epithelial Tumor,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,6.873722495999322,0.030565922853333413,Other Types
Ovarian Epithelial Tumor,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,6.464365387112904,0.03457532747769261,Other Types
Ovarian Epithelial Tumor,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,8.236679575426557,0.02083015710393983,Other Types
Ovarian Epithelial Tumor,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,10.280195395909848,0.012494013215882593,Other Types
Ovarian Epithelial Tumor,Regulation Of Apoptosis R-HSA-169911,10.280195395909848,0.012494013215882593,Other Types
Ovarian Epithelial Tumor,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,9.935135460235468,0.01355741523433209,Other Types
Ovarian Epithelial Tumor,Hedgehog Off State R-HSA-5610787,8.113573111264161,0.021530862434060594,Other Types
Ovarian Epithelial Tumor,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,8.323726710937015,0.02035200981835805,Other Types
Ovarian Epithelial Tumor,Orc1 Removal From Chromatin R-HSA-68949,8.446672350120597,0.019700023127898293,Other Types
Ovarian Epithelial Tumor,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,6.513266924981357,0.03406261051959126,Other Types
Ovarian Epithelial Tumor,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,8.512537185077035,0.01936157372294033,Other Types
Ovarian Epithelial Tumor,Cristae Formation R-HSA-8949613,15.20694896915947,0.004547160884128902,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,10.134159424430251,0.01293076446327412,Other Types
Ovarian Epithelial Tumor,Host Interactions Of HIV Factors R-HSA-162909,8.670306738580997,0.018580212704255857,Other Types
Ovarian Epithelial Tumor,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,5.784817521502928,0.04283013812915679,Other Types
Ovarian Epithelial Tumor,DNA Replication R-HSA-69306,5.371197089573345,0.049104254765388385,Other Types
Ovarian Epithelial Tumor,Vpu Mediated Degradation Of CD4 R-HSA-180534,8.677222700039023,0.018546879630603568,Other Types
Ovarian Epithelial Tumor,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,8.926594164326755,0.017393781202141367,Other Types
Ovarian Epithelial Tumor,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,7.20776691322335,0.027722128445749568,Other Types
Ovarian Epithelial Tumor,Degradation Of GLI1 By Proteasome R-HSA-5610780,8.729329546618501,0.01829814840064221,Other Types
Ovarian Epithelial Tumor,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,9.017712408784652,0.01699508921351207,Other Types
Ovarian Epithelial Tumor,Asymmetric Localization Of PCP Proteins R-HSA-4608870,8.9400922642012,0.017333981109662687,Other Types
Ovarian Epithelial Tumor,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,8.084800488985918,0.02169890571077786,Other Types
Ovarian Epithelial Tumor,ER-Phagosome Pathway R-HSA-1236974,8.076628684598196,0.021746934010989965,Other Types
Ovarian Epithelial Tumor,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,8.125773719784641,0.021460102481874778,Other Types
Ovarian Epithelial Tumor,Degradation Of GLI2 By Proteasome R-HSA-5610783,8.125773719784641,0.021460102481874778,Other Types
Ovarian Epithelial Tumor,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,8.787862613670193,0.01802373793859982,Other Types
Ovarian Epithelial Tumor,Metabolism Of Polyamines R-HSA-351202,7.032864401907334,0.02916720824702779,Other Types
Ovarian Epithelial Tumor,Transcriptional Regulation By RUNX3 R-HSA-8878159,11.74847626826849,0.008986532594839803,Other Types
Ovarian Epithelial Tumor,Hedgehog On State R-HSA-5632684,7.955439192971514,0.022475223182592978,Other Types
Ovarian Epithelial Tumor,Stabilization Of P53 R-HSA-69541,10.871301791946323,0.010904842821690654,Other Types
Ovarian Epithelial Tumor,Degradation Of DVL R-HSA-4641258,8.38104579775426,0.020044708108634828,Other Types
Ovarian Epithelial Tumor,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,8.000906003728108,0.022198430762272247,Other Types
Ovarian Epithelial Tumor,Golgi-to-ER Retrograde Transport R-HSA-8856688,5.894433537109848,0.04134096570410817,Other Types
Ovarian Epithelial Tumor,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,9.538053027724223,0.014926279948627916,Other Types
Ovarian Epithelial Tumor,Degradation Of AXIN R-HSA-4641257,8.055257361536244,0.021873176347037306,Other Types
Ovarian Epithelial Tumor,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,8.379966626915886,0.020050439501218393,Other Types
Ovarian Epithelial Tumor,Asparagine N-linked Glycosylation R-HSA-446203,6.641505230472599,0.032763145925944724,Other Types
Ovarian Epithelial Tumor,Regulation Of RAS By GAPs R-HSA-5658442,8.243096064566817,0.020794430534265905,Other Types
Ovarian Epithelial Tumor,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,9.689487512575042,0.01438456857446984,Other Types
Ovarian Epithelial Tumor,TP53 Regulates Metabolic Genes R-HSA-5628897,6.553611174599829,0.0336468566236938,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Signaling By VEGF R-HSA-194138,7.172852950440175,0.028003226015372785,Other Types
Ovarian Epithelial Tumor,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,9.239345253067452,0.01607234777505206,Other Types
Ovarian Epithelial Tumor,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,9.149436930884361,0.016438864269890285,Other Types
Ovarian Epithelial Tumor,Mitotic G2-G2/M Phases R-HSA-453274,5.750906655002004,0.04330461445817149,Other Types
Ovarian Epithelial Tumor,G2/M Transition R-HSA-69275,5.771151766736706,0.04302054758817521,Other Types
Ovarian Epithelial Tumor,Metabolism Of Nucleotides R-HSA-15869,11.644816908429535,0.009189818751183616,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,13.383080526785774,0.0064170465687203365,Other Types
Ovarian Epithelial Tumor,G1/S Transition R-HSA-69206,8.871942821261786,0.017638576422754085,Other Types
Ovarian Epithelial Tumor,"Platelet Activation, Signaling And Aggregation R-HSA-76002",5.9826365073933445,0.0401902367061131,Other Types
Ovarian Epithelial Tumor,Programmed Cell Death R-HSA-5357801,5.462406721617154,0.04762494006027519,Other Types
Ovarian Epithelial Tumor,Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,6.971656839390621,0.02969537393403065,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,RAC3 GTPase Cycle R-HSA-9013423,12.36521288648404,0.007887105844903404,Other Types
Ovarian Epithelial Tumor,Mitochondrial Translation R-HSA-5368287,16.443653975446733,0.003658337156643941,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Cell Cycle Checkpoints R-HSA-69620,18.51452277563216,0.002605698414791079,Other Types
Ovarian Epithelial Tumor,COPI-mediated Anterograde Transport R-HSA-6807878,7.84754900112236,0.023149697420160053,Other Types
Ovarian Epithelial Tumor,Protein Localization R-HSA-9609507,5.7566637325768735,0.0432235923886937,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Downstream Signal Transduction R-HSA-186763,5.352534017997395,0.04941414127508247,Other Types
Ovarian Epithelial Tumor,Mitochondrial Translation Termination R-HSA-5419276,13.226142957842242,0.006619770860140933,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,GPCR Downstream Signaling R-HSA-388396,14.565487266421101,0.005115292336734876,Other Types
Ovarian Epithelial Tumor,Signaling By GPCR R-HSA-372790,14.565487266421101,0.005115292336734876,Other Types
Ovarian Epithelial Tumor,Nucleotide Biosynthesis R-HSA-8956320,50.59103234226976,0.00010071890877673288,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Metabolism Of Vitamins And Cofactors R-HSA-196854,14.727354219060599,0.004963900189177433,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,G2/M Checkpoints R-HSA-69481,6.568784708588807,0.03349215781626204,Other Types
Ovarian Epithelial Tumor,Mitochondrial Translation Elongation R-HSA-5389840,15.455766466883441,0.004348227727526164,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Cell-Cell Communication R-HSA-1500931,20.233825036877693,0.0020068562811786355,Other Types
Ovarian Epithelial Tumor,RAC2 GTPase Cycle R-HSA-9013404,8.698352780668804,0.01844550456122356,Other Types
Ovarian Epithelial Tumor,rRNA Processing In Mitochondrion R-HSA-8868766,7.41742594002016,0.02610716350253547,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Influenza Infection R-HSA-168255,9.192310975511804,0.016262786168776862,Other Types
Ovarian Epithelial Tumor,Cell Junction Organization R-HSA-446728,17.123039146233157,0.0032623471642633205,Other Types
Ovarian Epithelial Tumor,Nuclear Envelope (NE) Reassembly R-HSA-2995410,9.564277753626977,0.014830651874199787,Other Types
Ovarian Epithelial Tumor,Nuclear Envelope Breakdown R-HSA-2980766,6.736101222670829,0.0318446729384472,Other Types
Ovarian Epithelial Tumor,Metabolism R-HSA-1430728,8.539411002276587,0.019225590509256707,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Heme Biosynthesis R-HSA-189451,7.10536984119645,0.028556847366596125,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Metabolism Of Porphyrins R-HSA-189445,7.105369369607544,0.02855685128362843,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Neddylation R-HSA-8951664,6.559459371465783,0.03358712534223418,Other Types
Ovarian Epithelial Tumor,rRNA Modification In Mitochondrion R-HSA-6793080,9.319381066114133,0.01575470252497167,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,FCERI Mediated MAPK Activation R-HSA-2871796,8.000251440099865,0.022202384961749016,Other Types
Ovarian Epithelial Tumor,Drug ADME R-HSA-9748784,7.319310680839936,0.02684767459676784,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Immune System R-HSA-168256,5.9393812591506014,0.040749399372858,Other Types
Ovarian Epithelial Tumor,Netrin-1 Signaling R-HSA-373752,6.383940257021475,0.035440050798151844,Other Types
Ovarian Epithelial Tumor,RHOV GTPase Cycle R-HSA-9013424,11.242322689383117,0.010036135414435708,Other Types
Ovarian Epithelial Tumor,Phosphorylation Of APC/C R-HSA-176412,7.304411125017331,0.02696244030170187,Other Types
Ovarian Epithelial Tumor,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,15.452600845209092,0.004350689356269489,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Citric Acid Cycle (TCA Cycle) R-HSA-71403,6.2436248221721335,0.03701552488809409,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,8.32561283900284,0.020341803576139926,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,DCC Mediated Attractive Signaling R-HSA-418885,8.986801041436925,0.01712903933729061,Other Types
Ovarian Epithelial Tumor,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,45.02418373324535,0.00015113964460739104,Other Types
Ovarian Epithelial Tumor,Semaphorin Interactions R-HSA-373755,15.414232483895871,0.00438066452072271,Other Types
Ovarian Epithelial Tumor,G Alpha (12/13) Signaling Events R-HSA-416482,5.404355940076197,0.04855976571043529,Other Types
Ovarian Epithelial Tumor,Frs2-mediated Activation R-HSA-170968,5.530587224768433,0.04655608439751163,Other Types
Ovarian Epithelial Tumor,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,5.453413962311537,0.04776824421224322,Other Types
Ovarian Epithelial Tumor,NRAGE Signals Death Thru JNK R-HSA-193648,12.76321592657512,0.007266489092401931,Other Types
Ovarian Epithelial Tumor,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,5.8805537910611285,0.041525844707017256,Other Types
Ovarian Epithelial Tumor,Kinesins R-HSA-983189,8.015529697508281,0.02211032094968797,Other Types
Ovarian Epithelial Tumor,COPII-mediated Vesicle Transport R-HSA-204005,9.319477639733078,0.015754324046870462,Other Types
Ovarian Epithelial Tumor,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",17.392101262688097,0.0031204589469206417,Other Types
Ovarian Epithelial Tumor,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,17.042852320201185,0.003306190373029992,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Signaling By EGFR R-HSA-177929,7.1259104835571305,0.02838687948776064,Other Types
Ovarian Epithelial Tumor,Signaling By Erythropoietin R-HSA-9006335,6.738759302809135,0.03181933909796292,Other Types
Ovarian Epithelial Tumor,NCAM Signaling For Neurite Out-Growth R-HSA-375165,7.0467708276209695,0.029048870893823072,Other Types
Ovarian Epithelial Tumor,Interleukin-17 Signaling R-HSA-448424,8.687534215863243,0.01849732085615976,Other Types
Ovarian Epithelial Tumor,MAP Kinase Activation R-HSA-450294,8.687534215863243,0.01849732085615976,Other Types
Ovarian Epithelial Tumor,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,5.391249016478861,0.04877406460031767,Other Types
Ovarian Epithelial Tumor,G Alpha (Q) Signaling Events R-HSA-416476,7.059850345668257,0.02893812448120296,Other Types
Ovarian Epithelial Tumor,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,6.933972127859084,0.03002659198016787,Other Types
Ovarian Epithelial Tumor,Tight Junction Interactions R-HSA-420029,14.10672149970755,0.0055770098725790255,Other Types
Ovarian Epithelial Tumor,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,5.482900351723827,0.0473004058505927,Other Types
Ovarian Epithelial Tumor,Mitotic Spindle Checkpoint R-HSA-69618,5.693663337011638,0.04412084278735884,Other Types
Ovarian Epithelial Tumor,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,18.832042091939673,0.0024797543752758237,Other Types
Ovarian Epithelial Tumor,Depolymerisation Of Nuclear Lamina R-HSA-4419969,6.8720160147065785,0.0305813766108298,Other Types
Ovarian Epithelial Tumor,Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,18.811666404906006,0.002487604197507449,Other Types
Ovarian Epithelial Tumor,ISG15 Antiviral Mechanism R-HSA-1169408,12.71346334184796,0.00734062999614721,Other Types
Ovarian Epithelial Tumor,RHOH GTPase Cycle R-HSA-9013407,8.909106488437066,0.017471643535263055,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,5.739167111563693,0.04347043057599184,Other Types
Ovarian Epithelial Tumor,Mitotic Prometaphase R-HSA-68877,5.401702773283725,0.04860304803449771,Other Types
Ovarian Epithelial Tumor,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,10.647473832760804,0.01147488164669573,Other Types
Ovarian Epithelial Tumor,Establishment Of Sister Chromatid Cohesion R-HSA-2468052,5.907346200315273,0.041169907468448175,Other Types
Ovarian Epithelial Tumor,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,5.379516672840551,0.04896691319300193,Other Types
Ovarian Epithelial Tumor,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,5.379516672840551,0.04896691319300193,Other Types
Ovarian Epithelial Tumor,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,5.379516672840551,0.04896691319300193,Other Types
Ovarian Epithelial Tumor,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,5.366848011549546,0.04917624593435322,Other Types
Ovarian Epithelial Tumor,MTOR Signaling R-HSA-165159,18.743190576632355,0.0025142139730651354,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Cell-cell Junction Organization R-HSA-421270,19.19391130380259,0.0023453743727253344,Other Types
Ovarian Epithelial Tumor,PI3K Cascade R-HSA-109704,24.071781616653194,0.0011843079956851735,Other Types
Ovarian Epithelial Tumor,Early SARS-CoV-2 Infection Events R-HSA-9772572,7.8873370390844775,0.022898024396511066,Other Types
Ovarian Epithelial Tumor,CD209 (DC-SIGN) Signaling R-HSA-5621575,8.897185950219827,0.017524970698521335,Other Types
Ovarian Epithelial Tumor,RHO GTPases Activate Formins R-HSA-5663220,5.450817329351885,0.04780972513530637,Other Types
Ovarian Epithelial Tumor,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,10.537264262823117,0.011769335137583619,Other Types
Ovarian Epithelial Tumor,IRS-mediated Signaling R-HSA-112399,21.828430710811336,0.001598178252353186,Other Types
Ovarian Epithelial Tumor,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,11.08826933152154,0.010385866892664028,Other Types
Ovarian Epithelial Tumor,Toll-like Receptor Cascades R-HSA-168898,17.44697330562091,0.003092478204841835,Other Types
Ovarian Epithelial Tumor,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,9.595298734721187,0.014718528486079855,Other Types
Ovarian Epithelial Tumor,RHO GTPases Activate PAKs R-HSA-5627123,5.703451144373814,0.043979899431210466,Other Types
Ovarian Epithelial Tumor,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,18.595323414049993,0.0025729027836058115,Other Types
Ovarian Epithelial Tumor,Glycolysis R-HSA-70171,7.568529311141454,0.02501652188568566,Other Types
Ovarian Epithelial Tumor,Regulation Of TP53 Expression And Degradation R-HSA-6806003,6.169017818581667,0.037889486964368925,Other Types
Ovarian Epithelial Tumor,Regulation Of TP53 Degradation R-HSA-6804757,6.215532957627937,0.037341562547049977,Other Types
Ovarian Epithelial Tumor,Nuclear Import Of Rev Protein R-HSA-180746,5.408988277085876,0.04848431405241891,Other Types
Ovarian Epithelial Tumor,Oncogene Induced Senescence R-HSA-2559585,5.994049777125105,0.040044326059380735,Other Types
Ovarian Epithelial Tumor,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,10.545631233898282,0.011746649557278645,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Signaling By FGFR1 R-HSA-5654736,15.452590876718261,0.0043506971106581655,Other Types
Ovarian Epithelial Tumor,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,14.200548405370213,0.00547845460281051,Other Types
Ovarian Epithelial Tumor,MyD88-independent TLR4 Cascade R-HSA-166166,18.207720711738357,0.0027350969874469773,Other Types
Ovarian Epithelial Tumor,Transcriptional Regulation By E2F6 R-HSA-8953750,8.762396541165643,0.0181424837352728,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,IRS-related Events Triggered By IGF1R R-HSA-2428928,7.267528706679773,0.027249213898922733,Other Types
Ovarian Epithelial Tumor,Signaling By FGFR3 R-HSA-5654741,12.145157102615658,0.008258907250081264,Other Types
Ovarian Epithelial Tumor,Signaling By FGFR4 R-HSA-5654743,12.145157102615658,0.008258907250081264,Other Types
Ovarian Epithelial Tumor,Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,5.3407546853443515,0.04961101340030187,Other Types
Ovarian Epithelial Tumor,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,6.18010662034866,0.03775794433015327,Other Types
Ovarian Epithelial Tumor,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,6.18010662034866,0.03775794433015327,Other Types
Ovarian Epithelial Tumor,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,6.18010662034866,0.03775794433015327,Other Types
Ovarian Epithelial Tumor,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,6.18010662034866,0.03775794433015327,Other Types
Ovarian Epithelial Tumor,Transcriptional Regulation By VENTX R-HSA-8853884,15.052646094726338,0.004676279575579853,Other Types
Ovarian Epithelial Tumor,FRS-mediated FGFR1 Signaling R-HSA-5654693,11.33833160809623,0.009825649187696192,Other Types
Ovarian Epithelial Tumor,Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,5.926216848082308,0.040921537703148624,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Clathrin-mediated Endocytosis R-HSA-8856828,9.401940245953883,0.015435286562069182,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Activation Of Pre-Replicative Complex R-HSA-68962,11.160345241113422,0.010220364274908572,Other Types
Ovarian Epithelial Tumor,p75NTR Signals Via NF-kB R-HSA-193639,8.74642377668548,0.018217466958843936,Other Types
Ovarian Epithelial Tumor,Signaling By FGFR1 In Disease R-HSA-5655302,7.14246616394486,0.028250817291665318,Other Types
Ovarian Epithelial Tumor,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,6.2394467357749415,0.03706378674692865,Other Types
Ovarian Epithelial Tumor,Interleukin-7 Signaling R-HSA-1266695,6.713116344628737,0.032064809129759,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,6.231077521471238,0.03716070174226962,Other Types
Ovarian Epithelial Tumor,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,7.481916948564164,0.02563446549656747,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,PI-3K cascade:FGFR1 R-HSA-5654689,19.01143457203066,0.002411964624413171,Other Types
Ovarian Epithelial Tumor,Cell Cycle R-HSA-1640170,5.74530633056084,0.04338361606497364,Other Types
Ovarian Epithelial Tumor,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,5.903635151808295,0.041218976588504264,Other Types
Ovarian Epithelial Tumor,IGF1R Signaling Cascade R-HSA-2428924,8.429535331491746,0.019789304082885577,Other Types
Ovarian Epithelial Tumor,Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,8.429535331491746,0.019789304082885577,Other Types
Ovarian Epithelial Tumor,FRS-mediated FGFR4 Signaling R-HSA-5654712,7.151110323140529,0.028180103676169178,Other Types
Ovarian Epithelial Tumor,FRS-mediated FGFR3 Signaling R-HSA-5654706,7.151110323140529,0.028180103676169178,Other Types
Ovarian Epithelial Tumor,FRS-mediated FGFR2 Signaling R-HSA-5654700,7.151110323140529,0.028180103676169178,Other Types
Ovarian Epithelial Tumor,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,5.464137639397581,0.04759741994616862,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,E2F Mediated Regulation Of DNA Replication R-HSA-113510,13.6230394365779,0.006121909469173244,Other Types
Ovarian Epithelial Tumor,FGFR1 Mutant Receptor Activation R-HSA-1839124,5.402508168760758,0.0485899040501833,Other Types
Ovarian Epithelial Tumor,Cellular Senescence R-HSA-2559583,6.543272570080384,0.03375278129506202,Other Types
Ovarian Epithelial Tumor,Activated NTRK2 Signals Thru FRS2 And FRS3 R-HSA-9028731,6.24008169052115,0.037056447117927827,Other Types
Ovarian Epithelial Tumor,PTK6 Regulates Cell Cycle R-HSA-8849470,5.3527978927727515,0.049409742468252825,Other Types
Ovarian Epithelial Tumor,Extra-nuclear Estrogen Signaling R-HSA-9009391,6.13997465327765,0.03823678618131019,Other Types
Ovarian Epithelial Tumor,Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,13.056677538770918,0.006847791823699245,Other Types
Ovarian Epithelial Tumor,Signaling By NTRK2 (TRKB) R-HSA-9006115,6.885631906013739,0.03045834722852679,Other Types
Ovarian Epithelial Tumor,SLC-mediated Transmembrane Transport R-HSA-425407,7.741710155293538,0.02383639084281158,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,TP53 Regulates Transcription Of Additional Cell Death Genes With Uncertain Roles In P53-Dependent Apoptosis R-HSA-6803205,16.88591352540052,0.003394157241344343,Other Types
Ovarian Epithelial Tumor,Signaling By NOTCH2 R-HSA-1980145,6.670570056923667,0.03247740923196732,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,L1CAM Interactions R-HSA-373760,11.470383824678342,0.009545124849121067,Other Types
Ovarian Epithelial Tumor,Attenuation Phase R-HSA-3371568,8.849329482614921,0.017741136565648973,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,17.51860952222791,0.003056420467163703,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,RET Signaling R-HSA-8853659,6.122656240491681,0.03844580658091824,Other Types
Ovarian Epithelial Tumor,SUMOylation Of Intracellular Receptors R-HSA-4090294,7.470762522602088,0.025715444779938038,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Pyroptosis R-HSA-5620971,6.547856574321282,0.03370576353707449,Other Types
Ovarian Epithelial Tumor,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,343.02950084116117,7.444601782300597e-08,Other Types
Ovarian Epithelial Tumor,PI Metabolism R-HSA-1483255,6.377439198709107,0.035511142626282986,Other Types
Ovarian Epithelial Tumor,Signaling By FGFR4 In Disease R-HSA-5655291,12.556784600882997,0.007580403967482068,Other Types
Ovarian Epithelial Tumor,Signaling By FGFR3 In Disease R-HSA-5655332,15.173109310118331,0.004575090833612799,Other Types
Ovarian Epithelial Tumor,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,8.301172609964357,0.02047455717607384,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Potential Therapeutics For SARS R-HSA-9679191,8.246624936471365,0.020774814990805537,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,MASTL Facilitates Mitotic Progression R-HSA-2465910,15.006856688484959,0.004715477935242816,Other Types
Ovarian Epithelial Tumor,Iron Uptake And Transport R-HSA-917937,6.7209717884682,0.03198935775032307,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,7.610616388986913,0.024723048278775205,Other Types
Ovarian Epithelial Tumor,PERK Regulates Gene Expression R-HSA-381042,6.778773759992503,0.0314410350275149,Other Types
Ovarian Epithelial Tumor,SLBP Independent Processing Of Histone Pre-mRNAs R-HSA-111367,7.992092071417139,0.022251750221141904,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,SLBP Dependent Processing Of Replication-Dependent Histone Pre-mRNAs R-HSA-77588,7.992092071417139,0.022251750221141904,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,8.625819677361351,0.01879644485004739,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Meiosis R-HSA-1500620,6.041052231588193,0.03945048256224006,Other Types
Ovarian Epithelial Tumor,Reproduction R-HSA-1474165,6.041051168194936,0.03945049587037717,Other Types
Ovarian Epithelial Tumor,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,5.331204238797001,0.04977136853249454,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,5.840433348026942,0.04206619887886981,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,RHO GTPases Activate IQGAPs R-HSA-5626467,13.045579846481951,0.006863065640927385,Other Types
Ovarian Epithelial Tumor,NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,19.613185820427223,0.0022008825126572117,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Regulation Of NF-kappa B Signaling R-HSA-9758274,6.515219011179366,0.0340423444144697,Other Types
Ovarian Epithelial Tumor,Processive Synthesis On Lagging Strand R-HSA-69183,9.443043944121348,0.015279301371651535,Other Types
Ovarian Epithelial Tumor,Removal Of Flap Intermediate R-HSA-69166,9.443043944121348,0.015279301371651535,Other Types
Ovarian Epithelial Tumor,Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,5.579118658116909,0.04581383897561977,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,DNA Damage Bypass R-HSA-73893,6.817681898243527,0.03107864045815514,Other Types
Ovarian Epithelial Tumor,Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,5.642250902829137,0.04487069711139547,Other Types
Ovarian Epithelial Tumor,Signaling By NOTCH1 R-HSA-1980143,6.504984216851793,0.03414877012408595,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,14.192601883461435,0.005486716437894179,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,HDACs Deacetylate Histones R-HSA-3214815,23.78447809994701,0.0012291237728317013,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,HSF1-dependent Transactivation R-HSA-3371571,9.471872096670804,0.015171084532919668,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Regulation Of Beta-Cell Development R-HSA-186712,11.466137552192604,0.009553987526425327,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Regulation Of Gene Expression In Beta Cells R-HSA-210745,24.635788157632557,0.0011021230521166543,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Activation Of HOX Genes During Differentiation R-HSA-5619507,8.86275937845734,0.01768013644753842,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Chromosome Maintenance R-HSA-73886,6.3776890078115835,0.03550840751532019,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Metalloprotease DUBs R-HSA-5689901,25.447629753671347,0.0009959570177576578,Other Types
Ovarian Epithelial Tumor,Notch-HLH Transcription Pathway R-HSA-350054,6.377150401873568,0.03551430493960363,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,8.499148326748324,0.019429775179837575,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Amyloid Fiber Formation R-HSA-977225,5.779139213589531,0.04290912534504601,Ovarian Epithelial Tumor
Ovarian Epithelial Tumor,Fanconi Anemia Pathway R-HSA-6783310,19.038713941803493,0.002401860498796663,Other Types
Merkel Cell Carcinoma,G1/S DNA Damage Checkpoints R-HSA-69615,44.41190842021402,0.0026340167564367673,Other Types
Merkel Cell Carcinoma,p53-Dependent G1 DNA Damage Response R-HSA-69563,47.86077548837757,0.0022908439343693947,Other Types
Merkel Cell Carcinoma,Asparagine N-linked Glycosylation R-HSA-446203,44.074992647831046,0.0026716172116369825,Other Types
Merkel Cell Carcinoma,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,60.78526636665898,0.0014600351446091488,Other Types
Merkel Cell Carcinoma,G1/S Transition R-HSA-69206,57.54107583718495,0.0016198761423289092,Other Types
Merkel Cell Carcinoma,"Platelet Activation, Signaling And Aggregation R-HSA-76002",27.538491129358686,0.006307017547221086,Other Types
Merkel Cell Carcinoma,Mitotic G1 Phase And G1/S Transition R-HSA-453279,62.86905257932334,0.0013695339430817516,Other Types
Merkel Cell Carcinoma,EPH-Ephrin Signaling R-HSA-2682334,9.187231474909824,0.0387408262834853,Other Types
Merkel Cell Carcinoma,Muscle Contraction R-HSA-397014,18.777657316407932,0.012317487190259085,Other Types
Merkel Cell Carcinoma,RHO GTPase Effectors R-HSA-195258,43.13321865345548,0.0027810987417690447,Other Types
Merkel Cell Carcinoma,Smooth Muscle Contraction R-HSA-445355,16.619180027058754,0.015139844374378158,Other Types
Merkel Cell Carcinoma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,189.40389728403738,0.00016152496370827133,Other Types
Merkel Cell Carcinoma,Transcriptional Regulation By RUNX1 R-HSA-8878171,8.352788376748341,0.044557581280060564,Merkel Cell Carcinoma
Merkel Cell Carcinoma,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,185.07237232703892,0.00016903774714376393,Other Types
Merkel Cell Carcinoma,MET Activates PTK2 Signaling R-HSA-8874081,30.022817472743373,0.005401070128305752,Other Types
Merkel Cell Carcinoma,Platelet Degranulation R-HSA-114608,7.960076797298415,0.047762053964677545,Other Types
Merkel Cell Carcinoma,VxPx Cargo-Targeting To Cilium R-HSA-5620916,10.247839228581265,0.03286242681726509,Other Types
Merkel Cell Carcinoma,Interferon Alpha/Beta Signaling R-HSA-909733,129.63545616808779,0.0003393854384318818,Other Types
Merkel Cell Carcinoma,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,168.47531585186124,0.0002032759179542887,Other Types
Merkel Cell Carcinoma,Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,7.733899099534952,0.04976815846798095,Other Types
Merkel Cell Carcinoma,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,9.586009701009228,0.03635739326445601,Merkel Cell Carcinoma
Merkel Cell Carcinoma,SARS-CoV-1 Infection R-HSA-9678108,131.40118068753645,0.00033054746515139027,Other Types
Merkel Cell Carcinoma,RHO GTPases Activate PAKs R-HSA-5627123,7.873566461601403,0.048514692186796965,Other Types
Merkel Cell Carcinoma,DNA Replication Initiation R-HSA-68952,31.238059636647478,0.0050274744350415615,Other Types
Merkel Cell Carcinoma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,24.61534050262538,0.007698516226172462,Other Types
Merkel Cell Carcinoma,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,60.43926379858062,0.0014759279022874482,Merkel Cell Carcinoma
Merkel Cell Carcinoma,MyD88-independent TLR4 Cascade R-HSA-166166,178.36796660870613,0.00018174282706790568,Other Types
Merkel Cell Carcinoma,Transcriptional Regulation By TP53 R-HSA-3700989,250.06339046101624,9.344597419207282e-05,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,43.16725811047355,0.002777025289282671,Merkel Cell Carcinoma
Merkel Cell Carcinoma,MET Activates RAS Signaling R-HSA-8851805,28.630890291675776,0.005882547381167878,Other Types
Merkel Cell Carcinoma,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,44.96215683566374,0.0025742933457972724,Merkel Cell Carcinoma
Merkel Cell Carcinoma,FRS-mediated FGFR4 Signaling R-HSA-5654712,37.48257993167991,0.0036053113532901688,Other Types
Merkel Cell Carcinoma,FRS-mediated FGFR3 Signaling R-HSA-5654706,37.48257993167991,0.0036053113532901688,Other Types
Merkel Cell Carcinoma,FRS-mediated FGFR2 Signaling R-HSA-5654700,37.48257993167991,0.0036053113532901688,Other Types
Merkel Cell Carcinoma,Signaling By NOTCH2 R-HSA-1980145,40.46740083172441,0.0031302477461944487,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,180.46468382919602,0.00017761972820713536,Other Types
Merkel Cell Carcinoma,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,55.354671233232175,0.0017428821586567443,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Attenuation Phase R-HSA-3371568,10.352253756274603,0.032357542194904027,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Intrinsic Pathway For Apoptosis R-HSA-109606,231.92496627832827,0.0001084112871754583,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Gene Expression (Transcription) R-HSA-74160,125.62032646819009,0.00036085100790816255,Merkel Cell Carcinoma
Merkel Cell Carcinoma,RNA Polymerase II Transcription R-HSA-73857,519.3823082708828,2.1959523632404605e-05,Merkel Cell Carcinoma
Merkel Cell Carcinoma,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,31.159065624079062,0.005050563000334121,Merkel Cell Carcinoma
Merkel Cell Carcinoma,SUMOylation Of Intracellular Receptors R-HSA-4090294,7.728464608287256,0.049817916458467885,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Nephrin Family Interactions R-HSA-373753,1689.366345219803,2.0940723370836944e-06,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Generic Transcription Pathway R-HSA-212436,619.676045884565,1.5458378959467624e-05,Merkel Cell Carcinoma
Merkel Cell Carcinoma,MicroRNA (miRNA) Biogenesis R-HSA-203927,43.877128593828814,0.002694075793718448,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Iron Uptake And Transport R-HSA-917937,50.78322407767114,0.0020499576026645136,Merkel Cell Carcinoma
Merkel Cell Carcinoma,SUMOylation Of Transcription Cofactors R-HSA-3899300,213.15792146781178,0.0001280224344524481,Merkel Cell Carcinoma
Merkel Cell Carcinoma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,35.788770610691756,0.003924624166463882,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Estrogen-dependent Gene Expression R-HSA-9018519,59.06672762230135,0.001541599357441364,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Inositol Phosphate Metabolism R-HSA-1483249,140.24905022346732,0.000291061254451245,Merkel Cell Carcinoma
Merkel Cell Carcinoma,RHOBTB1 GTPase Cycle R-HSA-9013422,122.75707081968272,0.00037742722787132424,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,40.235866258332884,0.0031636363764142314,Merkel Cell Carcinoma
Merkel Cell Carcinoma,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,42.388510828559305,0.0028725088901628377,Merkel Cell Carcinoma
Merkel Cell Carcinoma,SHC1 Events In EGFR Signaling R-HSA-180336,8.240118869704485,0.0454429274866652,Other Types
Merkel Cell Carcinoma,STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,83.67908047040737,0.0007926583277399892,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Metal Ion SLC Transporters R-HSA-425410,8.117066811570947,0.046440545243159444,Other Types
Merkel Cell Carcinoma,TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,51.6483734740639,0.0019859153349312993,Other Types
Merkel Cell Carcinoma,Translesion Synthesis By POLH R-HSA-110320,128.76232113955714,0.0003438872902222018,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Plasma Lipoprotein Clearance R-HSA-8964043,42.504517711505244,0.002857975646010886,Merkel Cell Carcinoma
Merkel Cell Carcinoma,HSF1-dependent Transactivation R-HSA-3371571,101.49233912517526,0.0005461132607573741,Merkel Cell Carcinoma
Merkel Cell Carcinoma,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",97.25912974044772,0.0005930522173730696,Merkel Cell Carcinoma
Merkel Cell Carcinoma,STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,47.779952993449285,0.002298099252311321,Other Types
Merkel Cell Carcinoma,Activation Of HOX Genes During Differentiation R-HSA-5619507,40.45549313293625,0.003131951980943203,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Chromosome Maintenance R-HSA-73886,47.28947503231552,0.002342877372280548,Merkel Cell Carcinoma
Merkel Cell Carcinoma,VLDLR Internalisation And Degradation R-HSA-8866427,77.30625719028467,0.0009229282854923498,Merkel Cell Carcinoma
Merkel Cell Carcinoma,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,38.9585515509734,0.003357811220896981,Merkel Cell Carcinoma
Merkel Cell Carcinoma,DNA Repair R-HSA-73894,34.86271633848747,0.004117467548203591,Merkel Cell Carcinoma
Pleural Mesothelioma,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,9.002858423436816,0.00587865104204075,Pleural Mesothelioma
Pleural Mesothelioma,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",10.703018367961835,0.003015490965186949,Pleural Mesothelioma
Pleural Mesothelioma,Respiratory Electron Transport R-HSA-611105,7.795407745866781,0.009690256624307043,Pleural Mesothelioma
Pleural Mesothelioma,Mitochondrial Biogenesis R-HSA-1592230,6.743089007711626,0.015283207286256144,Pleural Mesothelioma
Pleural Mesothelioma,Mitochondrial tRNA Aminoacylation R-HSA-379726,4.30658405461945,0.047997493425368215,Pleural Mesothelioma
Pleural Mesothelioma,Leishmania Infection R-HSA-9658195,4.519192209928112,0.043176880444193974,Other Types
Pleural Mesothelioma,Cristae Formation R-HSA-8949613,10.645167855827056,0.0030828160212873165,Pleural Mesothelioma
Pleural Mesothelioma,Golgi-to-ER Retrograde Transport R-HSA-8856688,7.59152306954951,0.010568289301183056,Other Types
Pleural Mesothelioma,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,9.674688215105327,0.004494195788668538,Other Types
Pleural Mesothelioma,VEGFA-VEGFR2 Pathway R-HSA-4420097,4.429666138289917,0.04513742236221911,Other Types
Pleural Mesothelioma,Asparagine N-linked Glycosylation R-HSA-446203,11.806577439171482,0.0019945816479067834,Other Types
Pleural Mesothelioma,Cytoprotection By HMOX1 R-HSA-9707564,16.78817509648493,0.00036254927001052353,Pleural Mesothelioma
Pleural Mesothelioma,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,7.019195074717168,0.013534601454885909,Pleural Mesothelioma
Pleural Mesothelioma,TP53 Regulates Metabolic Genes R-HSA-5628897,30.92455059822855,7.696563719686515e-06,Pleural Mesothelioma
Pleural Mesothelioma,Signaling By MET R-HSA-6806834,8.125717040352606,0.008432430752469461,Other Types
Pleural Mesothelioma,Signaling By VEGF R-HSA-194138,4.495369124272463,0.04368911918813875,Other Types
Pleural Mesothelioma,Mitotic G2-G2/M Phases R-HSA-453274,5.463996206208602,0.02738288530960978,Other Types
Pleural Mesothelioma,FCGR3A-mediated Phagocytosis R-HSA-9664422,9.459663265291994,0.00489411772798977,Other Types
Pleural Mesothelioma,Metabolism Of Nucleotides R-HSA-15869,10.680887997799216,0.0030410550926300633,Pleural Mesothelioma
Pleural Mesothelioma,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,13.285168678698586,0.0011718325721955275,Other Types
Pleural Mesothelioma,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,5.846762109764535,0.022912796031249436,Other Types
Pleural Mesothelioma,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,7.075888314850127,0.013203452141232332,Other Types
Pleural Mesothelioma,ER To Golgi Anterograde Transport R-HSA-199977,5.072724605004101,0.03297342207205093,Other Types
Pleural Mesothelioma,"Platelet Activation, Signaling And Aggregation R-HSA-76002",8.98259845946694,0.005927053732160425,Other Types
Pleural Mesothelioma,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,8.94693843817981,0.006013307578322581,Other Types
Pleural Mesothelioma,Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,4.447951496819519,0.0447290329803431,Pleural Mesothelioma
Pleural Mesothelioma,RAC3 GTPase Cycle R-HSA-9013423,7.021813997547687,0.013519104943518564,Other Types
Pleural Mesothelioma,EPH-Ephrin Signaling R-HSA-2682334,4.415488907209712,0.04545693221882044,Other Types
Pleural Mesothelioma,Mitochondrial Translation R-HSA-5368287,16.98997737239863,0.00033998547011302637,Pleural Mesothelioma
Pleural Mesothelioma,Transport To Golgi And Subsequent Modification R-HSA-948021,5.498235150793103,0.026946076798323906,Other Types
Pleural Mesothelioma,COPI-mediated Anterograde Transport R-HSA-6807878,6.562494523342365,0.0165605535002713,Other Types
Pleural Mesothelioma,Death Receptor Signaling R-HSA-73887,5.5496174163492045,0.026304963346321528,Other Types
Pleural Mesothelioma,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,9.503462949081163,0.004809613891983297,Other Types
Pleural Mesothelioma,MET Promotes Cell Motility R-HSA-8875878,6.593084168464095,0.0163361794751023,Other Types
Pleural Mesothelioma,Transport Of Small Molecules R-HSA-382551,10.033473726112293,0.0039038685184551664,Pleural Mesothelioma
Pleural Mesothelioma,Platelet Aggregation (Plug Formation) R-HSA-76009,12.571522119701116,0.0015102676364145038,Other Types
Pleural Mesothelioma,Integrin Signaling R-HSA-354192,12.571522119701116,0.0015102676364145038,Other Types
Pleural Mesothelioma,EPHB-mediated Forward Signaling R-HSA-3928662,18.85598821139628,0.000190585042706305,Other Types
Pleural Mesothelioma,Protein Localization R-HSA-9609507,6.576027904006703,0.016460871316384372,Pleural Mesothelioma
Pleural Mesothelioma,Downstream Signal Transduction R-HSA-186763,8.186326814378623,0.008221623450450273,Other Types
Pleural Mesothelioma,Mitochondrial Translation Termination R-HSA-5419276,32.91231868942223,4.865597433762137e-06,Pleural Mesothelioma
Pleural Mesothelioma,Signaling By PDGF R-HSA-186797,6.210169729125072,0.019404465178028518,Other Types
Pleural Mesothelioma,RHO GTPase Effectors R-HSA-195258,7.129101811098625,0.012900701747624638,Other Types
Pleural Mesothelioma,Nucleotide Biosynthesis R-HSA-8956320,13.350270300220245,0.0011453279296546903,Pleural Mesothelioma
Pleural Mesothelioma,Mitochondrial Translation Initiation R-HSA-5368286,18.472743479578494,0.00021417236665424572,Pleural Mesothelioma
Pleural Mesothelioma,Metabolism Of Vitamins And Cofactors R-HSA-196854,15.005183095622753,0.0006494192323979725,Pleural Mesothelioma
Pleural Mesothelioma,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,8.635381628720262,0.006827895316764347,Pleural Mesothelioma
Pleural Mesothelioma,Mitochondrial Translation Elongation R-HSA-5389840,13.415175431023941,0.0011195488990801534,Pleural Mesothelioma
Pleural Mesothelioma,Cell-Cell Communication R-HSA-1500931,4.990466746376003,0.034303519825600835,Other Types
Pleural Mesothelioma,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,12.932677932014224,0.001327383364658342,Other Types
Pleural Mesothelioma,Signaling To ERKs R-HSA-187687,9.924592599719443,0.004073559116002957,Other Types
Pleural Mesothelioma,RHOJ GTPase Cycle R-HSA-9013409,4.614907619539492,0.041185411730587575,Other Types
Pleural Mesothelioma,"PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",8.95590828778401,0.005991483339528832,Other Types
Pleural Mesothelioma,Cell Junction Organization R-HSA-446728,12.60047923129758,0.0014946402132048574,Other Types
Pleural Mesothelioma,Deubiquitination R-HSA-5688426,4.54539964011916,0.042621114134159574,Pleural Mesothelioma
Pleural Mesothelioma,XBP1(S) Activates Chaperone Genes R-HSA-381038,6.6153427999180225,0.01617501462555288,Other Types
Pleural Mesothelioma,IRE1alpha Activates Chaperones R-HSA-381070,6.6153427999180225,0.01617501462555288,Other Types
Pleural Mesothelioma,Smooth Muscle Contraction R-HSA-445355,6.849168237838868,0.01458365077722254,Other Types
Pleural Mesothelioma,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,8.15356785248496,0.008334837968197948,Pleural Mesothelioma
Pleural Mesothelioma,Metabolism R-HSA-1430728,18.762915239709166,0.00019604311161419097,Pleural Mesothelioma
Pleural Mesothelioma,Heme Biosynthesis R-HSA-189451,12.607072801830872,0.001491106399072088,Pleural Mesothelioma
Pleural Mesothelioma,Metabolism Of Porphyrins R-HSA-189445,12.607072392976974,0.0014911066179155762,Pleural Mesothelioma
Pleural Mesothelioma,rRNA Modification In Mitochondrion R-HSA-6793080,4.876884755566616,0.036239270933718745,Pleural Mesothelioma
Pleural Mesothelioma,Drug ADME R-HSA-9748784,6.870982366618738,0.014444198521256876,Pleural Mesothelioma
Pleural Mesothelioma,Prolonged ERK Activation Events R-HSA-169893,17.610040694501148,0.000279650449032611,Other Types
Pleural Mesothelioma,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,8.923252970795932,0.006071353771922689,Other Types
Pleural Mesothelioma,Netrin-1 Signaling R-HSA-373752,4.568842336055257,0.042130744904911394,Other Types
Pleural Mesothelioma,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,17.560784640040644,0.00028399213526790777,Pleural Mesothelioma
Pleural Mesothelioma,Citric Acid Cycle (TCA Cycle) R-HSA-71403,12.148538471623453,0.0017599352371895193,Pleural Mesothelioma
Pleural Mesothelioma,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,7.0518990852169186,0.01334247726280906,Pleural Mesothelioma
Pleural Mesothelioma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,25.018127809778665,3.3444530192247514e-05,Other Types
Pleural Mesothelioma,Ubiquinol Biosynthesis R-HSA-2142789,6.9871181845666195,0.013725994631705525,Pleural Mesothelioma
Pleural Mesothelioma,DCC Mediated Attractive Signaling R-HSA-418885,6.830780400204992,0.014702348521165053,Other Types
Pleural Mesothelioma,mTORC1-mediated Signaling R-HSA-166208,4.7407778940944425,0.038720864477211334,Other Types
Pleural Mesothelioma,Semaphorin Interactions R-HSA-373755,4.275471151543119,0.04875224224686897,Other Types
Pleural Mesothelioma,Metabolism Of Cofactors R-HSA-8978934,7.017584837853915,0.013544139115509966,Pleural Mesothelioma
Pleural Mesothelioma,Unfolded Protein Response (UPR) R-HSA-381119,5.2836515700804565,0.029817082275576785,Other Types
Pleural Mesothelioma,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,6.9554116280290925,0.013918101359927321,Other Types
Pleural Mesothelioma,Frs2-mediated Activation R-HSA-170968,14.689696755197337,0.0007221238986232849,Other Types
Pleural Mesothelioma,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,12.731322479410766,0.0014261813928637052,Other Types
Pleural Mesothelioma,MET Receptor Recycling R-HSA-8875656,6.156742965821632,0.019880887005586864,Other Types
Pleural Mesothelioma,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,10.645949625214872,0.0030818953987145356,Other Types
Pleural Mesothelioma,Kinesins R-HSA-983189,17.932125413994175,0.0002529702585974009,Other Types
Pleural Mesothelioma,MET Activates PTK2 Signaling R-HSA-8874081,7.3118899884281445,0.011917353304462393,Other Types
Pleural Mesothelioma,Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,6.058701390294834,0.02078905527416696,Other Types
Pleural Mesothelioma,ERBB2 Regulates Cell Motility R-HSA-6785631,9.491731504935075,0.0048320906965019636,Other Types
Pleural Mesothelioma,Late Phase Of HIV Life Cycle R-HSA-162599,6.932112359659525,0.014061150308482704,Pleural Mesothelioma
Pleural Mesothelioma,Cilium Assembly R-HSA-5617833,20.026336866478054,0.00013434599862284277,Other Types
Pleural Mesothelioma,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,9.331695691458062,0.0051504147983290165,Other Types
Pleural Mesothelioma,Platelet Degranulation R-HSA-114608,7.7263114103288855,0.009978536057650072,Other Types
Pleural Mesothelioma,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,10.177997888419204,0.003690403513823456,Other Types
Pleural Mesothelioma,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,4.981446580501843,0.034452967739344136,Pleural Mesothelioma
Pleural Mesothelioma,MAP2K And MAPK Activation R-HSA-5674135,4.920870120892418,0.03547557545350489,Other Types
Pleural Mesothelioma,VxPx Cargo-Targeting To Cilium R-HSA-5620916,11.682874930934203,0.0020876539928447358,Other Types
Pleural Mesothelioma,G Alpha (S) Signaling Events R-HSA-418555,4.34614350722903,0.04705668841494305,Other Types
Pleural Mesothelioma,Signal Amplification R-HSA-392518,4.6619009148416115,0.04024536902134821,Other Types
Pleural Mesothelioma,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,13.035421723214355,0.001279851750857214,Other Types
Pleural Mesothelioma,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,10.0709916797313,0.0038471918914273753,Other Types
Pleural Mesothelioma,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,4.540504977164506,0.04272430245492582,Other Types
Pleural Mesothelioma,GPER1 Signaling R-HSA-9634597,5.0099454290998615,0.033983246054910425,Other Types
Pleural Mesothelioma,HIV Life Cycle R-HSA-162587,5.540208199674832,0.026421091092284885,Pleural Mesothelioma
Pleural Mesothelioma,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,8.014166354008402,0.008836029939754752,Pleural Mesothelioma
Pleural Mesothelioma,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,15.329144360157608,0.0005829309523495722,Other Types
Pleural Mesothelioma,Depolymerisation Of Nuclear Lamina R-HSA-4419969,6.469225381222204,0.01726586936265391,Other Types
Pleural Mesothelioma,Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,9.713980275833821,0.004425038742207735,Other Types
Pleural Mesothelioma,MHC Class II Antigen Presentation R-HSA-2132295,5.779463772439775,0.023636424645664504,Other Types
Pleural Mesothelioma,RHOH GTPase Cycle R-HSA-9013407,6.347468063010433,0.018236830745507145,Pleural Mesothelioma
Pleural Mesothelioma,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,7.311410571441713,0.011919822372696218,Other Types
Pleural Mesothelioma,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,6.727529627240582,0.015388881248306606,Other Types
Pleural Mesothelioma,Post NMDA Receptor Activation Events R-HSA-438064,8.569623846703415,0.007014780923817693,Other Types
Pleural Mesothelioma,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,4.750587548212315,0.038535812213828465,Other Types
Pleural Mesothelioma,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,4.750587548212315,0.038535812213828465,Other Types
Pleural Mesothelioma,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,4.750587548212315,0.038535812213828465,Other Types
Pleural Mesothelioma,SARS-CoV-1 Infection R-HSA-9678108,6.083899694620143,0.02055135190705593,Other Types
Pleural Mesothelioma,CD209 (DC-SIGN) Signaling R-HSA-5621575,4.302094142744612,0.04810559824621513,Other Types
Pleural Mesothelioma,Regulation Of IFNG Signaling R-HSA-877312,4.757125716372394,0.03841302185099906,Other Types
Pleural Mesothelioma,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,6.577504046182817,0.016450038538952896,Other Types
Pleural Mesothelioma,AURKA Activation By TPX2 R-HSA-8854518,12.786522303826093,0.0013983267780629267,Other Types
Pleural Mesothelioma,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,5.88827623574357,0.022478634328007296,Other Types
Pleural Mesothelioma,Centrosome Maturation R-HSA-380287,8.476573624786457,0.007288841568727238,Other Types
Pleural Mesothelioma,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,7.031950578689814,0.013459308727231507,Pleural Mesothelioma
Pleural Mesothelioma,RNA Polymerase III Transcription Termination R-HSA-73980,6.992859937094768,0.013691518189650745,Other Types
Pleural Mesothelioma,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,7.972847711459409,0.008990845373882481,Other Types
Pleural Mesothelioma,Mitochondrial Calcium Ion Transport R-HSA-8949215,4.845955284829433,0.0367872415134025,Pleural Mesothelioma
Pleural Mesothelioma,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,8.298179236340012,0.007847549518650286,Other Types
Pleural Mesothelioma,RHO GTPases Activate PAKs R-HSA-5627123,8.917496902555191,0.006085552347148175,Other Types
Pleural Mesothelioma,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,4.349873148193913,0.046969061062942304,Other Types
Pleural Mesothelioma,Regulation Of TP53 Expression And Degradation R-HSA-6806003,5.830553753168503,0.023084812509498575,Other Types
Pleural Mesothelioma,Regulation Of TP53 Degradation R-HSA-6804757,6.223768972185418,0.019285215162550173,Other Types
Pleural Mesothelioma,Oncogene Induced Senescence R-HSA-2559585,6.113520495066443,0.02027575440645603,Other Types
Pleural Mesothelioma,Cellular Response To Chemical Stress R-HSA-9711123,7.005763700101286,0.013614383642689184,Pleural Mesothelioma
Pleural Mesothelioma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,15.28442244236171,0.0005916540408692565,Other Types
Pleural Mesothelioma,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,7.998672983627495,0.008893737249153705,Pleural Mesothelioma
Pleural Mesothelioma,trans-Golgi Network Vesicle Budding R-HSA-199992,5.534334334961225,0.026493873442274433,Pleural Mesothelioma
Pleural Mesothelioma,Transcriptional Regulation By E2F6 R-HSA-8953750,4.49862074382978,0.04361880485958481,Pleural Mesothelioma
Pleural Mesothelioma,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,12.944731622991714,0.0013217092228396863,Other Types
Pleural Mesothelioma,Transcriptional Regulation By TP53 R-HSA-3700989,21.24034178343655,9.442255844969069e-05,Pleural Mesothelioma
Pleural Mesothelioma,Diseases Of Glycosylation R-HSA-3781865,8.524409521424124,0.007146518563650798,Other Types
Pleural Mesothelioma,RHOC GTPase Cycle R-HSA-9013106,5.144854781339316,0.03185413610641637,Pleural Mesothelioma
Pleural Mesothelioma,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,4.343183420709259,0.04712636556538771,Other Types
Pleural Mesothelioma,PKMTs Methylate Histone Lysines R-HSA-3214841,7.863279665252747,0.009415935575445847,Pleural Mesothelioma
Pleural Mesothelioma,Processing Of SMDT1 R-HSA-8949664,4.497573695024488,0.043641432842674584,Pleural Mesothelioma
Pleural Mesothelioma,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,5.576367041963474,0.02597789580645889,Other Types
Pleural Mesothelioma,Interleukin-7 Signaling R-HSA-1266695,15.586171986307772,0.0005354210569573011,Pleural Mesothelioma
Pleural Mesothelioma,RHOB GTPase Cycle R-HSA-9013026,5.291712295459066,0.02970329951369012,Pleural Mesothelioma
Pleural Mesothelioma,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,16.184399132483822,0.00044029772813013375,Other Types
Pleural Mesothelioma,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,5.926826394585041,0.022083592077425232,Other Types
Pleural Mesothelioma,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,8.897583967354949,0.006134951946002263,Other Types
Pleural Mesothelioma,tRNA Processing In Nucleus R-HSA-6784531,6.071337666211492,0.020669476575536822,Other Types
Pleural Mesothelioma,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,5.832254064570031,0.02306670060614292,Pleural Mesothelioma
Pleural Mesothelioma,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,8.0793968267175,0.008597520476076275,Pleural Mesothelioma
Pleural Mesothelioma,E2F Mediated Regulation Of DNA Replication R-HSA-113510,8.087966801239274,0.008566711814540232,Other Types
Pleural Mesothelioma,PTK6 Regulates Cell Cycle R-HSA-8849470,11.110622537342708,0.0025840939261755746,Other Types
Pleural Mesothelioma,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,5.720026829006849,0.024296559740084028,Other Types
Pleural Mesothelioma,Extra-nuclear Estrogen Signaling R-HSA-9009391,6.504924698774395,0.01699207547714294,Other Types
Pleural Mesothelioma,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,4.677677518964961,0.03993516594044032,Other Types
Pleural Mesothelioma,RUNX2 Regulates Bone Development R-HSA-8941326,5.247311672932023,0.03033608334896285,Other Types
Pleural Mesothelioma,SLC-mediated Transmembrane Transport R-HSA-425407,13.823132285042501,0.0009712433310637953,Pleural Mesothelioma
Pleural Mesothelioma,Amino Acid Transport Across Plasma Membrane R-HSA-352230,7.213612268551073,0.01243542253649025,Pleural Mesothelioma
Pleural Mesothelioma,Signaling By NOTCH2 R-HSA-1980145,6.052906215084243,0.020844150778496683,Pleural Mesothelioma
Pleural Mesothelioma,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,7.439249827093803,0.011280859038383498,Other Types
Pleural Mesothelioma,RND2 GTPase Cycle R-HSA-9696270,4.717796492003684,0.03915828452534962,Pleural Mesothelioma
Pleural Mesothelioma,Signaling By Hippo R-HSA-2028269,6.86872845661288,0.014458539142463676,Pleural Mesothelioma
Pleural Mesothelioma,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,10.088279447883291,0.0038213779671191,Pleural Mesothelioma
Pleural Mesothelioma,Attenuation Phase R-HSA-3371568,4.674876544129015,0.03999004399805157,Pleural Mesothelioma
Pleural Mesothelioma,Glycosaminoglycan Metabolism R-HSA-1630316,9.67031426233028,0.004501966791404938,Other Types
Pleural Mesothelioma,Intrinsic Pathway For Apoptosis R-HSA-109606,27.9680700592835,1.571956960513976e-05,Pleural Mesothelioma
Pleural Mesothelioma,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,8.502435460397232,0.007211516140753087,Pleural Mesothelioma
Pleural Mesothelioma,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,5.80357933027818,0.023374258466542758,Pleural Mesothelioma
Pleural Mesothelioma,PPARA Activates Gene Expression R-HSA-1989781,6.915523664333613,0.014163982351801805,Pleural Mesothelioma
Pleural Mesothelioma,Intra-Golgi Traffic R-HSA-6811438,11.201488729261147,0.002497367856485464,Other Types
Pleural Mesothelioma,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,10.911235128966892,0.0027860874410749036,Pleural Mesothelioma
Pleural Mesothelioma,SUMOylation Of Intracellular Receptors R-HSA-4090294,12.179451684914378,0.0017402492313744271,Pleural Mesothelioma
Pleural Mesothelioma,Nephrin Family Interactions R-HSA-373753,8.627911267999368,0.006848850090516578,Pleural Mesothelioma
Pleural Mesothelioma,Generic Transcription Pathway R-HSA-212436,5.674815044355092,0.02481235302989527,Pleural Mesothelioma
Pleural Mesothelioma,Cyclin D Associated Events In G1 R-HSA-69231,5.9733974748152,0.02161654238906197,Other Types
Pleural Mesothelioma,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,6.120027168401408,0.02021576251462446,Other Types
Pleural Mesothelioma,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,4.9910767382491805,0.03429343941325986,Pleural Mesothelioma
Pleural Mesothelioma,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",15.436798520690182,0.0005624984007016067,Pleural Mesothelioma
Pleural Mesothelioma,Recycling Pathway Of L1 R-HSA-437239,5.068793271176792,0.0330356705564621,Pleural Mesothelioma
Pleural Mesothelioma,Adherens Junctions Interactions R-HSA-418990,5.167805365306572,0.03150689849358465,Other Types
Pleural Mesothelioma,tRNA Processing R-HSA-72306,4.798505816153386,0.03764592139529568,Other Types
Pleural Mesothelioma,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,4.7706708919876295,0.038160021322164256,Pleural Mesothelioma
Pleural Mesothelioma,Potential Therapeutics For SARS R-HSA-9679191,9.483783301132593,0.004847384035794427,Pleural Mesothelioma
Pleural Mesothelioma,MicroRNA (miRNA) Biogenesis R-HSA-203927,7.06303374443824,0.013277749687993124,Pleural Mesothelioma
Pleural Mesothelioma,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,6.135053718851666,0.020077963296339988,Other Types
Pleural Mesothelioma,SUMOylation Of Immune Response Proteins R-HSA-4755510,4.564195953976551,0.042227433889167644,Pleural Mesothelioma
Pleural Mesothelioma,Transcription Of HIV Genome R-HSA-167172,5.9759496275169885,0.021591264408695555,Pleural Mesothelioma
Pleural Mesothelioma,Iron Uptake And Transport R-HSA-917937,12.580247012800738,0.0015055404591262063,Pleural Mesothelioma
Pleural Mesothelioma,Basigin Interactions R-HSA-210991,13.72286378736862,0.0010056079019208199,Pleural Mesothelioma
Pleural Mesothelioma,SUMOylation Of Transcription Cofactors R-HSA-3899300,8.888246883728508,0.006158265683770306,Pleural Mesothelioma
Pleural Mesothelioma,Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,7.748946253384069,0.009883079755159152,Other Types
Pleural Mesothelioma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,22.451511255710933,6.70610103754212e-05,Pleural Mesothelioma
Pleural Mesothelioma,Late SARS-CoV-2 Infection Events R-HSA-9772573,8.1991801851892,0.008177662392488586,Other Types
Pleural Mesothelioma,Epigenetic Regulation Of Gene Expression R-HSA-212165,13.739881660746914,0.000999683816735434,Pleural Mesothelioma
Pleural Mesothelioma,Estrogen-dependent Gene Expression R-HSA-9018519,4.6316018454894685,0.040848686014513046,Pleural Mesothelioma
Pleural Mesothelioma,Inositol Phosphate Metabolism R-HSA-1483249,6.454676071294121,0.01737884367123419,Pleural Mesothelioma
Pleural Mesothelioma,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,5.680017199642292,0.024752392998026805,Other Types
Pleural Mesothelioma,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,4.630123730033821,0.040878375535756975,Pleural Mesothelioma
Pleural Mesothelioma,RHOBTB1 GTPase Cycle R-HSA-9013422,4.8711085365426605,0.036340912911891975,Pleural Mesothelioma
Pleural Mesothelioma,HIV Elongation Arrest And Recovery R-HSA-167287,16.049852867266264,0.0004599745072461705,Pleural Mesothelioma
Pleural Mesothelioma,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,22.978596831387307,5.7948671959381294e-05,Pleural Mesothelioma
Pleural Mesothelioma,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,5.219105348391269,0.030745832655217888,Pleural Mesothelioma
Pleural Mesothelioma,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,4.342710214475286,0.047137515026606555,Pleural Mesothelioma
Pleural Mesothelioma,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,5.122708830818658,0.03219323272079381,Pleural Mesothelioma
Pleural Mesothelioma,Aggrephagy R-HSA-9646399,9.89839968296668,0.004115567874832289,Other Types
Pleural Mesothelioma,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,10.565779587566926,0.00317788014214751,Pleural Mesothelioma
Pleural Mesothelioma,Interleukin-37 Signaling R-HSA-9008059,5.721057326595329,0.024284942427634956,Pleural Mesothelioma
Pleural Mesothelioma,"WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",7.647555081306116,0.010318615988693266,Pleural Mesothelioma
Pleural Mesothelioma,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,7.6475551698513735,0.010318615599283388,Pleural Mesothelioma
Pleural Mesothelioma,Retrograde Neurotrophin Signaling R-HSA-177504,4.336930806024601,0.04727392543368677,Pleural Mesothelioma
Pleural Mesothelioma,Translesion Synthesis By POLH R-HSA-110320,8.579604280149114,0.0069860603054389,Pleural Mesothelioma
Pleural Mesothelioma,Plasma Lipoprotein Clearance R-HSA-8964043,6.191555454109234,0.019569010620699913,Pleural Mesothelioma
Pleural Mesothelioma,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",7.576074130155261,0.010638286258879867,Pleural Mesothelioma
Pleural Mesothelioma,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",5.385408201395619,0.028415448744312188,Pleural Mesothelioma
Pleural Mesothelioma,Nef Mediated CD4 Down-regulation R-HSA-167590,5.246702602437566,0.03034486696532891,Pleural Mesothelioma
Pleural Mesothelioma,Nef Mediated CD8 Down-regulation R-HSA-182218,5.246702602437566,0.03034486696532891,Pleural Mesothelioma
Pleural Mesothelioma,Regulation Of Beta-Cell Development R-HSA-186712,14.29140907159159,0.0008267581162745232,Pleural Mesothelioma
Pleural Mesothelioma,RND3 GTPase Cycle R-HSA-9696264,5.869486031863578,0.022674009743605297,Pleural Mesothelioma
Pleural Mesothelioma,Regulation Of Gene Expression In Beta Cells R-HSA-210745,17.626753193256555,0.0002781936714801354,Pleural Mesothelioma
Pleural Mesothelioma,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",4.307316295369506,0.04797988890553066,Pleural Mesothelioma
Pleural Mesothelioma,Activation Of HOX Genes During Differentiation R-HSA-5619507,6.654149448711221,0.01589819726710017,Pleural Mesothelioma
Pleural Mesothelioma,Chromosome Maintenance R-HSA-73886,4.552701401822216,0.042467697018471404,Pleural Mesothelioma
Pleural Mesothelioma,LDL Clearance R-HSA-8964038,8.136950323768893,0.008392918413772061,Pleural Mesothelioma
Pleural Mesothelioma,VLDLR Internalisation And Degradation R-HSA-8866427,6.122768753910581,0.020190543564900045,Pleural Mesothelioma
Pleural Mesothelioma,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,5.721089669652961,0.024284577907632082,Pleural Mesothelioma
Pleural Mesothelioma,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,6.90233200584029,0.014246345864430219,Pleural Mesothelioma
Pleural Mesothelioma,TBC/RABGAPs R-HSA-8854214,6.129690988397315,0.020127022394380436,Pleural Mesothelioma
Pleural Mesothelioma,RND1 GTPase Cycle R-HSA-9696273,4.610925178525821,0.04126619538886454,Pleural Mesothelioma
Pleural Mesothelioma,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,6.744718063175825,0.015272189496350211,Pleural Mesothelioma
Pleural Mesothelioma,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,8.188134965792553,0.008215423636117259,Other Types
Pleural Mesothelioma,RNA Polymerase I Promoter Clearance R-HSA-73854,4.244743395432295,0.049510733987109604,Pleural Mesothelioma
Pleural Mesothelioma,RNA Polymerase I Transcription R-HSA-73864,4.244743395432295,0.049510733987109604,Pleural Mesothelioma
Pleural Mesothelioma,Signaling By NOTCH3 R-HSA-9012852,7.652491272770571,0.010296932275956926,Pleural Mesothelioma
Hepatocellular Carcinoma,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,4.622931128558622,0.04183531638580037,Hepatocellular Carcinoma
Hepatocellular Carcinoma,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",5.326123168604353,0.02994023771696443,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Mitochondrial Biogenesis R-HSA-1592230,4.833491077273209,0.037794558561223005,Hepatocellular Carcinoma
Hepatocellular Carcinoma,G1/S DNA Damage Checkpoints R-HSA-69615,6.283706817566331,0.019361668568270696,Other Types
Hepatocellular Carcinoma,p53-Dependent G1 DNA Damage Response R-HSA-69563,6.019926521163069,0.021786567293362227,Other Types
Hepatocellular Carcinoma,Cristae Formation R-HSA-8949613,5.848623741271759,0.023541045243862514,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Golgi-to-ER Retrograde Transport R-HSA-8856688,5.516175619637814,0.027412071265340825,Other Types
Hepatocellular Carcinoma,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,6.900520291734595,0.01477668719823444,Other Types
Hepatocellular Carcinoma,Asparagine N-linked Glycosylation R-HSA-446203,6.95047687412983,0.01446158776320335,Other Types
Hepatocellular Carcinoma,Cytoprotection By HMOX1 R-HSA-9707564,6.622889659177669,0.01667205130076199,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,5.152528427577199,0.03247829811675786,Hepatocellular Carcinoma
Hepatocellular Carcinoma,TP53 Regulates Metabolic Genes R-HSA-5628897,26.638930425323522,2.7638438532691872e-05,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Signaling By MET R-HSA-6806834,9.724661664701244,0.004675818611220366,Other Types
Hepatocellular Carcinoma,Mitotic G2-G2/M Phases R-HSA-453274,6.022929385597613,0.021757135129035696,Other Types
Hepatocellular Carcinoma,Metabolism Of Nucleotides R-HSA-15869,14.794781909157892,0.0007760843165782978,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,11.822179410753016,0.0021453130990265992,Other Types
Hepatocellular Carcinoma,ER To Golgi Anterograde Transport R-HSA-199977,4.94132691891682,0.03589583301615072,Other Types
Hepatocellular Carcinoma,G1/S Transition R-HSA-69206,6.428312612744545,0.018160334735524548,Other Types
Hepatocellular Carcinoma,"Platelet Activation, Signaling And Aggregation R-HSA-76002",6.687597621686328,0.01620741448600225,Other Types
Hepatocellular Carcinoma,Mitotic G1 Phase And G1/S Transition R-HSA-453279,5.271107275516171,0.030719821742097597,Other Types
Hepatocellular Carcinoma,Mitochondrial Translation R-HSA-5368287,5.539790893227908,0.027114892164656866,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Transport To Golgi And Subsequent Modification R-HSA-948021,5.327479197007326,0.029921303172621132,Other Types
Hepatocellular Carcinoma,COPI-mediated Anterograde Transport R-HSA-6807878,5.980086317077931,0.02218126519941622,Other Types
Hepatocellular Carcinoma,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,5.111921312812845,0.03310609028631482,Other Types
Hepatocellular Carcinoma,MET Promotes Cell Motility R-HSA-8875878,5.375130525011857,0.029264337189378473,Other Types
Hepatocellular Carcinoma,Transport Of Small Molecules R-HSA-382551,6.114822432582217,0.020877436926941922,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Platelet Aggregation (Plug Formation) R-HSA-76009,12.848354399276856,0.0014942399815105656,Other Types
Hepatocellular Carcinoma,Integrin Signaling R-HSA-354192,12.848354399276856,0.0014942399815105656,Other Types
Hepatocellular Carcinoma,EPHB-mediated Forward Signaling R-HSA-3928662,9.78791573746237,0.004563343987520551,Other Types
Hepatocellular Carcinoma,Downstream Signal Transduction R-HSA-186763,8.708061005497976,0.00697082836668495,Other Types
Hepatocellular Carcinoma,Mitochondrial Translation Termination R-HSA-5419276,16.091587766609344,0.0005119028351304622,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Signaling By PDGF R-HSA-186797,7.965880470155492,0.009425363695005013,Other Types
Hepatocellular Carcinoma,RHO GTPase Effectors R-HSA-195258,10.446086847986322,0.003553666587682993,Other Types
Hepatocellular Carcinoma,Nucleotide Biosynthesis R-HSA-8956320,12.749671679411342,0.0015463301988499784,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Mitochondrial Translation Initiation R-HSA-5368286,8.585303105111986,0.007322974208179246,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Metabolism Of Vitamins And Cofactors R-HSA-196854,10.478626037856092,0.0035105334188376427,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Mitochondrial Translation Elongation R-HSA-5389840,4.469706524605502,0.04508091246297596,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Cell-Cell Communication R-HSA-1500931,4.636018751788103,0.04157049280313334,Other Types
Hepatocellular Carcinoma,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,7.741090475650871,0.010345856961092033,Other Types
Hepatocellular Carcinoma,Cell Junction Organization R-HSA-446728,9.369454991002016,0.005366605338331729,Other Types
Hepatocellular Carcinoma,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,10.79057769308188,0.003124880768772073,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Nuclear Envelope Breakdown R-HSA-2980766,4.443252038697935,0.04566944591417147,Other Types
Hepatocellular Carcinoma,Metabolism R-HSA-1430728,12.151830564240528,0.0019075034859770228,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Heme Biosynthesis R-HSA-189451,6.24720721199376,0.019678629565468245,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Metabolism Of Porphyrins R-HSA-189445,6.247207034306115,0.019678631122423986,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Drug ADME R-HSA-9748784,8.373140571926784,0.00797855203164393,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Prolonged ERK Activation Events R-HSA-169893,7.398214209006687,0.011946351721524386,Other Types
Hepatocellular Carcinoma,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,9.957552706145897,0.004276066463923632,Other Types
Hepatocellular Carcinoma,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,22.093472011337624,8.896137176719506e-05,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Citric Acid Cycle (TCA Cycle) R-HSA-71403,6.8221097450394925,0.015286659397402305,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,6.857819046850702,0.015052039461189255,Hepatocellular Carcinoma
Hepatocellular Carcinoma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,29.5687965523025,1.3779850884058956e-05,Other Types
Hepatocellular Carcinoma,mTORC1-mediated Signaling R-HSA-166208,5.837246829414755,0.023663005491273287,Other Types
Hepatocellular Carcinoma,Semaphorin Interactions R-HSA-373755,5.189510944701678,0.031918090656647184,Other Types
Hepatocellular Carcinoma,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,8.507377128140352,0.007556624728106348,Other Types
Hepatocellular Carcinoma,Frs2-mediated Activation R-HSA-170968,5.077057918366166,0.03365590949477895,Other Types
Hepatocellular Carcinoma,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,20.429134388148977,0.00014081082878429678,Other Types
Hepatocellular Carcinoma,MET Receptor Recycling R-HSA-8875656,7.743326994486976,0.010336225241166529,Other Types
Hepatocellular Carcinoma,Interferon Signaling R-HSA-913531,4.399199912610414,0.04666875673575936,Other Types
Hepatocellular Carcinoma,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,14.54309948840161,0.0008428897319446295,Other Types
Hepatocellular Carcinoma,Kinesins R-HSA-983189,15.782392799387464,0.0005645151855594034,Other Types
Hepatocellular Carcinoma,MET Activates PTK2 Signaling R-HSA-8874081,6.471127023188993,0.017820658610682487,Other Types
Hepatocellular Carcinoma,Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,6.1814832627617795,0.020263972372271326,Other Types
Hepatocellular Carcinoma,Protein Ubiquitination R-HSA-8852135,5.244411905232809,0.031106236924808853,Other Types
Hepatocellular Carcinoma,ERBB2 Regulates Cell Motility R-HSA-6785631,6.878818062715401,0.014915928982288145,Other Types
Hepatocellular Carcinoma,Cilium Assembly R-HSA-5617833,13.330541548131173,0.00126578737556058,Other Types
Hepatocellular Carcinoma,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,5.227421011904426,0.03135500265374206,Other Types
Hepatocellular Carcinoma,Platelet Degranulation R-HSA-114608,7.252028192188184,0.012710116965959108,Other Types
Hepatocellular Carcinoma,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,7.803187215572186,0.010082064771070933,Other Types
Hepatocellular Carcinoma,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,12.345128737127036,0.001781552535871176,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Elastic Fibre Formation R-HSA-1566948,4.640633584799799,0.04147756234427229,Other Types
Hepatocellular Carcinoma,VxPx Cargo-Targeting To Cilium R-HSA-5620916,5.092923603157988,0.033404442188923765,Other Types
Hepatocellular Carcinoma,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,7.302846193568233,0.012438674294403927,Other Types
Hepatocellular Carcinoma,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,8.763142311773532,0.006818898448015152,Other Types
Hepatocellular Carcinoma,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,5.5129994487340905,0.027452316680594818,Other Types
Hepatocellular Carcinoma,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,12.193306148672898,0.0018796812117616336,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,10.631642619595148,0.0033152323875990488,Other Types
Hepatocellular Carcinoma,Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,5.348627334576981,0.029627727574469482,Other Types
Hepatocellular Carcinoma,MHC Class II Antigen Presentation R-HSA-2132295,5.607224486707013,0.026285846197004574,Other Types
Hepatocellular Carcinoma,Transferrin Endocytosis And Recycling R-HSA-917977,6.0630081702417264,0.021368502005507557,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,6.583762193490864,0.01696014096826882,Other Types
Hepatocellular Carcinoma,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,5.924420450573585,0.022746102233409705,Other Types
Hepatocellular Carcinoma,Establishment Of Sister Chromatid Cohesion R-HSA-2468052,4.8020757378750005,0.03836866810360289,Other Types
Hepatocellular Carcinoma,MTOR Signaling R-HSA-165159,5.9476621721891085,0.02250835200213335,Hepatocellular Carcinoma
Hepatocellular Carcinoma,SARS-CoV-1 Infection R-HSA-9678108,5.7203430517260285,0.024957706495712224,Other Types
Hepatocellular Carcinoma,Regulation Of IFNG Signaling R-HSA-877312,4.505298720305076,0.04430250220504511,Other Types
Hepatocellular Carcinoma,AURKA Activation By TPX2 R-HSA-8854518,7.871099006248712,0.00980201368581291,Other Types
Hepatocellular Carcinoma,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,5.7234853204759055,0.02492189347111578,Other Types
Hepatocellular Carcinoma,Centrosome Maturation R-HSA-380287,7.530670682558779,0.01129782589655559,Other Types
Hepatocellular Carcinoma,RNA Polymerase III Transcription Termination R-HSA-73980,5.116628773733853,0.03303262231549213,Other Types
Hepatocellular Carcinoma,Mitochondrial Calcium Ion Transport R-HSA-8949215,6.208366462218966,0.02002224821221613,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,7.380604878870149,0.01203561605574196,Other Types
Hepatocellular Carcinoma,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,5.119286760083256,0.032991220343008665,Other Types
Hepatocellular Carcinoma,RHO GTPases Activate PAKs R-HSA-5627123,4.970018777691962,0.035408787724619556,Other Types
Hepatocellular Carcinoma,Glycolysis R-HSA-70171,6.581119183793196,0.01697979861509215,Other Types
Hepatocellular Carcinoma,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,5.48189229143431,0.027849972971023883,Other Types
Hepatocellular Carcinoma,Signaling By TGFB Family Members R-HSA-9006936,8.655371558455697,0.007119644081853075,Other Types
Hepatocellular Carcinoma,Regulation Of TP53 Expression And Degradation R-HSA-6806003,4.591350879283163,0.042482165752531775,Other Types
Hepatocellular Carcinoma,Integrin Cell Surface Interactions R-HSA-216083,4.63125322027445,0.04166670325960192,Other Types
Hepatocellular Carcinoma,Regulation Of TP53 Degradation R-HSA-6804757,5.20953495186623,0.03161927557185546,Other Types
Hepatocellular Carcinoma,RNA Polymerase III Transcription Initiation R-HSA-76046,6.068594443070768,0.021314947450817405,Other Types
Hepatocellular Carcinoma,Oncogene Induced Senescence R-HSA-2559585,5.079384531228525,0.03361890125867899,Other Types
Hepatocellular Carcinoma,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,4.731527106000749,0.039693887899052475,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,4.635827128701963,0.04157435663220515,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Signaling By TGF-beta Receptor Complex R-HSA-170834,5.225168328043407,0.031388150807034096,Other Types
Hepatocellular Carcinoma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,14.02093806408104,0.001002368007555633,Other Types
Hepatocellular Carcinoma,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,7.111810798270727,0.013493566127990735,Hepatocellular Carcinoma
Hepatocellular Carcinoma,trans-Golgi Network Vesicle Budding R-HSA-199992,4.783679587270329,0.03870938633951799,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Transcriptional Regulation By E2F6 R-HSA-8953750,8.04453477298461,0.009124872824276717,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,9.085305008058741,0.005999936611894436,Other Types
Hepatocellular Carcinoma,Transcriptional Regulation By TP53 R-HSA-3700989,24.893533826125843,4.270671271834907e-05,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Diseases Of Glycosylation R-HSA-3781865,5.106306551528901,0.033193956993099974,Other Types
Hepatocellular Carcinoma,SARS-CoV-2 Infection R-HSA-9694516,4.283126811504482,0.049421852330176985,Other Types
Hepatocellular Carcinoma,RHOC GTPase Cycle R-HSA-9013106,6.181455468925449,0.02026422395214021,Hepatocellular Carcinoma
Hepatocellular Carcinoma,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,6.019096590268582,0.021794709535836676,Other Types
Hepatocellular Carcinoma,PKMTs Methylate Histone Lysines R-HSA-3214841,5.611512980089523,0.026234084145068306,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Protein Folding R-HSA-391251,4.529787159931079,0.04377570875949892,Other Types
Hepatocellular Carcinoma,Clathrin-mediated Endocytosis R-HSA-8856828,5.897312046392783,0.023026934967086857,Hepatocellular Carcinoma
Hepatocellular Carcinoma,mRNA 3-End Processing R-HSA-72187,4.8172465376302345,0.03809021394375903,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,9.881234747114748,0.004402782430209998,Other Types
Hepatocellular Carcinoma,Interleukin-7 Signaling R-HSA-1266695,15.154173176366148,0.0006904824166967694,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Transmission Across Chemical Synapses R-HSA-112315,5.695662010582543,0.02524099856128642,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,10.626008012344135,0.003322209522449695,Other Types
Hepatocellular Carcinoma,Glucose Metabolism R-HSA-70326,4.4059766064061066,0.04651344004349835,Other Types
Hepatocellular Carcinoma,PI-3K cascade:FGFR1 R-HSA-5654689,5.174547134900237,0.032143451228302346,Other Types
Hepatocellular Carcinoma,Neuronal System R-HSA-112316,7.946134361115351,0.0095024996950713,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,11.131284603175008,0.0027558441717605614,Other Types
Hepatocellular Carcinoma,MET Activates RAS Signaling R-HSA-8851805,5.046579035785067,0.03414494929654584,Other Types
Hepatocellular Carcinoma,tRNA Processing In Nucleus R-HSA-6784531,7.498221717474384,0.011453033807255012,Other Types
Hepatocellular Carcinoma,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,4.632863080275522,0.04163417416135229,Hepatocellular Carcinoma
Hepatocellular Carcinoma,E2F Mediated Regulation Of DNA Replication R-HSA-113510,7.556584254204073,0.011175541069778595,Other Types
Hepatocellular Carcinoma,PTK6 Regulates Cell Cycle R-HSA-8849470,24.93256250154762,4.2285606619963496e-05,Other Types
Hepatocellular Carcinoma,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,4.499041607641164,0.04443824511336994,Other Types
Hepatocellular Carcinoma,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,4.850723984888027,0.037483720862840124,Other Types
Hepatocellular Carcinoma,Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,4.508095638609479,0.04424197615196898,Other Types
Hepatocellular Carcinoma,SLC-mediated Transmembrane Transport R-HSA-425407,6.88094567127908,0.014902214359271904,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Signaling By NOTCH2 R-HSA-1980145,5.138344474543633,0.03269606069867693,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,14.621242176610425,0.0008215008849137819,Other Types
Hepatocellular Carcinoma,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,4.669365585346695,0.04090419369735724,Other Types
Hepatocellular Carcinoma,RND2 GTPase Cycle R-HSA-9696270,5.404727847824849,0.02886438147751931,Hepatocellular Carcinoma
Hepatocellular Carcinoma,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,9.737414386791205,0.004652900408970071,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Attenuation Phase R-HSA-3371568,7.715661688327553,0.01045606522596922,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Glycosaminoglycan Metabolism R-HSA-1630316,11.643206491888888,0.002287838299591683,Other Types
Hepatocellular Carcinoma,Intrinsic Pathway For Apoptosis R-HSA-109606,21.94090822641486,9.271660319952734e-05,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,12.291156830441803,0.0018157809058152038,Hepatocellular Carcinoma
Hepatocellular Carcinoma,PPARA Activates Gene Expression R-HSA-1989781,10.114575739893972,0.004027723076533663,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Gene Expression (Transcription) R-HSA-74160,4.604452830521299,0.04221244893457472,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Intra-Golgi Traffic R-HSA-6811438,5.404330823264704,0.02886970609635876,Other Types
Hepatocellular Carcinoma,Metabolism Of Lipids R-HSA-556833,8.608795208399147,0.007254101251159187,Hepatocellular Carcinoma
Hepatocellular Carcinoma,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,8.953903843301454,0.006320157374349034,Hepatocellular Carcinoma
Hepatocellular Carcinoma,SUMOylation Of Intracellular Receptors R-HSA-4090294,12.968844419410281,0.0014332181045156104,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Nephrin Family Interactions R-HSA-373753,4.933493956275195,0.03603009683170277,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Cyclin D Associated Events In G1 R-HSA-69231,5.6111210620559495,0.026238809879248187,Other Types
Hepatocellular Carcinoma,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,6.57799339005668,0.017003079544217238,Hepatocellular Carcinoma
Hepatocellular Carcinoma,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",7.279080064323986,0.012564816327507737,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Recycling Pathway Of L1 R-HSA-437239,9.963151767872626,0.0042669284107360725,Hepatocellular Carcinoma
Hepatocellular Carcinoma,tRNA Processing R-HSA-72306,6.0820214776513675,0.021186832795854375,Other Types
Hepatocellular Carcinoma,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,5.980539943648759,0.022176726698161137,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Potential Therapeutics For SARS R-HSA-9679191,10.551316543106864,0.0034162304935835682,Hepatocellular Carcinoma
Hepatocellular Carcinoma,MicroRNA (miRNA) Biogenesis R-HSA-203927,6.1946489181972355,0.020145189805322792,Hepatocellular Carcinoma
Hepatocellular Carcinoma,SHC-mediated cascade:FGFR1 R-HSA-5654688,4.52740909925543,0.04382655556531094,Other Types
Hepatocellular Carcinoma,SUMOylation Of Immune Response Proteins R-HSA-4755510,5.954078022561797,0.022443208043089892,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Iron Uptake And Transport R-HSA-917937,13.481569333788455,0.0012022949064803196,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Basigin Interactions R-HSA-210991,10.445119485204309,0.00355495774209742,Hepatocellular Carcinoma
Hepatocellular Carcinoma,SUMOylation Of Transcription Cofactors R-HSA-3899300,11.632332431178313,0.0022968250732928173,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,10.966838943123022,0.002927642435064733,Other Types
Hepatocellular Carcinoma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,24.184849446886375,5.120147991598164e-05,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Late SARS-CoV-2 Infection Events R-HSA-9772573,8.496023085864723,0.007591346359863375,Other Types
Hepatocellular Carcinoma,Epigenetic Regulation Of Gene Expression R-HSA-212165,11.416581648168277,0.0024833428070889134,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Estrogen-dependent Gene Expression R-HSA-9018519,4.636132457258825,0.04156820027146441,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Inositol Phosphate Metabolism R-HSA-1483249,14.003684554674528,0.0010081702765399028,Hepatocellular Carcinoma
Hepatocellular Carcinoma,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,5.608768911966381,0.026267191928197434,Other Types
Hepatocellular Carcinoma,RHOBTB1 GTPase Cycle R-HSA-9013422,4.523589536828477,0.04390836299612106,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Processing Of Intronless Pre-mRNAs R-HSA-77595,5.968649368214194,0.02229603230907338,Hepatocellular Carcinoma
Hepatocellular Carcinoma,HIV Elongation Arrest And Recovery R-HSA-167287,15.830706318120074,0.0005559200663163448,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,24.04117044033338,5.313810585953441e-05,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,5.232765914358995,0.031276508798562135,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,5.795743926459026,0.02411390232639042,Hepatocellular Carcinoma
Hepatocellular Carcinoma,SHC1 Events In ERBB2 Signaling R-HSA-1250196,5.365784279344862,0.029391915294219206,Other Types
Hepatocellular Carcinoma,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,6.750320325464169,0.015770658546212228,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Aggrephagy R-HSA-9646399,7.546212193754232,0.011224310443291858,Other Types
Hepatocellular Carcinoma,FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,4.451223766383114,0.04549119393782609,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Signaling By NOTCH1 R-HSA-1980143,5.973392219042013,0.022248359132337154,Hepatocellular Carcinoma
Hepatocellular Carcinoma,DNA Damage Recognition In GG-NER R-HSA-5696394,4.379867947336955,0.047115048493815606,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,9.435195193100945,0.005230758896140961,Hepatocellular Carcinoma
Hepatocellular Carcinoma,"WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",8.394971443867513,0.007908207014159207,Hepatocellular Carcinoma
Hepatocellular Carcinoma,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,8.394971445069185,0.007908207010305882,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Retrograde Neurotrophin Signaling R-HSA-177504,5.979505485529317,0.02218707788206363,Hepatocellular Carcinoma
Hepatocellular Carcinoma,TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,5.22800320217901,0.0313464421001919,Other Types
Hepatocellular Carcinoma,Plasma Lipoprotein Clearance R-HSA-8964043,7.187097636666857,0.013066490107027219,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,6.172093079951383,0.020349166260783057,Hepatocellular Carcinoma
Hepatocellular Carcinoma,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",10.252516781528591,0.003822548941470462,Hepatocellular Carcinoma
Hepatocellular Carcinoma,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",8.654255551897407,0.00712283360515994,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Nef Mediated CD4 Down-regulation R-HSA-167590,6.107583683117142,0.020945283371923716,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Nef Mediated CD8 Down-regulation R-HSA-182218,6.107583683117142,0.020945283371923716,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Regulation Of Beta-Cell Development R-HSA-186712,11.575976622957093,0.0023440217225721566,Hepatocellular Carcinoma
Hepatocellular Carcinoma,RND3 GTPase Cycle R-HSA-9696264,4.411692026851286,0.04638289907852476,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Regulation Of BACH1 Activity R-HSA-9708530,6.02286935717008,0.021757723057210916,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Regulation Of Gene Expression In Beta Cells R-HSA-210745,11.476117845951356,0.0024302736046279854,Hepatocellular Carcinoma
Hepatocellular Carcinoma,STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,4.507865465120579,0.04424695365580783,Other Types
Hepatocellular Carcinoma,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",5.4349017643350965,0.028462892898376668,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Activation Of HOX Genes During Differentiation R-HSA-5619507,7.684658292898861,0.010592185631094493,Hepatocellular Carcinoma
Hepatocellular Carcinoma,LDL Clearance R-HSA-8964038,7.865435184014663,0.009825039637375717,Hepatocellular Carcinoma
Hepatocellular Carcinoma,VLDLR Internalisation And Degradation R-HSA-8866427,8.126547831091704,0.008822727046738862,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Metabolism Of Steroids R-HSA-8957322,10.420145438972389,0.0035884692670495894,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,10.307853364284034,0.003743479129899646,Hepatocellular Carcinoma
Hepatocellular Carcinoma,RND1 GTPase Cycle R-HSA-9696273,5.500275312770598,0.027614205712706324,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,7.770919411929727,0.010218205093955922,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,4.504780455288241,0.044313727815748084,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,6.06376862484594,0.021361202902388157,Hepatocellular Carcinoma
Hepatocellular Carcinoma,RNA Polymerase I Promoter Clearance R-HSA-73854,4.801209383879256,0.038384638392113535,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,6.5390116473181195,0.01729640057857174,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,6.882498392769121,0.014892214264063086,Hepatocellular Carcinoma
Hepatocellular Carcinoma,RNA Polymerase I Transcription R-HSA-73864,4.801209383879256,0.038384638392113535,Hepatocellular Carcinoma
Hepatocellular Carcinoma,Signaling By NOTCH3 R-HSA-9012852,6.354458169602538,0.01876324418625054,Hepatocellular Carcinoma
Liposarcoma,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",7.181510171797051,0.016436524664781845,Liposarcoma
Liposarcoma,Respiratory Electron Transport R-HSA-611105,5.73969208341549,0.029163975837689884,Liposarcoma
Liposarcoma,tRNA Aminoacylation R-HSA-379724,6.333985924430282,0.022889484847018422,Liposarcoma
Liposarcoma,Mitochondrial tRNA Aminoacylation R-HSA-379726,4.997601839689102,0.03998649649367441,Liposarcoma
Liposarcoma,Cytoprotection By HMOX1 R-HSA-9707564,11.449291083463589,0.0037883917371667524,Liposarcoma
Liposarcoma,"Platelet Activation, Signaling And Aggregation R-HSA-76002",8.4617976769446,0.010249507640167509,Other Types
Liposarcoma,Death Receptor Signaling R-HSA-73887,7.397064496967343,0.015146155076520885,Other Types
Liposarcoma,Platelet Aggregation (Plug Formation) R-HSA-76009,7.1788491404657115,0.016453221649324123,Other Types
Liposarcoma,Integrin Signaling R-HSA-354192,7.1788491404657115,0.016453221649324123,Other Types
Liposarcoma,EPHB-mediated Forward Signaling R-HSA-3928662,12.501278478480979,0.0027482055294713024,Other Types
Liposarcoma,Downstream Signal Transduction R-HSA-186763,5.704132535874141,0.029598192634972403,Other Types
Liposarcoma,Mitochondrial Translation Termination R-HSA-5419276,6.494687419392359,0.021469663534352337,Liposarcoma
Liposarcoma,Signaling By PDGF R-HSA-186797,4.587578489559271,0.047936658946543094,Other Types
Liposarcoma,Mitochondrial Translation Initiation R-HSA-5368286,6.612067922190431,0.02049630785198161,Liposarcoma
Liposarcoma,Metabolism Of Vitamins And Cofactors R-HSA-196854,9.671320800970873,0.0067390110583533235,Liposarcoma
Liposarcoma,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,5.4385827876481825,0.03308716706324086,Other Types
Liposarcoma,Signaling To ERKs R-HSA-187687,4.544416282694101,0.048875780653932055,Other Types
Liposarcoma,"PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",4.948449246823878,0.04085401397958413,Other Types
Liposarcoma,Smooth Muscle Contraction R-HSA-445355,4.863586800800117,0.04240365874701442,Other Types
Liposarcoma,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,5.702937152862142,0.029612918285224853,Liposarcoma
Liposarcoma,Metabolism R-HSA-1430728,15.760048745745037,0.0010994839863348463,Liposarcoma
Liposarcoma,MET Activates RAP1 And RAC1 R-HSA-8875555,6.77033809648568,0.01926288903789286,Other Types
Liposarcoma,Prolonged ERK Activation Events R-HSA-169893,5.684657628166549,0.02983915418680786,Other Types
Liposarcoma,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,5.495107493827253,0.03230643095912902,Other Types
Liposarcoma,Citric Acid Cycle (TCA Cycle) R-HSA-71403,7.3563532166575465,0.015380728928235374,Liposarcoma
Liposarcoma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,7.848925091508195,0.012799227418232634,Other Types
Liposarcoma,G Alpha (12/13) Signaling Events R-HSA-416482,4.607083653832162,0.04751916105453986,Other Types
Liposarcoma,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,5.188241501007772,0.036817612403993345,Other Types
Liposarcoma,MET Receptor Recycling R-HSA-8875656,10.534344983485985,0.005067014970317246,Other Types
Liposarcoma,Signaling By ERBB2 R-HSA-1227986,5.274685135305658,0.035477075481111016,Other Types
Liposarcoma,Kinesins R-HSA-983189,4.998284952929987,0.039974591119810096,Other Types
Liposarcoma,MET Activates PTK2 Signaling R-HSA-8874081,5.297893218842396,0.03512683577593736,Other Types
Liposarcoma,Cilium Assembly R-HSA-5617833,8.270732031116255,0.010976422540154913,Other Types
Liposarcoma,Platelet Degranulation R-HSA-114608,6.615035482082719,0.02047236389068083,Other Types
Liposarcoma,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,5.201779674462448,0.0366038504834464,Other Types
Liposarcoma,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,7.166903328951648,0.01652841656975159,Liposarcoma
Liposarcoma,TNF Signaling R-HSA-75893,4.804706923192258,0.04351893072745772,Other Types
Liposarcoma,Apoptotic Factor-Mediated Response R-HSA-111471,8.233102596281446,0.011126412415600605,Liposarcoma
Liposarcoma,VxPx Cargo-Targeting To Cilium R-HSA-5620916,7.023380541691883,0.0174632725209193,Other Types
Liposarcoma,Interferon Alpha/Beta Signaling R-HSA-909733,6.926195069101155,0.018130669654508307,Other Types
Liposarcoma,Signal Amplification R-HSA-392518,5.136535689000882,0.03764741828448369,Other Types
Liposarcoma,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,5.935484768873647,0.02690054397611258,Other Types
Liposarcoma,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,7.228070555997003,0.016147488110809967,Other Types
Liposarcoma,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,5.454151285928523,0.03286997887962335,Other Types
Liposarcoma,Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,7.377238379719496,0.015259876384141897,Other Types
Liposarcoma,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,6.022589952538829,0.025959005935440677,Liposarcoma
Liposarcoma,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,8.184239464302209,0.01132467855759106,Other Types
Liposarcoma,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,8.827464454779118,0.009005956900086267,Other Types
Liposarcoma,RHO GTPases Activate CIT R-HSA-5625900,5.13308339130079,0.037703588839975606,Other Types
Liposarcoma,SARS-CoV-1 Infection R-HSA-9678108,5.472735070365773,0.03261287639513322,Other Types
Liposarcoma,CD209 (DC-SIGN) Signaling R-HSA-5621575,5.554653578623368,0.03150685228552879,Other Types
Liposarcoma,AURKA Activation By TPX2 R-HSA-8854518,10.700981253639162,0.004801533082494186,Other Types
Liposarcoma,Centrosome Maturation R-HSA-380287,7.396707452828332,0.0151481944765161,Other Types
Liposarcoma,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,5.941074232539679,0.026838960156205408,Other Types
Liposarcoma,Mitochondrial Calcium Ion Transport R-HSA-8949215,4.624176941905717,0.04715676039114166,Liposarcoma
Liposarcoma,Regulation Of TP53 Expression And Degradation R-HSA-6806003,5.174730958744609,0.037032378320878925,Other Types
Liposarcoma,NF-kB Is Activated And Signals Survival R-HSA-209560,9.887580051702253,0.006267732298544713,Other Types
Liposarcoma,Regulation Of TP53 Degradation R-HSA-6804757,6.147761993561996,0.02467154963682543,Other Types
Liposarcoma,Cellular Response To Chemical Stress R-HSA-9711123,7.082750200426847,0.017069410364221976,Liposarcoma
Liposarcoma,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,5.499753396013661,0.03224321116677635,Liposarcoma
Liposarcoma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,7.150235938942827,0.016633989919273676,Other Types
Liposarcoma,MyD88-independent TLR4 Cascade R-HSA-166166,5.013590020376239,0.03970892592373586,Other Types
Liposarcoma,RHO GTPases Activate PKNs R-HSA-5625740,4.53387944283238,0.04910828000114519,Other Types
Liposarcoma,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,9.352162536313418,0.007509989336557324,Other Types
Liposarcoma,Transcriptional Regulation By TP53 R-HSA-3700989,25.681408197889333,0.000114198698537998,Liposarcoma
Liposarcoma,HATs Acetylate Histones R-HSA-3214847,4.647201354836582,0.04667367758806045,Liposarcoma
Liposarcoma,Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,4.521859541668596,0.04937507659687073,Other Types
Liposarcoma,Transmission Across Chemical Synapses R-HSA-112315,5.402669859807684,0.033594516929587565,Liposarcoma
Liposarcoma,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,8.536731391592042,0.009979514316135227,Other Types
Liposarcoma,Neuronal System R-HSA-112316,5.73205146883406,0.02925665290401296,Liposarcoma
Liposarcoma,MET Activates RAS Signaling R-HSA-8851805,5.178613963962846,0.03697050540867153,Other Types
Liposarcoma,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,9.28987224989857,0.007671893986703911,Other Types
Liposarcoma,Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,4.526713103574304,0.04926714326494993,Other Types
Liposarcoma,RUNX2 Regulates Bone Development R-HSA-8941326,8.69783663703334,0.009426013928727946,Other Types
Liposarcoma,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,5.146163431426957,0.03749128092420286,Other Types
Liposarcoma,Intrinsic Pathway For Apoptosis R-HSA-109606,14.02098132168061,0.0017683207520317046,Liposarcoma
Liposarcoma,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,4.7452124111125205,0.0446805625146621,Other Types
Liposarcoma,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,5.235070044238713,0.03608428372686353,Other Types
Liposarcoma,Meiotic Recombination R-HSA-912446,4.995522251629475,0.040022765073349585,Liposarcoma
Liposarcoma,Generic Transcription Pathway R-HSA-212436,6.0980847828078195,0.02517351752798545,Liposarcoma
Liposarcoma,Cyclin D Associated Events In G1 R-HSA-69231,5.119056142842798,0.037932818436877874,Other Types
Liposarcoma,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,5.165049031844241,0.03718717512372164,Liposarcoma
Liposarcoma,Translation Initiation Complex Formation R-HSA-72649,5.579742860415804,0.03117680610802881,Other Types
Liposarcoma,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,6.339731077056378,0.0228369042657167,Other Types
Liposarcoma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,7.277063222003703,0.015849608833614245,Liposarcoma
Liposarcoma,"Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",7.419898216657314,0.015016380392462841,Other Types
Liposarcoma,Regulated Proteolysis Of p75NTR R-HSA-193692,5.667540503571933,0.030052810688332116,Other Types
Liposarcoma,Aggrephagy R-HSA-9646399,4.871871295514219,0.042249413227422046,Other Types
Liposarcoma,"WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",6.660907434233665,0.020106290653046675,Liposarcoma
Liposarcoma,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,6.660907287670402,0.020106291810623664,Liposarcoma
Liposarcoma,TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,7.315409095991548,0.015620841312204705,Other Types
Liposarcoma,Plasma Lipoprotein Clearance R-HSA-8964043,5.970698639357963,0.026515257951362604,Liposarcoma
Liposarcoma,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",6.3376066933527655,0.022856330804980587,Liposarcoma
Liposarcoma,Nef Mediated CD4 Down-regulation R-HSA-167590,5.937129475363407,0.0268824060010595,Liposarcoma
Liposarcoma,Nef Mediated CD8 Down-regulation R-HSA-182218,5.937129475363407,0.0268824060010595,Liposarcoma
Liposarcoma,Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,4.617820462281646,0.047291149793762144,Other Types
Liposarcoma,STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,10.39893655102585,0.00529504981947523,Other Types
Liposarcoma,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",5.6758539995000765,0.029948822000029258,Liposarcoma
Liposarcoma,LDL Clearance R-HSA-8964038,7.127271871421753,0.016780712995697913,Liposarcoma
Liposarcoma,VLDLR Internalisation And Degradation R-HSA-8866427,6.1444760528180185,0.02470439529015249,Liposarcoma
Colorectal Adenocarcinoma,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,5.576791512167893,0.03121542310469629,Other Types
Colorectal Adenocarcinoma,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,5.050317859186207,0.039079701078894906,Colorectal Adenocarcinoma
Colorectal Adenocarcinoma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,5.124040926919794,0.03785117422954377,Colorectal Adenocarcinoma
Colorectal Adenocarcinoma,Ion Channel Transport R-HSA-983712,4.570948953534589,0.048295976783007115,Other Types
Colorectal Adenocarcinoma,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,11.09878382895118,0.004229201754523343,Colorectal Adenocarcinoma
Colorectal Adenocarcinoma,FGFR2 Mutant Receptor Activation R-HSA-1839126,5.268976744922337,0.0355638395959655,Other Types
Colorectal Adenocarcinoma,FGFR2 Alternative Splicing R-HSA-6803529,5.050037157612016,0.03908446611297116,Other Types
Colorectal Adenocarcinoma,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,4.674719392300915,0.0461038372342598,Other Types
Colorectal Adenocarcinoma,Signaling By FGFR2 IIIa TM R-HSA-8851708,4.8987704755424835,0.04175305515337564,Other Types
Colorectal Adenocarcinoma,rRNA Processing R-HSA-72312,7.359714919415181,0.015361202694798856,Colorectal Adenocarcinoma
Colorectal Adenocarcinoma,ROS And RNS Production In Phagocytes R-HSA-1222556,4.886894435571568,0.041971360048335356,Other Types
Colorectal Adenocarcinoma,Insulin Receptor Recycling R-HSA-77387,4.886894435571568,0.041971360048335356,Other Types
Colorectal Adenocarcinoma,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,6.267919678076826,0.023504229868187863,Colorectal Adenocarcinoma
Colorectal Adenocarcinoma,Transferrin Endocytosis And Recycling R-HSA-917977,5.7790201737395,0.028692260150592088,Other Types
Colorectal Adenocarcinoma,Mitotic Telophase/Cytokinesis R-HSA-68884,5.390209107335818,0.03377264690992156,Other Types
Colorectal Adenocarcinoma,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,8.344649746197417,0.01068844800246089,Other Types
Colorectal Adenocarcinoma,Cohesin Loading Onto Chromatin R-HSA-2470946,5.380741247340656,0.033908721813981905,Other Types
Colorectal Adenocarcinoma,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,111.89559544313627,1.2498087263432694e-08,Other Types
Colorectal Adenocarcinoma,RHOC GTPase Cycle R-HSA-9013106,5.080878169409862,0.03856492478252853,Other Types
Colorectal Adenocarcinoma,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,6.763663505041829,0.019313155199974282,Other Types
Colorectal Adenocarcinoma,mRNA 3-End Processing R-HSA-72187,5.351888189394436,0.03432732703161444,Other Types
Colorectal Adenocarcinoma,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,4.6364016870446925,0.04689954920291937,Colorectal Adenocarcinoma
Colorectal Adenocarcinoma,RHOB GTPase Cycle R-HSA-9013026,4.813212693029678,0.04335573500972329,Other Types
Colorectal Adenocarcinoma,Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,6.370940361029635,0.022553682202244196,Other Types
Colorectal Adenocarcinoma,RNA Polymerase II Transcription Termination R-HSA-73856,4.802773438569295,0.04355612682452875,Other Types
Colorectal Adenocarcinoma,RAB Geranylgeranylation R-HSA-8873719,7.306285024778095,0.01567493045936156,Other Types
Colorectal Adenocarcinoma,tRNA Processing In Nucleus R-HSA-6784531,6.466382962114391,0.021712237835138364,Colorectal Adenocarcinoma
Colorectal Adenocarcinoma,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,4.547789665715406,0.048801616484564485,Other Types
Colorectal Adenocarcinoma,Signaling By NOTCH2 R-HSA-1980145,8.46100811872073,0.010252396456118076,Other Types
Colorectal Adenocarcinoma,Signaling By Hippo R-HSA-2028269,5.158724058951258,0.03728870430137848,Other Types
Colorectal Adenocarcinoma,Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,5.08078141491553,0.03856654214299766,Colorectal Adenocarcinoma
Colorectal Adenocarcinoma,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,9.540750978856519,0.007043001804123334,Other Types
Colorectal Adenocarcinoma,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,4.505386742630548,0.04974345539116364,Other Types
Colorectal Adenocarcinoma,Intrinsic Pathway For Apoptosis R-HSA-109606,7.62429055990142,0.013909617823434745,Other Types
Colorectal Adenocarcinoma,Dual Incision In TC-NER R-HSA-6782135,4.538278115610925,0.04901106551087385,Other Types
Colorectal Adenocarcinoma,Gene Expression (Transcription) R-HSA-74160,5.374778924991051,0.03399473889340206,Other Types
Colorectal Adenocarcinoma,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,14.449925776343841,0.0015684055249493125,Other Types
Colorectal Adenocarcinoma,SUMOylation Of Intracellular Receptors R-HSA-4090294,8.245240501216191,0.011077777309468538,Other Types
Colorectal Adenocarcinoma,Nephrin Family Interactions R-HSA-373753,12.668798118158993,0.0026144930645978833,Other Types
Colorectal Adenocarcinoma,Generic Transcription Pathway R-HSA-212436,4.922654014522966,0.04131800135554552,Other Types
Colorectal Adenocarcinoma,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,4.7279320347374645,0.04502468021302475,Other Types
Colorectal Adenocarcinoma,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,5.3508670047318505,0.034342251531808504,Other Types
Colorectal Adenocarcinoma,tRNA Processing R-HSA-72306,6.084252451724554,0.02531536954677799,Colorectal Adenocarcinoma
Colorectal Adenocarcinoma,Nucleotide Excision Repair R-HSA-5696398,5.78173029198082,0.02866007888024393,Other Types
Colorectal Adenocarcinoma,MicroRNA (miRNA) Biogenesis R-HSA-203927,6.188117130704942,0.02427223135067844,Other Types
Colorectal Adenocarcinoma,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,8.351706631880601,0.010661408365611686,Colorectal Adenocarcinoma
Colorectal Adenocarcinoma,Iron Uptake And Transport R-HSA-917937,8.565956895350542,0.0098764148766923,Other Types
Colorectal Adenocarcinoma,SUMOylation Of Transcription Cofactors R-HSA-3899300,30.18992211895716,4.897573120529432e-05,Other Types
Colorectal Adenocarcinoma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,6.492638043067435,0.02148712231107671,Other Types
Colorectal Adenocarcinoma,Late SARS-CoV-2 Infection Events R-HSA-9772573,6.013817687857897,0.026052091224292563,Colorectal Adenocarcinoma
Colorectal Adenocarcinoma,Activation Of BH3-only Proteins R-HSA-114452,5.207505517830001,0.036513873898031964,Other Types
Colorectal Adenocarcinoma,Estrogen-dependent Gene Expression R-HSA-9018519,4.751433443707787,0.04455742637236204,Other Types
Colorectal Adenocarcinoma,Inositol Phosphate Metabolism R-HSA-1483249,5.069687606022514,0.038752509277636384,Other Types
Colorectal Adenocarcinoma,SUMOylation Of Transcription Factors R-HSA-3232118,11.091874236858086,0.00423845785919914,Other Types
Colorectal Adenocarcinoma,RHOBTB1 GTPase Cycle R-HSA-9013422,7.09402161664599,0.01699578822909811,Other Types
Colorectal Adenocarcinoma,HIV Elongation Arrest And Recovery R-HSA-167287,5.0995279771101405,0.03825463275394096,Other Types
Colorectal Adenocarcinoma,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,6.051139491439635,0.02565869427773776,Other Types
Colorectal Adenocarcinoma,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,6.27664921479728,0.023421924791360335,Colorectal Adenocarcinoma
Colorectal Adenocarcinoma,Telomere Maintenance R-HSA-157579,5.538085497316204,0.031727011939738196,Other Types
Colorectal Adenocarcinoma,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,5.523141704658377,0.03192711064168375,Other Types
Colorectal Adenocarcinoma,DNA Damage Bypass R-HSA-73893,4.891257880624455,0.0418909979634766,Other Types
Colorectal Adenocarcinoma,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,4.530652514360343,0.04917974060406855,Other Types
Colorectal Adenocarcinoma,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,6.1480670375194055,0.024668503019880075,Other Types
Colorectal Adenocarcinoma,Pre-NOTCH Expression And Processing R-HSA-1912422,6.701226698021329,0.019790713683914277,Other Types
Colorectal Adenocarcinoma,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",4.5765164307448565,0.04817533148202634,Colorectal Adenocarcinoma
Colorectal Adenocarcinoma,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,8.231811018387852,0.011131601921868826,Other Types
Colorectal Adenocarcinoma,"WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",5.461348600742815,0.032770129154561345,Other Types
Colorectal Adenocarcinoma,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,5.461348658767625,0.03277012835098404,Other Types
Colorectal Adenocarcinoma,TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,8.349941362598605,0.010668164972464946,Other Types
Colorectal Adenocarcinoma,Translesion Synthesis By POLH R-HSA-110320,7.431241252723068,0.014952385252033821,Other Types
Colorectal Adenocarcinoma,Plasma Lipoprotein Clearance R-HSA-8964043,5.358666549143041,0.03422845169289299,Other Types
Colorectal Adenocarcinoma,Pre-NOTCH Transcription And Translation R-HSA-1912408,17.198997789194305,0.0007578157384929701,Other Types
Colorectal Adenocarcinoma,Regulation Of Beta-Cell Development R-HSA-186712,6.996531564049917,0.017644797852148383,Other Types
Colorectal Adenocarcinoma,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,4.751523207608165,0.044555652513940655,Colorectal Adenocarcinoma
Colorectal Adenocarcinoma,Activation Of HOX Genes During Differentiation R-HSA-5619507,4.505316689364052,0.04974502879828172,Other Types
Colorectal Adenocarcinoma,VLDLR Internalisation And Degradation R-HSA-8866427,6.999263650498557,0.017626227934264906,Other Types
Colorectal Adenocarcinoma,TBC/RABGAPs R-HSA-8854214,6.747792618302566,0.01943328295635874,Other Types
Colorectal Adenocarcinoma,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,6.466392755874882,0.021712153358927788,Colorectal Adenocarcinoma
Hodgkin Lymphoma,Golgi-to-ER Retrograde Transport R-HSA-8856688,8.45479448394625,0.013136761822222048,Hodgkin Lymphoma
Hodgkin Lymphoma,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,4.9348329758893,0.04631771875491585,Hodgkin Lymphoma
Hodgkin Lymphoma,Asparagine N-linked Glycosylation R-HSA-446203,5.996749418092228,0.030658964750157544,Hodgkin Lymphoma
Hodgkin Lymphoma,TP53 Regulates Metabolic Genes R-HSA-5628897,8.736914179325018,0.01201344081844493,Other Types
Hodgkin Lymphoma,Signaling By MET R-HSA-6806834,9.398742618232875,0.009794076570194021,Hodgkin Lymphoma
Hodgkin Lymphoma,Signaling By VEGF R-HSA-194138,4.796502878197662,0.04899979363595221,Hodgkin Lymphoma
Hodgkin Lymphoma,Mitotic G2-G2/M Phases R-HSA-453274,6.319646994444911,0.027212754513117207,Hodgkin Lymphoma
Hodgkin Lymphoma,G2/M Transition R-HSA-69275,6.130081427536226,0.0291764429929759,Hodgkin Lymphoma
Hodgkin Lymphoma,Metabolism Of Nucleotides R-HSA-15869,11.991676467538639,0.004691991026611256,Other Types
Hodgkin Lymphoma,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,10.869112625771514,0.006378051117751482,Hodgkin Lymphoma
Hodgkin Lymphoma,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,6.795004985276356,0.022939815216776505,Hodgkin Lymphoma
Hodgkin Lymphoma,mRNA Splicing - Major Pathway R-HSA-72163,11.02998410271958,0.0060972762995387805,Other Types
Hodgkin Lymphoma,Signaling By WNT R-HSA-195721,5.626469360424519,0.035271656985604825,Other Types
Hodgkin Lymphoma,TCF Dependent Signaling In Response To WNT R-HSA-201681,5.445527779799064,0.037824893084849355,Other Types
Hodgkin Lymphoma,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,7.553126333421435,0.017657956091784114,Other Types
Hodgkin Lymphoma,mRNA Splicing R-HSA-72172,11.132156270723096,0.005926490354913233,Other Types
Hodgkin Lymphoma,Downstream Signal Transduction R-HSA-186763,9.042237472042297,0.01092302751307462,Hodgkin Lymphoma
Hodgkin Lymphoma,mRNA Splicing - Minor Pathway R-HSA-72165,8.33739913074027,0.013640434464721806,Other Types
Hodgkin Lymphoma,Nucleotide Biosynthesis R-HSA-8956320,78.43663410501063,1.3079945226994348e-06,Other Types
Hodgkin Lymphoma,Metabolism Of Vitamins And Cofactors R-HSA-196854,8.94442128591908,0.011259151390765401,Other Types
Hodgkin Lymphoma,Cell-Cell Communication R-HSA-1500931,5.345338479700893,0.039333500904370024,Hodgkin Lymphoma
Hodgkin Lymphoma,Signaling To ERKs R-HSA-187687,5.067080975934971,0.04391654560829769,Hodgkin Lymphoma
Hodgkin Lymphoma,"PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",7.959033294435108,0.015426249251452384,Hodgkin Lymphoma
Hodgkin Lymphoma,Cell Junction Organization R-HSA-446728,8.600032032733466,0.012543685192946184,Hodgkin Lymphoma
Hodgkin Lymphoma,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,11.086056423007127,0.006002843145378987,Hodgkin Lymphoma
Hodgkin Lymphoma,Nuclear Envelope Breakdown R-HSA-2980766,7.19950169803139,0.01991915588395851,Hodgkin Lymphoma
Hodgkin Lymphoma,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,83.51851935361016,9.389942786599645e-07,Other Types
Hodgkin Lymphoma,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,8.24284857652531,0.014062724617943783,Other Types
Hodgkin Lymphoma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,10.997447498995191,0.006152872429481613,Hodgkin Lymphoma
Hodgkin Lymphoma,Regulation Of Signaling By CBL R-HSA-912631,6.9854606857889525,0.021454501885661892,Hodgkin Lymphoma
Hodgkin Lymphoma,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,10.756613627609346,0.006583445869687169,Hodgkin Lymphoma
Hodgkin Lymphoma,Kinesins R-HSA-983189,7.839295967192918,0.016047989555115372,Hodgkin Lymphoma
Hodgkin Lymphoma,COPII-mediated Vesicle Transport R-HSA-204005,5.8342846844797105,0.032588420494599674,Hodgkin Lymphoma
Hodgkin Lymphoma,ERBB2 Regulates Cell Motility R-HSA-6785631,6.463668940860178,0.025825300258879476,Hodgkin Lymphoma
Hodgkin Lymphoma,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",8.259765885226518,0.013986045587312562,Hodgkin Lymphoma
Hodgkin Lymphoma,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,4.859747270271239,0.04775105415577314,Other Types
Hodgkin Lymphoma,FGFR2 Mutant Receptor Activation R-HSA-1839126,7.332024998829554,0.01903372850967197,Other Types
Hodgkin Lymphoma,FGFR2 Alternative Splicing R-HSA-6803529,4.988409637139202,0.04532645066149336,Other Types
Hodgkin Lymphoma,Late Phase Of HIV Life Cycle R-HSA-162599,12.401802778420832,0.004210860633407394,Other Types
Hodgkin Lymphoma,Cilium Assembly R-HSA-5617833,9.681609882681958,0.00899526387243237,Hodgkin Lymphoma
Hodgkin Lymphoma,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,4.892022420160889,0.04712851738033414,Hodgkin Lymphoma
Hodgkin Lymphoma,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,4.892022420160889,0.04712851738033414,Hodgkin Lymphoma
Hodgkin Lymphoma,Signaling By FGFR2 IIIa TM R-HSA-8851708,6.525692529850653,0.025253770019056716,Other Types
Hodgkin Lymphoma,rRNA Processing R-HSA-72312,4.958745005362546,0.045872123941236374,Hodgkin Lymphoma
Hodgkin Lymphoma,ROS And RNS Production In Phagocytes R-HSA-1222556,5.929911665448112,0.03143580616643477,Other Types
Hodgkin Lymphoma,Insulin Receptor Recycling R-HSA-77387,5.929911665448112,0.03143580616643477,Other Types
Hodgkin Lymphoma,Signaling By Erythropoietin R-HSA-9006335,4.836284865120397,0.04820980521903736,Hodgkin Lymphoma
Hodgkin Lymphoma,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,12.800162064368376,0.0037980625744446785,Hodgkin Lymphoma
Hodgkin Lymphoma,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,8.828609295194411,0.011673005749464723,Hodgkin Lymphoma
Hodgkin Lymphoma,HIV Life Cycle R-HSA-162587,7.142176732386147,0.020317220721168656,Other Types
Hodgkin Lymphoma,RHOH GTPase Cycle R-HSA-9013407,16.321130804622218,0.0016396618459956498,Other Types
Hodgkin Lymphoma,Transferrin Endocytosis And Recycling R-HSA-917977,7.889038770212474,0.015786168125106092,Other Types
Hodgkin Lymphoma,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,6.443306339127643,0.02601627609303312,Hodgkin Lymphoma
Hodgkin Lymphoma,Post NMDA Receptor Activation Events R-HSA-438064,7.193956380857546,0.019957256556920763,Hodgkin Lymphoma
Hodgkin Lymphoma,Gap Junction Trafficking And Regulation R-HSA-157858,5.505108988010981,0.03696050561614195,Other Types
Hodgkin Lymphoma,MTOR Signaling R-HSA-165159,9.697255335639278,0.00895336743387977,Other Types
Hodgkin Lymphoma,SARS-CoV-1 Infection R-HSA-9678108,4.949699988135183,0.04604006875490418,Hodgkin Lymphoma
Hodgkin Lymphoma,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,13.385564268505332,0.0032744123257043276,Hodgkin Lymphoma
Hodgkin Lymphoma,Rab Regulation Of Trafficking R-HSA-9007101,5.803145861324928,0.03297456250271956,Other Types
Hodgkin Lymphoma,AURKA Activation By TPX2 R-HSA-8854518,11.101248471122245,0.005977554343935459,Hodgkin Lymphoma
Hodgkin Lymphoma,Centrosome Maturation R-HSA-380287,6.3822547105224325,0.026599000903585693,Hodgkin Lymphoma
Hodgkin Lymphoma,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,6.594368054246444,0.024638371411978662,Other Types
Hodgkin Lymphoma,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,13.091120319104187,0.003526411150129031,Other Types
Hodgkin Lymphoma,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,7.569063298017387,0.017563417455050065,Hodgkin Lymphoma
Hodgkin Lymphoma,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,4.95688277503777,0.04590664109138817,Hodgkin Lymphoma
Hodgkin Lymphoma,mRNA Capping R-HSA-72086,23.635908253359375,0.0003904403388593684,Other Types
Hodgkin Lymphoma,Glycolysis R-HSA-70171,12.013271451085778,0.0046651001386725085,Hodgkin Lymphoma
Hodgkin Lymphoma,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,6.091485013129675,0.029596650100066346,Other Types
Hodgkin Lymphoma,Signaling By FGFR1 R-HSA-5654736,7.413722959840498,0.018511085595713305,Hodgkin Lymphoma
Hodgkin Lymphoma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,7.627719405082909,0.01722058508706059,Hodgkin Lymphoma
Hodgkin Lymphoma,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,15.727235186621176,0.0018737696501843956,Other Types
Hodgkin Lymphoma,trans-Golgi Network Vesicle Budding R-HSA-199992,5.789399699220805,0.03314675719888994,Other Types
Hodgkin Lymphoma,Autophagy R-HSA-9612973,5.099808411027918,0.04334552928882517,Hodgkin Lymphoma
Hodgkin Lymphoma,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,19.426009950242715,0.0008540960545497221,Other Types
Hodgkin Lymphoma,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,9.06825325952683,0.010835630317518313,Hodgkin Lymphoma
Hodgkin Lymphoma,Signaling By FGFR3 R-HSA-5654741,5.844518863287609,0.0324626878186406,Hodgkin Lymphoma
Hodgkin Lymphoma,Signaling By FGFR4 R-HSA-5654743,5.844518863287609,0.0324626878186406,Hodgkin Lymphoma
Hodgkin Lymphoma,SARS-CoV-2 Infection R-HSA-9694516,5.368645718358035,0.03897622841383681,Hodgkin Lymphoma
Hodgkin Lymphoma,RHOC GTPase Cycle R-HSA-9013106,19.99026272644804,0.0007642617072885368,Other Types
Hodgkin Lymphoma,PKMTs Methylate Histone Lysines R-HSA-3214841,5.42697879425459,0.03809890979940844,Other Types
Hodgkin Lymphoma,HIV Transcription Initiation R-HSA-167161,10.894505814480361,0.006332737205507983,Other Types
Hodgkin Lymphoma,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,5.35556390886372,0.03917627737000724,Other Types
Hodgkin Lymphoma,Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,5.06154712439757,0.04401398636781999,Other Types
Hodgkin Lymphoma,Clathrin-mediated Endocytosis R-HSA-8856828,7.460611354662419,0.018218801285206265,Other Types
Hodgkin Lymphoma,mRNA 3-End Processing R-HSA-72187,7.052765050321234,0.02095707129580412,Other Types
Hodgkin Lymphoma,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,8.054819313463799,0.014949295315609575,Hodgkin Lymphoma
Hodgkin Lymphoma,Golgi Associated Vesicle Biogenesis R-HSA-432722,5.654860145000558,0.03488995938623007,Other Types
Hodgkin Lymphoma,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,7.304206364290704,0.019215664507725834,Hodgkin Lymphoma
Hodgkin Lymphoma,Interleukin-7 Signaling R-HSA-1266695,10.114877377540845,0.007915470503519166,Other Types
Hodgkin Lymphoma,Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658,4.787077002234845,0.04918924319218649,Other Types
Hodgkin Lymphoma,RHOB GTPase Cycle R-HSA-9013026,15.882202183476444,0.0018091058191118364,Other Types
Hodgkin Lymphoma,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,10.061823677655882,0.008039151204475367,Hodgkin Lymphoma
Hodgkin Lymphoma,PI-3K cascade:FGFR1 R-HSA-5654689,5.563383248975103,0.03613779421421119,Hodgkin Lymphoma
Hodgkin Lymphoma,Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,9.860484660368815,0.008529682597453049,Other Types
Hodgkin Lymphoma,RNA Polymerase II Transcription Termination R-HSA-73856,6.420783006143764,0.026229474043439983,Other Types
Hodgkin Lymphoma,tRNA Processing In Nucleus R-HSA-6784531,17.527864223750406,0.0012615410108133085,Hodgkin Lymphoma
Hodgkin Lymphoma,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,4.985764973597784,0.04537478154729492,Other Types
Hodgkin Lymphoma,E2F Mediated Regulation Of DNA Replication R-HSA-113510,6.148216617882497,0.02898145394407757,Hodgkin Lymphoma
Hodgkin Lymphoma,PTK6 Regulates Cell Cycle R-HSA-8849470,48.622308124222236,1.4897609342339795e-05,Hodgkin Lymphoma
Hodgkin Lymphoma,Macroautophagy R-HSA-1632852,4.757201997422953,0.049795535114910625,Hodgkin Lymphoma
Hodgkin Lymphoma,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,5.592170779374099,0.03573944622745517,Hodgkin Lymphoma
Hodgkin Lymphoma,Signaling By NOTCH2 R-HSA-1980145,6.347294640001741,0.02693966780646881,Other Types
Hodgkin Lymphoma,RNA Polymerase II Pre-transcription Events R-HSA-674695,8.934893610424725,0.011292538229551022,Other Types
Hodgkin Lymphoma,G1/S-Specific Transcription R-HSA-69205,16.13463391115421,0.001709281476517421,Other Types
Hodgkin Lymphoma,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,16.778822584677506,0.0014824167959592081,Other Types
Hodgkin Lymphoma,Signaling By Hippo R-HSA-2028269,8.13339665541182,0.014570995557130328,Other Types
Hodgkin Lymphoma,Formation Of Early Elongation Complex R-HSA-113418,5.233949088740174,0.041096007133590524,Other Types
Hodgkin Lymphoma,NoRC Negatively Regulates rRNA Expression R-HSA-427413,8.352245938169176,0.01357549248107823,Other Types
Hodgkin Lymphoma,Formation Of RNA Pol II Elongation Complex R-HSA-112382,12.628219230039761,0.003970128616347348,Other Types
Hodgkin Lymphoma,Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,5.9677432981089416,0.030993256874662825,Other Types
Hodgkin Lymphoma,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,7.528060039516103,0.01780787102426462,Other Types
Hodgkin Lymphoma,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,9.088117580709737,0.010769452854908192,Other Types
Hodgkin Lymphoma,Glycosaminoglycan Metabolism R-HSA-1630316,6.842341808130214,0.02255955607100404,Hodgkin Lymphoma
Hodgkin Lymphoma,Intrinsic Pathway For Apoptosis R-HSA-109606,17.567639869677112,0.00125093259888964,Other Types
Hodgkin Lymphoma,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,10.200494774785257,0.007720564727038071,Other Types
Hodgkin Lymphoma,Impaired BRCA2 Binding To PALB2 R-HSA-9709603,6.405616507298283,0.026374204317954793,Hodgkin Lymphoma
Hodgkin Lymphoma,Dual Incision In TC-NER R-HSA-6782135,16.380448307379716,0.0016182183471498484,Other Types
Hodgkin Lymphoma,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,6.012948516809095,0.03047414004647412,Other Types
Hodgkin Lymphoma,PPARA Activates Gene Expression R-HSA-1989781,9.758931557909307,0.008790428869471425,Other Types
Hodgkin Lymphoma,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,5.660865922875294,0.03480984767185518,Other Types
Hodgkin Lymphoma,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,20.279660344422627,0.0007224974969087816,Other Types
Hodgkin Lymphoma,SUMOylation Of Intracellular Receptors R-HSA-4090294,8.270184523302861,0.013939067886608996,Other Types
Hodgkin Lymphoma,Nephrin Family Interactions R-HSA-373753,8.723532248087327,0.012064096892277245,Other Types
Hodgkin Lymphoma,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,11.637888389639787,0.005159550911875895,Hodgkin Lymphoma
Hodgkin Lymphoma,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,4.765552701666107,0.049625164440507616,Hodgkin Lymphoma
Hodgkin Lymphoma,DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,5.473217509544762,0.03742020959414584,Other Types
Hodgkin Lymphoma,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,6.1910249082324365,0.028527294067021668,Hodgkin Lymphoma
Hodgkin Lymphoma,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,6.1910249082324365,0.028527294067021668,Hodgkin Lymphoma
Hodgkin Lymphoma,Adherens Junctions Interactions R-HSA-418990,6.500319276213035,0.02548574361696683,Hodgkin Lymphoma
Hodgkin Lymphoma,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,10.867474699118329,0.006380987043583522,Other Types
Hodgkin Lymphoma,Metabolism Of Carbohydrates R-HSA-71387,6.453684209318196,0.02591873580329306,Hodgkin Lymphoma
Hodgkin Lymphoma,tRNA Processing R-HSA-72306,13.015490390213515,0.0035947664257891046,Hodgkin Lymphoma
Hodgkin Lymphoma,Nucleotide Excision Repair R-HSA-5696398,10.152255191528564,0.007829677306031294,Other Types
Hodgkin Lymphoma,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,8.848458614738824,0.011600816783071576,Other Types
Hodgkin Lymphoma,Potential Therapeutics For SARS R-HSA-9679191,5.25791384893239,0.04070897056520772,Other Types
Hodgkin Lymphoma,MicroRNA (miRNA) Biogenesis R-HSA-203927,7.845624907121952,0.01601439377081492,Other Types
Hodgkin Lymphoma,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,7.285061305890875,0.019342071019769987,Hodgkin Lymphoma
Hodgkin Lymphoma,Transcription Of HIV Genome R-HSA-167172,15.612575915575903,0.001923359898063058,Other Types
Hodgkin Lymphoma,Iron Uptake And Transport R-HSA-917937,16.078834178809515,0.001730780368266181,Other Types
Hodgkin Lymphoma,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",5.295185815056807,0.04011564372550317,Hodgkin Lymphoma
Hodgkin Lymphoma,DNA Strand Elongation R-HSA-69190,5.655157325573761,0.03488599009525024,Other Types
Hodgkin Lymphoma,SUMOylation Of Transcription Cofactors R-HSA-3899300,7.914608520930993,0.015653547220199196,Other Types
Hodgkin Lymphoma,Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,9.786221297518583,0.008719449252219576,Hodgkin Lymphoma
Hodgkin Lymphoma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,14.328261837977276,0.002598533887817264,Other Types
Hodgkin Lymphoma,Late SARS-CoV-2 Infection Events R-HSA-9772573,13.501494284085002,0.0031810307600860024,Hodgkin Lymphoma
Hodgkin Lymphoma,Epigenetic Regulation Of Gene Expression R-HSA-212165,5.398533494599645,0.038523741488135116,Other Types
Hodgkin Lymphoma,Inositol Phosphate Metabolism R-HSA-1483249,9.264529901551116,0.010202167352929215,Other Types
Hodgkin Lymphoma,SUMOylation Of Transcription Factors R-HSA-3232118,15.05637368675537,0.0021868711500203663,Other Types
Hodgkin Lymphoma,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,10.24315564133698,0.007625558427940808,Other Types
Hodgkin Lymphoma,Meiosis R-HSA-1500620,7.481597181421892,0.018089754515837577,Hodgkin Lymphoma
Hodgkin Lymphoma,Reproduction R-HSA-1474165,7.481597759866975,0.01808975097377654,Hodgkin Lymphoma
Hodgkin Lymphoma,RHOBTB1 GTPase Cycle R-HSA-9013422,6.530647356676315,0.02520876383587447,Other Types
Hodgkin Lymphoma,HIV Elongation Arrest And Recovery R-HSA-167287,13.659453161243524,0.003058773274261935,Other Types
Hodgkin Lymphoma,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,13.592602229175974,0.003109830007738115,Other Types
Hodgkin Lymphoma,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,12.665802513847176,0.0039317502430071235,Other Types
Hodgkin Lymphoma,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,12.544020625255047,0.00405771536161776,Other Types
Hodgkin Lymphoma,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,4.935914490457933,0.04629745326984217,Hodgkin Lymphoma
Hodgkin Lymphoma,Telomere Maintenance R-HSA-157579,5.532961536107694,0.03656452730094752,Other Types
Hodgkin Lymphoma,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,7.467472885027831,0.018176488644933226,Other Types
Hodgkin Lymphoma,Aggrephagy R-HSA-9646399,12.257954859621146,0.004372708164369619,Hodgkin Lymphoma
Hodgkin Lymphoma,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,6.666327822042049,0.024012542307946135,Other Types
Hodgkin Lymphoma,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,16.77238042304253,0.0014845040951471365,Other Types
Hodgkin Lymphoma,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,7.037204228952675,0.02107085237156696,Other Types
Hodgkin Lymphoma,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,7.4419821019842995,0.018334270389226734,Other Types
Hodgkin Lymphoma,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,7.245803717949857,0.01960436421134966,Other Types
Hodgkin Lymphoma,HDACs Deacetylate Histones R-HSA-3214815,10.430208448472923,0.007224888055545989,Other Types
Hodgkin Lymphoma,E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,5.079598339837421,0.0436970896855735,Hodgkin Lymphoma
Hodgkin Lymphoma,Pre-NOTCH Transcription And Translation R-HSA-1912408,5.533201855547572,0.03656113278818952,Other Types
Hodgkin Lymphoma,Regulation Of Beta-Cell Development R-HSA-186712,20.379654550907787,0.0007086916216519888,Other Types
Hodgkin Lymphoma,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,5.272739746582454,0.04047171090482259,Hodgkin Lymphoma
Hodgkin Lymphoma,RND3 GTPase Cycle R-HSA-9696264,4.942493857273548,0.04617439747766273,Other Types
Hodgkin Lymphoma,Regulation Of Gene Expression In Beta Cells R-HSA-210745,22.29250764919815,0.0004957066930093737,Other Types
Hodgkin Lymphoma,Activation Of HOX Genes During Differentiation R-HSA-5619507,10.214757254292714,0.007688647876798853,Other Types
Hodgkin Lymphoma,Chromosome Maintenance R-HSA-73886,5.421046664398249,0.0381870426959044,Other Types
Hodgkin Lymphoma,Dual Incision In GG-NER R-HSA-5696400,14.097815471864644,0.0027472995729198577,Other Types
Hodgkin Lymphoma,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,8.566455376002615,0.012677938805247691,Other Types
Hodgkin Lymphoma,TBC/RABGAPs R-HSA-8854214,13.606784343900527,0.0030989155644731686,Other Types
Hodgkin Lymphoma,RND1 GTPase Cycle R-HSA-9696273,8.86690650796048,0.011534196099001501,Other Types
Hodgkin Lymphoma,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,6.427397664719812,0.026166647497920636,Other Types
Hodgkin Lymphoma,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,9.054346254700603,0.010882246428793515,Hodgkin Lymphoma
Hodgkin Lymphoma,RNA Polymerase I Promoter Clearance R-HSA-73854,8.204994979368784,0.014236104164342206,Other Types
Hodgkin Lymphoma,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,5.859564180047654,0.03227889519242376,Other Types
Hodgkin Lymphoma,RNA Polymerase I Transcription R-HSA-73864,8.204994979368784,0.014236104164342206,Other Types
Hodgkin Lymphoma,Signaling By NOTCH3 R-HSA-9012852,9.439060237435694,0.009675262444763369,Other Types
Leiomyosarcoma,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,4.239708193934956,0.04963628200660947,Leiomyosarcoma
Leiomyosarcoma,Complex I Biogenesis R-HSA-6799198,4.3007235237486805,0.04813865336300078,Leiomyosarcoma
Leiomyosarcoma,Translation R-HSA-72766,4.57652724746983,0.04197136789724293,Leiomyosarcoma
Leiomyosarcoma,tRNA Aminoacylation R-HSA-379724,10.488181494480406,0.00327388851994876,Leiomyosarcoma
Leiomyosarcoma,Mitochondrial tRNA Aminoacylation R-HSA-379726,6.399239441531346,0.017816820027729743,Leiomyosarcoma
Leiomyosarcoma,Cytoprotection By HMOX1 R-HSA-9707564,9.968489084794221,0.004004199760503323,Leiomyosarcoma
Leiomyosarcoma,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,4.6275495346042845,0.04093013851238011,Leiomyosarcoma
Leiomyosarcoma,"Platelet Activation, Signaling And Aggregation R-HSA-76002",8.150393692421243,0.00834589804290911,Other Types
Leiomyosarcoma,EPH-Ephrin Signaling R-HSA-2682334,4.232579646608571,0.04981463686611555,Other Types
Leiomyosarcoma,Mitochondrial Translation R-HSA-5368287,4.596403775418306,0.041562263817831326,Leiomyosarcoma
Leiomyosarcoma,Death Receptor Signaling R-HSA-73887,6.0948046905150495,0.0204494122610203,Other Types
Leiomyosarcoma,Platelet Aggregation (Plug Formation) R-HSA-76009,7.281998366267142,0.012072377409351498,Other Types
Leiomyosarcoma,Integrin Signaling R-HSA-354192,7.281998366267142,0.012072377409351498,Other Types
Leiomyosarcoma,EPHB-mediated Forward Signaling R-HSA-3928662,16.6215922974616,0.000382396583222226,Other Types
Leiomyosarcoma,Downstream Signal Transduction R-HSA-186763,4.281612730557519,0.048602209575469846,Other Types
Leiomyosarcoma,Mitochondrial Translation Termination R-HSA-5419276,8.545915428088675,0.007083524621350101,Leiomyosarcoma
Leiomyosarcoma,RHO GTPase Effectors R-HSA-195258,4.404276239359011,0.045711423315655766,Other Types
Leiomyosarcoma,Mitochondrial Translation Initiation R-HSA-5368286,7.667370619861372,0.010231871490199905,Leiomyosarcoma
Leiomyosarcoma,Metabolism Of Vitamins And Cofactors R-HSA-196854,9.751687431883465,0.004359759674635448,Leiomyosarcoma
Leiomyosarcoma,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,8.390866672680165,0.007551643227464654,Other Types
Leiomyosarcoma,Smooth Muscle Contraction R-HSA-445355,4.442333539632388,0.04485406406782591,Other Types
Leiomyosarcoma,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,8.358373995769034,0.007653965644410116,Leiomyosarcoma
Leiomyosarcoma,Metabolism R-HSA-1430728,22.74380421656682,6.183097807359379e-05,Leiomyosarcoma
Leiomyosarcoma,rRNA Modification In Mitochondrion R-HSA-6793080,5.12450276502259,0.0321656154775087,Leiomyosarcoma
Leiomyosarcoma,Prolonged ERK Activation Events R-HSA-169893,7.883431290047722,0.009336132198603223,Other Types
Leiomyosarcoma,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,5.2256863887156655,0.030649684438226136,Other Types
Leiomyosarcoma,Citric Acid Cycle (TCA Cycle) R-HSA-71403,8.069605862908553,0.008632866860682369,Leiomyosarcoma
Leiomyosarcoma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,4.473196524824411,0.04417198095631879,Other Types
Leiomyosarcoma,mTORC1-mediated Signaling R-HSA-166208,5.354057330575776,0.028839343480838466,Other Types
Leiomyosarcoma,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,6.3990514312669315,0.017818325916710617,Other Types
Leiomyosarcoma,MET Receptor Recycling R-HSA-8875656,6.533784791932844,0.016774224804731442,Other Types
Leiomyosarcoma,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,4.748672907277873,0.038571852997560926,Other Types
Leiomyosarcoma,Signaling By ERBB2 R-HSA-1227986,6.622223213272509,0.01612555094910724,Other Types
Leiomyosarcoma,Interleukin-12 Signaling R-HSA-9020591,5.3658551450894,0.028679008403171967,Other Types
Leiomyosarcoma,MET Activates PTK2 Signaling R-HSA-8874081,5.911829784364782,0.02223635147603133,Other Types
Leiomyosarcoma,Cilium Assembly R-HSA-5617833,5.656516323075486,0.025024543576666825,Other Types
Leiomyosarcoma,Platelet Degranulation R-HSA-114608,4.623373943878814,0.04101425868522568,Other Types
Leiomyosarcoma,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,5.915317291727537,0.022200723005867014,Other Types
Leiomyosarcoma,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,8.501223307643027,0.007215120332479362,Leiomyosarcoma
Leiomyosarcoma,TNF Signaling R-HSA-75893,4.5176725968316225,0.04320935360268033,Other Types
Leiomyosarcoma,Apoptotic Factor-Mediated Response R-HSA-111471,5.9600358652371925,0.02174941759140193,Leiomyosarcoma
Leiomyosarcoma,VxPx Cargo-Targeting To Cilium R-HSA-5620916,4.836506314604855,0.03695648210353072,Other Types
Leiomyosarcoma,Signal Amplification R-HSA-392518,6.789903086726544,0.014970040841276157,Other Types
Leiomyosarcoma,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,4.312265469975997,0.04786109052310487,Other Types
Leiomyosarcoma,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,6.528576737844946,0.016813309567846088,Leiomyosarcoma
Leiomyosarcoma,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,5.916279019694719,0.022190909055059427,Other Types
Leiomyosarcoma,Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,5.040569764934958,0.033486413008246355,Other Types
Leiomyosarcoma,RNA Polymerase III Chain Elongation R-HSA-73780,5.668639794607204,0.024883737509459755,Other Types
Leiomyosarcoma,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,6.801061611252813,0.014896439913975995,Leiomyosarcoma
Leiomyosarcoma,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,4.942885754117332,0.0351000681733468,Other Types
Leiomyosarcoma,Apoptotic Execution Phase R-HSA-75153,4.621867033175688,0.041044663827563506,Other Types
Leiomyosarcoma,Sema4D In Semaphorin Signaling R-HSA-400685,4.481564076687659,0.043989059697810674,Other Types
Leiomyosarcoma,RHO GTPases Activate CIT R-HSA-5625900,5.0837717531987785,0.032799198809890365,Other Types
Leiomyosarcoma,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,4.602717361328457,0.04143324932782246,Other Types
Leiomyosarcoma,SARS-CoV-1 Infection R-HSA-9678108,4.279197091909554,0.048661159371436155,Other Types
Leiomyosarcoma,AURKA Activation By TPX2 R-HSA-8854518,4.236767991455028,0.04970975834276699,Other Types
Leiomyosarcoma,RNA Polymerase III Transcription Termination R-HSA-73980,6.11388774462585,0.020272363123432457,Other Types
Leiomyosarcoma,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,4.759403915104126,0.038370338551155875,Other Types
Leiomyosarcoma,Mitochondrial Calcium Ion Transport R-HSA-8949215,6.385332347527064,0.01792858946525623,Leiomyosarcoma
Leiomyosarcoma,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,4.705085328879696,0.03940258942273719,Other Types
Leiomyosarcoma,RHO GTPases Activate PAKs R-HSA-5627123,6.435880737969546,0.017525993910374793,Other Types
Leiomyosarcoma,Regulation Of TP53 Expression And Degradation R-HSA-6806003,4.5426942441463245,0.04267811429130629,Other Types
Leiomyosarcoma,Integrin Cell Surface Interactions R-HSA-216083,4.531373370983727,0.04291756031167877,Other Types
Leiomyosarcoma,NF-kB Is Activated And Signals Survival R-HSA-209560,6.208859064182082,0.01941600108810949,Other Types
Leiomyosarcoma,Regulation Of TP53 Degradation R-HSA-6804757,5.93135776026557,0.02203766256695357,Other Types
Leiomyosarcoma,DNA Replication Initiation R-HSA-68952,4.943665439399552,0.03508685088216259,Other Types
Leiomyosarcoma,Signaling By TGF-beta Receptor Complex R-HSA-170834,4.67477139935901,0.03999210568327283,Other Types
Leiomyosarcoma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,4.8086153769960855,0.03746111617669174,Other Types
Leiomyosarcoma,Regulation Of TP53 Activity Thru Association With Co-factors R-HSA-6804759,4.689568388703205,0.03970312784290121,Other Types
Leiomyosarcoma,RHO GTPases Activate PKNs R-HSA-5625740,4.722125818534381,0.03907546214905407,Other Types
Leiomyosarcoma,Regulated Necrosis R-HSA-5218859,4.818646401386905,0.03727874506249966,Other Types
Leiomyosarcoma,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,4.422099799953342,0.04530762977427964,Other Types
Leiomyosarcoma,Transcriptional Regulation By TP53 R-HSA-3700989,8.361075107308658,0.007645402143407773,Leiomyosarcoma
Leiomyosarcoma,Diseases Of Glycosylation R-HSA-3781865,4.712678178871371,0.039256453283257664,Other Types
Leiomyosarcoma,HATs Acetylate Histones R-HSA-3214847,4.735728166125892,0.0388165101767114,Leiomyosarcoma
Leiomyosarcoma,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,5.4926512673524925,0.027016784424553828,Other Types
Leiomyosarcoma,Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,5.530501620479876,0.026541483776376416,Other Types
Leiomyosarcoma,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,7.2577605773132055,0.012199703038101396,Leiomyosarcoma
Leiomyosarcoma,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,4.748271824040327,0.0385794076604838,Other Types
Leiomyosarcoma,Mitophagy R-HSA-5205647,4.44653156120776,0.044760597656028675,Leiomyosarcoma
Leiomyosarcoma,Glycerophospholipid Biosynthesis R-HSA-1483206,4.434967463032908,0.045018593523713506,Leiomyosarcoma
Leiomyosarcoma,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,4.934830046686948,0.035236953983915145,Leiomyosarcoma
Leiomyosarcoma,RHO GTPases Activate ROCKs R-HSA-5627117,5.335547880194072,0.029092897318832307,Other Types
Leiomyosarcoma,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,5.500244923024179,0.026920677607426915,Other Types
Leiomyosarcoma,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,4.5591662303321385,0.042332379545589896,Other Types
Leiomyosarcoma,Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,4.670155709648089,0.04008272739456791,Other Types
Leiomyosarcoma,RUNX2 Regulates Bone Development R-HSA-8941326,5.277556598319469,0.029903438015465713,Other Types
Leiomyosarcoma,Detoxification Of Reactive Oxygen Species R-HSA-3299685,4.598170868426561,0.0415261091394215,Leiomyosarcoma
Leiomyosarcoma,SLC-mediated Transmembrane Transport R-HSA-425407,5.113532143025683,0.03233491849055629,Leiomyosarcoma
Leiomyosarcoma,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,4.243538841183687,0.049540735965555485,Other Types
Leiomyosarcoma,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,4.989402316129565,0.03432111794577234,Leiomyosarcoma
Leiomyosarcoma,Intrinsic Pathway For Apoptosis R-HSA-109606,4.322503359004754,0.047616388390078784,Leiomyosarcoma
Leiomyosarcoma,Downregulation Of ERBB2 Signaling R-HSA-8863795,6.172429778845228,0.019739679832490593,Other Types
Leiomyosarcoma,TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,5.223944836784137,0.030675095799540187,Other Types
Leiomyosarcoma,Meiotic Recombination R-HSA-912446,6.065486149855865,0.02072475565898322,Leiomyosarcoma
Leiomyosarcoma,SHC1 Events In ERBB2 Signaling R-HSA-1250196,4.4365907312931325,0.04498227810747299,Other Types
Leiomyosarcoma,Viral mRNA Translation R-HSA-192823,4.7094283071444565,0.03931892796643629,Leiomyosarcoma
Leiomyosarcoma,Nef Mediated CD4 Down-regulation R-HSA-167590,4.98621557306761,0.03437386410548286,Leiomyosarcoma
Leiomyosarcoma,Nef Mediated CD8 Down-regulation R-HSA-182218,4.98621557306761,0.03437386410548286,Leiomyosarcoma
Nerve Sheath Tumor,TP53 Regulates Metabolic Genes R-HSA-5628897,51.05024254113986,0.01903114748207979,Nerve Sheath Tumor
Nerve Sheath Tumor,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,29.768633223091594,0.03198924555495336,Nerve Sheath Tumor
Nerve Sheath Tumor,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,22.33707994879477,0.04197031761049939,Other Types
Nerve Sheath Tumor,RHO GTPase Effectors R-HSA-195258,46.85440108720832,0.020682875609554337,Other Types
Nerve Sheath Tumor,Cell-Cell Communication R-HSA-1500931,26.16968830030694,0.03615265766810822,Other Types
Nerve Sheath Tumor,Cell Junction Organization R-HSA-446728,27.948639061841344,0.03396739072809378,Other Types
Nerve Sheath Tumor,Drug ADME R-HSA-9748784,62.79918631397846,0.015553244250279208,Nerve Sheath Tumor
Nerve Sheath Tumor,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,91.05994669330131,0.010804126152966269,Other Types
Nerve Sheath Tumor,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,28.190721865004015,0.03369027621081558,Other Types
Nerve Sheath Tumor,Unfolded Protein Response (UPR) R-HSA-381119,72.37255411258916,0.013537451627189107,Other Types
Nerve Sheath Tumor,Interferon Signaling R-HSA-913531,292.6935123392771,0.0033991330586880526,Other Types
Nerve Sheath Tumor,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,24.506286021637415,0.03846674516208967,Other Types
Nerve Sheath Tumor,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,34.54486656835167,0.02774861720943873,Nerve Sheath Tumor
Nerve Sheath Tumor,PI3K/AKT Signaling In Cancer R-HSA-2219528,121.80251113358834,0.00811026881671728,Nerve Sheath Tumor
Nerve Sheath Tumor,Late Phase Of HIV Life Cycle R-HSA-162599,694.7103973562162,0.0014363481498438947,Nerve Sheath Tumor
Nerve Sheath Tumor,Cilium Assembly R-HSA-5617833,81.70729021534102,0.012018614324575983,Other Types
Nerve Sheath Tumor,Platelet Degranulation R-HSA-114608,519.2344496526753,0.001920366366206095,Other Types
Nerve Sheath Tumor,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,169.34704806419265,0.005853238914997718,Nerve Sheath Tumor
Nerve Sheath Tumor,G-protein Beta:Gamma Signaling R-HSA-397795,53.88823152249725,0.018055861661524595,Nerve Sheath Tumor
Nerve Sheath Tumor,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,34.12073919938228,0.028079145431080824,Other Types
Nerve Sheath Tumor,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,38.03850057720129,0.025295901596621668,Other Types
Nerve Sheath Tumor,MHC Class II Antigen Presentation R-HSA-2132295,548.4170670496625,0.0018184575227212804,Other Types
Nerve Sheath Tumor,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,51.10661792177874,0.019010749193307107,Other Types
Nerve Sheath Tumor,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,58.28983290856224,0.016726431311330194,Other Types
Nerve Sheath Tumor,Post NMDA Receptor Activation Events R-HSA-438064,168.47681243554868,0.005883206445806113,Other Types
Nerve Sheath Tumor,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,20.360719378347785,0.04576866572453859,Other Types
Nerve Sheath Tumor,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,20.360719378347785,0.04576866572453859,Other Types
Nerve Sheath Tumor,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,20.360719378347785,0.04576866572453859,Other Types
Nerve Sheath Tumor,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,315.0675164718447,0.0031588916947027346,Other Types
Nerve Sheath Tumor,Rab Regulation Of Trafficking R-HSA-9007101,97.21202747499036,0.010130739021143274,Nerve Sheath Tumor
Nerve Sheath Tumor,AURKA Activation By TPX2 R-HSA-8854518,29.73923497917334,0.032019365416975,Other Types
Nerve Sheath Tumor,Centrosome Maturation R-HSA-380287,54.831816057460095,0.017753368721726996,Other Types
Nerve Sheath Tumor,Mitotic Telophase/Cytokinesis R-HSA-68884,98.04116060092507,0.010046350209673212,Nerve Sheath Tumor
Nerve Sheath Tumor,Cohesin Loading Onto Chromatin R-HSA-2470946,755.7317539905164,0.0013206002403021936,Nerve Sheath Tumor
Nerve Sheath Tumor,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,54.32674118011168,0.017914012745858087,Other Types
Nerve Sheath Tumor,EPHA-mediated Growth Cone Collapse R-HSA-3928663,18.673512715761266,0.04960121354365042,Nerve Sheath Tumor
Nerve Sheath Tumor,"Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",198.17413245323337,0.005008191466518562,Other Types
Nerve Sheath Tumor,mRNA Capping R-HSA-72086,440.69424007387875,0.0022614525232669764,Nerve Sheath Tumor
Nerve Sheath Tumor,Glycolysis R-HSA-70171,233.9450026002715,0.004247295582550484,Other Types
Nerve Sheath Tumor,Growth Hormone Receptor Signaling R-HSA-982772,74.07823308953225,0.01323190582085514,Other Types
Nerve Sheath Tumor,G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,29.049246729849802,0.03274295091644955,Nerve Sheath Tumor
Nerve Sheath Tumor,Signaling By FGFR1 R-HSA-5654736,33.68303665558134,0.02842861375707996,Other Types
Nerve Sheath Tumor,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,264.740642436533,0.003756013824164238,Nerve Sheath Tumor
Nerve Sheath Tumor,Transcriptional Regulation By E2F6 R-HSA-8953750,322.7196552939914,0.0030843360839702253,Nerve Sheath Tumor
Nerve Sheath Tumor,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,45.521725066160215,0.021269196502620175,Nerve Sheath Tumor
Nerve Sheath Tumor,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,62.81762208389706,0.015548785579386173,Other Types
Nerve Sheath Tumor,Transcriptional Regulation By TP53 R-HSA-3700989,828.9772835281599,0.0012041272922609615,Nerve Sheath Tumor
Nerve Sheath Tumor,Diseases Of Glycosylation R-HSA-3781865,211.4815985404747,0.004695267249403957,Other Types
Nerve Sheath Tumor,SARS-CoV-2 Infection R-HSA-9694516,51.515467339386205,0.0188641138329691,Other Types
Nerve Sheath Tumor,PKMTs Methylate Histone Lysines R-HSA-3214841,73.25816352686981,0.013377068008954433,Nerve Sheath Tumor
Nerve Sheath Tumor,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,27.51474037126842,0.03447566105853161,Nerve Sheath Tumor
Nerve Sheath Tumor,Protein Folding R-HSA-391251,57.63009224364813,0.016913082409535755,Other Types
Nerve Sheath Tumor,HIV Transcription Initiation R-HSA-167161,27.11362727873632,0.03495925082309904,Nerve Sheath Tumor
Nerve Sheath Tumor,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,70.76690343913062,0.013838260120830715,Nerve Sheath Tumor
Nerve Sheath Tumor,Chaperonin-mediated Protein Folding R-HSA-390466,77.5770013457677,0.012646410717856516,Other Types
Nerve Sheath Tumor,RIPK1-mediated Regulated Necrosis R-HSA-5213460,69.40326492139314,0.014104429296226465,Nerve Sheath Tumor
Nerve Sheath Tumor,mRNA 3-End Processing R-HSA-72187,67.70703362675694,0.014450158159760007,Nerve Sheath Tumor
Nerve Sheath Tumor,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,54.84997118608236,0.01774764793530424,Other Types
Nerve Sheath Tumor,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,56.26285091221913,0.01731347358537741,Other Types
Nerve Sheath Tumor,SARS-CoV-2-host Interactions R-HSA-9705683,35.55236714741222,0.026993812698237543,Other Types
Nerve Sheath Tumor,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,170.37558465858496,0.00581821140898932,Other Types
Nerve Sheath Tumor,Glucose Metabolism R-HSA-70326,376.2141452659833,0.0026475094120318263,Other Types
Nerve Sheath Tumor,PI3K Events In ERBB2 Signaling R-HSA-1963642,51.04508468774801,0.019033015932887018,Other Types
Nerve Sheath Tumor,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,57.99352100119757,0.016809750437807847,Other Types
Nerve Sheath Tumor,PI-3K cascade:FGFR1 R-HSA-5654689,56.90956319259757,0.0171217497058244,Other Types
Nerve Sheath Tumor,MET Activates RAS Signaling R-HSA-8851805,127.08538061059676,0.007777051908327043,Other Types
Nerve Sheath Tumor,Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,31.42139269791984,0.030382503654575108,Nerve Sheath Tumor
Nerve Sheath Tumor,RNA Polymerase II Transcription Termination R-HSA-73856,139.9510092671128,0.007069674119534679,Nerve Sheath Tumor
Nerve Sheath Tumor,Interferon Gamma Signaling R-HSA-877300,292.4743260729016,0.003401667455531465,Other Types
Nerve Sheath Tumor,tRNA Processing In Nucleus R-HSA-6784531,27.8932974994074,0.03403138234708073,Other Types
Nerve Sheath Tumor,RHO GTPases Activate ROCKs R-HSA-5627117,24.931076838208483,0.037848061690556295,Nerve Sheath Tumor
Nerve Sheath Tumor,PTK6 Regulates Cell Cycle R-HSA-8849470,1536.1093125335842,0.000650360333815093,Other Types
Nerve Sheath Tumor,Extra-nuclear Estrogen Signaling R-HSA-9009391,38.36652777217913,0.0250876964421802,Other Types
Nerve Sheath Tumor,Metabolism Of Non-Coding RNA R-HSA-194441,95.4692482433247,0.010312823338428135,Other Types
Nerve Sheath Tumor,Signaling By NOTCH2 R-HSA-1980145,98.73210318945273,0.009977092952655187,Nerve Sheath Tumor
Nerve Sheath Tumor,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,76.6088556024406,0.012803173681526555,Other Types
Nerve Sheath Tumor,Regulation Of Necroptotic Cell Death R-HSA-5675482,111.86695240646888,0.008821085138446084,Nerve Sheath Tumor
Nerve Sheath Tumor,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,24.80203145104377,0.03803389319229279,Nerve Sheath Tumor
Nerve Sheath Tumor,Formation Of Early Elongation Complex R-HSA-113418,155.90370294476855,0.006353155002658206,Nerve Sheath Tumor
Nerve Sheath Tumor,NoRC Negatively Regulates rRNA Expression R-HSA-427413,231.76920748333436,0.004286912169256151,Nerve Sheath Tumor
Nerve Sheath Tumor,Formation Of RNA Pol II Elongation Complex R-HSA-112382,100.3720516007994,0.009816472662483668,Nerve Sheath Tumor
Nerve Sheath Tumor,Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,171.27958181199145,0.005787769529171311,Other Types
Nerve Sheath Tumor,Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,168.84233384605645,0.005870582013991652,Nerve Sheath Tumor
Nerve Sheath Tumor,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,122.58087184327694,0.008059391341245932,Nerve Sheath Tumor
Nerve Sheath Tumor,Intrinsic Pathway For Apoptosis R-HSA-109606,138.26448395455267,0.0071549854162522184,Nerve Sheath Tumor
Nerve Sheath Tumor,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,50.490243769070396,0.01923617458753146,Nerve Sheath Tumor
Nerve Sheath Tumor,Selective Autophagy R-HSA-9663891,502.5377588097814,0.001983980302156255,Other Types
Nerve Sheath Tumor,Downregulation Of ERBB2 Signaling R-HSA-8863795,95.80873932612218,0.010276842004819974,Nerve Sheath Tumor
Nerve Sheath Tumor,KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,93.73949553339995,0.010500136556673957,Other Types
Nerve Sheath Tumor,Dual Incision In TC-NER R-HSA-6782135,25.645191026612697,0.03685167968834766,Nerve Sheath Tumor
Nerve Sheath Tumor,Gene Expression (Transcription) R-HSA-74160,76.27434602955195,0.012858245065731121,Nerve Sheath Tumor
Nerve Sheath Tumor,Metabolism Of Lipids R-HSA-556833,54.78721841051647,0.017767437370154994,Nerve Sheath Tumor
Nerve Sheath Tumor,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,23.377573171021567,0.040213431136261225,Nerve Sheath Tumor
Nerve Sheath Tumor,SUMOylation Of Intracellular Receptors R-HSA-4090294,147.94958453421165,0.006691294820578175,Nerve Sheath Tumor
Nerve Sheath Tumor,Nephrin Family Interactions R-HSA-373753,36.45945368113961,0.026348531956064375,Nerve Sheath Tumor
Nerve Sheath Tumor,Circadian Clock R-HSA-400253,33.60780950913613,0.028489554315402062,Nerve Sheath Tumor
Nerve Sheath Tumor,Metabolism Of RNA R-HSA-8953854,65.56935200647484,0.014910774748626203,Other Types
Nerve Sheath Tumor,Adherens Junctions Interactions R-HSA-418990,20.84263535970967,0.04478042931752645,Other Types
Nerve Sheath Tumor,RNA Polymerase I Promoter Escape R-HSA-73772,61.990478342361236,0.015751377922576287,Nerve Sheath Tumor
Nerve Sheath Tumor,Metabolism Of Carbohydrates R-HSA-71387,66.93340526203558,0.014613532352712101,Other Types
Nerve Sheath Tumor,Nucleotide Excision Repair R-HSA-5696398,24.964603421277992,0.03780007872904706,Nerve Sheath Tumor
Nerve Sheath Tumor,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",29.81012770652624,0.03194682887015807,Other Types
Nerve Sheath Tumor,DNA Strand Elongation R-HSA-69190,23.895396427736028,0.039392798836834754,Nerve Sheath Tumor
Nerve Sheath Tumor,SUMOylation Of Transcription Cofactors R-HSA-3899300,339.4445470174117,0.0029330346021945813,Nerve Sheath Tumor
Nerve Sheath Tumor,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,21.499914530563533,0.04349944720953454,Nerve Sheath Tumor
Nerve Sheath Tumor,Late SARS-CoV-2 Infection Events R-HSA-9772573,80.38434291161161,0.012212805057576482,Other Types
Nerve Sheath Tumor,Activation Of BH3-only Proteins R-HSA-114452,168.30507930156563,0.005889156556805691,Nerve Sheath Tumor
Nerve Sheath Tumor,Peroxisomal Protein Import R-HSA-9033241,206.33152014029392,0.004811617608335645,Nerve Sheath Tumor
Nerve Sheath Tumor,HIV Elongation Arrest And Recovery R-HSA-167287,59.14625303671193,0.01649019513544626,Nerve Sheath Tumor
Nerve Sheath Tumor,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,202.91894511079397,0.004891943830872443,Nerve Sheath Tumor
Nerve Sheath Tumor,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,49.12142915049552,0.019756426663680413,Nerve Sheath Tumor
Nerve Sheath Tumor,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,62.186797855756566,0.015702817006245158,Nerve Sheath Tumor
Nerve Sheath Tumor,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,54.086430704895335,0.017991471032545427,Nerve Sheath Tumor
Nerve Sheath Tumor,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,18.57998697017699,0.04983253653028857,Nerve Sheath Tumor
Nerve Sheath Tumor,STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,123.17728129369767,0.008020836978806664,Nerve Sheath Tumor
Nerve Sheath Tumor,Aggrephagy R-HSA-9646399,99.1626759879701,0.009934414980565603,Other Types
Nerve Sheath Tumor,SHC-related Events Triggered By IGF1R R-HSA-2428933,71.71130963560456,0.013659733350497196,Other Types
Nerve Sheath Tumor,Pre-NOTCH Expression And Processing R-HSA-1912422,20611.713920719987,4.8512570840940136e-05,Nerve Sheath Tumor
Nerve Sheath Tumor,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,26.186966927194455,0.03613008070628384,Nerve Sheath Tumor
Nerve Sheath Tumor,DNA Damage Recognition In GG-NER R-HSA-5696394,70.03396030930277,0.013980062059342558,Nerve Sheath Tumor
Nerve Sheath Tumor,Sensory Perception R-HSA-9709957,313.1748549258354,0.0031778914429062524,Nerve Sheath Tumor
Nerve Sheath Tumor,G0 And Early G1 R-HSA-1538133,69.8135451619089,0.014023275773810615,Nerve Sheath Tumor
Nerve Sheath Tumor,E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,2454.0533068122627,0.0004072402088341409,Other Types
Nerve Sheath Tumor,Pre-NOTCH Transcription And Translation R-HSA-1912408,28013.124685669765,3.569564152790801e-05,Nerve Sheath Tumor
Nerve Sheath Tumor,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,71.59116894988172,0.013682188112575983,Other Types
Nerve Sheath Tumor,Activation Of HOX Genes During Differentiation R-HSA-5619507,33.12015873301126,0.028891020952670744,Nerve Sheath Tumor
Nerve Sheath Tumor,Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,77.06654689082617,0.012728582370096426,Other Types
Nerve Sheath Tumor,Metabolism Of Steroids R-HSA-8957322,19.906513022017062,0.04674087957634279,Nerve Sheath Tumor
Nerve Sheath Tumor,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,50.494979547803055,0.01923442219975383,Nerve Sheath Tumor
Nerve Sheath Tumor,Dual Incision In GG-NER R-HSA-5696400,37.29728053544706,0.02577934069859133,Nerve Sheath Tumor
Nerve Sheath Tumor,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,128.98182982779122,0.007664015304576884,Nerve Sheath Tumor
Nerve Sheath Tumor,RNA Polymerase I Promoter Clearance R-HSA-73854,91.1228245051614,0.010796791246602237,Nerve Sheath Tumor
Nerve Sheath Tumor,RNA Polymerase I Transcription R-HSA-73864,91.1228245051614,0.010796791246602237,Nerve Sheath Tumor
Nerve Sheath Tumor,Lagging Strand Synthesis R-HSA-69186,22.383053332957168,0.04188945409400823,Nerve Sheath Tumor
T-Lymphoblastic Leukemia/Lymphoma,Mitochondrial Biogenesis R-HSA-1592230,4.393105383074119,0.045246549459536364,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Cristae Formation R-HSA-8949613,10.090363735152058,0.0036131971039587924,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Golgi-to-ER Retrograde Transport R-HSA-8856688,10.041971750659853,0.0036834002827820698,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,10.255404915701812,0.003384455151079123,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,VEGFA-VEGFR2 Pathway R-HSA-4420097,4.997309452725667,0.03354080135507559,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Asparagine N-linked Glycosylation R-HSA-446203,4.636371010945239,0.04006095891506363,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Cytoprotection By HMOX1 R-HSA-9707564,5.185608579885163,0.030612764222913928,Other Types
T-Lymphoblastic Leukemia/Lymphoma,TP53 Regulates Metabolic Genes R-HSA-5628897,22.499962596069913,5.592938590610351e-05,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Signaling By MET R-HSA-6806834,7.109326538638644,0.012593252929762577,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Signaling By VEGF R-HSA-194138,5.01140694840466,0.03331118124395204,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,FCGR3A-mediated Phagocytosis R-HSA-9664422,6.781828694137406,0.01457247723480155,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Metabolism Of Nucleotides R-HSA-15869,13.248492064021159,0.0010937250005040068,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,10.024770572974946,0.003708709028255649,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,5.620436468314939,0.024871837524226517,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,7.664942646973775,0.00987373324964522,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,6.847425540636575,0.01415033215149462,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,RAC3 GTPase Cycle R-HSA-9013423,4.942970345320609,0.03444241162700446,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Mitochondrial Translation R-HSA-5368287,6.643124222851128,0.015511173321361961,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,4.563990863492388,0.041531235843958306,Other Types
T-Lymphoblastic Leukemia/Lymphoma,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,8.496152063723558,0.006927433479797144,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Transport Of Small Molecules R-HSA-382551,4.417047921691315,0.044704383082800815,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Platelet Aggregation (Plug Formation) R-HSA-76009,7.995718828420232,0.008563631109171119,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Integrin Signaling R-HSA-354192,7.995718828420232,0.008563631109171119,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,EPHB-mediated Forward Signaling R-HSA-3928662,11.716518208708552,0.0019250739701859774,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Protein Localization R-HSA-9609507,5.547416070295268,0.025746663756121748,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Mitochondrial Translation Termination R-HSA-5419276,17.050550696298632,0.00029687304547270103,Other Types
T-Lymphoblastic Leukemia/Lymphoma,RHO GTPase Effectors R-HSA-195258,5.369511533775494,0.028023408964327756,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Nucleotide Biosynthesis R-HSA-8956320,21.231266279880767,8.100477787480663e-05,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Mitochondrial Translation Initiation R-HSA-5368286,8.288179999500832,0.007561969626166632,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Metabolism Of Vitamins And Cofactors R-HSA-196854,9.72113785453076,0.004187907560210443,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,5.864420639466453,0.022177826180544417,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Mitochondrial Translation Elongation R-HSA-5389840,6.073054173301855,0.02012740749560759,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Cell-Cell Communication R-HSA-1500931,5.569148494119238,0.02548280641833393,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,8.98778991743647,0.005645757637343707,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,RHOJ GTPase Cycle R-HSA-9013409,5.430104882421573,0.027223955242352795,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Cell Junction Organization R-HSA-446728,14.224583809766255,0.0007726430934266704,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,XBP1(S) Activates Chaperone Genes R-HSA-381038,5.31460218077279,0.028770277339628936,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,IRE1alpha Activates Chaperones R-HSA-381070,5.31460218077279,0.028770277339628936,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,5.701303335382618,0.023941004827449992,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Metabolism R-HSA-1430728,9.383761207261797,0.004800336689732071,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Heme Biosynthesis R-HSA-189451,11.007986841246142,0.0025227375855659735,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Metabolism Of Porphyrins R-HSA-189445,11.007986239443031,0.0025227381712979824,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Drug ADME R-HSA-9748784,8.272877226410507,0.007611094280384606,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Prolonged ERK Activation Events R-HSA-169893,7.139785631450768,0.012424671469371288,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,24.733696755528516,2.9834047574463577e-05,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Citric Acid Cycle (TCA Cycle) R-HSA-71403,6.592998683453732,0.015866510592178758,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,6.691361614551411,0.015177426825721322,Other Types
T-Lymphoblastic Leukemia/Lymphoma,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,10.853897646015081,0.002677645241058174,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Ubiquinol Biosynthesis R-HSA-2142789,5.842148878777435,0.02240992356416479,Other Types
T-Lymphoblastic Leukemia/Lymphoma,DCC Mediated Attractive Signaling R-HSA-418885,4.90584528077323,0.03507382314382476,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Metabolism Of Cofactors R-HSA-8978934,7.01510578052156,0.013130743977554949,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Unfolded Protein Response (UPR) R-HSA-381119,4.810089473727283,0.036762425374533565,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Frs2-mediated Activation R-HSA-170968,8.104738693458664,0.008174307886522843,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,7.137441443124081,0.012437557919285112,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,5.629705163830326,0.024763154106675952,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Kinesins R-HSA-983189,13.494207476800867,0.0010012124500185552,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,5.408048833033608,0.027512008620851333,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,ERBB2 Regulates Cell Motility R-HSA-6785631,8.16509859117467,0.007967069944274313,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,4.4633517919287,0.043676264146749674,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Late Phase Of HIV Life Cycle R-HSA-162599,9.251326708651666,0.005066717569083625,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Cilium Assembly R-HSA-5617833,12.526935453890788,0.001422939504806942,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,8.954511968245013,0.005723839195021016,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,7.630862276597756,0.010020649633999143,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,4.972279134118629,0.03395282424634514,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,MAP2K And MAPK Activation R-HSA-5674135,5.762143904577148,0.02326595409525305,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,VxPx Cargo-Targeting To Cilium R-HSA-5620916,5.242297040199493,0.02978747539516117,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,10.834082788561599,0.002698300318755896,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,8.633941438630611,0.006539020426669807,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,GPER1 Signaling R-HSA-9634597,4.842777801836274,0.03617606178394853,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,HIV Life Cycle R-HSA-162587,8.755819146439395,0.006215130423501464,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,7.051226557739491,0.012921784876538948,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,9.141099360750749,0.005300668626558636,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Post NMDA Receptor Activation Events R-HSA-438064,10.257657167510985,0.0033814441534634134,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,MTOR Signaling R-HSA-165159,4.2767682560934395,0.04798746199064497,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Cell-cell Junction Organization R-HSA-421270,5.204465928635181,0.03033546272170134,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,10.07032751689443,0.003642086697308881,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Rab Regulation Of Trafficking R-HSA-9007101,5.263170774696701,0.029489803410753614,Other Types
T-Lymphoblastic Leukemia/Lymphoma,AURKA Activation By TPX2 R-HSA-8854518,5.384263314730081,0.027826420715164144,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,6.7274881692375015,0.014932617857439883,Other Types
T-Lymphoblastic Leukemia/Lymphoma,RNA Polymerase III Transcription Termination R-HSA-73980,5.007842601367911,0.033369072590324664,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,4.464076124256677,0.04366039182482836,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,mRNA Capping R-HSA-72086,6.349439522194695,0.01772477211519827,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Glycolysis R-HSA-70171,6.08420717698445,0.020023816179895796,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Regulation Of IFNA/IFNB Signaling R-HSA-912694,6.250418409159713,0.01854735969226133,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,7.88387905461644,0.008984089469481463,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Transcriptional Regulation By E2F6 R-HSA-8953750,7.624535708391478,0.010048183904978336,Other Types
T-Lymphoblastic Leukemia/Lymphoma,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,6.081833470626991,0.020045814526272868,Other Types
T-Lymphoblastic Leukemia/Lymphoma,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,6.105638444563394,0.01982639669936506,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,5.861191282040608,0.0222113154338539,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Transcriptional Regulation By TP53 R-HSA-3700989,10.768646008529506,0.00276774525948422,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Diseases Of Glycosylation R-HSA-3781865,6.687207642840996,0.01520585611540101,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,PKMTs Methylate Histone Lysines R-HSA-3214841,5.573663596249038,0.025428362195778296,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Protein Folding R-HSA-391251,4.553436674540031,0.04175059417703267,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,HIV Transcription Initiation R-HSA-167161,13.189497393408251,0.0011172828866676079,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Chaperonin-mediated Protein Folding R-HSA-390466,4.379592891273849,0.045555764655309014,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,6.515841511237224,0.016431006250333818,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Interleukin-7 Signaling R-HSA-1266695,12.272039573902603,0.001563621140422152,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,7.504539787013961,0.010586348122416845,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,PI3K Events In ERBB2 Signaling R-HSA-1963642,4.306835778370413,0.04726173990011927,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,6.5883135312006695,0.01590017582392155,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,7.493137396867626,0.010639097712722432,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Unwinding Of DNA R-HSA-176974,8.34902180476761,0.007370038716207309,Other Types
T-Lymphoblastic Leukemia/Lymphoma,tRNA Processing In Nucleus R-HSA-6784531,6.912717377896296,0.013743387395962217,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,PTK6 Regulates Cell Cycle R-HSA-8849470,14.721789956608244,0.0006495899891734996,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Extra-nuclear Estrogen Signaling R-HSA-9009391,9.660862045341183,0.0042907922946084625,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Detoxification Of Reactive Oxygen Species R-HSA-3299685,6.144430290370927,0.019474464770273356,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,SLC-mediated Transmembrane Transport R-HSA-425407,6.384890624054848,0.01744006135997225,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Amino Acid Transport Across Plasma Membrane R-HSA-352230,4.5606599095308455,0.04160032769290748,Other Types
T-Lymphoblastic Leukemia/Lymphoma,RNA Polymerase II Pre-transcription Events R-HSA-674695,12.32988187401628,0.0015304287972815005,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,4.6237503778471165,0.04031310615336989,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,RND2 GTPase Cycle R-HSA-9696270,4.326317076030202,0.046798071146354196,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,8.614653255211312,0.0065919381091905935,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Signaling By Hippo R-HSA-2028269,4.898481847746629,0.035200575736709386,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Formation Of Early Elongation Complex R-HSA-113418,5.817235210164744,0.022672721062456665,Other Types
T-Lymphoblastic Leukemia/Lymphoma,NoRC Negatively Regulates rRNA Expression R-HSA-427413,5.986988012321329,0.020946878922683588,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Formation Of RNA Pol II Elongation Complex R-HSA-112382,11.804172719747983,0.0018625010225291677,Other Types
T-Lymphoblastic Leukemia/Lymphoma,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,7.198578734739898,0.0121061936003041,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,6.436134279681439,0.01703733512748498,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Glycosaminoglycan Metabolism R-HSA-1630316,8.548665838670157,0.006776524008665084,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Intrinsic Pathway For Apoptosis R-HSA-109606,18.714090785187466,0.00017437570853805806,Other Types
T-Lymphoblastic Leukemia/Lymphoma,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,5.728557577675778,0.02363598052645849,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,5.313691913923757,0.02878284228298426,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Dual Incision In TC-NER R-HSA-6782135,8.26048476080553,0.007651130605715126,Other Types
T-Lymphoblastic Leukemia/Lymphoma,PPARA Activates Gene Expression R-HSA-1989781,4.324639354387673,0.04683780179699635,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Intra-Golgi Traffic R-HSA-6811438,4.641275933807362,0.03996343683896853,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,12.344011338995328,0.0015224368351520765,Other Types
T-Lymphoblastic Leukemia/Lymphoma,SUMOylation Of Intracellular Receptors R-HSA-4090294,8.939603908978649,0.005759198081721222,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Telomere Extension By Telomerase R-HSA-171319,4.431837663930593,0.044373094962885794,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,4.853639302946838,0.03598352880531049,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",19.653969233241455,0.00013028978334118425,Other Types
T-Lymphoblastic Leukemia/Lymphoma,DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,5.605354137312116,0.025049815008736605,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Adherens Junctions Interactions R-HSA-418990,8.915431816634982,0.005817034209298426,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,4.520903439327312,0.04243491430543628,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Metabolism Of Carbohydrates R-HSA-71387,4.774969369029219,0.03740418040334634,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,tRNA Processing R-HSA-72306,7.020115472958149,0.013101543706991412,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Nucleotide Excision Repair R-HSA-5696398,4.856863694598201,0.035926591467466566,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,5.04129326200586,0.03283012317793913,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Potential Therapeutics For SARS R-HSA-9679191,12.132308042323954,0.001647055243134962,Other Types
T-Lymphoblastic Leukemia/Lymphoma,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,6.625373019567893,0.01563600491003116,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Transcription Of HIV Genome R-HSA-167172,18.986019950307206,0.00016016913260948136,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Iron Uptake And Transport R-HSA-917937,11.562540654740353,0.0020405597559357987,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Basigin Interactions R-HSA-210991,9.357861628994545,0.004851212309931431,Other Types
T-Lymphoblastic Leukemia/Lymphoma,DNA Strand Elongation R-HSA-69190,7.925065860357257,0.0088266912942943,Other Types
T-Lymphoblastic Leukemia/Lymphoma,SUMOylation Of Transcription Cofactors R-HSA-3899300,11.046222350436294,0.002485818240838603,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,7.734078375758494,0.009582853276886556,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,12.952541697504993,0.0012175687895638289,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Late SARS-CoV-2 Infection Events R-HSA-9772573,7.465393516329588,0.010768646661375196,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Epigenetic Regulation Of Gene Expression R-HSA-212165,11.350169951863235,0.002212290771850948,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Inositol Phosphate Metabolism R-HSA-1483249,4.992925130069239,0.033612569906365485,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,6.615934711754332,0.015702825065992052,Other Types
T-Lymphoblastic Leukemia/Lymphoma,HIV Elongation Arrest And Recovery R-HSA-167287,7.872222578179212,0.009029188272047491,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,7.666035956916581,0.009869059134888489,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,10.776952839107143,0.0027588234649029097,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,10.61058993857001,0.0029435870465084925,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,7.908894489753351,0.008888130496962836,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Aggrephagy R-HSA-9646399,4.197309332344529,0.049965926323631615,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Leading Strand Synthesis R-HSA-69109,4.33213312019125,0.04666063031724405,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Pre-NOTCH Expression And Processing R-HSA-1912422,4.396094822212799,0.04517845656884159,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,4.412550701670281,0.04480566574486535,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,11.083874331946008,0.0024500325520458418,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,5.452575256081703,0.026933906075856395,Other Types
T-Lymphoblastic Leukemia/Lymphoma,FOXO-mediated Transcription R-HSA-9614085,6.0551157300639895,0.02029525927044038,Other Types
T-Lymphoblastic Leukemia/Lymphoma,HDACs Deacetylate Histones R-HSA-3214815,16.656005219084314,0.00033788778843674996,Other Types
T-Lymphoblastic Leukemia/Lymphoma,E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,4.407715636589093,0.044914842331319926,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,Pre-NOTCH Transcription And Translation R-HSA-1912408,5.364172596293488,0.028095081252285197,Other Types
T-Lymphoblastic Leukemia/Lymphoma,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",4.198230627182374,0.049942471075402055,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Regulation Of Beta-Cell Development R-HSA-186712,12.174293748169411,0.0016214913830658903,Other Types
T-Lymphoblastic Leukemia/Lymphoma,RND3 GTPase Cycle R-HSA-9696264,9.140967823559961,0.005300954710074585,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Regulation Of Gene Expression In Beta Cells R-HSA-210745,13.676941957163931,0.0009378935392905664,Other Types
T-Lymphoblastic Leukemia/Lymphoma,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,6.210062788473152,0.01889452815137791,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Dual Incision In GG-NER R-HSA-5696400,5.507155534640976,0.02624346243369168,Other Types
T-Lymphoblastic Leukemia/Lymphoma,TBC/RABGAPs R-HSA-8854214,5.3881129162931165,0.027775266585899353,Other Types
T-Lymphoblastic Leukemia/Lymphoma,RND1 GTPase Cycle R-HSA-9696273,5.017758999186058,0.03320828792611504,Other Types
T-Lymphoblastic Leukemia/Lymphoma,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,10.27531930832856,0.0033579322172767084,T-Lymphoblastic Leukemia/Lymphoma
T-Lymphoblastic Leukemia/Lymphoma,RNA Polymerase I Promoter Clearance R-HSA-73854,4.609858232594137,0.040592697726856336,Other Types
T-Lymphoblastic Leukemia/Lymphoma,RNA Polymerase I Transcription R-HSA-73864,4.609858232594137,0.040592697726856336,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Lagging Strand Synthesis R-HSA-69186,5.840345041992473,0.022428838157394597,Other Types
T-Lymphoblastic Leukemia/Lymphoma,Signaling By NOTCH3 R-HSA-9012852,7.705029817665365,0.009703918513255964,Other Types
